country,term,count
DZ,ASTHENIA,1
DZ,AUTOIMMUNE THYROIDITIS,1
DZ,DISCOMFORT,1
DZ,DRUG HYPERSENSITIVITY,1
DZ,DRUG-INDUCED LIVER INJURY,1
DZ,EXOPHTHALMOS,1
DZ,EXTRA DOSE ADMINISTERED,1
DZ,FATIGUE,1
DZ,GAIT DISTURBANCE,1
DZ,HEADACHE,1
DZ,HEMIPLEGIA,1
DZ,HYPERBILIRUBINAEMIA,1
DZ,HYPERTONIC BLADDER,1
DZ,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
DZ,INJECTION SITE PRURITUS,1
DZ,INJECTION SITE ULCER,1
DZ,MYASTHENIA GRAVIS,1
DZ,OTITIS MEDIA,1
DZ,PARALYSIS,1
DZ,PYREXIA,1
DZ,RENAL FAILURE,1
DZ,SEIZURE,1
DZ,THYROIDITIS ACUTE,1
DZ,WEIGHT INCREASED,1
AR,DEATH,25
AR,MULTIPLE SCLEROSIS RELAPSE,17
AR,PYREXIA,16
AR,HEADACHE,14
AR,URINARY TRACT INFECTION,13
AR,HYPERTENSION,12
AR,CENTRAL NERVOUS SYSTEM LESION,10
AR,FALL,9
AR,GAIT DISTURBANCE,9
AR,MATERNAL EXPOSURE DURING PREGNANCY,9
AR,PAIN,9
AR,PNEUMONIA,9
AR,CEREBROVASCULAR ACCIDENT,7
AR,FATIGUE,7
AR,HYPOAESTHESIA,7
AR,PAIN IN EXTREMITY,7
AR,AMNESIA,6
AR,ASTHENIA,6
AR,DEPRESSION,6
AR,DIPLOPIA,6
AR,MULTIPLE SCLEROSIS,6
AR,VOMITING,6
AR,ABORTION SPONTANEOUS,5
AR,ANAEMIA,5
AR,DYSPHAGIA,5
AR,GENERAL PHYSICAL HEALTH DETERIORATION,5
AR,INJECTION SITE PAIN,5
AR,SYNCOPE,5
AR,ABNORMAL BEHAVIOUR,4
AR,CELLULITIS,4
AR,CHILLS,4
AR,CHOLELITHIASIS,4
AR,CONVULSION,4
AR,DEPRESSED MOOD,4
AR,DRUG DOSE OMISSION,4
AR,DRUG-INDUCED LIVER INJURY,4
AR,FEELING ABNORMAL,4
AR,GASTRITIS,4
AR,INFLUENZA LIKE ILLNESS,4
AR,NEPHROLITHIASIS,4
AR,TREATMENT NONCOMPLIANCE,4
AR,UTERINE LEIOMYOMA,4
AR,VERTIGO,4
AR,ABDOMINAL PAIN,3
AR,APATHY,3
AR,AUTOIMMUNE HEPATITIS,3
AR,BALANCE DISORDER,3
AR,BEDRIDDEN,3
AR,BRONCHITIS,3
AR,CAESAREAN SECTION,3
AR,CARDIAC ARREST,3
AR,CARDIO-RESPIRATORY ARREST,3
AR,CATARACT,3
AR,DECREASED APPETITE,3
AR,EATING DISORDER,3
AR,ESCHAR,3
AR,GALLBLADDER DISORDER,3
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
AR,INJECTION SITE ERYTHEMA,3
AR,LIVER DISORDER,3
AR,LOSS OF CONSCIOUSNESS,3
AR,LUNG NEOPLASM MALIGNANT,3
AR,MEMORY IMPAIRMENT,3
AR,MIGRAINE,3
AR,MUSCULAR WEAKNESS,3
AR,MYALGIA,3
AR,PERITONITIS,3
AR,RESPIRATORY DISORDER,3
AR,SPEECH DISORDER,3
AR,THROMBOSIS,3
AR,TREMOR,3
AR,URINARY INCONTINENCE,3
AR,WEIGHT INCREASED,3
AR,ACTIVITIES OF DAILY LIVING IMPAIRED,2
AR,AFFECTIVE DISORDER,2
AR,ANGER,2
AR,ANKLE FRACTURE,2
AR,ANXIETY,2
AR,APPLICATION SITE PAIN,2
AR,ARRHYTHMIA,2
AR,ARTHROPATHY,2
AR,BONE MARROW DISORDER,2
AR,BRADYPHRENIA,2
AR,BRAIN NEOPLASM,2
AR,BRAIN NEOPLASM MALIGNANT,2
AR,CALCULUS BLADDER,2
AR,COGNITIVE DISORDER,2
AR,COMA,2
AR,CRYING,2
AR,DIABETES MELLITUS,2
AR,DIARRHOEA,2
AR,DIZZINESS,2
AR,ECTOPIC PREGNANCY,2
AR,ELECTROENCEPHALOGRAM ABNORMAL,2
AR,ENTEROCOLITIS,2
AR,EYE SWELLING,2
AR,FEMUR FRACTURE,2
AR,GASTRIC DISORDER,2
AR,GASTROINTESTINAL DISORDER,2
AR,GENERAL SYMPTOM,2
AR,HEAD INJURY,2
AR,HEPATITIS TOXIC,2
AR,HYPERSENSITIVITY,2
AR,HYPERTENSIVE CRISIS,2
AR,INFLAMMATION,2
AR,INJECTION SITE BRUISING,2
AR,INJECTION SITE PAPULE,2
AR,INJURY,2
AR,KIDNEY INFECTION,2
AR,LACK OF INJECTION SITE ROTATION,2
AR,LIGAMENT SPRAIN,2
AR,LOW BIRTH WEIGHT BABY,2
AR,LUNG DISORDER,2
AR,LYMPHOMA,2
AR,MALAISE,2
AR,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
AR,MENINGIOMA,2
AR,MUSCULOSKELETAL DISORDER,2
AR,MYOCARDIAL INFARCTION,2
AR,NAUSEA,2
AR,NEOPLASM MALIGNANT,2
AR,PERIPHERAL SWELLING,2
AR,PLATELET COUNT INCREASED,2
AR,PROCEDURAL HAEMORRHAGE,2
AR,PRODUCT DISTRIBUTION ISSUE,2
AR,RASH,2
AR,RED BLOOD CELL COUNT DECREASED,2
AR,RESPIRATORY FAILURE,2
AR,RETINAL DETACHMENT,2
AR,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,2
AR,SEIZURE,2
AR,STRESS,2
AR,SUDDEN DEATH,2
AR,SUICIDE ATTEMPT,2
AR,THYROID DISORDER,2
AR,THYROID NEOPLASM,2
AR,VARICOSE VEIN,2
AR,VIITH NERVE PARALYSIS,2
AR,VISION BLURRED,2
AR,WEIGHT DECREASED,2
AR,WHITE BLOOD CELL COUNT DECREASED,2
AR,ABDOMINAL DISCOMFORT,1
AR,ABDOMINAL HERNIA REPAIR,1
AR,ABDOMINAL MASS,1
AR,ABDOMINAL NEOPLASM,1
AR,ABDOMINAL PAIN UPPER,1
AR,ABORTION,1
AR,ABULIA,1
AR,ACUTE MYOCARDIAL INFARCTION,1
AR,ALOPECIA,1
AR,ANAEMIA POSTOPERATIVE,1
AR,ANTI-THYROID ANTIBODY POSITIVE,1
AR,APHASIA,1
AR,APPENDICITIS,1
AR,APPLICATION SITE ALOPECIA,1
AR,APPLICATION SITE DISCOLOURATION,1
AR,APPLICATION SITE INDURATION,1
AR,APPLICATION SITE PRURITUS,1
AR,APPLICATION SITE RASH,1
AR,ARTHRALGIA,1
AR,ARTHROPOD STING,1
AR,ASPIRATION,1
AR,ASPIRATION BRONCHIAL,1
AR,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
AR,BACK PAIN,1
AR,BACTERAEMIA,1
AR,BENIGN SALIVARY GLAND NEOPLASM,1
AR,BIPOLAR DISORDER,1
AR,BLADDER PROLAPSE,1
AR,BLINDNESS,1
AR,BLINDNESS UNILATERAL,1
AR,BLISTER INFECTED,1
AR,BLOOD GLUCOSE INCREASED,1
AR,BLOOD IRON DECREASED,1
AR,BLOOD PRESSURE ABNORMAL,1
AR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
AR,BLOOD URINE PRESENT,1
AR,BONE CYST,1
AR,BONE DISORDER,1
AR,BRAIN INJURY,1
AR,BRAIN OEDEMA,1
AR,BREAST CALCIFICATIONS,1
AR,BREAST CANCER,1
AR,BREAST CANCER FEMALE,1
AR,BREAST CANCER METASTATIC,1
AR,BREAST NEOPLASM,1
AR,BRONCHIAL DISORDER,1
AR,BRONCHOSPASM,1
AR,BURNING SENSATION,1
AR,CARDIAC DISORDER,1
AR,CARDIAC PACEMAKER INSERTION,1
AR,CAROTID BODY TUMOUR,1
AR,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
AR,CEREBRAL INFARCTION,1
AR,CEREBROVASCULAR DISORDER,1
AR,CHEST PAIN,1
AR,CHOLANGITIS,1
AR,CHOLECYSTECTOMY,1
AR,CHOLECYSTITIS,1
AR,CHOLECYSTITIS ACUTE,1
AR,CHRONIC GASTRITIS,1
AR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
AR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AR,COAGULATION TIME PROLONGED,1
AR,COELIAC DISEASE,1
AR,COMPLEX PARTIAL SEIZURES,1
AR,COMPLICATION OF PREGNANCY,1
AR,CONDITION AGGRAVATED,1
AR,CONFUSIONAL STATE,1
AR,CONGESTIVE CARDIOMYOPATHY,1
AR,CONJUNCTIVAL DISORDER,1
AR,CONNECTIVE TISSUE DISORDER,1
AR,CONSTIPATION,1
AR,COORDINATION ABNORMAL,1
AR,COUGH,1
AR,CROSS INFECTION,1
AR,DEEP VEIN THROMBOSIS,1
AR,DEFICIENCY ANAEMIA,1
AR,DEHYDRATION,1
AR,DELIRIUM,1
AR,DEMENTIA,1
AR,DENTAL CARE,1
AR,DESMOID TUMOUR,1
AR,DIABETIC RETINOPATHY,1
AR,DISCOMFORT,1
AR,DISEASE PROGRESSION,1
AR,DISORIENTATION,1
AR,DIVERTICULUM,1
AR,DUODENAL ULCER,1
AR,DYSPNOEA,1
AR,DYSSTASIA,1
AR,EAR DISCOMFORT,1
AR,EAR INFECTION VIRAL,1
AR,ENCEPHALITIS,1
AR,ENCEPHALOPATHY,1
AR,ENTERAL NUTRITION,1
AR,EPILEPSY,1
AR,EPISTAXIS,1
AR,ERYSIPELAS,1
AR,EXPOSURE VIA FATHER,1
AR,EYE HAEMORRHAGE,1
AR,EYE PAIN,1
AR,FACIAL PARALYSIS,1
AR,FAECAL INCONTINENCE,1
AR,FAECES DISCOLOURED,1
AR,FEAR,1
AR,FIBROMYALGIA,1
AR,FLUID INTAKE REDUCED,1
AR,FLUID RETENTION,1
AR,FOAMING AT MOUTH,1
AR,FOETAL EXPOSURE DURING PREGNANCY,1
AR,FRONTAL LOBE EPILEPSY,1
AR,FUNCTIONAL GASTROINTESTINAL DISORDER,1
AR,GALLBLADDER PAIN,1
AR,GASTROENTERITIS,1
AR,HAEMATOCRIT DECREASED,1
AR,HAEMORRHAGE,1
AR,HAEMORRHAGE IN PREGNANCY,1
AR,HAEMORRHAGIC ANAEMIA,1
AR,HAEMORRHAGIC STROKE,1
AR,HALLUCINATION_ VISUAL,1
AR,HEMIPARESIS,1
AR,HEMIPLEGIA,1
AR,HEPATIC ENCEPHALOPATHY,1
AR,HEPATIC ENZYME INCREASED,1
AR,HEPATIC STEATOSIS,1
AR,HEPATITIS VIRAL,1
AR,HIP ARTHROPLASTY,1
AR,HIP FRACTURE,1
AR,HOSPITALISATION,1
AR,HYPERAESTHESIA,1
AR,HYPERAMYLASAEMIA,1
AR,HYPERCHOLESTEROLAEMIA,1
AR,HYPERCOAGULATION,1
AR,HYPERHIDROSIS,1
AR,HYPERURICAEMIA,1
AR,HYPOKINESIA,1
AR,HYPOPHAGIA,1
AR,HYPORESPONSIVE TO STIMULI,1
AR,HYPOTHERMIA,1
AR,ILEUS,1
AR,ILEUS PARALYTIC,1
AR,IMPLANT SITE INFECTION,1
AR,INCISION SITE COMPLICATION,1
AR,INCONTINENCE,1
AR,INCORRECT DOSE ADMINISTERED,1
AR,INCORRECT DRUG ADMINISTRATION DURATION,1
AR,INFECTED SKIN ULCER,1
AR,INFECTION,1
AR,INFLUENZA,1
AR,INJECTION SITE DISCOLOURATION,1
AR,INJECTION SITE INDURATION,1
AR,INJECTION SITE NECROSIS,1
AR,INJECTION SITE REACTION,1
AR,INTERVERTEBRAL DISC PROTRUSION,1
AR,INTRACRANIAL ANEURYSM,1
AR,INVESTIGATION,1
AR,ISCHAEMIC STROKE,1
AR,JOINT CONTRACTURE,1
AR,LARGE INTESTINE POLYP,1
AR,LEUKAEMIA,1
AR,LIP SWELLING,1
AR,LIVE BIRTH,1
AR,LOCAL SWELLING,1
AR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
AR,LOWER LIMB FRACTURE,1
AR,LUNG INFECTION,1
AR,LUNG PERFORATION,1
AR,MACULOPATHY,1
AR,MENSTRUATION IRREGULAR,1
AR,MENTAL DISORDER,1
AR,MIDDLE EAR EFFUSION,1
AR,MOBILITY DECREASED,1
AR,MOOD ALTERED,1
AR,MOOD SWINGS,1
AR,MOTOR DYSFUNCTION,1
AR,MOUTH HAEMORRHAGE,1
AR,MUCOCUTANEOUS RASH,1
AR,MULTIPLE FRACTURES,1
AR,MUSCLE RIGIDITY,1
AR,MUSCLE RUPTURE,1
AR,MUSCLE SPASMS,1
AR,MUSCULOSKELETAL DISCOMFORT,1
AR,MUSCULOSKELETAL STIFFNESS,1
AR,NASOPHARYNGITIS,1
AR,NEURALGIA,1
AR,OPHTHALMIC HERPES SIMPLEX,1
AR,OPTIC NEURITIS,1
AR,ORGAN FAILURE,1
AR,OSTEOARTHRITIS,1
AR,OVERDOSE,1
AR,OVERWEIGHT,1
AR,PANCREATITIS,1
AR,PARAESTHESIA,1
AR,PARALYSIS,1
AR,PEMPHIGUS,1
AR,PERICARDITIS,1
AR,PERIPHERAL VASCULAR DISORDER,1
AR,PERIPHERAL VENOUS DISEASE,1
AR,PETIT MAL EPILEPSY,1
AR,PHARYNGITIS BACTERIAL,1
AR,PLACENTAL DISORDER,1
AR,PLANTAR FASCIITIS,1
AR,PNEUMONIA ASPIRATION,1
AR,PNEUMOTHORAX SPONTANEOUS,1
AR,POLYMYOSITIS,1
AR,POSTOPERATIVE WOUND INFECTION,1
AR,PRESCRIBED UNDERDOSE,1
AR,PRODUCT USE ISSUE,1
AR,PROLAPSE REPAIR,1
AR,PULMONARY INFARCTION,1
AR,PULMONARY OEDEMA,1
AR,PYELONEPHRITIS,1
AR,QUADRIPARESIS,1
AR,RAYNAUD^S PHENOMENON,1
AR,REFUSAL OF TREATMENT BY PATIENT,1
AR,RENAL DISORDER,1
AR,RENAL PAIN,1
AR,RESPIRATORY TRACT INFECTION,1
AR,SALIVARY HYPERSECRETION,1
AR,SCIATICA,1
AR,SEPSIS,1
AR,SINUSITIS,1
AR,SKIN DISCOLOURATION,1
AR,SKULL FRACTURE,1
AR,SOCIAL FEAR,1
AR,SOMNOLENCE,1
AR,SPINAL CORD DISORDER,1
AR,SPINAL FRACTURE,1
AR,SPINAL MENINGEAL CYST,1
AR,SPINAL OPERATION,1
AR,STOMATITIS,1
AR,SUPRAVENTRICULAR TACHYARRHYTHMIA,1
AR,SWELLING,1
AR,TACHYCARDIA,1
AR,THERMAL BURN,1
AR,THROMBOPHLEBITIS,1
AR,TINNITUS,1
AR,TOBACCO WITHDRAWAL SYMPTOMS,1
AR,TRAUMATIC FRACTURE,1
AR,TURBINECTOMY,1
AR,TYPE 1 DIABETES MELLITUS,1
AR,UHTHOFF^S PHENOMENON,1
AR,ULCER,1
AR,UPPER LIMB FRACTURE,1
AR,URINARY RETENTION,1
AR,URINARY TRACT INJURY,1
AR,UROSEPSIS,1
AR,UTERINE CYST,1
AR,UTERINE DISORDER,1
AR,UTERINE HAEMORRHAGE,1
AR,VARICOSE ULCERATION,1
AR,VASCULITIS,1
AR,VENTRICULAR FIBRILLATION,1
AR,VERTIGO POSITIONAL,1
AR,VIRAL INFECTION,1
AR,VIRAL SEPSIS,1
AR,VISUAL ACUITY REDUCED,1
AR,VOLVULUS,1
AR,WALKING DISABILITY,1
AR,WEIGHT GAIN POOR,1
AU,FATIGUE,19
AU,INFLUENZA LIKE ILLNESS,14
AU,BREAST CANCER,12
AU,PAIN,11
AU,HEADACHE,8
AU,MALAISE,8
AU,MULTIPLE SCLEROSIS RELAPSE,8
AU,FALL,6
AU,GAIT DISTURBANCE,6
AU,INJECTION SITE BRUISING,6
AU,MULTIPLE SCLEROSIS,6
AU,MUSCLE SPASMS,6
AU,WEIGHT DECREASED,6
AU,DEPRESSED MOOD,5
AU,HYPERTENSION,5
AU,MOBILITY DECREASED,5
AU,ANXIETY,4
AU,ARTHRALGIA,4
AU,DRUG DOSE OMISSION,4
AU,FEELING ABNORMAL,4
AU,INJECTION SITE PAIN,4
AU,MYALGIA,4
AU,PROCEDURAL PAIN,4
AU,PYREXIA,4
AU,ASTHENIA,3
AU,BURNING SENSATION,3
AU,CEREBROVASCULAR ACCIDENT,3
AU,CHILLS,3
AU,DECREASED APPETITE,3
AU,DEPRESSION,3
AU,DIZZINESS,3
AU,HEAD DISCOMFORT,3
AU,INJECTION SITE ERYTHEMA,3
AU,MIGRAINE,3
AU,NAUSEA,3
AU,PNEUMONIA,3
AU,PULMONARY HYPERTENSION,3
AU,SARCOIDOSIS,3
AU,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,3
AU,SPEECH DISORDER,3
AU,STRESS,3
AU,URINARY TRACT INFECTION,3
AU,VOMITING,3
AU,WEIGHT INCREASED,3
AU,ABORTION SPONTANEOUS,2
AU,BACK DISORDER,2
AU,BALANCE DISORDER,2
AU,BASAL CELL CARCINOMA,2
AU,BLOOD CHOLESTEROL INCREASED,2
AU,CYSTITIS,2
AU,DEEP VEIN THROMBOSIS,2
AU,DIARRHOEA,2
AU,DYSPNOEA,2
AU,EYE PAIN,2
AU,FEELING HOT,2
AU,FRUSTRATION,2
AU,GENERAL SYMPTOM,2
AU,HERNIA,2
AU,HYPOAESTHESIA,2
AU,HYPOPHAGIA,2
AU,INFECTION,2
AU,MALIGNANT MELANOMA,2
AU,MATERNAL EXPOSURE DURING PREGNANCY,2
AU,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,2
AU,MUSCULAR WEAKNESS,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,NECK PAIN,2
AU,NECROTISING FASCIITIS,2
AU,NEURALGIA,2
AU,OROPHARYNGEAL PAIN,2
AU,PARAESTHESIA,2
AU,POST PROCEDURAL COMPLICATION,2
AU,PYELONEPHRITIS,2
AU,RASH,2
AU,STILLBIRTH,2
AU,SUBCUTANEOUS ABSCESS,2
AU,TEARFULNESS,2
AU,UNDERDOSE,2
AU,UPPER LIMB FRACTURE,2
AU,VIRAL INFECTION,2
AU,ABASIA,1
AU,ABDOMINAL DISCOMFORT,1
AU,ABDOMINAL OPERATION,1
AU,ABNORMAL LOSS OF WEIGHT,1
AU,ABNORMAL SENSATION IN EYE,1
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,1
AU,ADVERSE EVENT,1
AU,AFFECT LABILITY,1
AU,AFFECTIVE DISORDER,1
AU,ALANINE AMINOTRANSFERASE INCREASED,1
AU,ANAPHYLACTIC SHOCK,1
AU,ASPARTATE AMINOTRANSFERASE INCREASED,1
AU,ATRIAL FIBRILLATION,1
AU,BACK PAIN,1
AU,BASEDOW^S DISEASE,1
AU,BENIGN LUNG NEOPLASM,1
AU,BENIGN NEOPLASM OF THYROID GLAND,1
AU,BLADDER NECK SUSPENSION,1
AU,BLINDNESS,1
AU,BLOOD GLUCOSE INCREASED,1
AU,BLOOD PRESSURE INCREASED,1
AU,BODY TEMPERATURE DECREASED,1
AU,BONE MARROW DISORDER,1
AU,BREAST CANCER FEMALE,1
AU,BREAST MASS,1
AU,CANDIDA INFECTION,1
AU,CELLULITIS,1
AU,CENTRAL NERVOUS SYSTEM LESION,1
AU,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
AU,CEREBRAL DISORDER,1
AU,CHEST PAIN,1
AU,CHOLECYSTITIS ACUTE,1
AU,CHOLELITHIASIS,1
AU,COELIAC DISEASE,1
AU,COGNITIVE DISORDER,1
AU,CONSTIPATION,1
AU,CYSTITIS HAEMORRHAGIC,1
AU,CYSTITIS INTERSTITIAL,1
AU,DEHYDRATION,1
AU,DEVICE BREAKAGE,1
AU,DEVICE FAILURE,1
AU,DEVICE ISSUE,1
AU,DIABETIC FOOT,1
AU,DIFFUSE LARGE B-CELL LYMPHOMA,1
AU,DIPLOPIA,1
AU,DISEASE PROGRESSION,1
AU,DRUG INEFFECTIVE,1
AU,DRUG INTOLERANCE,1
AU,DYSARTHRIA,1
AU,DYSKINESIA,1
AU,EMOTIONAL DISTRESS,1
AU,EPIDURAL BLOOD PATCH,1
AU,EPILEPSY,1
AU,ESCHERICHIA INFECTION,1
AU,EYE HAEMORRHAGE,1
AU,FAECALOMA,1
AU,FEAR OF INJECTION,1
AU,FEBRILE CONVULSION,1
AU,FINE MOTOR SKILL DYSFUNCTION,1
AU,FOETAL HYPOKINESIA,1
AU,FOOD CRAVING,1
AU,FOREARM FRACTURE,1
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
AU,GASTROINTESTINAL CARCINOMA,1
AU,GASTROINTESTINAL INFECTION,1
AU,GASTROINTESTINAL STOMA COMPLICATION,1
AU,GASTROINTESTINAL TRACT ADENOMA,1
AU,GASTROOESOPHAGEAL REFLUX DISEASE,1
AU,GENERAL PHYSICAL HEALTH DETERIORATION,1
AU,GOUT,1
AU,GROWTH RETARDATION,1
AU,HAEMOLYTIC ANAEMIA,1
AU,HEART RATE IRREGULAR,1
AU,HELICOBACTER INFECTION,1
AU,HEPATIC ENZYME INCREASED,1
AU,HEPATITIS,1
AU,HEPATITIS C,1
AU,HEPATOTOXICITY,1
AU,HIP FRACTURE,1
AU,HUMERUS FRACTURE,1
AU,HYPERCOAGULATION,1
AU,HYPERTHYROIDISM,1
AU,HYPOACUSIS,1
AU,HYPOTHYROIDISM,1
AU,HYSTERECTOMY,1
AU,IMPAIRED HEALING,1
AU,IMPAIRED WORK ABILITY,1
AU,INCORRECT DOSE ADMINISTERED,1
AU,INFLUENZA,1
AU,INJECTION SITE DERMATITIS,1
AU,INJECTION SITE HAEMORRHAGE,1
AU,INJECTION SITE INFECTION,1
AU,INJECTION SITE ULCER,1
AU,INSOMNIA,1
AU,INTENTIONAL PRODUCT USE ISSUE,1
AU,IRRITABLE BOWEL SYNDROME,1
AU,JOINT DESTRUCTION,1
AU,JOINT STIFFNESS,1
AU,KAPOSI^S SARCOMA,1
AU,LARGE INTESTINE POLYP,1
AU,LETHARGY,1
AU,LIGAMENT RUPTURE,1
AU,LIMB INJURY,1
AU,LIMB OPERATION,1
AU,LIVER FUNCTION TEST ABNORMAL,1
AU,LUNG TRANSPLANT,1
AU,MACROCYTOSIS,1
AU,MAMMOPLASTY,1
AU,MENINGIOMA,1
AU,MILIARIA,1
AU,MUSCLE ATROPHY,1
AU,MUSCLE INJURY,1
AU,MUSCLE SPASTICITY,1
AU,MUSCULOSKELETAL DISORDER,1
AU,MYOCARDIAL INFARCTION,1
AU,NASOPHARYNGITIS,1
AU,NEPHROPATHY,1
AU,NOCTURIA,1
AU,NORMAL PRESSURE HYDROCEPHALUS,1
AU,NOSOCOMIAL INFECTION,1
AU,OPTIC NEURITIS,1
AU,ORAL HERPES,1
AU,ORCHITIS,1
AU,ORGAN FAILURE,1
AU,ORTHOPAEDIC PROCEDURE,1
AU,PAIN IN EXTREMITY,1
AU,PERIORBITAL CONTUSION,1
AU,PLEUROPERICARDITIS,1
AU,PNEUMOTHORAX,1
AU,POOR PERIPHERAL CIRCULATION,1
AU,POST PROCEDURAL INFECTION,1
AU,POST PROCEDURAL SWELLING,1
AU,POSTPARTUM HAEMORRHAGE,1
AU,PRESYNCOPE,1
AU,PRODUCT COLOUR ISSUE,1
AU,PROSTATOMEGALY,1
AU,PRURITUS,1
AU,PSORIASIS,1
AU,PSYCHIATRIC SYMPTOM,1
AU,RADIATION ASSOCIATED PAIN,1
AU,RADIATION SKIN INJURY,1
AU,RENAL CANCER METASTATIC,1
AU,RENAL DISORDER,1
AU,RENAL FAILURE,1
AU,RENAL FAILURE ACUTE,1
AU,REPRODUCTIVE TRACT DISORDER,1
AU,RESTLESS LEGS SYNDROME,1
AU,RETINAL EXUDATES,1
AU,RETINAL VEIN THROMBOSIS,1
AU,RETINOPATHY,1
AU,RHEUMATOID ARTHRITIS,1
AU,SEBORRHOEIC DERMATITIS,1
AU,SEIZURE,1
AU,SENSATION OF HEAVINESS,1
AU,SENSORY DISTURBANCE,1
AU,SEPSIS,1
AU,SKIN CANCER,1
AU,SKIN INFECTION,1
AU,SOMNOLENCE,1
AU,STAPHYLOCOCCAL ABSCESS,1
AU,TACHYCARDIA,1
AU,TENDON RUPTURE,1
AU,THERMAL BURN,1
AU,THERMOHYPOAESTHESIA,1
AU,THROMBOSIS,1
AU,TRANSIENT ISCHAEMIC ATTACK,1
AU,TUBERCULOSIS,1
AU,TUBULOINTERSTITIAL NEPHRITIS,1
AU,TYPE 2 DIABETES MELLITUS,1
AU,UMBILICAL CORD THROMBOSIS,1
AU,UPPER RESPIRATORY TRACT INFECTION,1
AU,URINE ODOUR ABNORMAL,1
AU,UTERINE CANCER,1
AU,VASODILATION PROCEDURE,1
AU,VISION BLURRED,1
AU,VISUAL ACUITY REDUCED,1
AU,VISUAL IMPAIRMENT,1
AU,VITAMIN D DECREASED,1
AU,VOLVULUS,1
AU,WOUND INFECTION,1
AU,WRIST FRACTURE,1
AU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
AT,DEATH,9
AT,MULTIPLE SCLEROSIS RELAPSE,5
AT,INFLUENZA LIKE ILLNESS,4
AT,LOW BIRTH WEIGHT BABY,4
AT,EPILEPSY,3
AT,FOETAL EXPOSURE DURING PREGNANCY,3
AT,INJECTION SITE PAIN,3
AT,MATERNAL EXPOSURE DURING PREGNANCY,3
AT,MYOCARDIAL INFARCTION,3
AT,PAIN IN EXTREMITY,3
AT,PANNICULITIS,3
AT,BREAST CANCER,2
AT,CEREBROVASCULAR ACCIDENT,2
AT,DRUG INTOLERANCE,2
AT,GENERAL PHYSICAL HEALTH DETERIORATION,2
AT,HYPERTENSION,2
AT,INFLUENZA,2
AT,MUSCLE SPASMS,2
AT,PERIPHERAL SWELLING,2
AT,PLACENTA PRAEVIA,2
AT,PNEUMONIA,2
AT,ABDOMINAL DISTENSION,1
AT,ABDOMINAL SEPSIS,1
AT,ABSCESS,1
AT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
AT,ADRENAL ADENOMA,1
AT,AMMONIA INCREASED,1
AT,ANAEMIA,1
AT,ANAL FISTULA,1
AT,ANGINA PECTORIS,1
AT,ANGIOMYOLIPOMA,1
AT,ASTHENIA,1
AT,AUTOIMMUNE HEPATITIS,1
AT,BACK PAIN,1
AT,BALANCE DISORDER,1
AT,BLINDNESS,1
AT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AT,BLOOD IRON INCREASED,1
AT,BLOOD THYROID STIMULATING HORMONE INCREASED,1
AT,BONE CYST,1
AT,BREAST CYST,1
AT,BREECH PRESENTATION,1
AT,CAESAREAN SECTION,1
AT,CARDIAC DISORDER,1
AT,CATARACT,1
AT,CHILLS,1
AT,CIRCULATORY COLLAPSE,1
AT,CUTANEOUS LUPUS ERYTHEMATOSUS,1
AT,DEPRESSION,1
AT,DIPLOPIA,1
AT,DRUG HYPERSENSITIVITY,1
AT,DRUG INEFFECTIVE,1
AT,DRUG-INDUCED LIVER INJURY,1
AT,DYSAESTHESIA,1
AT,ERYTHEMA,1
AT,FALL,1
AT,FATIGUE,1
AT,FLATULENCE,1
AT,FOETAL EXPOSURE TIMING UNSPECIFIED,1
AT,GASTRITIS,1
AT,GASTROINTESTINAL PAIN,1
AT,HAEMOGLOBIN DECREASED,1
AT,HAEMORRHAGE IN PREGNANCY,1
AT,HELICOBACTER GASTRITIS,1
AT,HEMIPLEGIA,1
AT,HEPATIC NEOPLASM,1
AT,HORMONE LEVEL ABNORMAL,1
AT,HYPOAESTHESIA ORAL,1
AT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
AT,INFECTION,1
AT,INFLAMMATION,1
AT,INJECTION SITE BRUISING,1
AT,INJECTION SITE INDURATION,1
AT,INJECTION SITE NECROSIS,1
AT,LACK OF INJECTION SITE ROTATION,1
AT,LIMB DISCOMFORT,1
AT,LOCAL SWELLING,1
AT,LOWER LIMB FRACTURE,1
AT,LUNG DISORDER,1
AT,LYMPHOCYTE COUNT DECREASED,1
AT,MALIGNANT MELANOMA STAGE I,1
AT,METAPLASIA,1
AT,MOBILITY DECREASED,1
AT,MUSCULAR WEAKNESS,1
AT,MUSCULOSKELETAL STIFFNESS,1
AT,NECROSIS,1
AT,NEOPLASM MALIGNANT,1
AT,OBESITY,1
AT,OEDEMA PERIPHERAL,1
AT,ORAL DISCOMFORT,1
AT,OSTEONECROSIS,1
AT,PAIN,1
AT,PALPITATIONS,1
AT,PLATELET DISORDER,1
AT,PLEURAL NEOPLASM,1
AT,PORTAL VEIN THROMBOSIS,1
AT,POST PROCEDURAL COMPLICATION,1
AT,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
AT,PREMATURE SEPARATION OF PLACENTA,1
AT,PRURITUS,1
AT,PYREXIA,1
AT,RED CELL DISTRIBUTION WIDTH INCREASED,1
AT,RESPIRATION ABNORMAL,1
AT,ROSACEA,1
AT,SARCOIDOSIS,1
AT,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
AT,SENSORY DISTURBANCE,1
AT,SERUM FERRITIN INCREASED,1
AT,SINUSITIS,1
AT,SKIN MASS,1
AT,SKIN SWELLING,1
AT,SLOW RESPONSE TO STIMULI,1
AT,SOFT TISSUE DISORDER,1
AT,SPINAL OPERATION,1
AT,SWELLING FACE,1
AT,SYNCOPE,1
AT,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
AT,THYROID CANCER,1
AT,TOOTH DISORDER,1
AT,TREATMENT FAILURE,1
AT,TUBERCULIN TEST POSITIVE,1
AT,URINARY TRACT INFECTION,1
AT,UTERINE NEOPLASM,1
AT,VASCULITIS,1
AT,VISUAL ACUITY REDUCED,1
AT,VITAMIN B12 DEFICIENCY,1
AT,WEIGHT DECREASED,1
AT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
BH,NEUROMYELITIS OPTICA,1
BH,URINARY INCONTINENCE,1
BE,DEATH,32
BE,INFLUENZA LIKE ILLNESS,22
BE,FATIGUE,12
BE,PULMONARY HYPERTENSION,12
BE,MULTIPLE SCLEROSIS RELAPSE,11
BE,INJECTION SITE ERYTHEMA,9
BE,BREAST CANCER,8
BE,FALL,7
BE,MYOCARDIAL INFARCTION,7
BE,EPILEPSY,6
BE,GAIT DISTURBANCE,6
BE,HEADACHE,6
BE,PAIN,6
BE,DEPRESSION,5
BE,HYPERTENSION,5
BE,INJECTION SITE INDURATION,5
BE,ASTHENIA,4
BE,BALANCE DISORDER,4
BE,CHILLS,4
BE,MALAISE,4
BE,MULTIPLE SCLEROSIS,4
BE,MYALGIA,4
BE,NAUSEA,4
BE,PARAESTHESIA,4
BE,PYREXIA,4
BE,URTICARIA,4
BE,VISUAL IMPAIRMENT,4
BE,ABORTION SPONTANEOUS,3
BE,ANGIOEDEMA,3
BE,ANXIETY,3
BE,BACK PAIN,3
BE,CEREBROVASCULAR ACCIDENT,3
BE,CROHN^S DISEASE,3
BE,DRUG DOSE OMISSION,3
BE,INJECTION SITE ABSCESS,3
BE,INSOMNIA,3
BE,MATERNAL EXPOSURE DURING PREGNANCY,3
BE,MUSCULOSKELETAL STIFFNESS,3
BE,NECK PAIN,3
BE,PALPITATIONS,3
BE,PANCREATITIS,3
BE,POOR QUALITY SLEEP,3
BE,POST PROCEDURAL COMPLICATION,3
BE,RENAL IMPAIRMENT,3
BE,SYNCOPE,3
BE,THROMBOCYTOPENIA,3
BE,URINARY TRACT INFECTION,3
BE,ABDOMINAL PAIN,2
BE,ALCOHOL ABUSE,2
BE,ARTHRALGIA,2
BE,BENIGN BREAST NEOPLASM,2
BE,BLADDER DISORDER,2
BE,BRAIN NEOPLASM,2
BE,BREAST NEOPLASM,2
BE,CARDIAC OPERATION,2
BE,CARDIAC VALVE DISEASE,2
BE,CEREBRAL HAEMORRHAGE,2
BE,CHEST DISCOMFORT,2
BE,CHEST PAIN,2
BE,CYST,2
BE,DECREASED APPETITE,2
BE,DRUG ABUSE,2
BE,DRUG-INDUCED LIVER INJURY,2
BE,DYSPNOEA,2
BE,ERYTHEMA,2
BE,GASTRIC DISORDER,2
BE,GENERAL SYMPTOM,2
BE,GLIOBLASTOMA,2
BE,HIP FRACTURE,2
BE,HYPERGLYCAEMIA,2
BE,INFARCTION,2
BE,INFECTION,2
BE,INJECTION SITE HAEMATOMA,2
BE,INJECTION SITE PAIN,2
BE,KNEE ARTHROPLASTY,2
BE,LIVER FUNCTION TEST ABNORMAL,2
BE,LOSS OF CONTROL OF LEGS,2
BE,LUNG DISORDER,2
BE,LYMPHOPENIA,2
BE,MENISCUS OPERATION,2
BE,MUSCULAR WEAKNESS,2
BE,NASOPHARYNGITIS,2
BE,OPTIC NEURITIS,2
BE,PNEUMONIA,2
BE,POST PROCEDURAL HAEMORRHAGE,2
BE,RENAL FAILURE,2
BE,RETINAL DETACHMENT,2
BE,SKIN CANCER,2
BE,SOMNOLENCE,2
BE,SPEECH DISORDER,2
BE,SPINAL FRACTURE,2
BE,STRESS,2
BE,VOMITING,2
BE,WEIGHT DECREASED,2
BE,ABASIA,1
BE,ABDOMINAL DISCOMFORT,1
BE,ABDOMINAL PAIN LOWER,1
BE,ABDOMINAL PAIN UPPER,1
BE,ABORTION INDUCED,1
BE,ACUTE KIDNEY INJURY,1
BE,ACUTE LEUKAEMIA,1
BE,ADVERSE EVENT,1
BE,ALANINE AMINOTRANSFERASE INCREASED,1
BE,ALOPECIA,1
BE,ANAEMIA,1
BE,ANEURYSM,1
BE,ANGER,1
BE,ANTI-THYROID ANTIBODY POSITIVE,1
BE,APHASIA,1
BE,APPENDICITIS,1
BE,ARRHYTHMIA,1
BE,ARTHROPOD BITE,1
BE,ASPARTATE AMINOTRANSFERASE INCREASED,1
BE,ASTHMA,1
BE,ATAXIA,1
BE,BACTERAEMIA,1
BE,BILIARY CYST,1
BE,BLOOD CHOLESTEROL INCREASED,1
BE,BLOOD LACTATE DEHYDROGENASE INCREASED,1
BE,BLOOD PRESSURE SYSTOLIC DECREASED,1
BE,BLOOD THYROID STIMULATING HORMONE DECREASED,1
BE,BONE INFARCTION,1
BE,BONE MARROW TOXICITY,1
BE,BRAIN NEOPLASM BENIGN,1
BE,BREAST CANCER METASTATIC,1
BE,BREAST CYST,1
BE,BREAST PAIN,1
BE,BRONCHOSPASM,1
BE,BURNING SENSATION,1
BE,BURNS THIRD DEGREE,1
BE,BURSITIS,1
BE,CAESAREAN SECTION,1
BE,CARDIAC ARREST,1
BE,CARDIAC MYXOMA,1
BE,CARDIO-RESPIRATORY ARREST,1
BE,CATHETER SITE PAIN,1
BE,CELLULITIS,1
BE,CENTRAL NERVOUS SYSTEM LESION,1
BE,CEREBRAL THROMBOSIS,1
BE,CERVIX DISORDER,1
BE,CERVIX NEOPLASM,1
BE,CHOLELITHIASIS,1
BE,CHRONIC MYELOID LEUKAEMIA,1
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BE,COGNITIVE DISORDER,1
BE,COLON CANCER,1
BE,COMA,1
BE,CONFUSIONAL STATE,1
BE,COORDINATION ABNORMAL,1
BE,CORONARY ARTERIAL STENT INSERTION,1
BE,DEREALISATION,1
BE,DIABETES MELLITUS,1
BE,DIARRHOEA,1
BE,DIPLOPIA,1
BE,DISCOMFORT,1
BE,DIZZINESS,1
BE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
BE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
BE,DRY EYE,1
BE,DRY MOUTH,1
BE,DYSAESTHESIA,1
BE,DYSPHAGIA,1
BE,DYSPNOEA EXERTIONAL,1
BE,DYSURIA,1
BE,ENTEROCOCCAL INFECTION,1
BE,EXOMPHALOS,1
BE,EYE IRRITATION,1
BE,EYE PAIN,1
BE,FACE OEDEMA,1
BE,FEBRILE CONVULSION,1
BE,FEELING ABNORMAL,1
BE,FEELING COLD,1
BE,FEELING JITTERY,1
BE,FEMUR FRACTURE,1
BE,FOETAL DISORDER,1
BE,FOOT FRACTURE,1
BE,FRACTURED COCCYX,1
BE,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
BE,GASTRIC HAEMORRHAGE,1
BE,GASTRIC ULCER PERFORATION,1
BE,GASTRITIS,1
BE,GASTROINTESTINAL HYPERMOTILITY,1
BE,GENERAL PHYSICAL HEALTH DETERIORATION,1
BE,GENITAL PROLAPSE,1
BE,GESTATIONAL DIABETES,1
BE,GROIN PAIN,1
BE,HAEMANGIOMA,1
BE,HAEMATOCHEZIA,1
BE,HAEMATOMA,1
BE,HAEMATURIA,1
BE,HAEMORRHAGE,1
BE,HEAD INJURY,1
BE,HEPATIC CYST,1
BE,HEPATIC ENZYME ABNORMAL,1
BE,HEPATIC ENZYME INCREASED,1
BE,HEPATIC LESION,1
BE,HEPATIC NEOPLASM,1
BE,HIP ARTHROPLASTY,1
BE,HODGKIN^S DISEASE,1
BE,HYPERAESTHESIA,1
BE,HYPERHIDROSIS,1
BE,HYPERSENSITIVITY,1
BE,HYPERTONIC BLADDER,1
BE,HYPOAESTHESIA,1
BE,HYPOGLYCAEMIA,1
BE,HYPOKALAEMIA,1
BE,HYPOKINESIA,1
BE,HYPOTHYROIDISM,1
BE,HYPOVOLAEMIC SHOCK,1
BE,ILL-DEFINED DISORDER,1
BE,IMPAIRED HEALING,1
BE,INCOHERENT,1
BE,INJECTION SITE BRUISING,1
BE,INJECTION SITE INFECTION,1
BE,INJECTION SITE INJURY,1
BE,INJECTION SITE MASS,1
BE,INJECTION SITE NECROSIS,1
BE,INJECTION SITE PHLEBITIS,1
BE,INJECTION SITE WARMTH,1
BE,INTENTIONAL DRUG MISUSE,1
BE,INTERVERTEBRAL DISC DISORDER,1
BE,INTERVERTEBRAL DISC PROTRUSION,1
BE,INTESTINAL OBSTRUCTION,1
BE,INVASIVE DUCTAL BREAST CARCINOMA,1
BE,KARYOTYPE ANALYSIS ABNORMAL,1
BE,KLEBSIELLA INFECTION,1
BE,KNEE OPERATION,1
BE,LACK OF INJECTION SITE ROTATION,1
BE,LACK OF SPONTANEOUS SPEECH,1
BE,LARYNGEAL CANCER STAGE III,1
BE,LEG AMPUTATION,1
BE,LEUKOPENIA,1
BE,LOCALISED OEDEMA,1
BE,LOSS OF CONSCIOUSNESS,1
BE,LOW BIRTH WEIGHT BABY,1
BE,LOWER LIMB FRACTURE,1
BE,LUNG CANCER METASTATIC,1
BE,LUNG INFECTION,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LUNG OPERATION,1
BE,LYME DISEASE,1
BE,LYMPHADENOPATHY,1
BE,MASTECTOMY,1
BE,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
BE,MENINGIOMA,1
BE,MENINGITIS,1
BE,MENISCUS REMOVAL,1
BE,MENTAL DISORDER,1
BE,MENTAL IMPAIRMENT,1
BE,MIGRAINE WITH AURA,1
BE,MOBILITY DECREASED,1
BE,MOOD ALTERED,1
BE,MOOD SWINGS,1
BE,MOVEMENT DISORDER,1
BE,MULTI-ORGAN FAILURE,1
BE,MUSCLE RIGIDITY,1
BE,MUSCLE SPASTICITY,1
BE,MUSCLE TIGHTNESS,1
BE,MUSCULOSKELETAL PAIN,1
BE,NECROSIS,1
BE,NEOPLASM,1
BE,NEOPLASM MALIGNANT,1
BE,NIGHT SWEATS,1
BE,NO ADVERSE EVENT,1
BE,NYSTAGMUS,1
BE,OCULAR ICTERUS,1
BE,OEDEMA,1
BE,OESOPHAGEAL DISORDER,1
BE,ORAL DISORDER,1
BE,OSTEOARTHRITIS,1
BE,OSTEOPOROSIS,1
BE,OVARIAN NEOPLASM,1
BE,OVERDOSE,1
BE,PAIN IN EXTREMITY,1
BE,PANCREATIC DISORDER,1
BE,PANNICULITIS,1
BE,PERIARTHRITIS CALCAREA,1
BE,PERONEAL NERVE PALSY,1
BE,PLEURAL EFFUSION,1
BE,POOR PERIPHERAL CIRCULATION,1
BE,PORPHYRIA NON-ACUTE,1
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
BE,PRE-ECLAMPSIA,1
BE,PREGNANCY WITH CONTRACEPTIVE DEVICE,1
BE,PROCEDURAL ANXIETY,1
BE,PROCEDURAL PAIN,1
BE,PROSTATE CANCER,1
BE,PRURITUS GENERALISED,1
BE,PULMONARY PAIN,1
BE,PULMONARY SEPSIS,1
BE,PULMONARY TUBERCULOSIS,1
BE,PYELONEPHRITIS,1
BE,RASH GENERALISED,1
BE,RASH PAPULAR,1
BE,RECTAL CANCER,1
BE,RENAL COLIC,1
BE,RENAL FUNCTION TEST ABNORMAL,1
BE,RESTLESSNESS,1
BE,RHINORRHOEA,1
BE,ROTATOR CUFF SYNDROME,1
BE,SCHWANNOMA,1
BE,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
BE,SERUM SICKNESS,1
BE,SHOULDER ARTHROPLASTY,1
BE,SHOULDER OPERATION,1
BE,SKIN NECROSIS,1
BE,SKIN ULCER,1
BE,SNEEZING,1
BE,SOFT TISSUE NECROSIS,1
BE,STAPHYLOCOCCAL INFECTION,1
BE,STAPHYLOCOCCAL SKIN INFECTION,1
BE,STARING,1
BE,SUICIDAL IDEATION,1
BE,TEARFULNESS,1
BE,TENDON DISORDER,1
BE,TENDON RUPTURE,1
BE,THROAT CANCER,1
BE,THROMBOSIS,1
BE,THROMBOTIC MICROANGIOPATHY,1
BE,THYROID DISORDER,1
BE,THYROID FUNCTION TEST ABNORMAL,1
BE,THYROIDITIS,1
BE,THYROXINE FREE INCREASED,1
BE,TONSILLITIS,1
BE,TOOTH FRACTURE,1
BE,TOOTHACHE,1
BE,TREATMENT NONCOMPLIANCE,1
BE,TREMOR,1
BE,TRI-IODOTHYRONINE INCREASED,1
BE,TUBERCULOSIS,1
BE,TYPE 1 DIABETES MELLITUS,1
BE,ULCERATIVE KERATITIS,1
BE,UNDERDOSE,1
BE,UNDERWEIGHT,1
BE,URINARY BLADDER HAEMORRHAGE,1
BE,URINARY INCONTINENCE,1
BE,URINARY RETENTION,1
BE,UVEITIS,1
BE,VERTIGO,1
BE,VERTIGO POSITIONAL,1
BE,VESTIBULAR DISORDER,1
BE,VIITH NERVE PARALYSIS,1
BE,VIRAL PERICARDITIS,1
BE,WALKING DISTANCE TEST ABNORMAL,1
BE,WEIGHT INCREASED,1
BE,WOLFF-PARKINSON-WHITE SYNDROME,1
BE,WOUND,1
BE,WOUND INFECTION,1
BE,WRIST FRACTURE,1
BE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
BE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
BR,MULTIPLE SCLEROSIS RELAPSE,304
BR,HEADACHE,241
BR,PAIN,180
BR,PYREXIA,170
BR,FATIGUE,154
BR,MALAISE,142
BR,GAIT DISTURBANCE,117
BR,ASTHENIA,108
BR,MUSCULAR WEAKNESS,97
BR,URINARY TRACT INFECTION,95
BR,BALANCE DISORDER,93
BR,DIZZINESS,89
BR,HYPOAESTHESIA,89
BR,INJECTION SITE ERYTHEMA,84
BR,INJECTION SITE PAIN,83
BR,CENTRAL NERVOUS SYSTEM LESION,81
BR,INFLUENZA LIKE ILLNESS,77
BR,HYPERTENSION,75
BR,PAIN IN EXTREMITY,72
BR,NAUSEA,70
BR,MATERNAL EXPOSURE DURING PREGNANCY,68
BR,VISION BLURRED,68
BR,ARTHRALGIA,66
BR,FALL,66
BR,DEPRESSION,65
BR,TREMOR,65
BR,CHILLS,64
BR,MULTIPLE SCLEROSIS,63
BR,PNEUMONIA,60
BR,VOMITING,59
BR,LABYRINTHITIS,55
BR,PARAESTHESIA,55
BR,ANXIETY,54
BR,DRUG INEFFECTIVE,51
BR,INSOMNIA,48
BR,NERVOUSNESS,45
BR,SPEECH DISORDER,44
BR,DYSPNOEA,43
BR,INJECTION SITE NODULE,43
BR,URINARY INCONTINENCE,43
BR,SOMNOLENCE,42
BR,DIABETES MELLITUS,41
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,41
BR,MEMORY IMPAIRMENT,41
BR,MYALGIA,40
BR,BACK PAIN,38
BR,BLOOD PRESSURE INCREASED,38
BR,ANAEMIA,37
BR,INJECTION SITE BRUISING,37
BR,CEREBROVASCULAR ACCIDENT,34
BR,CHOLELITHIASIS,34
BR,INFLUENZA,33
BR,STRESS,33
BR,ALANINE AMINOTRANSFERASE INCREASED,32
BR,CAESAREAN SECTION,32
BR,CONSTIPATION,32
BR,DRUG DOSE OMISSION,32
BR,SYNCOPE,32
BR,DIARRHOEA,31
BR,ASPARTATE AMINOTRANSFERASE INCREASED,29
BR,MUSCULOSKELETAL STIFFNESS,27
BR,VISUAL IMPAIRMENT,27
BR,DECREASED APPETITE,26
BR,FEELING ABNORMAL,26
BR,NEPHROLITHIASIS,26
BR,ABDOMINAL PAIN,25
BR,INJECTION SITE HAEMATOMA,25
BR,DYSPHAGIA,24
BR,MOBILITY DECREASED,24
BR,DEATH,23
BR,DRUG-INDUCED LIVER INJURY,23
BR,EYE PAIN,23
BR,INJECTION SITE HAEMORRHAGE,23
BR,LACK OF INJECTION SITE ROTATION,22
BR,MOTOR DYSFUNCTION,22
BR,MUSCLE SPASMS,22
BR,SPINAL PAIN,22
BR,WEIGHT DECREASED,22
BR,ABASIA,21
BR,APATHY,21
BR,DECREASED IMMUNE RESPONSIVENESS,21
BR,DENGUE FEVER,21
BR,DIPLOPIA,21
BR,EMOTIONAL DISORDER,21
BR,INTERVERTEBRAL DISC PROTRUSION,21
BR,ALOPECIA,20
BR,CONVULSION,20
BR,HEPATIC STEATOSIS,20
BR,NECK PAIN,20
BR,OPTIC NEURITIS,20
BR,CRYING,19
BR,FEELING COLD,19
BR,LIMB DISCOMFORT,19
BR,SENSORY LOSS,19
BR,ABDOMINAL PAIN UPPER,18
BR,ABORTION SPONTANEOUS,18
BR,CONFUSIONAL STATE,18
BR,LOSS OF CONSCIOUSNESS,18
BR,MUSCULOSKELETAL DISORDER,18
BR,BREAST CANCER,17
BR,DEPRESSED MOOD,17
BR,DYSSTASIA,17
BR,SEIZURE,17
BR,WEIGHT INCREASED,17
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,17
BR,BLINDNESS,16
BR,BURNING SENSATION,16
BR,CHOKING,16
BR,DISEASE PROGRESSION,16
BR,GASTRITIS,16
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,16
BR,SENSATION OF HEAVINESS,16
BR,THROMBOSIS,16
BR,BLOOD CHOLESTEROL INCREASED,15
BR,DISCOMFORT,15
BR,HEMIPARESIS,15
BR,LIVER DISORDER,15
BR,SINUSITIS,15
BR,BEDRIDDEN,14
BR,COGNITIVE DISORDER,14
BR,GENERAL SYMPTOM,14
BR,HYPOTHYROIDISM,14
BR,IMMUNODEFICIENCY,14
BR,LIMB INJURY,14
BR,NASOPHARYNGITIS,14
BR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,14
BR,BLOOD GLUCOSE INCREASED,13
BR,CHEST PAIN,13
BR,COMA,13
BR,GENERAL PHYSICAL HEALTH DETERIORATION,13
BR,INFECTION,13
BR,INJECTION SITE INDURATION,13
BR,INJECTION SITE REACTION,13
BR,MENORRHAGIA,13
BR,MICTURITION URGENCY,13
BR,MIGRAINE,13
BR,PROLONGED LABOUR,13
BR,UTERINE LEIOMYOMA,13
BR,COUGH,12
BR,DRUG HYPERSENSITIVITY,12
BR,INFLAMMATION,12
BR,PRURITUS,12
BR,VIITH NERVE PARALYSIS,12
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,11
BR,AGITATION,11
BR,ARRHYTHMIA,11
BR,BIPOLAR DISORDER,11
BR,CATARACT,11
BR,GLAUCOMA,11
BR,HYPOTENSION,11
BR,INTENTIONAL PRODUCT MISUSE,11
BR,LIPODYSTROPHY ACQUIRED,11
BR,LUNG INFECTION,11
BR,OEDEMA PERIPHERAL,11
BR,PERIPHERAL SWELLING,11
BR,RENAL FAILURE,11
BR,ROAD TRAFFIC ACCIDENT,11
BR,AMNESIA,10
BR,BLOOD PRESSURE DECREASED,10
BR,BLOOD TRIGLYCERIDES INCREASED,10
BR,COORDINATION ABNORMAL,10
BR,EATING DISORDER,10
BR,FAECAL INCONTINENCE,10
BR,FEAR,10
BR,FEELING HOT,10
BR,FORMICATION,10
BR,INJECTION SITE PRURITUS,10
BR,MOVEMENT DISORDER,10
BR,MYOCARDIAL INFARCTION,10
BR,OROPHARYNGEAL PAIN,10
BR,PANIC DISORDER,10
BR,PARALYSIS,10
BR,TACHYCARDIA,10
BR,URINARY RETENTION,10
BR,WHITE BLOOD CELL COUNT DECREASED,10
BR,WOUND,10
BR,ABDOMINAL DISTENSION,9
BR,APHASIA,9
BR,BLOOD PRESSURE ABNORMAL,9
BR,DYSPHONIA,9
BR,ENDOMETRIOSIS,9
BR,EPILEPSY,9
BR,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,9
BR,FEMUR FRACTURE,9
BR,HAEMORRHAGE,9
BR,HYPERHIDROSIS,9
BR,INJECTION SITE DISCOLOURATION,9
BR,OSTEOPOROSIS,9
BR,SENSORY DISTURBANCE,9
BR,SPINAL DISORDER,9
BR,SWELLING,9
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,9
BR,ACUTE MYOCARDIAL INFARCTION,8
BR,BLINDNESS UNILATERAL,8
BR,CARDIAC ARREST,8
BR,CARDIO-RESPIRATORY ARREST,8
BR,CONTUSION,8
BR,DRY MOUTH,8
BR,EMOTIONAL DISTRESS,8
BR,EXPOSURE VIA FATHER,8
BR,FEAR OF INJECTION,8
BR,FEEDING DISORDER,8
BR,FOETAL EXPOSURE DURING PREGNANCY,8
BR,GASTROOESOPHAGEAL REFLUX DISEASE,8
BR,HAEMATOMA,8
BR,HEAD DISCOMFORT,8
BR,HEART RATE INCREASED,8
BR,HYPERSENSITIVITY,8
BR,HYPOACUSIS,8
BR,HYPOKINESIA,8
BR,HYSTERECTOMY,8
BR,INJURY,8
BR,ISCHAEMIC STROKE,8
BR,LOSS OF CONTROL OF LEGS,8
BR,MUSCLE SPASTICITY,8
BR,MUSCLE TWITCHING,8
BR,OSTEONECROSIS,8
BR,PHARYNGITIS,8
BR,PLATELET COUNT DECREASED,8
BR,SEPSIS,8
BR,SKIN DISCOLOURATION,8
BR,TREATMENT FAILURE,8
BR,TYPE 2 DIABETES MELLITUS,8
BR,VAGINAL HAEMORRHAGE,8
BR,VARICOSE VEIN,8
BR,BLOOD CHOLESTEROL ABNORMAL,7
BR,BREAST MASS,7
BR,DRY SKIN,7
BR,DYSURIA,7
BR,HEMIPLEGIA,7
BR,HEPATIC ENZYME ABNORMAL,7
BR,INJECTION SITE SWELLING,7
BR,IRRITABILITY,7
BR,LOW BIRTH WEIGHT BABY,7
BR,MENTAL DISORDER,7
BR,NEUROGENIC BLADDER,7
BR,NEUROMYELITIS OPTICA,7
BR,NORMAL NEWBORN,7
BR,OESOPHAGITIS,7
BR,PALLOR,7
BR,PALPITATIONS,7
BR,PYELONEPHRITIS,7
BR,RESPIRATORY FAILURE,7
BR,THYROID DISORDER,7
BR,THYROID NEOPLASM,7
BR,TINNITUS,7
BR,TUBERCULOSIS,7
BR,UPPER LIMB FRACTURE,7
BR,VERTIGO,7
BR,VITAMIN D DECREASED,7
BR,ABORTION,6
BR,ANKLE FRACTURE,6
BR,BLOOD ALKALINE PHOSPHATASE INCREASED,6
BR,BLOOD PRESSURE FLUCTUATION,6
BR,BRAIN INJURY,6
BR,DELIRIUM,6
BR,DISTURBANCE IN ATTENTION,6
BR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,6
BR,DYSARTHRIA,6
BR,ERYSIPELAS,6
BR,ERYTHEMA,6
BR,FACIAL PAIN,6
BR,FIBROMYALGIA,6
BR,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,6
BR,GASTRIC DISORDER,6
BR,HEAD INJURY,6
BR,HYPERTENSIVE CRISIS,6
BR,IMMUNE SYSTEM DISORDER,6
BR,INJECTION SITE MASS,6
BR,MOOD ALTERED,6
BR,MULTI-ORGAN FAILURE,6
BR,MUSCULOSKELETAL PAIN,6
BR,NODULE,6
BR,OBESITY SURGERY,6
BR,OSTEOARTHRITIS,6
BR,RENAL DISORDER,6
BR,RHEUMATOID ARTHRITIS,6
BR,RHINITIS,6
BR,SEPTIC SHOCK,6
BR,SUICIDAL IDEATION,6
BR,ANGIOPATHY,5
BR,APPENDICITIS,5
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,5
BR,BLOOD GLUCOSE ABNORMAL,5
BR,CARDIAC DISORDER,5
BR,CARDIAC FAILURE,5
BR,COLITIS,5
BR,CYST,5
BR,DEAFNESS,5
BR,DEMYELINATION,5
BR,DRUG INTOLERANCE,5
BR,DYSPEPSIA,5
BR,EAR INFECTION,5
BR,EAR PAIN,5
BR,ESCHAR,5
BR,EYE DISORDER,5
BR,FLATULENCE,5
BR,HERPES ZOSTER,5
BR,INFARCTION,5
BR,INTRACRANIAL ANEURYSM,5
BR,LEIOMYOMA,5
BR,LIVER INJURY,5
BR,LUNG DISORDER,5
BR,MONOPLEGIA,5
BR,OPTIC NERVE DISORDER,5
BR,ORAL DISCOMFORT,5
BR,PARKINSON^S DISEASE,5
BR,THYROID CANCER,5
BR,THYROID FUNCTION TEST ABNORMAL,5
BR,TONSILLITIS,5
BR,TOOTH DISORDER,5
BR,UNRESPONSIVE TO STIMULI,5
BR,VISUAL ACUITY REDUCED,5
BR,VITAMIN D DEFICIENCY,5
BR,AGGRESSION,4
BR,ALANINE AMINOTRANSFERASE ABNORMAL,4
BR,ANGINA PECTORIS,4
BR,ARTHRITIS,4
BR,ARTHROPATHY,4
BR,ASTHMA,4
BR,ATROPHY,4
BR,BLINDNESS TRANSIENT,4
BR,BLOOD CREATININE INCREASED,4
BR,BONE PAIN,4
BR,BREAST PAIN,4
BR,BRONCHITIS,4
BR,CARDIOMEGALY,4
BR,CENTRAL NERVOUS SYSTEM INFLAMMATION,4
BR,CHEST DISCOMFORT,4
BR,CONDITION AGGRAVATED,4
BR,CYANOSIS,4
BR,CYSTITIS,4
BR,DIPLEGIA,4
BR,EMPHYSEMA,4
BR,EYE HAEMORRHAGE,4
BR,FOETAL EXPOSURE TIMING UNSPECIFIED,4
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,4
BR,GALLBLADDER DISORDER,4
BR,GASTROENTERITIS,4
BR,GESTATIONAL HYPERTENSION,4
BR,HELICOBACTER INFECTION,4
BR,HEPATOMEGALY,4
BR,HIATUS HERNIA,4
BR,HYPOAESTHESIA ORAL,4
BR,ILL-DEFINED DISORDER,4
BR,INCORRECT DOSE ADMINISTERED,4
BR,INDURATION,4
BR,INGUINAL HERNIA,4
BR,INJECTION SITE FIBROSIS,4
BR,INVASIVE DUCTAL BREAST CARCINOMA,4
BR,LOCAL SWELLING,4
BR,MATERNAL EXPOSURE TIMING UNSPECIFIED,4
BR,MUSCLE ATROPHY,4
BR,MUSCLE DISORDER,4
BR,MYOPIA,4
BR,NERVOUS SYSTEM DISORDER,4
BR,NEURALGIA,4
BR,NOSOCOMIAL INFECTION,4
BR,OBESITY,4
BR,OCULAR DISCOMFORT,4
BR,OSTEOPENIA,4
BR,OVARIAN CYST,4
BR,OVERWEIGHT,4
BR,PERIPHERAL COLDNESS,4
BR,PETIT MAL EPILEPSY,4
BR,PREMATURE BABY,4
BR,PULMONARY EMBOLISM,4
BR,RENAL ATROPHY,4
BR,RENAL PAIN,4
BR,RETCHING,4
BR,RHINORRHOEA,4
BR,SERUM FERRITIN INCREASED,4
BR,SKIN EXFOLIATION,4
BR,SLEEP DISORDER,4
BR,TENSION,4
BR,THYROID MASS,4
BR,TOOTHACHE,4
BR,TRIGEMINAL NEURALGIA,4
BR,URINARY TRACT INFECTION BACTERIAL,4
BR,VENOUS OCCLUSION,4
BR,VIRAL INFECTION,4
BR,VITAMIN B12 DEFICIENCY,4
BR,ACNE,3
BR,ANAPHYLACTIC SHOCK,3
BR,APPENDICECTOMY,3
BR,ASTHENOPIA,3
BR,ASTIGMATISM,3
BR,ATAXIA,3
BR,AUTOIMMUNE THYROIDITIS,3
BR,BACTERIAL INFECTION,3
BR,BENIGN HYDATIDIFORM MOLE,3
BR,BILIRUBIN CONJUGATED INCREASED,3
BR,BLADDER OPERATION,3
BR,BLOOD BILIRUBIN INCREASED,3
BR,BLOOD TEST ABNORMAL,3
BR,BLOOD TRIGLYCERIDES ABNORMAL,3
BR,BODY TEMPERATURE INCREASED,3
BR,BONE LOSS,3
BR,BRONCHOPNEUMONIA,3
BR,CANDIDA INFECTION,3
BR,CHOLECYSTECTOMY,3
BR,CHROMATURIA,3
BR,CHRONIC KIDNEY DISEASE,3
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
BR,CHRONIC SINUSITIS,3
BR,COLITIS ULCERATIVE,3
BR,CROHN^S DISEASE,3
BR,DEAFNESS UNILATERAL,3
BR,DEEP VEIN THROMBOSIS,3
BR,DEHYDRATION,3
BR,DERMATITIS ALLERGIC,3
BR,DEVICE ISSUE,3
BR,DYSGEUSIA,3
BR,EAR DISCOMFORT,3
BR,ENCEPHALITIS,3
BR,EPISTAXIS,3
BR,ESCHERICHIA URINARY TRACT INFECTION,3
BR,EYE PRURITUS,3
BR,FEELING OF BODY TEMPERATURE CHANGE,3
BR,FEMALE STERILISATION,3
BR,FLUID INTAKE REDUCED,3
BR,FOOT FRACTURE,3
BR,GAIT INABILITY,3
BR,GASTRITIS EROSIVE,3
BR,GASTROINTESTINAL CARCINOMA,3
BR,GASTROINTESTINAL DISORDER,3
BR,GASTROINTESTINAL HYPERMOTILITY,3
BR,GASTROINTESTINAL MOTILITY DISORDER,3
BR,GENERALISED TONIC-CLONIC SEIZURE,3
BR,GINGIVITIS,3
BR,HAEMATOCHEZIA,3
BR,HAEMORRHAGE IN PREGNANCY,3
BR,HAEMORRHAGIC OVARIAN CYST,3
BR,HAEMORRHOIDS,3
BR,HEPATIC NEOPLASM,3
BR,HEPATITIS C,3
BR,HYPERCHOLESTEROLAEMIA,3
BR,HYPERGLYCAEMIA,3
BR,HYPERTONIC BLADDER,3
BR,HYPOTHERMIA,3
BR,IMMUNOSUPPRESSION,3
BR,INJECTION SITE ATROPHY,3
BR,INJECTION SITE INFECTION,3
BR,INJECTION SITE NECROSIS,3
BR,INJECTION SITE OEDEMA,3
BR,INTENTIONAL PRODUCT USE ISSUE,3
BR,INTESTINAL POLYP,3
BR,IRON DEFICIENCY ANAEMIA,3
BR,IRRITABLE BOWEL SYNDROME,3
BR,JOINT DISLOCATION,3
BR,JOINT STIFFNESS,3
BR,JOINT SWELLING,3
BR,KIDNEY INFECTION,3
BR,LACERATION,3
BR,LACRIMATION INCREASED,3
BR,LACTOSE INTOLERANCE,3
BR,LEIOMYOSARCOMA,3
BR,LIGAMENT SPRAIN,3
BR,LIMB DEFORMITY,3
BR,LOWER LIMB FRACTURE,3
BR,LYMPHADENITIS BACTERIAL,3
BR,MAMMOPLASTY,3
BR,MUSCLE RIGIDITY,3
BR,MYELITIS,3
BR,NECROSIS,3
BR,NEOPLASM MALIGNANT,3
BR,NO ADVERSE EVENT,3
BR,OCULAR ICTERUS,3
BR,ORAL PAIN,3
BR,PAIN IN JAW,3
BR,PANCREATITIS,3
BR,PATIENT-DEVICE INCOMPATIBILITY,3
BR,PETECHIAE,3
BR,PLATELET COUNT INCREASED,3
BR,PNEUMONIA BACTERIAL,3
BR,POLLAKIURIA,3
BR,POLYMENORRHOEA,3
BR,POOR QUALITY SLEEP,3
BR,POST PROCEDURAL INFECTION,3
BR,PREMATURE DELIVERY,3
BR,PREMATURE RUPTURE OF MEMBRANES,3
BR,PREMATURE SEPARATION OF PLACENTA,3
BR,PRURITUS GENERALISED,3
BR,RENAL COLIC,3
BR,RENAL CYST,3
BR,RETINAL DETACHMENT,3
BR,SCIATICA,3
BR,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,3
BR,SLUGGISHNESS,3
BR,STRABISMUS,3
BR,SUICIDE ATTEMPT,3
BR,TENDONITIS,3
BR,THERAPY CESSATION,3
BR,TONGUE PARALYSIS,3
BR,TOOTH FRACTURE,3
BR,UMBILICAL HERNIA,3
BR,URINARY TRACT DISORDER,3
BR,UTERINE HAEMORRHAGE,3
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
BR,ABDOMINAL DISCOMFORT,2
BR,ABDOMINAL PAIN LOWER,2
BR,ABSCESS,2
BR,ADVERSE DRUG REACTION,2
BR,ANAESTHETIC COMPLICATION,2
BR,ANGIOEDEMA,2
BR,APHONIA,2
BR,APPARENT DEATH,2
BR,APPENDIX DISORDER,2
BR,ASPIRATION,2
BR,ASTHMATIC CRISIS,2
BR,ATRIAL FIBRILLATION,2
BR,AUTOIMMUNE DISORDER,2
BR,BASEDOW^S DISEASE,2
BR,BENIGN NEOPLASM OF THYROID GLAND,2
BR,BLADDER PAIN,2
BR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
BR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
BR,BLOOD UREA INCREASED,2
BR,BONE LESION,2
BR,BONE MARROW DISORDER,2
BR,BOWEL MOVEMENT IRREGULARITY,2
BR,BRAIN NEOPLASM BENIGN,2
BR,BREAST DISORDER,2
BR,BREAST INFLAMMATION,2
BR,BREAST PROSTHESIS IMPLANTATION,2
BR,BRUXISM,2
BR,BURSITIS,2
BR,CARDIAC OPERATION,2
BR,CARDIOVASCULAR DISORDER,2
BR,CARPAL TUNNEL SYNDROME,2
BR,CELLULITIS,2
BR,CEREBRAL ATROPHY,2
BR,CEREBRAL DISORDER,2
BR,CEREBRAL ISCHAEMIA,2
BR,CEREBRAL THROMBOSIS,2
BR,CERVIX DISORDER,2
BR,CHOLECYSTITIS,2
BR,COMMUNICATION DISORDER,2
BR,CONJUNCTIVITIS,2
BR,CORONARY ARTERY OCCLUSION,2
BR,DECREASED ACTIVITY,2
BR,DECUBITUS ULCER,2
BR,DEMENTIA ALZHEIMER^S TYPE,2
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
BR,DERMATITIS,2
BR,DIVERTICULITIS,2
BR,DRUG ABUSE,2
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,2
BR,DRY EYE,2
BR,DUODENAL ULCER,2
BR,DYSGRAPHIA,2
BR,EROSIVE OESOPHAGITIS,2
BR,EXPIRED PRODUCT ADMINISTERED,2
BR,EYE INFLAMMATION,2
BR,EYE MOVEMENT DISORDER,2
BR,EYE SWELLING,2
BR,FACE INJURY,2
BR,FACIAL PARALYSIS,2
BR,FAECES DISCOLOURED,2
BR,FEELING OF DESPAIR,2
BR,FLUID RETENTION,2
BR,FOETAL HEART RATE ABNORMAL,2
BR,FOETAL HEART RATE DECREASED,2
BR,FOETAL MALFORMATION,2
BR,FOOD POISONING,2
BR,FOOT DEFORMITY,2
BR,GASTRIC MUCOSAL LESION,2
BR,GASTRIC ULCER,2
BR,GENERALISED ERYTHEMA,2
BR,GESTATIONAL DIABETES,2
BR,GROIN ABSCESS,2
BR,HAEMANGIOMA,2
BR,HAEMORRHOID OPERATION,2
BR,HANGOVER,2
BR,HEART RATE ABNORMAL,2
BR,HEART RATE DECREASED,2
BR,HEAT STROKE,2
BR,HELICOBACTER GASTRITIS,2
BR,HEPATIC CANCER,2
BR,HEPATIC CIRRHOSIS,2
BR,HEPATIC ENZYME INCREASED,2
BR,HEPATITIS,2
BR,HERPES VIRUS INFECTION,2
BR,HIGH DENSITY LIPOPROTEIN DECREASED,2
BR,HIGH RISK PREGNANCY,2
BR,HIP ARTHROPLASTY,2
BR,HIV INFECTION,2
BR,HORDEOLUM,2
BR,HYPERAEMIA,2
BR,HYPERREFLEXIA,2
BR,HYPERTHYROIDISM,2
BR,IMPAIRED HEALING,2
BR,IMPATIENCE,2
BR,IMPLANT SITE CYST,2
BR,IMPLANT SITE INFLAMMATION,2
BR,INCONTINENCE,2
BR,INITIAL INSOMNIA,2
BR,INJECTION SITE ABSCESS,2
BR,INJECTION SITE DERMATITIS,2
BR,INJECTION SITE INJURY,2
BR,INJECTION SITE VESICLES,2
BR,INJECTION SITE WARMTH,2
BR,INTERVERTEBRAL DISC DEGENERATION,2
BR,ISCHAEMIA,2
BR,JOINT LOCK,2
BR,KIDNEY FIBROSIS,2
BR,LARYNGEAL OEDEMA,2
BR,LIMB MASS,2
BR,LIVER FUNCTION TEST ABNORMAL,2
BR,LIVER INDURATION,2
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
BR,LOW DENSITY LIPOPROTEIN INCREASED,2
BR,LYMPH NODE TUBERCULOSIS,2
BR,LYMPHADENITIS,2
BR,LYMPHOCYTE COUNT DECREASED,2
BR,MACULAR OEDEMA,2
BR,MASS,2
BR,MECONIUM IN AMNIOTIC FLUID,2
BR,MEDIASTINUM NEOPLASM,2
BR,MENINGIOMA,2
BR,MENINGIOMA BENIGN,2
BR,MENSTRUAL DISORDER,2
BR,MENSTRUATION DELAYED,2
BR,MENSTRUATION IRREGULAR,2
BR,METAMORPHOPSIA,2
BR,METASTASES TO LUNG,2
BR,MICTURITION DISORDER,2
BR,MITRAL VALVE PROLAPSE,2
BR,MUSCLE CONTRACTIONS INVOLUNTARY,2
BR,MUSCULOSKELETAL DISCOMFORT,2
BR,MYOCARDIAL ISCHAEMIA,2
BR,MYOCARDITIS,2
BR,NAIL BED INFLAMMATION,2
BR,NASAL CONGESTION,2
BR,NECK MASS,2
BR,NEPHROPATHY,2
BR,NEURITIS,2
BR,NEURODEGENERATIVE DISORDER,2
BR,NEUROMA,2
BR,NEUROMYELITIS OPTICA SPECTRUM DISORDER,2
BR,NEUROPATHY PERIPHERAL,2
BR,NIGHT BLINDNESS,2
BR,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,2
BR,OLIGOHYDRAMNIOS,2
BR,OVARIAN CANCER,2
BR,PANCREATIC CYST,2
BR,PANCREATIC DISORDER,2
BR,PANCREATITIS CHRONIC,2
BR,PANIC REACTION,2
BR,PAPILLARY THYROID CANCER,2
BR,PARAESTHESIA ORAL,2
BR,PARAPARESIS,2
BR,PELVIC FRACTURE,2
BR,PHYSICAL ASSAULT,2
BR,PLACENTAL DISORDER,2
BR,PLEURAL EFFUSION,2
BR,PNEUMONIA ASPIRATION,2
BR,POLYNEUROPATHY,2
BR,POST PROCEDURAL COMPLICATION,2
BR,POSTOPERATIVE WOUND COMPLICATION,2
BR,PRESCRIBED OVERDOSE,2
BR,PRESCRIBED UNDERDOSE,2
BR,PRESYNCOPE,2
BR,PROCEDURAL ANXIETY,2
BR,PROCEDURAL PAIN,2
BR,PROCTALGIA,2
BR,PRODUCT DISTRIBUTION ISSUE,2
BR,PRODUCT PREPARATION ERROR,2
BR,PRODUCT USE ISSUE,2
BR,PROGRESSIVE MULTIPLE SCLEROSIS,2
BR,PSEUDOMONAS INFECTION,2
BR,PULMONARY FIBROSIS,2
BR,PULMONARY TUBERCULOSIS,2
BR,PULPITIS DENTAL,2
BR,QUALITY OF LIFE DECREASED,2
BR,RADIUS FRACTURE,2
BR,RENAL IMPAIRMENT,2
BR,RESPIRATORY ARREST,2
BR,RESPIRATORY FATIGUE,2
BR,RESPIRATORY TRACT INFECTION,2
BR,RHINITIS ALLERGIC,2
BR,RIB FRACTURE,2
BR,ROTATOR CUFF SYNDROME,2
BR,SALIVARY HYPERSECRETION,2
BR,SCOLIOSIS,2
BR,SERUM FERRITIN DECREASED,2
BR,SKIN LESION,2
BR,SKIN STRIAE,2
BR,SNEEZING,2
BR,SPINAL COLUMN INJURY,2
BR,SPINAL COLUMN STENOSIS,2
BR,SPINAL OSTEOARTHRITIS,2
BR,SUPRAVENTRICULAR TACHYCARDIA,2
BR,SURGERY,2
BR,TACHYARRHYTHMIA,2
BR,TEMPERATURE INTOLERANCE,2
BR,THIRST,2
BR,THROMBOCYTOPENIA,2
BR,THROMBOPHLEBITIS SUPERFICIAL,2
BR,TIBIA FRACTURE,2
BR,TONGUE DISCOLOURATION,2
BR,TONGUE DISORDER,2
BR,TOOTH INFECTION,2
BR,TOOTH LOSS,2
BR,UHTHOFF^S PHENOMENON,2
BR,ULCER,2
BR,UNDERWEIGHT,2
BR,UNEVALUABLE EVENT,2
BR,URINE ODOUR ABNORMAL,2
BR,URTICARIA,2
BR,UTERINE CYST,2
BR,VIRAL SINUSITIS,2
BR,VISUAL FIELD DEFECT,2
BR,VITAMIN B COMPLEX DEFICIENCY,2
BR,VITAMIN B12 DECREASED,2
BR,VOCAL CORD THICKENING,2
BR,WHITE BLOOD CELL COUNT INCREASED,2
BR,WOUND INFECTION,2
BR,WOUND NECROSIS,2
BR,YELLOW SKIN,2
BR,ABDOMINAL HERNIA,1
BR,ABDOMINAL INFECTION,1
BR,ABDOMINAL NEOPLASM,1
BR,ABNORMAL BEHAVIOUR,1
BR,ABNORMAL SENSATION IN EYE,1
BR,ABORTION INDUCED,1
BR,ACCIDENT,1
BR,ACCIDENT AT HOME,1
BR,ACOUSTIC NEUROMA,1
BR,ACUTE KIDNEY INJURY,1
BR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
BR,ADENOMYOSIS,1
BR,ADNEXA UTERI PAIN,1
BR,ADNEXAL TORSION,1
BR,ALTERED STATE OF CONSCIOUSNESS,1
BR,ALTERED VISUAL DEPTH PERCEPTION,1
BR,AMENORRHOEA,1
BR,AMNIOTIC FLUID VOLUME DECREASED,1
BR,ANAL FISSURE,1
BR,ANAL HAEMORRHAGE,1
BR,ANAL SPHINCTER ATONY,1
BR,ANEURYSM,1
BR,ANGLE CLOSURE GLAUCOMA,1
BR,ANIMAL BITE,1
BR,ANOSMIA,1
BR,ANTI-THYROID ANTIBODY POSITIVE,1
BR,ANTINUCLEAR ANTIBODY POSITIVE,1
BR,ANTIPHOSPHOLIPID SYNDROME,1
BR,APHTHOUS STOMATITIS,1
BR,APNOEA,1
BR,APPARENT LIFE THREATENING EVENT,1
BR,APPENDICITIS PERFORATED,1
BR,APPETITE DISORDER,1
BR,APPLICATION SITE PAIN,1
BR,ARTERIAL OCCLUSIVE DISEASE,1
BR,ARTERIOSCLEROSIS,1
BR,ARTERITIS CORONARY,1
BR,ARTHRITIS INFECTIVE,1
BR,ARTHROSCOPY,1
BR,ATRIOVENTRICULAR BLOCK,1
BR,AUTISM SPECTRUM DISORDER,1
BR,AXILLARY MASS,1
BR,BACTERIAL TEST POSITIVE,1
BR,BED REST,1
BR,BENIGN BREAST NEOPLASM,1
BR,BENIGN GASTROINTESTINAL NEOPLASM,1
BR,BENIGN HEPATIC NEOPLASM,1
BR,BENIGN NEOPLASM,1
BR,BENIGN NEOPLASM OF EYE,1
BR,BENIGN OVARIAN TUMOUR,1
BR,BILIARY TRACT DISORDER,1
BR,BLADDER DILATATION,1
BR,BLEPHAROSPASM,1
BR,BLISTER,1
BR,BLOOD BILIRUBIN ABNORMAL,1
BR,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
BR,BLOOD BLISTER,1
BR,BLOOD CALCIUM INCREASED,1
BR,BLOOD CHOLESTEROL,1
BR,BLOOD CREATININE ABNORMAL,1
BR,BLOOD GLUCOSE FLUCTUATION,1
BR,BLOOD INSULIN INCREASED,1
BR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
BR,BLOOD POTASSIUM ABNORMAL,1
BR,BLOOD PRESSURE DIASTOLIC INCREASED,1
BR,BLOOD PRESSURE SYSTOLIC INCREASED,1
BR,BLOOD SODIUM INCREASED,1
BR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
BR,BLOOD URINE PRESENT,1
BR,BODY TEMPERATURE ABNORMAL,1
BR,BONE DISORDER,1
BR,BONE EROSION,1
BR,BONE INFARCTION,1
BR,BRAIN OEDEMA,1
BR,BREAST CANCER FEMALE,1
BR,BREAST CANCER MALE,1
BR,BREAST NEOPLASM,1
BR,BREATH SOUNDS ABNORMAL,1
BR,BREECH PRESENTATION,1
BR,BRONCHIOLITIS,1
BR,BRONCHOSPASM,1
BR,BURNS SECOND DEGREE,1
BR,BURNS THIRD DEGREE,1
BR,CACHEXIA,1
BR,CALCINOSIS,1
BR,CALCULUS BLADDER,1
BR,CALCULUS URETERIC,1
BR,CARDIAC ENZYMES INCREASED,1
BR,CARDIAC HYPERTROPHY,1
BR,CARDIAC MURMUR,1
BR,CARDIAC VALVE DISEASE,1
BR,CARDIOMYOPATHY,1
BR,CAROTID ARTERY DISEASE,1
BR,CAROTID ARTERY OCCLUSION,1
BR,CAROTID ARTERY STENOSIS,1
BR,CARPAL TUNNEL DECOMPRESSION,1
BR,CATARACT OPERATION,1
BR,CATARRH,1
BR,CELLULITIS STAPHYLOCOCCAL,1
BR,CENTRAL NERVOUS SYSTEM INFECTION,1
BR,CENTRAL OBESITY,1
BR,CEREBELLAR ATROPHY,1
BR,CEREBELLAR TUMOUR,1
BR,CEREBRAL HAEMORRHAGE,1
BR,CEREBRAL MICROHAEMORRHAGE,1
BR,CEREBRAL VENOUS THROMBOSIS,1
BR,CEREBRAL VENTRICLE DILATATION,1
BR,CERVICAL CONISATION,1
BR,CERVICAL DYSPLASIA,1
BR,CERVICAL INCOMPETENCE,1
BR,CERVIX HAEMORRHAGE UTERINE,1
BR,CHIKUNGUNYA VIRUS INFECTION,1
BR,CHOKING SENSATION,1
BR,CHOLECYSTITIS INFECTIVE,1
BR,CHORIORETINAL ATROPHY,1
BR,CIRCULATORY COLLAPSE,1
BR,CLAVICLE FRACTURE,1
BR,CLEFT LIP AND PALATE,1
BR,COAGULATION FACTOR X LEVEL ABNORMAL,1
BR,COAGULATION TEST ABNORMAL,1
BR,COAGULOPATHY,1
BR,COLD SWEAT,1
BR,COLON NEOPLASM,1
BR,COMPLEX REGIONAL PAIN SYNDROME,1
BR,COMPUTERISED TOMOGRAM ABNORMAL,1
BR,CONCOMITANT DISEASE AGGRAVATED,1
BR,CONGESTIVE CARDIOMYOPATHY,1
BR,CONTRAST MEDIA ALLERGY,1
BR,CORONARY ARTERY DISEASE,1
BR,CORONARY ARTERY STENOSIS,1
BR,CRANIAL NERVE DISORDER,1
BR,CSF SHUNT OPERATION,1
BR,CYANOSIS CENTRAL,1
BR,DANDRUFF,1
BR,DECREASED INTEREST,1
BR,DEFORMITY,1
BR,DELIRIUM FEBRILE,1
BR,DEMENTIA,1
BR,DENTAL CARIES,1
BR,DENTAL IMPLANTATION,1
BR,DEPENDENCE ON RESPIRATOR,1
BR,DEPENDENT PERSONALITY DISORDER,1
BR,DEVICE BREAKAGE,1
BR,DEVICE DIFFICULT TO USE,1
BR,DEVICE DISLOCATION,1
BR,DIABETES MELLITUS INADEQUATE CONTROL,1
BR,DIABETIC NEUROPATHY,1
BR,DISTRACTIBILITY,1
BR,DRUG DISPENSING ERROR,1
BR,DRUG DOSE TITRATION NOT PERFORMED,1
BR,DRUG EFFECT DECREASED,1
BR,DRUG PRESCRIBING ERROR,1
BR,DRUG RESISTANCE,1
BR,DRUG TOLERANCE,1
BR,DRY THROAT,1
BR,DUMPING SYNDROME,1
BR,DUODENITIS,1
BR,DYSENTERY,1
BR,DYSFUNCTIONAL UTERINE BLEEDING,1
BR,DYSHIDROTIC ECZEMA,1
BR,DYSKINESIA,1
BR,DYSLIPIDAEMIA,1
BR,DYSMENORRHOEA,1
BR,DYSPHEMIA,1
BR,DYSPNOEA EXERTIONAL,1
BR,DYSTONIA,1
BR,EAR CONGESTION,1
BR,ECHOCARDIOGRAM ABNORMAL,1
BR,ELECTROCARDIOGRAM ABNORMAL,1
BR,EMBOLISM,1
BR,EMPYEMA,1
BR,ENCEPHALITIS AUTOIMMUNE,1
BR,ENDOCARDITIS,1
BR,ENDOCRINE DISORDER,1
BR,ENDODONTIC PROCEDURE,1
BR,ENDOMETRIAL DISORDER,1
BR,ENDOMETRIAL HYPERPLASIA,1
BR,ENTERITIS INFECTIOUS,1
BR,ENTEROCOLITIS,1
BR,ENZYME LEVEL INCREASED,1
BR,EPIGASTRIC DISCOMFORT,1
BR,EROSIVE DUODENITIS,1
BR,EVANS SYNDROME,1
BR,EXERCISE LACK OF,1
BR,EXOSTOSIS,1
BR,EXPOSURE DURING BREAST FEEDING,1
BR,EXTRAPULMONARY TUBERCULOSIS,1
BR,EXTRAVASATION BLOOD,1
BR,EXTREMITY NECROSIS,1
BR,EYE COLOUR CHANGE,1
BR,EYE INFECTION FUNGAL,1
BR,EYE INFECTION TOXOPLASMAL,1
BR,EYE INJURY,1
BR,EYE OEDEMA,1
BR,EYELID FUNCTION DISORDER,1
BR,EYELID THICKENING,1
BR,FACE OEDEMA,1
BR,FACIAL BONES FRACTURE,1
BR,FACIAL PARESIS,1
BR,FACIAL SPASM,1
BR,FAECES HARD,1
BR,FAECES PALE,1
BR,FAILED INDUCTION OF LABOUR,1
BR,FAMILY STRESS,1
BR,FAT TISSUE DECREASED,1
BR,FAT TISSUE INCREASED,1
BR,FEAR OF DEATH,1
BR,FEEDING DISORDER NEONATAL,1
BR,FEELING DRUNK,1
BR,FEELINGS OF WORTHLESSNESS,1
BR,FIBULA FRACTURE,1
BR,FLAVIVIRUS INFECTION,1
BR,FLUSHING,1
BR,FOETAL DEATH,1
BR,FOETAL GROWTH RESTRICTION,1
BR,FOETAL MALPOSITION,1
BR,FOOD INTOLERANCE,1
BR,FREQUENT BOWEL MOVEMENTS,1
BR,FRUSTRATION,1
BR,FUNGAL SKIN INFECTION,1
BR,GALLBLADDER ENLARGEMENT,1
BR,GALLBLADDER OPERATION,1
BR,GASTRIC HAEMORRHAGE,1
BR,GASTRIC NEOPLASM,1
BR,GASTROINTESTINAL BACTERIAL INFECTION,1
BR,GASTROINTESTINAL CANDIDIASIS,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL INFECTION,1
BR,GASTROINTESTINAL NEOPLASM,1
BR,GASTROINTESTINAL TRACT ADENOMA,1
BR,GENITAL CYST,1
BR,GENITAL INFECTION FEMALE,1
BR,GINGIVAL BLEEDING,1
BR,GINGIVAL DISORDER,1
BR,GLOMERULONEPHRITIS,1
BR,GLUCOSE TOLERANCE IMPAIRED,1
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
BR,GOITRE,1
BR,GOUT,1
BR,GRANULOMA,1
BR,GROIN PAIN,1
BR,GUN SHOT WOUND,1
BR,H1N1 INFLUENZA,1
BR,HAEMANGIOMA OF LIVER,1
BR,HAEMATOCRIT DECREASED,1
BR,HAEMATOSALPINX,1
BR,HAEMOGLOBIN DECREASED,1
BR,HALLUCINATION_ AUDITORY,1
BR,HEAD AND NECK CANCER,1
BR,HEAD TITUBATION,1
BR,HELMINTHIC INFECTION,1
BR,HEPATIC CONGESTION,1
BR,HEPATIC ENCEPHALOPATHY,1
BR,HEPATIC ENZYME DECREASED,1
BR,HEPATIC FIBROSIS,1
BR,HEPATIC HAEMORRHAGE,1
BR,HEPATIC INFECTION,1
BR,HEPATITIS A,1
BR,HEPATITIS FULMINANT,1
BR,HERNIA PAIN,1
BR,HERPES OPHTHALMIC,1
BR,HICCUPS,1
BR,HILAR LYMPHADENOPATHY,1
BR,HOMICIDAL IDEATION,1
BR,HORMONE LEVEL ABNORMAL,1
BR,HYPERAESTHESIA,1
BR,HYPERSOMNIA,1
BR,HYPERVENTILATION,1
BR,HYPERVITAMINOSIS D,1
BR,HYPOGLYCAEMIA,1
BR,HYPOKALAEMIA,1
BR,HYPOMENORRHOEA,1
BR,HYPOPHAGIA,1
BR,HYPOREFLEXIA,1
BR,HYPOVITAMINOSIS,1
BR,HYPOXIA,1
BR,HYSTEROSALPINGECTOMY,1
BR,IMPAIRED QUALITY OF LIFE,1
BG,ABORTION MISSED,1
BG,ASPHYXIA,1
BG,BRONCHOSPASM,1
BG,DRUG INTOLERANCE,1
BG,FALL,1
BG,HAEMATEMESIS,1
BG,HEAD INJURY,1
BG,INFLUENZA,1
BG,MALAISE,1
BG,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
BG,PREGNANCY,1
BG,VERTEBRAL ARTERY DISSECTION,1
BG,VOMITING,1
CA,MULTIPLE SCLEROSIS RELAPSE,46
CA,FATIGUE,35
CA,INFLUENZA LIKE ILLNESS,29
CA,HEADACHE,26
CA,FALL,24
CA,PAIN IN EXTREMITY,23
CA,DEATH,21
CA,INJECTION SITE ERYTHEMA,21
CA,GAIT DISTURBANCE,20
CA,INJECTION SITE PAIN,20
CA,MALAISE,20
CA,MULTIPLE SCLEROSIS,20
CA,NAUSEA,20
CA,HYPOAESTHESIA,19
CA,PAIN,17
CA,PYREXIA,17
CA,PNEUMONIA,16
CA,BREAST CANCER,15
CA,MUSCULAR WEAKNESS,14
CA,MYOCARDIAL INFARCTION,14
CA,ASTHENIA,13
CA,DEPRESSION,13
CA,DRUG INEFFECTIVE,12
CA,URINARY TRACT INFECTION,12
CA,ARTHRALGIA,11
CA,BACK PAIN,11
CA,CENTRAL NERVOUS SYSTEM LESION,11
CA,DIZZINESS,11
CA,DRUG DOSE OMISSION,11
CA,HYPERTENSION,11
CA,CHILLS,10
CA,INJECTION SITE BRUISING,10
CA,MYALGIA,10
CA,PARAESTHESIA,10
CA,VOMITING,10
CA,BALANCE DISORDER,9
CA,DIABETES MELLITUS,9
CA,LOSS OF CONSCIOUSNESS,9
CA,MUSCLE SPASMS,9
CA,PULMONARY ARTERIAL HYPERTENSION,9
CA,CHEST PAIN,8
CA,INSOMNIA,8
CA,MUSCULOSKELETAL PAIN,8
CA,OPTIC NEURITIS,8
CA,SYNCOPE,8
CA,VISUAL IMPAIRMENT,8
CA,CEREBROVASCULAR ACCIDENT,7
CA,CONFUSIONAL STATE,7
CA,INJECTION SITE MASS,7
CA,MATERNAL EXPOSURE DURING PREGNANCY,7
CA,MOBILITY DECREASED,7
CA,NEPHROLITHIASIS,7
CA,SEPSIS,7
CA,TREMOR,7
CA,BURNING SENSATION,6
CA,CELLULITIS,6
CA,COGNITIVE DISORDER,6
CA,CONTUSION,6
CA,FEELING ABNORMAL,6
CA,FOETAL EXPOSURE DURING PREGNANCY,6
CA,INJECTION SITE WARMTH,6
CA,MIGRAINE,6
CA,NASOPHARYNGITIS,6
CA,PARALYSIS,6
CA,PULMONARY EMBOLISM,6
CA,ROAD TRAFFIC ACCIDENT,6
CA,THROMBOSIS,6
CA,WEIGHT DECREASED,6
CA,WHITE BLOOD CELL COUNT DECREASED,6
CA,ANKLE FRACTURE,5
CA,BLOOD GLUCOSE INCREASED,5
CA,BLOOD PRESSURE DECREASED,5
CA,CHOLELITHIASIS,5
CA,DIARRHOEA,5
CA,DYSPHAGIA,5
CA,DYSPNOEA,5
CA,HEPATIC CIRRHOSIS,5
CA,HEPATIC ENZYME INCREASED,5
CA,HEPATIC MASS,5
CA,HYPERHIDROSIS,5
CA,INFLUENZA,5
CA,INJECTION SITE INDURATION,5
CA,INJECTION SITE SWELLING,5
CA,MUSCULOSKELETAL STIFFNESS,5
CA,PLATELET COUNT DECREASED,5
CA,SOMNOLENCE,5
CA,VERTIGO,5
CA,VISION BLURRED,5
CA,WEIGHT INCREASED,5
CA,ABASIA,4
CA,ABDOMINAL DISCOMFORT,4
CA,ABORTION SPONTANEOUS,4
CA,ACUTE MYOCARDIAL INFARCTION,4
CA,ALANINE AMINOTRANSFERASE INCREASED,4
CA,ANXIETY,4
CA,ARTHRITIS,4
CA,ASPARTATE AMINOTRANSFERASE INCREASED,4
CA,BIPOLAR DISORDER,4
CA,BLOOD CREATININE INCREASED,4
CA,BLOOD PRESSURE INCREASED,4
CA,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,4
CA,GENERAL SYMPTOM,4
CA,HAEMOGLOBIN DECREASED,4
CA,HEMIPARESIS,4
CA,HIP FRACTURE,4
CA,HOT FLUSH,4
CA,HYPERSENSITIVITY,4
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
CA,INFECTION,4
CA,INJECTION SITE CELLULITIS,4
CA,INJECTION SITE INFECTION,4
CA,INJECTION SITE INFLAMMATION,4
CA,LYMPHADENOPATHY,4
CA,MALIGNANT MELANOMA,4
CA,MEMORY IMPAIRMENT,4
CA,MENTAL DISORDER,4
CA,NECK PAIN,4
CA,NORMAL NEWBORN,4
CA,PANCREATITIS,4
CA,PERIPHERAL SWELLING,4
CA,POLLAKIURIA,4
CA,PRURITUS,4
CA,SUICIDAL IDEATION,4
CA,TYPE 2 DIABETES MELLITUS,4
CA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
CA,ALOPECIA,3
CA,ANAEMIA,3
CA,APHASIA,3
CA,ASCITES,3
CA,BRONCHITIS,3
CA,CAESAREAN SECTION,3
CA,CONSTIPATION,3
CA,CYSTITIS,3
CA,DEAFNESS,3
CA,DECREASED APPETITE,3
CA,DEPRESSED MOOD,3
CA,DEVICE ISSUE,3
CA,DIPLOPIA,3
CA,DISORIENTATION,3
CA,DRUG ADMINISTERED AT INAPPROPRIATE SITE,3
CA,FEELING COLD,3
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
CA,GASTROOESOPHAGEAL REFLUX DISEASE,3
CA,HAEMOLYTIC URAEMIC SYNDROME,3
CA,HEAD DISCOMFORT,3
CA,INJECTION SITE PRURITUS,3
CA,INJECTION SITE RASH,3
CA,INJECTION SITE REACTION,3
CA,INTRACRANIAL ANEURYSM,3
CA,KIDNEY INFECTION,3
CA,LIVER DISORDER,3
CA,LOWER RESPIRATORY TRACT INFECTION,3
CA,LUNG NEOPLASM MALIGNANT,3
CA,MATERNAL EXPOSURE TIMING UNSPECIFIED,3
CA,MENORRHAGIA,3
CA,MOOD SWINGS,3
CA,MUSCLE TIGHTNESS,3
CA,MUSCULOSKELETAL CHEST PAIN,3
CA,NECK INJURY,3
CA,OSTEOPOROSIS,3
CA,PHARYNGITIS STREPTOCOCCAL,3
CA,RENAL FAILURE,3
CA,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,3
CA,SINUSITIS,3
CA,SKIN DISCOLOURATION,3
CA,STRESS,3
CA,THROMBOCYTOPENIA,3
CA,THROMBOTIC THROMBOCYTOPENIC PURPURA,3
CA,TRIGEMINAL NEURALGIA,3
CA,UPPER LIMB FRACTURE,3
CA,URINARY INCONTINENCE,3
CA,ABDOMINAL PAIN,2
CA,ABDOMINAL PAIN LOWER,2
CA,ABDOMINAL PAIN UPPER,2
CA,ACNE,2
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,2
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,2
CA,ADVERSE DRUG REACTION,2
CA,ADVERSE EVENT,2
CA,AGITATION,2
CA,APATHY,2
CA,AUTOIMMUNE HEPATITIS,2
CA,BACK INJURY,2
CA,BACTERIAL INFECTION,2
CA,BASEDOW^S DISEASE,2
CA,BILIARY CIRRHOSIS PRIMARY,2
CA,BLINDNESS,2
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,2
CA,BLOOD PRESSURE DIASTOLIC INCREASED,2
CA,BLOOD URINE PRESENT,2
CA,BODY TEMPERATURE INCREASED,2
CA,BONE PAIN,2
CA,BRADYCARDIA,2
CA,BREAST CANCER METASTATIC,2
CA,CARDIAC DISORDER,2
CA,CARDIOMEGALY,2
CA,CARDIOMYOPATHY,2
CA,CHOKING SENSATION,2
CA,CLAVICLE FRACTURE,2
CA,COELIAC DISEASE,2
CA,COLITIS ULCERATIVE,2
CA,CONCUSSION,2
CA,CONVULSION,2
CA,CORONARY ARTERY BYPASS,2
CA,COSTOCHONDRITIS,2
CA,COUGH,2
CA,CROHN^S DISEASE,2
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CA,DERMATITIS,2
CA,DISEASE PROGRESSION,2
CA,DRUG INTOLERANCE,2
CA,DYSPEPSIA,2
CA,EMOTIONAL DISORDER,2
CA,EPILEPSY,2
CA,EPISTAXIS,2
CA,ERYTHEMA,2
CA,EYE SWELLING,2
CA,FACIAL BONES FRACTURE,2
CA,FAECES DISCOLOURED,2
CA,FEELING HOT,2
CA,FEMUR FRACTURE,2
CA,FOETAL DISTRESS SYNDROME,2
CA,GASTROINTESTINAL DISORDER,2
CA,GASTROINTESTINAL MOTILITY DISORDER,2
CA,GENERALISED OEDEMA,2
CA,GRAND MAL CONVULSION,2
CA,HAEMATOCHEZIA,2
CA,HAEMOLYTIC ANAEMIA,2
CA,HEART RATE INCREASED,2
CA,HIP ARTHROPLASTY,2
CA,HYPOACUSIS,2
CA,HYPOTENSION,2
CA,HYPOTONIA,2
CA,HYPOXIA,2
CA,IMMUNE THROMBOCYTOPENIC PURPURA,2
CA,IMPAIRED SELF-CARE,2
CA,INGUINAL HERNIA,2
CA,INJECTION SITE ABSCESS,2
CA,INJECTION SITE ATROPHY,2
CA,INJECTION SITE DISCOLOURATION,2
CA,INJECTION SITE HAEMORRHAGE,2
CA,INJECTION SITE NECROSIS,2
CA,INJECTION SITE SCAR,2
CA,INTERVERTEBRAL DISC PROTRUSION,2
CA,INTRACRANIAL MASS,2
CA,KNEE ARTHROPLASTY,2
CA,KYPHOSCOLIOSIS,2
CA,LEUKOPENIA,2
CA,LIP SWELLING,2
CA,LIVE BIRTH,2
CA,LIVER FUNCTION TEST ABNORMAL,2
CA,LOCALISED INFECTION,2
CA,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,2
CA,MALIGNANT MELANOMA IN SITU,2
CA,METASTASIS,2
CA,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,2
CA,MICTURITION URGENCY,2
CA,MOTOR DYSFUNCTION,2
CA,MOVEMENT DISORDER,2
CA,MUSCLE SPASTICITY,2
CA,NASAL SEPTUM DEVIATION,2
CA,NEURALGIA,2
CA,NEUROPATHY PERIPHERAL,2
CA,NEUTRALISING ANTIBODIES,2
CA,NYSTAGMUS,2
CA,OEDEMA PERIPHERAL,2
CA,OPHTHALMOPLEGIA,2
CA,OROPHARYNGEAL PAIN,2
CA,OSTEOARTHRITIS,2
CA,PAIN OF SKIN,2
CA,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
CA,PRODUCTIVE COUGH,2
CA,PSYCHOTIC DISORDER,2
CA,PULMONARY TUBERCULOSIS,2
CA,RASH,2
CA,RECTAL HAEMORRHAGE,2
CA,RENAL FAILURE ACUTE,2
CA,RENAL FAILURE CHRONIC,2
CA,RESPIRATORY RATE INCREASED,2
CA,RHABDOMYOLYSIS,2
CA,ROTATOR CUFF SYNDROME,2
CA,SARCOIDOSIS,2
CA,SENSORY DISTURBANCE,2
CA,SHOCK HAEMORRHAGIC,2
CA,SLEEP APNOEA SYNDROME,2
CA,SLEEP DISORDER,2
CA,SPEECH DISORDER,2
CA,STAPHYLOCOCCAL INFECTION,2
CA,SWELLING,2
CA,SWELLING FACE,2
CA,THROMBOCYTOPENIC PURPURA,2
CA,TRACHEAL MASS,2
CA,TRANSIENT ISCHAEMIC ATTACK,2
CA,TUBERCULOSIS,2
CA,UNEVALUABLE EVENT,2
CA,URTICARIA,2
CA,VENOUS INSUFFICIENCY,2
CA,WHITE BLOOD CELL COUNT INCREASED,2
CA,WOUND,2
CA,ABULIA,1
CA,ACCIDENT,1
CA,ACCIDENTAL OVERDOSE,1
CA,ADDISON^S DISEASE,1
CA,ADENOCARCINOMA OF COLON,1
CA,AKINESIA,1
CA,ALVEOLAR RHABDOMYOSARCOMA,1
CA,AMENORRHOEA,1
CA,AMNESIA,1
CA,AMNIORRHOEA,1
CA,ANGER,1
CA,ANGINA PECTORIS,1
CA,ANGIOGRAM RETINA ABNORMAL,1
CA,ANGIOPLASTY,1
CA,APPENDICITIS,1
CA,APPENDICITIS PERFORATED,1
CA,ARTERIOSCLEROSIS,1
CA,ARTHRITIS BACTERIAL,1
CA,ARTHRITIS INFECTIVE,1
CA,ATAXIA,1
CA,ATRIAL FIBRILLATION,1
CA,AUTOIMMUNE DISORDER,1
CA,AUTOIMMUNE THYROIDITIS,1
CA,BACTERAEMIA,1
CA,BACTERIAL SEPSIS,1
CA,BASAL CELL CARCINOMA,1
CA,BEDRIDDEN,1
CA,BICUSPID AORTIC VALVE,1
CA,BIPOLAR I DISORDER,1
CA,BLINDNESS TRANSIENT,1
CA,BLINDNESS UNILATERAL,1
CA,BLISTER,1
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CA,BLOOD CREATINE INCREASED,1
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CA,BLOOD CREATININE DECREASED,1
CA,BLOOD IMMUNOGLOBULIN G DECREASED,1
CA,BLOOD IRON DECREASED,1
CA,BLOOD IRON INCREASED,1
CA,BLOOD POTASSIUM INCREASED,1
CA,BLOOD TRIGLYCERIDES ABNORMAL,1
CA,BONE CANCER,1
CA,BONE MARROW FAILURE,1
CA,BRAIN ABSCESS,1
CA,BRAIN NEOPLASM MALIGNANT,1
CA,BREAST ABSCESS,1
CA,BREAST CANCER FEMALE,1
CA,BREAST MASS,1
CA,BREAST NEOPLASM,1
CA,BREAST TENDERNESS,1
CA,BRONCHITIS CHRONIC,1
CA,BUNION,1
CA,CARDIAC ABLATION,1
CA,CARDIAC ARREST,1
CA,CARDIAC FAILURE,1
CA,CARDIAC FLUTTER,1
CA,CARDIAC INFECTION,1
CA,CARDIAC OPERATION,1
CA,CAST APPLICATION,1
CA,CEREBELLAR ATAXIA,1
CA,CEREBRAL ATROPHY,1
CA,CEREBRAL HAEMATOMA,1
CA,CEREBRAL HAEMORRHAGE,1
CA,CEREBROSPINAL FLUID LEAKAGE,1
CA,CERVICAL VERTEBRAL FRACTURE,1
CA,CHOLECYSTECTOMY,1
CA,CLEAR CELL CARCINOMA OF CERVIX,1
CA,CLOSTRIDIUM DIFFICILE INFECTION,1
CA,CLUMSINESS,1
CA,CLUTTERING,1
CA,COLITIS ISCHAEMIC,1
CA,COLON CANCER STAGE II,1
CA,COLORECTAL CANCER RECURRENT,1
CA,COMPLETED SUICIDE,1
CA,CORONARY ARTERIAL STENT INSERTION,1
CA,CORONARY ARTERY DISEASE,1
CA,CORONARY ARTERY OCCLUSION,1
CA,COW^S MILK INTOLERANCE,1
CA,DECREASED ACTIVITY,1
CA,DECREASED IMMUNE RESPONSIVENESS,1
CA,DEEP VEIN THROMBOSIS,1
CA,DEHYDRATION,1
CA,DELIRIUM,1
CA,DEMENTIA ALZHEIMER^S TYPE,1
CA,DEVICE MALFUNCTION,1
CA,DIABETIC KETOACIDOSIS,1
CA,DIAPHRAGM MUSCLE WEAKNESS,1
CA,DIAPHRAGMATIC DISORDER,1
CA,DISTURBANCE IN ATTENTION,1
CA,DIVERTICULITIS,1
CA,DRUG ABUSE,1
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CA,DRUG PRESCRIBING ERROR,1
CA,DRY SKIN,1
CA,DUPUYTREN^S CONTRACTURE,1
CA,DYSARTHRIA,1
CA,DYSKINESIA,1
CA,DYSPLASTIC NAEVUS,1
CA,DYSSTASIA,1
CA,DYSURIA,1
CA,EAR CONGESTION,1
CA,EAR PAIN,1
CA,ECTOPIC PREGNANCY,1
CA,EOSINOPHILIA,1
CA,ESCHERICHIA BACTERAEMIA,1
CA,EXPANDED DISABILITY STATUS SCALE,1
CA,EXPOSURE DURING PREGNANCY,1
CA,EXPOSURE VIA FATHER,1
CA,EYELID OEDEMA,1
CA,FAECAL INCONTINENCE,1
CA,FEAR OF INJECTION,1
CA,FEELING DRUNK,1
CA,FIBROMYALGIA,1
CA,FINE MOTOR SKILL DYSFUNCTION,1
CA,FLUSHING,1
CA,FOETAL HEART RATE DECREASED,1
CA,FOOT FRACTURE,1
CA,FREQUENT BOWEL MOVEMENTS,1
CA,FUNGAL INFECTION,1
CA,GALLBLADDER DISORDER,1
CA,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
CA,GASTRIC ULCER HAEMORRHAGE,1
CA,GASTROLITHIASIS,1
CA,GENERAL PHYSICAL HEALTH DETERIORATION,1
CA,GENITAL CONTUSION,1
CA,GINGIVAL CANCER,1
CA,GINGIVAL SWELLING,1
CA,GINGIVITIS,1
CA,GRANULAR CELL TUMOUR,1
CA,GRANULOMA,1
CA,GUILLAIN-BARRE SYNDROME,1
CA,HAEMATOCRIT DECREASED,1
CA,HAEMORRHAGE,1
CA,HAEMORRHAGIC STROKE,1
CA,HAEMORRHOIDS,1
CA,HEAD INJURY,1
CA,HEART DISEASE CONGENITAL,1
CA,HEART RATE IRREGULAR,1
CA,HEART VALVE INCOMPETENCE,1
CA,HELPLESSNESS,1
CA,HEMIPLEGIA,1
CA,HEPATIC PAIN,1
CA,HEPATIC STEATOSIS,1
CA,HEPATITIS ACUTE,1
CA,HER-2 POSITIVE BREAST CANCER,1
CA,HERNIA,1
CA,HERPES ZOSTER OTICUS,1
CA,HICCUPS,1
CA,HORDEOLUM,1
CA,HUMERUS FRACTURE,1
CA,HYPERAESTHESIA,1
CA,HYPERCALCAEMIA,1
CA,HYPERGLYCAEMIA,1
CA,HYPERREFLEXIA,1
CA,HYPERTENSIVE CRISIS,1
CA,HYPERTHYROIDISM,1
CA,HYPOKINESIA,1
CA,HYPONATRAEMIA,1
CA,HYSTERECTOMY,1
CA,HYSTEROCELE,1
CA,IDIOPATHIC PULMONARY FIBROSIS,1
CA,ILL-DEFINED DISORDER,1
CA,IMMUNE SYSTEM DISORDER,1
CA,IMPAIRED HEALING,1
CA,IMPATIENCE,1
CA,INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT,1
CA,INCORRECT DOSE ADMINISTERED,1
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CA,INFECTIOUS PLEURAL EFFUSION,1
CA,INJECTION RELATED REACTION,1
CA,INJECTION SITE EXTRAVASATION,1
CA,INJECTION SITE HAEMATOMA,1
CA,INJECTION SITE HYPERSENSITIVITY,1
CA,INJECTION SITE INJURY,1
CA,INJECTION SITE ULCER,1
CA,INJECTION SITE URTICARIA,1
CA,INJURY ASSOCIATED WITH DEVICE,1
CA,INTENTIONAL PRODUCT MISUSE,1
CA,INTERMITTENT CLAUDICATION,1
CA,INTERNAL HAEMORRHAGE,1
CA,INTERNAL HERNIA,1
CA,INTERNATIONAL NORMALISED RATIO INCREASED,1
CA,INTESTINAL STENOSIS,1
CA,INTRA-ABDOMINAL HAEMORRHAGE,1
CA,INTRACRANIAL PRESSURE INCREASED,1
CA,IRRITABILITY,1
CA,JOINT INJURY,1
CA,JUGULAR VEIN THROMBOSIS,1
CA,LABOUR COMPLICATION,1
CA,LABYRINTHITIS,1
CA,LARYNGEAL CANCER,1
CA,LATENT TUBERCULOSIS,1
CA,LEFT VENTRICULAR DYSFUNCTION,1
CA,LETHARGY,1
CA,LIBIDO DECREASED,1
CA,LIMB RECONSTRUCTIVE SURGERY,1
CA,LIPODYSTROPHY ACQUIRED,1
CA,LIPOSUCTION,1
CA,LIVER FUNCTION TEST INCREASED,1
CA,LOCAL SWELLING,1
CA,LOSS OF CONTROL OF LEGS,1
CA,LOWER LIMB FRACTURE,1
CA,LUMBAR PUNCTURE,1
CA,LYMPHADENITIS,1
CA,MALIGNANT HYPERTENSION,1
CA,MELANOCYTIC NAEVUS,1
CA,MENOPAUSE,1
CA,MENSTRUATION DELAYED,1
CA,MENSTRUATION IRREGULAR,1
CA,METASTASES TO LIVER,1
CA,MICROANGIOPATHY,1
CA,MICTURITION DISORDER,1
CA,MOOD ALTERED,1
CA,MUSCLE TWITCHING,1
CA,MUSCULOSKELETAL DISCOMFORT,1
CA,MUSCULOSKELETAL DISORDER,1
CA,MYELITIS,1
CA,MYELOID LEUKAEMIA,1
CA,MYOPIA,1
CA,NASAL DISORDER,1
CA,NEAR DROWNING,1
CA,NECROSIS,1
CA,NECROTISING FASCIITIS,1
CA,NEEDLE FATIGUE,1
CA,NEEDLE ISSUE,1
CA,NEOPLASM MALIGNANT,1
CA,NEOPLASM PROGRESSION,1
CA,NEPHRITIS,1
CA,NERVE INJURY,1
CA,NEUROLOGICAL EXAMINATION ABNORMAL,1
CA,NEUTROPENIA,1
CA,NEUTROPHIL COUNT DECREASED,1
CA,NO ADVERSE EVENT,1
CA,NOCTURIA,1
CA,NON-HODGKIN^S LYMPHOMA,1
CA,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
CA,OBESITY,1
CA,OLIGURIA,1
CA,ONYCHALGIA,1
CA,ONYCHOMADESIS,1
CA,OSTEOMYELITIS,1
CA,OSTEONECROSIS,1
CA,OSTEOPENIA,1
CA,OVARIAN CANCER,1
CA,OVARIAN CANCER STAGE III,1
CA,OVARIAN HYPERSTIMULATION SYNDROME,1
CA,OVERDOSE,1
CA,PAINFUL RESPIRATION,1
CA,PALPITATIONS,1
CA,PANCREATIC MASS,1
CA,PAPILLARY THYROID CANCER,1
CA,PAPILLOEDEMA,1
CA,PARANOIA,1
CA,PARTIAL SEIZURES,1
CA,PELVIC ABSCESS,1
CA,PERICARDITIS,1
CA,PERIPHERAL ARTERY STENOSIS,1
CA,PERITONITIS,1
CA,PERONEAL MUSCULAR ATROPHY,1
CA,PETIT MAL EPILEPSY,1
CA,PHARYNGEAL OEDEMA,1
CA,PITUITARY TUMOUR,1
CA,PITUITARY TUMOUR BENIGN,1
CA,PLASMA CELL MYELOMA,1
CA,PLATELET COUNT INCREASED,1
CA,PLEURAL EFFUSION,1
CA,PNEUMONIA STREPTOCOCCAL,1
CA,PNEUMOTHORAX,1
CA,PORPHYRIA NON-ACUTE,1
CA,PORPHYRIN METABOLISM DISORDER,1
CA,POST PROCEDURAL COMPLICATION,1
CA,POST PROCEDURAL INFECTION,1
CA,POST-TRAUMATIC NECK SYNDROME,1
CA,POSTOPERATIVE WOUND INFECTION,1
CA,PREMATURE DELIVERY,1
CA,PRESBYOPIA,1
CA,PROCEDURAL INTESTINAL PERFORATION,1
CA,PROCEDURAL PAIN,1
CA,PRODUCT QUALITY ISSUE,1
CA,PROGRESSIVE MULTIPLE SCLEROSIS,1
CA,PROSTATE CANCER,1
CA,PSORIATIC ARTHROPATHY,1
CA,PSYCHOMOTOR SKILLS IMPAIRED,1
CA,PULMONARY SEPSIS,1
CA,PYELONEPHRITIS,1
CA,RASH MACULAR,1
CA,RASH PRURITIC,1
CA,RED BLOOD CELL COUNT DECREASED,1
CA,RED BLOOD CELL COUNT INCREASED,1
CA,RENAL ABSCESS,1
CA,RENAL AMYLOIDOSIS,1
CA,RESPIRATORY ARREST,1
CA,RESPIRATORY TRACT INFECTION,1
CA,RESTLESS LEGS SYNDROME,1
CA,RETICULOCYTE COUNT DECREASED,1
CA,RETINAL HAEMORRHAGE,1
CA,RETINOPATHY,1
CA,RETINOPATHY HYPERTENSIVE,1
CA,RHEUMATOID ARTHRITIS,1
CA,RHINORRHOEA,1
CA,RIB FRACTURE,1
CA,RIGHT VENTRICULAR FAILURE,1
CA,SCAR,1
CA,SCRATCH,1
CA,SELF-INJURIOUS IDEATION,1
CA,SENSORY LOSS,1
CA,SINUS CONGESTION,1
CA,SKIN BURNING SENSATION,1
CA,SKIN CANCER,1
CA,SKIN EROSION,1
CA,SKIN FRAGILITY,1
CA,SKIN INDURATION,1
CA,SKIN INFECTION,1
CA,SKIN LESION,1
CA,SKIN MASS,1
CA,SKIN NECROSIS,1
CA,SKIN REACTION,1
CA,SKIN ULCER,1
CA,SPERM CONCENTRATION ZERO,1
CA,SPINAL COLUMN INJURY,1
CA,SPINAL COLUMN STENOSIS,1
CA,SPINAL DEFORMITY,1
CA,SPINAL FRACTURE,1
CA,SPINAL PAIN,1
CA,SQUAMOUS CELL CARCINOMA OF THE VULVA,1
CA,SUBDURAL HAEMATOMA,1
CA,SUICIDE THREAT,1
CA,SYNOVIAL CYST,1
CA,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CA,TACHYCARDIA,1
CA,TEMPERATURE INTOLERANCE,1
CA,TENDON DISCOMFORT,1
CA,TENDON RUPTURE,1
CA,TESTICULAR DISORDER,1
CA,THERMOHYPOAESTHESIA,1
CA,THIRST,1
CA,THROAT TIGHTNESS,1
CA,THROMBOTIC MICROANGIOPATHY,1
CA,THYROID CANCER,1
CA,TOOTH ABSCESS,1
CA,TOOTH FRACTURE,1
CA,TOXIC SHOCK SYNDROME,1
CA,TRISOMY 21,1
CA,TUBERCULIN TEST POSITIVE,1
CA,UHTHOFF^S PHENOMENON,1
CA,ULCER,1
CA,UMBILICAL HERNIA,1
CA,UNDERDOSE,1
CA,URINARY RETENTION,1
CA,URINE ODOUR ABNORMAL,1
CA,UTERINE DISORDER,1
CA,VAGINAL INFECTION,1
CA,VASCULAR SKIN DISORDER,1
CA,VASCULITIS CEREBRAL,1
CA,VASECTOMY,1
CA,VASOGENIC CEREBRAL OEDEMA,1
CA,VENOUS INJURY,1
CA,VESTIBULAR NEURONITIS,1
CA,VIRAL INFECTION,1
CA,VISUAL FIELD DEFECT,1
CA,VITREOUS DETACHMENT,1
CA,VITREOUS FLOATERS,1
CA,VOCAL CORD PARALYSIS,1
CA,VULVAL CANCER,1
CA,VULVOVAGINAL INJURY,1
CA,VULVOVAGINAL MYCOTIC INFECTION,1
CA,WALKING AID USER,1
CA,WHITE BLOOD CELL COUNT ABNORMAL,1
CA,WOUND DRAINAGE,1
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CA,X-LINKED CHROMOSOMAL DISORDER,1
CL,MULTIPLE SCLEROSIS RELAPSE,7
CL,HEADACHE,4
CL,MATERNAL EXPOSURE DURING PREGNANCY,4
CL,ABORTION SPONTANEOUS,3
CL,DIZZINESS,3
CL,OPTIC NEURITIS,3
CL,PYREXIA,3
CL,VOMITING,3
CL,ABDOMINAL DISTENSION,2
CL,DEPRESSION,2
CL,FATIGUE,2
CL,INFLUENZA LIKE ILLNESS,2
CL,INJECTION SITE NECROSIS,2
CL,MULTIPLE SCLEROSIS,2
CL,NAUSEA,2
CL,SKIN INJURY,2
CL,URINARY TRACT DISCOMFORT,2
CL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
CL,ABDOMINAL PAIN,1
CL,ABDOMINAL PAIN LOWER,1
CL,ABDOMINAL PAIN UPPER,1
CL,AGGRESSION,1
CL,ALANINE AMINOTRANSFERASE ABNORMAL,1
CL,ALANINE AMINOTRANSFERASE INCREASED,1
CL,ANTI-THYROID ANTIBODY,1
CL,ANXIETY,1
CL,APPENDICITIS,1
CL,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
CL,ASPARTATE AMINOTRANSFERASE INCREASED,1
CL,ATRIOVENTRICULAR SEPTAL DEFECT,1
CL,BALANCE DISORDER,1
CL,BRONCHIAL OBSTRUCTION,1
CL,BRONCHIECTASIS,1
CL,BRONCHITIS,1
CL,CANDIDURIA,1
CL,CHILLS,1
CL,CHOLELITHIASIS,1
CL,CHROMATURIA,1
CL,CITROBACTER TEST POSITIVE,1
CL,CRANIOCEREBRAL INJURY,1
CL,DEATH,1
CL,DECREASED APPETITE,1
CL,DIARRHOEA,1
CL,DIPLOPIA,1
CL,DISEASE PROGRESSION,1
CL,DRUG INEFFECTIVE,1
CL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CL,DRUG-INDUCED LIVER INJURY,1
CL,ECTOPIC PREGNANCY,1
CL,EPILEPSY,1
CL,ERYTHEMA,1
CL,EYE HAEMORRHAGE,1
CL,FALL,1
CL,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
CL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CL,GASTROINTESTINAL OBSTRUCTION,1
CL,GENERAL PHYSICAL HEALTH DETERIORATION,1
CL,GENERALISED TONIC-CLONIC SEIZURE,1
CL,HEPATIC ENZYME INCREASED,1
CL,HEPATITIS,1
CL,HEPATITIS ACUTE,1
CL,HYPERTENSION,1
CL,ILL-DEFINED DISORDER,1
CL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CL,INCORRECT PRODUCT STORAGE,1
CL,INFLAMMATORY PSEUDOTUMOUR,1
CL,INJECTION SITE ATROPHY,1
CL,INJECTION SITE ERYTHEMA,1
CL,INJECTION SITE ULCER,1
CL,INSOMNIA,1
CL,ISCHAEMIC STROKE,1
CL,JAUNDICE,1
CL,LACK OF INJECTION SITE ROTATION,1
CL,LIVER FUNCTION TEST ABNORMAL,1
CL,LIVER INJURY,1
CL,LUNG DISORDER,1
CL,MALAISE,1
CL,MEMORY IMPAIRMENT,1
CL,MIGRAINE,1
CL,MONOPARESIS,1
CL,MOTOR DYSFUNCTION,1
CL,MUSCLE TONE DISORDER,1
CL,MYALGIA,1
CL,NASOPHARYNGITIS,1
CL,NONINFECTIVE ENCEPHALITIS,1
CL,NYSTAGMUS,1
CL,OCULAR DISCOMFORT,1
CL,OPPORTUNISTIC INFECTION,1
CL,PARAESTHESIA,1
CL,PERINATAL DEPRESSION,1
CL,PRURITUS GENERALISED,1
CL,PYELONEPHRITIS,1
CL,SCHWANNOMA,1
CL,SEIZURE,1
CL,SENSORY LOSS,1
CL,STRESS,1
CL,SYNCOPE,1
CL,TOXICITY TO VARIOUS AGENTS,1
CL,UNEVALUABLE EVENT,1
CL,URINARY TRACT INFECTION,1
CL,URINARY TRACT INFECTION ENTEROCOCCAL,1
CL,URINE ABNORMALITY,1
CL,URINE ANALYSIS ABNORMAL,1
CL,URINE ODOUR ABNORMAL,1
CL,UTERINE LEIOMYOMA,1
CL,VISION BLURRED,1
CL,VISUAL IMPAIRMENT,1
CL,WHITE BLOOD CELL COUNT DECREASED,1
CL,WHITE BLOOD CELLS URINE POSITIVE,1
CN,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
CO,HEADACHE,29
CO,PYREXIA,18
CO,MULTIPLE SCLEROSIS RELAPSE,15
CO,PAIN,15
CO,DEATH,13
CO,PARAESTHESIA,11
CO,GAIT DISTURBANCE,10
CO,PAIN IN EXTREMITY,10
CO,ARTHRALGIA,9
CO,CHILLS,9
CO,ASTHENIA,8
CO,DEPRESSION,7
CO,INFLUENZA,7
CO,MALAISE,7
CO,VOMITING,7
CO,BACK PAIN,6
CO,BALANCE DISORDER,6
CO,CENTRAL NERVOUS SYSTEM LESION,6
CO,DIZZINESS,6
CO,HEMIPARESIS,6
CO,URINARY TRACT INFECTION,6
CO,VISION BLURRED,6
CO,HYPOAESTHESIA,5
CO,MOBILITY DECREASED,5
CO,MULTIPLE SCLEROSIS,5
CO,BLINDNESS UNILATERAL,4
CO,COUGH,4
CO,DEPRESSED MOOD,4
CO,FATIGUE,4
CO,LOSS OF CONSCIOUSNESS,4
CO,NAUSEA,4
CO,PNEUMONIA,4
CO,PRURITUS,4
CO,SEIZURE,4
CO,SENSORY LOSS,4
CO,ABASIA,3
CO,CHEST PAIN,3
CO,DECREASED APPETITE,3
CO,DEHYDRATION,3
CO,DIARRHOEA,3
CO,DISCOMFORT,3
CO,EYE DISORDER,3
CO,FALL,3
CO,ILL-DEFINED DISORDER,3
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
CO,INFLAMMATION,3
CO,INSOMNIA,3
CO,MATERNAL EXPOSURE DURING PREGNANCY,3
CO,MUSCLE SPASTICITY,3
CO,MYALGIA,3
CO,OPTIC NEURITIS,3
CO,RASH,3
CO,TACHYCARDIA,3
CO,VERTIGO,3
CO,ABDOMINAL PAIN,2
CO,ANXIETY,2
CO,ARRHYTHMIA,2
CO,ASPHYXIA,2
CO,BLINDNESS,2
CO,BREAST CANCER,2
CO,BRONCHITIS,2
CO,BURNING SENSATION,2
CO,DECREASED IMMUNE RESPONSIVENESS,2
CO,DELIRIUM,2
CO,DRUG INTOLERANCE,2
CO,DYSPNOEA,2
CO,EYE PAIN,2
CO,FOETAL CARDIAC DISORDER,2
CO,FOETAL EXPOSURE TIMING UNSPECIFIED,2
CO,HYPERHIDROSIS,2
CO,HYPERTENSION,2
CO,HYPOTONIA,2
CO,INFARCTION,2
CO,INJECTION SITE PAIN,2
CO,LOSS OF CONTROL OF LEGS,2
CO,MEMORY IMPAIRMENT,2
CO,MIGRAINE,2
CO,MUSCLE DISORDER,2
CO,MUSCLE SPASMS,2
CO,MUSCULAR WEAKNESS,2
CO,MYOCARDIAL INFARCTION,2
CO,NECK PAIN,2
CO,NERVOUSNESS,2
CO,NEUROMYELITIS OPTICA,2
CO,NEUROMYELITIS OPTICA SPECTRUM DISORDER,2
CO,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,2
CO,ORAL DISORDER,2
CO,PARALYSIS,2
CO,PERITONITIS,2
CO,PHOTOPHOBIA,2
CO,RESPIRATORY ARREST,2
CO,SLEEP DISORDER,2
CO,SYNCOPE,2
CO,TONSILLITIS,2
CO,TREMOR,2
CO,URINARY RETENTION,2
CO,WEIGHT DECREASED,2
CO,ABDOMINAL DISCOMFORT,1
CO,ABDOMINAL PAIN UPPER,1
CO,ABORTION INDUCED,1
CO,ABSCESS,1
CO,ALOPECIA,1
CO,AMNESIA,1
CO,APATHY,1
CO,APHASIA,1
CO,APPENDICITIS,1
CO,APPENDICITIS PERFORATED,1
CO,ATAXIA,1
CO,BLOOD COUNT ABNORMAL,1
CO,BLOOD TEST ABNORMAL,1
CO,BLOOD TRIGLYCERIDES INCREASED,1
CO,BONE PAIN,1
CO,BREAST DISORDER FEMALE,1
CO,CAESAREAN SECTION,1
CO,CARDIO-RESPIRATORY ARREST,1
CO,CHEST DISCOMFORT,1
CO,CHIKUNGUNYA VIRUS INFECTION,1
CO,CHOLECYSTITIS,1
CO,COMPLICATION OF DELIVERY,1
CO,COMPLICATION OF PREGNANCY,1
CO,CRYING,1
CO,DEAFNESS UNILATERAL,1
CO,DEEP VEIN THROMBOSIS,1
CO,DIPLOPIA,1
CO,DISEASE COMPLICATION,1
CO,DISORIENTATION,1
CO,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CO,DRUG EFFECT DECREASED,1
CO,DRUG INEFFECTIVE,1
CO,DYSGEUSIA,1
CO,EAR INFECTION,1
CO,EMOTIONAL DISORDER,1
CO,ENDOMETRITIS,1
CO,EPISTAXIS,1
CO,ERYTHEMA,1
CO,EYE MOVEMENT DISORDER,1
CO,EYE SWELLING,1
CO,EYE ULCER,1
CO,FACIAL PAIN,1
CO,FACIAL PARALYSIS,1
CO,FEELING ABNORMAL,1
CO,FEELING DRUNK,1
CO,FEELING HOT,1
CO,FEMUR FRACTURE,1
CO,FIBROMYALGIA,1
CO,FLANK PAIN,1
CO,FLUID RETENTION,1
CO,GASTROINTESTINAL INFECTION,1
CO,GENERAL PHYSICAL HEALTH DETERIORATION,1
CO,GENERALISED ERYTHEMA,1
CO,GENERALISED OEDEMA,1
CO,GLOMERULONEPHRITIS,1
CO,GLOSSODYNIA,1
CO,HAEMATEMESIS,1
CO,HAEMATURIA,1
CO,HAEMOGLOBIN DECREASED,1
CO,HEAD INJURY,1
CO,HEMIANAESTHESIA,1
CO,HEPATITIS,1
CO,HEPATOMEGALY,1
CO,HEPATOTOXICITY,1
CO,HORDEOLUM,1
CO,HYPERAESTHESIA,1
CO,HYPERSENSITIVITY,1
CO,HYPOTENSION,1
CO,HYPOTHERMIA,1
CO,INCISION SITE COMPLICATION,1
CO,INFECTION,1
CO,INTENTIONAL PRODUCT USE ISSUE,1
CO,INTERVERTEBRAL DISC OPERATION,1
CO,INTESTINAL OBSTRUCTION,1
CO,KIDNEY INFECTION,1
CO,LIMB INJURY,1
CO,LUNG DISORDER,1
CO,LYMPHOMA,1
CO,MASS,1
CO,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
CO,METASTATIC NEOPLASM,1
CO,MICTURITION URGENCY,1
CO,MOOD ALTERED,1
CO,MOTOR DYSFUNCTION,1
CO,MUSCLE RIGIDITY,1
CO,MYCOPLASMA INFECTION,1
CO,NEOPLASM,1
CO,NEPHROTIC SYNDROME,1
CO,NERVE COMPRESSION,1
CO,NIGHTMARE,1
CO,OCULAR DISCOMFORT,1
CO,ODYNOPHAGIA,1
CO,ORAL PAIN,1
CO,PARAESTHESIA ORAL,1
CO,PERIPHERAL COLDNESS,1
CO,PERIPHERAL SWELLING,1
CO,PROTEIN TOTAL ABNORMAL,1
CO,PULMONARY EMBOLISM,1
CO,PULMONARY GRANULOMA,1
CO,PULMONARY THROMBOSIS,1
CO,RAYNAUD^S PHENOMENON,1
CO,RENAL PAIN,1
CO,RESPIRATORY DISTRESS,1
CO,RESPIRATORY TRACT CONGESTION,1
CO,RESPIRATORY TRACT INFECTION,1
CO,SENSATION OF FOREIGN BODY,1
CO,SENSORY DISTURBANCE,1
CO,SKIN NECROSIS,1
CO,SKIN ULCER,1
CO,SOCIAL FEAR,1
CO,SOMNOLENCE,1
CO,SPINAL COLUMN INJURY,1
CO,SPINAL PAIN,1
CO,SWELLING,1
CO,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CO,THERAPEUTIC PROCEDURE,1
CO,THROMBOSIS,1
CO,TRANSAMINASES INCREASED,1
CO,TREATMENT NONCOMPLIANCE,1
CO,TUBERCULOSIS,1
CO,UNEVALUABLE EVENT,1
CO,UTERINE HAEMORRHAGE,1
CO,VAGINAL HAEMORRHAGE,1
CO,VIITH NERVE PARALYSIS,1
CO,VISUAL IMPAIRMENT,1
CO,WHITE BLOOD CELL ANALYSIS ABNORMAL,1
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CR,BONE PAIN,1
CR,CARDIOVASCULAR DISORDER,1
CR,DRUG INTOLERANCE,1
CR,FOOT FRACTURE,1
CR,GAIT DISTURBANCE,1
CR,HYPERSENSITIVITY,1
CR,INJECTION SITE CELLULITIS,1
CR,INTESTINAL OBSTRUCTION,1
CR,PANNICULITIS,1
CR,SKIN REACTION,1
CR,THROAT TIGHTNESS,1
CR,URTICARIA,1
HR,PYREXIA,3
HR,ERYTHEMA,2
HR,FATIGUE,2
HR,GLOMERULONEPHRITIS MEMBRANOUS,2
HR,LIPODYSTROPHY ACQUIRED,2
HR,ARTHRALGIA,1
HR,CONTUSION,1
HR,DEPRESSION,1
HR,DRUG USE DISORDER,1
HR,GENERAL SYMPTOM,1
HR,HYPOTHYROIDISM,1
HR,INFLUENZA LIKE ILLNESS,1
HR,INVASIVE LOBULAR BREAST CARCINOMA,1
HR,LISTLESS,1
HR,MALAISE,1
HR,MYOCARDIAL INFARCTION,1
HR,PAIN,1
HR,SCHIZOPHRENIFORM DISORDER,1
HR,SKIN NECROSIS,1
HR,SKIN TIGHTNESS,1
HR,SUICIDE ATTEMPT,1
HR,SWELLING,1
HR,VOLVULUS,1
CY,ACUTE KIDNEY INJURY,2
CY,BRADYCARDIA,2
CY,BREAST CANCER,1
CY,ECZEMA,1
CY,ERECTILE DYSFUNCTION,1
CY,GOITRE,1
CY,HEPATIC ENZYME INCREASED,1
CY,HYPERTHYROIDISM,1
CY,INTENTIONAL UNDERDOSE,1
CY,MYOCARDIAL INFARCTION,1
CZ,ABORTION SPONTANEOUS,5
CZ,EXPOSURE DURING PREGNANCY,4
CZ,MULTIPLE SCLEROSIS RELAPSE,4
CZ,DRUG-INDUCED LIVER INJURY,3
CZ,CAESAREAN SECTION,2
CZ,INFLUENZA LIKE ILLNESS,2
CZ,PREGNANCY,2
CZ,PULMONARY EMBOLISM,2
CZ,ABDOMINAL PAIN UPPER,1
CZ,ALOPECIA,1
CZ,ARRESTED LABOUR,1
CZ,BONE MARROW FAILURE,1
CZ,CHILLS,1
CZ,CONTUSION,1
CZ,DEPRESSION,1
CZ,DISEASE PROGRESSION,1
CZ,DYSPNOEA,1
CZ,ECTOPIC PREGNANCY,1
CZ,FALL,1
CZ,GERM CELL CANCER,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,HEPATIC LESION,1
CZ,HEPATITIS ACUTE,1
CZ,HEPATITIS TOXIC,1
CZ,HERPES VIRUS INFECTION,1
CZ,ILEUS,1
CZ,INVASIVE DUCTAL BREAST CARCINOMA,1
CZ,JAUNDICE,1
CZ,LEUKOPENIA,1
CZ,LIVER DISORDER,1
CZ,LOW BIRTH WEIGHT BABY,1
CZ,MASTOIDITIS,1
CZ,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
CZ,METASTASES TO LIVER,1
CZ,MYOCLONUS,1
CZ,NAUSEA,1
CZ,PANCREATIC NEOPLASM,1
CZ,PANCREATITIS ACUTE,1
CZ,PANIC ATTACK,1
CZ,PARANEOPLASTIC SYNDROME,1
CZ,PLEURISY,1
CZ,PNEUMONIA,1
CZ,PRE-ECLAMPSIA,1
CZ,PSORIASIS,1
CZ,PULMONARY ARTERIAL HYPERTENSION,1
CZ,PULMONARY HYPERTENSION,1
CZ,SWELLING FACE,1
CZ,THROMBOPHLEBITIS,1
CZ,THYROID DISORDER,1
CZ,URTICARIA,1
CZ,UTERINE HAEMATOMA,1
CZ,UTERINE LEIOMYOMA,1
CZ,VOMITING,1
DK,MALAISE,4
DK,MULTIPLE SCLEROSIS RELAPSE,4
DK,ABDOMINAL ABSCESS,3
DK,ABORTION SPONTANEOUS,3
DK,ACUTE DISSEMINATED ENCEPHALOMYELITIS,3
DK,APHASIA,3
DK,APPENDICITIS PERFORATED,3
DK,CENTRAL NERVOUS SYSTEM LESION,3
DK,COGNITIVE DISORDER,3
DK,DYSPNOEA,3
DK,HAEMANGIOMA,3
DK,HEMIPARESIS,3
DK,PELVIC FLUID COLLECTION,3
DK,PERITONITIS,3
DK,QUADRIPLEGIA,3
DK,SINUS POLYP,3
DK,ACUTE MYOCARDIAL INFARCTION,2
DK,DIZZINESS,2
DK,INFLUENZA LIKE ILLNESS,2
DK,LUNG ADENOCARCINOMA,2
DK,MATERNAL EXPOSURE DURING PREGNANCY,2
DK,METASTASES TO CENTRAL NERVOUS SYSTEM,2
DK,ABORTION INDUCED,1
DK,ACNE,1
DK,ACUTE HEPATIC FAILURE,1
DK,ALOPECIA,1
DK,ARTERIAL OCCLUSIVE DISEASE,1
DK,ARTHRALGIA,1
DK,BALANCE DISORDER,1
DK,CARDIAC FAILURE,1
DK,CARDIOMYOPATHY,1
DK,CHEST PAIN,1
DK,CLINICALLY ISOLATED SYNDROME,1
DK,CONGESTIVE CARDIOMYOPATHY,1
DK,CORNEAL DEPOSITS,1
DK,CORNEAL DISORDER,1
DK,CYSTITIS,1
DK,DISCOMFORT,1
DK,DRUG PRESCRIBING ERROR,1
DK,EPIGASTRIC DISCOMFORT,1
DK,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
DK,EXPOSURE DURING PREGNANCY,1
DK,FOETAL EXPOSURE DURING PREGNANCY,1
DK,GOITRE,1
DK,HAEMOLYTIC URAEMIC SYNDROME,1
DK,HEPATIC ENZYME INCREASED,1
DK,HYPERSENSITIVITY VASCULITIS,1
DK,INFECTION,1
DK,INJECTION SITE ERYTHEMA,1
DK,INJECTION SITE INFECTION,1
DK,INJECTION SITE PAIN,1
DK,INSOMNIA,1
DK,JC VIRUS INFECTION,1
DK,MALIGNANT MELANOMA OF EYELID,1
DK,MENINGOMYELOCELE,1
DK,MUSCLE ABSCESS,1
DK,MUSCLE SPASMS,1
DK,OSTEONECROSIS,1
DK,PAIN,1
DK,PANNICULITIS,1
DK,PARAESTHESIA,1
DK,PULMONARY ARTERIAL HYPERTENSION,1
DK,PULMONARY OEDEMA,1
DK,PYREXIA,1
DK,RHABDOMYOLYSIS,1
DK,SPLENIC HAEMATOMA,1
DK,SPLENIC RUPTURE,1
DK,SYNCOPE,1
DK,THYROIDITIS ACUTE,1
DK,TOOTH LOSS,1
DK,TREMOR,1
DK,VASCULAR CALCIFICATION,1
DK,VISUAL ACUITY REDUCED,1
DK,VOMITING,1
DO,FLAVIVIRUS INFECTION,2
DO,ANAL HAEMORRHAGE,1
DO,ASPIRATION,1
DO,DEATH,1
DO,DEHYDRATION,1
DO,DIARRHOEA,1
DO,FEELING ABNORMAL,1
DO,FEELING HOT,1
DO,HYPERAESTHESIA,1
DO,HYPERSENSITIVITY,1
DO,HYPOPHAGIA,1
DO,INJECTION SITE ABSCESS,1
DO,INJECTION SITE BRUISING,1
DO,INJECTION SITE PAIN,1
DO,INJECTION SITE PRURITUS,1
DO,LEUKOPENIA,1
DO,MEMORY IMPAIRMENT,1
DO,PNEUMONIA,1
DO,PROGRESSIVE MULTIPLE SCLEROSIS,1
DO,SCAR,1
DO,SKIN IRRITATION,1
DO,VAGINAL HAEMORRHAGE,1
DO,VOMITING,1
EC,HYPERTHYROIDISM,2
EC,MULTIPLE SCLEROSIS RELAPSE,2
EC,SEIZURE,2
EC,ALANINE AMINOTRANSFERASE INCREASED,1
EC,ASPARTATE AMINOTRANSFERASE INCREASED,1
EC,BACK PAIN,1
EC,CONJUNCTIVITIS,1
EC,DEATH,1
EC,DIZZINESS,1
EC,DRUG INEFFECTIVE,1
EC,FATIGUE,1
EC,HEADACHE,1
EC,HEPATIC ENZYME ABNORMAL,1
EC,IMMOBILE,1
EC,INFLUENZA,1
EC,PAIN IN EXTREMITY,1
EC,PARAESTHESIA,1
EC,POSTICTAL HEADACHE,1
EC,PULMONARY ARTERIAL HYPERTENSION,1
EC,PULMONARY HYPERTENSION,1
EC,RASH,1
EC,SPINAL PAIN,1
EC,TREMOR,1
EC,VOMITING,1
EG,DEATH,5
EG,CHILLS,2
EG,FATIGUE,2
EG,HAEMORRHAGE,2
EG,PYREXIA,2
EG,ABDOMINAL DISCOMFORT,1
EG,CHEST DISCOMFORT,1
EG,COMA,1
EG,DEEP VEIN THROMBOSIS,1
EG,DISTURBANCE IN ATTENTION,1
EG,DIZZINESS,1
EG,HYPERSENSITIVITY,1
EG,HYPOAESTHESIA,1
EG,INFLUENZA LIKE ILLNESS,1
EG,LIMB DISCOMFORT,1
EG,LOSS OF CONSCIOUSNESS,1
EG,NAUSEA,1
EG,NEPHRITIS,1
EG,OROPHARYNGEAL PAIN,1
EG,PAIN IN EXTREMITY,1
EG,PARALYSIS,1
EG,PLATELET COUNT DECREASED,1
EG,PRODUCT AVAILABILITY ISSUE,1
EG,PSYCHIATRIC SYMPTOM,1
EG,SLEEP TALKING,1
EG,TESTIS CANCER,1
EG,VOMITING,1
EE,AUTOIMMUNE DISORDER,2
EE,ALANINE AMINOTRANSFERASE INCREASED,1
EE,ASPARTATE AMINOTRANSFERASE INCREASED,1
EE,C-REACTIVE PROTEIN INCREASED,1
EE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,ALANINE AMINOTRANSFERASE INCREASED,2
FI,MATERNAL EXPOSURE DURING PREGNANCY,2
FI,PANCREATITIS,2
FI,ABDOMINAL PAIN,1
FI,ABORTION SPONTANEOUS,1
FI,ADVERSE DRUG REACTION,1
FI,AMENORRHOEA,1
FI,ANKYLOSING SPONDYLITIS,1
FI,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FI,BLOOD BILIRUBIN INCREASED,1
FI,BRADYCARDIA,1
FI,BREECH PRESENTATION,1
FI,CELLULITIS,1
FI,CHOLELITHIASIS,1
FI,CONDITION AGGRAVATED,1
FI,FALL,1
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,GLIOMA,1
FI,HEADACHE,1
FI,HEREDITARY MOTOR AND SENSORY NEUROPATHY,1
FI,HYPERTENSION,1
FI,HYPOTHYROIDISM,1
FI,INFERTILITY FEMALE,1
FI,PYREXIA,1
FR,MULTIPLE SCLEROSIS RELAPSE,32
FR,INFLUENZA LIKE ILLNESS,22
FR,PULMONARY ARTERIAL HYPERTENSION,16
FR,FATIGUE,13
FR,INJECTION SITE PAIN,12
FR,MATERNAL EXPOSURE DURING PREGNANCY,12
FR,BREAST CANCER,11
FR,HEADACHE,11
FR,ALANINE AMINOTRANSFERASE INCREASED,10
FR,FOETAL EXPOSURE DURING PREGNANCY,10
FR,HEPATOCELLULAR INJURY,10
FR,INJECTION SITE ERYTHEMA,10
FR,PYREXIA,10
FR,DRUG INTOLERANCE,9
FR,DRUG-INDUCED LIVER INJURY,9
FR,ABORTION SPONTANEOUS,8
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
FR,LOSS OF CONSCIOUSNESS,8
FR,NAUSEA,8
FR,THROMBOTIC MICROANGIOPATHY,8
FR,VOMITING,8
FR,DEPRESSION,7
FR,INJECTION SITE INFLAMMATION,7
FR,RENAL FAILURE,7
FR,TRANSAMINASES INCREASED,7
FR,WEIGHT DECREASED,7
FR,ASPARTATE AMINOTRANSFERASE INCREASED,6
FR,AUTOIMMUNE HEPATITIS,6
FR,CHOLESTASIS,6
FR,DERMATOMYOSITIS,6
FR,DYSPNOEA EXERTIONAL,6
FR,HAEMOLYTIC URAEMIC SYNDROME,6
FR,MALAISE,6
FR,METASTASIS,6
FR,ALOPECIA,5
FR,ASTHENIA,5
FR,COR PULMONALE CHRONIC,5
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,5
FR,DRUG INEFFECTIVE,5
FR,EPILEPSY,5
FR,HYPERTENSION,5
FR,LYMPHOPENIA,5
FR,MULTIPLE SCLEROSIS,5
FR,MYOCARDIAL INFARCTION,5
FR,OPTIC NEURITIS,5
FR,PAIN,5
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,5
FR,PRURITUS,5
FR,CARDIOGENIC SHOCK,4
FR,CHILLS,4
FR,COLD TYPE HAEMOLYTIC ANAEMIA,4
FR,DECREASED APPETITE,4
FR,DYSPNOEA,4
FR,HAEMOLYTIC ANAEMIA,4
FR,INJECTION SITE HAEMATOMA,4
FR,MYALGIA,4
FR,NASOPHARYNGITIS,4
FR,PLATELET COUNT DECREASED,4
FR,SEIZURE,4
FR,URINARY TRACT INFECTION,4
FR,VIRAL INFECTION,4
FR,ABNORMAL BEHAVIOUR,3
FR,ANAEMIA,3
FR,BACK PAIN,3
FR,BASEDOW^S DISEASE,3
FR,BLOOD TRIGLYCERIDES INCREASED,3
FR,CARDIAC DISORDER,3
FR,CARDIAC FAILURE,3
FR,CARDIOMEGALY,3
FR,CELL DEATH,3
FR,CERVIX CARCINOMA,3
FR,ERYTHEMA,3
FR,HEPATIC ENZYME INCREASED,3
FR,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
FR,INFLUENZA,3
FR,INJECTION SITE ABSCESS,3
FR,INJECTION SITE MASS,3
FR,INJECTION SITE NECROSIS,3
FR,INJECTION SITE PRURITUS,3
FR,INSOMNIA,3
FR,INTERVERTEBRAL DISC PROTRUSION,3
FR,IRRITABILITY,3
FR,MALIGNANT MELANOMA,3
FR,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,3
FR,MIGRAINE,3
FR,NEUTROPENIA,3
FR,NEUTROPHIL COUNT DECREASED,3
FR,NORMAL NEWBORN,3
FR,PAIN IN EXTREMITY,3
FR,PANCREATITIS,3
FR,SYNOVIAL SARCOMA,3
FR,THROMBOCYTOPENIA,3
FR,UTERINE LEIOMYOMA,3
FR,WHITE BLOOD CELL COUNT DECREASED,3
FR,ACUTE CORONARY SYNDROME,2
FR,ACUTE KIDNEY INJURY,2
FR,ALOPECIA AREATA,2
FR,ANAPLASTIC LARGE-CELL LYMPHOMA,2
FR,ANGIOEDEMA,2
FR,ANGLE CLOSURE GLAUCOMA,2
FR,ARTHRALGIA,2
FR,ARTHRITIS,2
FR,AUTOIMMUNE THYROIDITIS,2
FR,BASAL CELL CARCINOMA,2
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,2
FR,BRAIN MALFORMATION,2
FR,BREAST CANCER METASTATIC,2
FR,BURNING SENSATION,2
FR,CAESAREAN SECTION,2
FR,CEREBRAL VENTRICLE DILATATION,2
FR,CERVICAL DYSPLASIA,2
FR,COARCTATION OF THE AORTA,2
FR,COGNITIVE DISORDER,2
FR,COMA,2
FR,CONDITION AGGRAVATED,2
FR,CONJUNCTIVITIS,2
FR,CONSTIPATION,2
FR,COUGH,2
FR,DEAFNESS CONGENITAL,2
FR,DIARRHOEA,2
FR,DISABILITY,2
FR,DYSPHAGIA,2
FR,EAR PRURITUS,2
FR,ERYSIPELAS,2
FR,EXPOSURE VIA FATHER,2
FR,FALL,2
FR,FASCIITIS,2
FR,FOETAL EXPOSURE TIMING UNSPECIFIED,2
FR,FOETAL MALFORMATION,2
FR,GAIT DISTURBANCE,2
FR,HEPATITIS,2
FR,HERPES ZOSTER CUTANEOUS DISSEMINATED,2
FR,HUMAN CHORIONIC GONADOTROPIN DECREASED,2
FR,HUMAN CHORIONIC GONADOTROPIN INCREASED,2
FR,HYPERTHYROIDISM,2
FR,INJECTION SITE INDURATION,2
FR,INJECTION SITE INFECTION,2
FR,INJECTION SITE NODULE,2
FR,INJECTION SITE SWELLING,2
FR,INVASIVE DUCTAL BREAST CARCINOMA,2
FR,ISCHAEMIC HEPATITIS,2
FR,LEUKOPENIA,2
FR,MENOMETRORRHAGIA,2
FR,MUSCLE ATROPHY,2
FR,MUSCLE SPASMS,2
FR,NECROTISING FASCIITIS,2
FR,NEPHROTIC SYNDROME,2
FR,NERVOUS SYSTEM DISORDER,2
FR,NEUROENDOCRINE TUMOUR,2
FR,ODYNOPHAGIA,2
FR,PAPILLOMA VIRAL INFECTION,2
FR,PARAESTHESIA,2
FR,PARALYSIS,2
FR,PERICARDITIS,2
FR,PERIPHERAL ARTERY THROMBOSIS,2
FR,PLEURISY,2
FR,PREMATURE BABY,2
FR,PREMATURE DELIVERY,2
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
FR,RASH,2
FR,RECTAL CANCER,2
FR,RENAL DISORDER,2
FR,RENAL FAILURE ACUTE,2
FR,RENAL IMPAIRMENT,2
FR,RETINAL VEIN OCCLUSION,2
FR,SARCOIDOSIS,2
FR,SENSORY LOSS,2
FR,T-CELL LYMPHOMA,2
FR,TENDON RUPTURE,2
FR,THROMBOCYTOPENIC PURPURA,2
FR,THYROID DISORDER,2
FR,TOOTH LOSS,2
FR,URINARY INCONTINENCE,2
FR,VARICOSE VEIN,2
FR,VERTIGO,2
FR,VIRAL UVEITIS,2
FR,VISUAL FIELD DEFECT,2
FR,VISUAL IMPAIRMENT,2
FR,ABDOMINAL ABSCESS,1
FR,ABDOMINAL PAIN,1
FR,ABDOMINAL PAIN UPPER,1
FR,ABDOMINAL TENDERNESS,1
FR,ABORTION INDUCED,1
FR,ABSCESS,1
FR,ACCIDENTAL OVERDOSE,1
FR,ACUTE MYELOID LEUKAEMIA,1
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
FR,AGE-RELATED MACULAR DEGENERATION,1
FR,AGGRESSION,1
FR,AGRANULOCYTOSIS,1
FR,AMNIOTIC FLUID VOLUME DECREASED,1
FR,ANAL ABSCESS,1
FR,ANAL CANCER,1
FR,ANAL SQUAMOUS CELL CARCINOMA,1
FR,ANEURYSM RUPTURED,1
FR,ANGINA PECTORIS,1
FR,ANGIOSCLEROSIS,1
FR,ANTI-THYROID ANTIBODY POSITIVE,1
FR,ANXIETY,1
FR,APHTHOUS STOMATITIS,1
FR,APICAL GRANULOMA,1
FR,ASCITES,1
FR,ASTHMATIC CRISIS,1
FR,ATAXIA,1
FR,AUTOIMMUNE DISORDER,1
FR,AUTOIMMUNE PANCREATITIS,1
FR,AUTOIMMUNE PANCYTOPENIA,1
FR,BALANCE DISORDER,1
FR,BEDRIDDEN,1
FR,BENIGN PANCREATIC NEOPLASM,1
FR,BLOOD ALBUMIN DECREASED,1
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
FR,BLOOD CHOLESTEROL INCREASED,1
FR,BLOOD PRESSURE INCREASED,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BLOOD UREA DECREASED,1
FR,BODY TEMPERATURE INCREASED,1
FR,BONE NEOPLASM,1
FR,BREAST NEOPLASM,1
FR,BREATH SOUNDS,1
FR,BRONCHIAL CARCINOMA,1
FR,BRONCHITIS,1
FR,BURKITT^S LYMPHOMA,1
FR,CALCULUS BLADDER,1
FR,CANDIDA INFECTION,1
FR,CARCINOID TUMOUR OF THE SMALL BOWEL,1
FR,CEREBRAL CYST,1
FR,CEREBROVASCULAR ACCIDENT,1
FR,CERVICAL POLYP,1
FR,CERVICITIS HUMAN PAPILLOMA VIRUS,1
FR,CERVICOBRACHIAL SYNDROME,1
FR,CERVIX CARCINOMA STAGE 0,1
FR,CHEILITIS,1
FR,CHEST PAIN,1
FR,CHOLECYSTITIS,1
FR,CHOLELITHIASIS,1
FR,CHONDROCALCINOSIS,1
FR,CHRONIC MYELOID LEUKAEMIA,1
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FR,CIRCULATING ANTICOAGULANT POSITIVE,1
FR,CLAVICLE FRACTURE,1
FR,COLD SWEAT,1
FR,COLITIS ISCHAEMIC,1
FR,COLITIS ULCERATIVE,1
FR,COLON CANCER METASTATIC,1
FR,COLON NEOPLASM,1
FR,COMPLICATION OF PREGNANCY,1
FR,COMPULSIVE SEXUAL BEHAVIOUR,1
FR,CONFUSIONAL STATE,1
FR,CONVULSION,1
FR,CORNEAL ABSCESS,1
FR,CORONARY ARTERY DISSECTION,1
FR,CREATININE RENAL CLEARANCE DECREASED,1
FR,CRYSTAL ARTHROPATHY,1
FR,CUTANEOUS SARCOIDOSIS,1
FR,CUTANEOUS VASCULITIS,1
FR,CYSTITIS INTERSTITIAL,1
FR,CYTOKINE RELEASE SYNDROME,1
FR,CYTOMEGALOVIRUS TEST,1
FR,DEATH,1
FR,DECREASED ACTIVITY,1
FR,DELIRIUM,1
FR,DENTAL CARIES,1
FR,DEPRESSIVE SYMPTOM,1
FR,DERMATITIS CONTACT,1
FR,DERMO-HYPODERMITIS,1
FR,DEVICE DEPLOYMENT ISSUE,1
FR,DEVICE DIFFICULT TO USE,1
FR,DIABETES MELLITUS INADEQUATE CONTROL,1
FR,DISEASE PROGRESSION,1
FR,DIZZINESS,1
FR,DRUG HYPERSENSITIVITY,1
FR,DUODENITIS,1
FR,DYSGEUSIA,1
FR,DYSPHEMIA,1
FR,EAR HAEMORRHAGE,1
FR,EAR SWELLING,1
FR,EATING DISORDER,1
FR,ECCHYMOSIS,1
FR,ECTOPIC PREGNANCY,1
FR,ECZEMA,1
FR,ENDOMETRIOSIS,1
FR,ENDOTRACHEAL INTUBATION COMPLICATION,1
FR,EPISTAXIS,1
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,1
FR,ESCHERICHIA URINARY TRACT INFECTION,1
FR,EXPOSURE DURING PREGNANCY,1
FR,FAECAL INCONTINENCE,1
FR,FEEDING DISORDER,1
FR,FEELING COLD,1
FR,FEELING HOT,1
FR,FLUSHING,1
FR,FOETAL CARDIAC DISORDER,1
FR,FOETAL DISORDER,1
FR,FOETAL GROWTH RESTRICTION,1
FR,FOLLICULITIS,1
FR,FOREARM FRACTURE,1
FR,GALLBLADDER DISORDER,1
FR,GALLBLADDER OPERATION,1
FR,GASTROINTESTINAL STROMAL TUMOUR,1
FR,GENERALISED TONIC-CLONIC SEIZURE,1
FR,GENITAL HAEMORRHAGE,1
FR,GESTATIONAL DIABETES,1
FR,GINGIVAL ABSCESS,1
FR,GINGIVAL RECESSION,1
FR,GINGIVITIS,1
FR,GLAUCOMA,1
FR,GLOBULINS INCREASED,1
FR,HAEMANGIOMA,1
FR,HAEMANGIOMA OF LIVER,1
FR,HAEMANGIOMA OF SKIN,1
FR,HAEMATOCHEZIA,1
FR,HAEMATOMA,1
FR,HAEMOGLOBIN DECREASED,1
FR,HAEMOPTYSIS,1
FR,HALLUCINATION,1
FR,HAPTOGLOBIN,1
FR,HEAD DISCOMFORT,1
FR,HEAT STROKE,1
FR,HEMIPLEGIA,1
FR,HEPATIC STEATOSIS,1
FR,HEPATITIS B,1
FR,HEPATOMEGALY,1
FR,HEPATOTOXICITY,1
FR,HOMICIDAL IDEATION,1
FR,HOT FLUSH,1
FR,HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE,1
FR,HYPERCALCAEMIA,1
FR,HYPERGLYCAEMIA,1
FR,HYPERKERATOSIS,1
FR,HYPERSENSITIVITY VASCULITIS,1
FR,HYPERTENSIVE CRISIS,1
FR,HYPOKALAEMIA,1
FR,HYPOTHYROIDISM,1
FR,HYPOVOLAEMIC SHOCK,1
FR,IMMUNE THROMBOCYTOPENIC PURPURA,1
FR,IMMUNOGLOBULINS ABNORMAL,1
FR,IMMUNOSUPPRESSION,1
FR,IMPLANT SITE PAIN,1
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
FR,INCORRECT DOSE ADMINISTERED,1
FR,INCORRECT DRUG ADMINISTRATION RATE,1
FR,INFLAMMATION,1
FR,INFUSION SITE ERYTHEMA,1
FR,INJECTION SITE ATROPHY,1
FR,INJECTION SITE HAEMORRHAGE,1
FR,INJECTION SITE PLAQUE,1
FR,INJECTION SITE REACTION,1
FR,INJECTION SITE URTICARIA,1
FR,INJURY,1
FR,INTERVERTEBRAL DISC DISORDER,1
FR,INTRACRANIAL ANEURYSM,1
FR,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
FR,INVASIVE BREAST CARCINOMA,1
FR,ISCHAEMIC STROKE,1
FR,JAUNDICE,1
FR,KERATITIS,1
FR,LANGUAGE DISORDER,1
FR,LARGE INTESTINAL STENOSIS,1
FR,LEFT VENTRICULAR DYSFUNCTION,1
FR,LIP SWELLING,1
FR,LIPOMA,1
FR,LIVER DISORDER,1
FR,LIVER INJURY,1
FR,LOCALISED INFECTION,1
FR,LUNG DISORDER,1
FR,LUNG NEOPLASM MALIGNANT,1
FR,LYMPHADENOPATHY MEDIASTINAL,1
FR,LYMPHOCYTE PERCENTAGE INCREASED,1
FR,LYMPHOEDEMA,1
FR,MACROSOMIA,1
FR,MALIGNANT HYPERTENSION,1
FR,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
FR,MEASLES,1
FR,MEDICAL DEVICE COMPLICATION,1
FR,MICROCYTIC ANAEMIA,1
FR,MIDDLE EAR EFFUSION,1
FR,MITRAL VALVE DISEASE,1
FR,MONOCYTOSIS,1
FR,MONOPLEGIA,1
FR,MOTOR DYSFUNCTION,1
FR,MUCOCUTANEOUS HAEMORRHAGE,1
FR,MUSCLE INJURY,1
FR,MUSCLE SPASTICITY,1
FR,MUSCULOSKELETAL CHEST PAIN,1
FR,MUSCULOSKELETAL DISORDER,1
FR,MYOCARDITIS,1
FR,NECK PAIN,1
FR,NECROSIS,1
FR,NEGATIVE THOUGHTS,1
FR,NEONATAL ASPIRATION,1
FR,NEOPLASM MALIGNANT,1
FR,NERVE COMPRESSION,1
FR,NEURALGIA,1
FR,NIGHT SWEATS,1
FR,NO ADVERSE EVENT,1
FR,NONINFECTIVE ENCEPHALITIS,1
FR,OCULAR HYPERTENSION,1
FR,OESOPHAGITIS,1
FR,ORTHOSTATIC HYPOTENSION,1
FR,PALPITATIONS,1
FR,PANCREATIC CARCINOMA,1
FR,PANCREATITIS ACUTE,1
FR,PANCYTOPENIA,1
FR,PANIC ATTACK,1
FR,PARAPARESIS,1
FR,PATERNAL EXPOSURE BEFORE PREGNANCY,1
FR,PELVIC NEOPLASM,1
FR,PERINEAL CYST,1
FR,PERIODONTAL DISEASE,1
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
FR,PERIPHERAL PARALYSIS,1
FR,PERITONITIS,1
FR,PHARYNGEAL ERYTHEMA,1
FR,PHLEBITIS,1
FR,PLACENTA PRAEVIA HAEMORRHAGE,1
FR,PLEURAL EFFUSION,1
FR,PNEUMOCOCCAL INFECTION,1
FR,PNEUMONIA,1
FR,PNEUMONIA TULARAEMIA,1
FR,POLYARTHRITIS,1
FR,POLYHYDRAMNIOS,1
FR,POLYMYOSITIS,1
FR,POROKERATOSIS,1
FR,POSTPARTUM HAEMORRHAGE,1
FR,PREGNANCY,1
FR,PROCEDURAL PAIN,1
FR,PRODUCT DISTRIBUTION ISSUE,1
FR,PROTHROMBIN TIME SHORTENED,1
FR,PSORIASIS,1
FR,PSYCHIATRIC DECOMPENSATION,1
FR,PSYCHOMOTOR RETARDATION,1
FR,PSYCHOTIC DISORDER,1
FR,PULMONARY EMBOLISM,1
FR,PULMONARY HYPERTENSION,1
FR,PULMONARY SARCOIDOSIS,1
FR,PYELONEPHRITIS,1
FR,QUALITY OF LIFE DECREASED,1
FR,RASH GENERALISED,1
FR,RASH MACULO-PAPULAR,1
FR,RASH PRURITIC,1
FR,RED BLOOD CELL MORPHOLOGY ABNORMAL,1
FR,RENAL FAILURE CHRONIC,1
FR,RESPIRATORY DISORDER,1
FR,RESPIRATORY DISTRESS,1
FR,RETINOPATHY HYPERTENSIVE,1
FR,RETROPERITONEAL EFFUSION,1
FR,RHABDOMYOLYSIS,1
FR,SARCOMA OF SKIN,1
FR,SCIATICA,1
FR,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
FR,SEXUAL ABUSE,1
FR,SINGLE UMBILICAL ARTERY,1
FR,SJOGREN^S SYNDROME,1
FR,SKIN LESION,1
FR,SKIN REACTION,1
FR,SKIN TOXICITY,1
FR,SKULL MALFORMATION,1
FR,SLEEP DISORDER,1
FR,SLOW SPEECH,1
FR,SMALL INTESTINAL HAEMORRHAGE,1
FR,SOFT TISSUE NECROSIS,1
FR,SOLAR LENTIGO,1
FR,SPEECH DISORDER,1
FR,SPINA BIFIDA,1
FR,SPINAL COLUMN STENOSIS,1
FR,SPLENECTOMY,1
FR,SPLENIC LESION,1
FR,STRESS CARDIOMYOPATHY,1
FR,SUBDURAL HAEMATOMA,1
FR,SUICIDAL IDEATION,1
FR,SUICIDE ATTEMPT,1
FR,T-CELL TYPE ACUTE LEUKAEMIA,1
FR,TAKAYASU^S ARTERITIS,1
FR,TENDONITIS,1
FR,THERMAL BURN,1
FR,THROMBOPHLEBITIS SUPERFICIAL,1
FR,THROMBOSIS,1
FR,THYMUS HYPOPLASIA,1
FR,THYROIDECTOMY,1
FR,THYROXINE FREE INCREASED,1
FR,TINNITUS,1
FR,TONSILLITIS,1
FR,TOOTH ABSCESS,1
FR,TOOTH DISORDER,1
FR,TOOTH EXTRACTION,1
FR,TOOTH FRACTURE,1
FR,TOOTH INFECTION,1
FR,TOOTHACHE,1
FR,TRACHEITIS,1
FR,TRANSIENT ISCHAEMIC ATTACK,1
FR,TREMOR,1
FR,TRIGEMINAL NEURALGIA,1
FR,ULCERATIVE KERATITIS,1
FR,UPPER RESPIRATORY TRACT INFECTION,1
FR,URINARY TRACT INFECTION BACTERIAL,1
FR,VAGINAL HAEMORRHAGE,1
FR,VASCULITIS,1
FR,VASCULITIS NECROTISING,1
FR,VENOUS STENOSIS,1
FR,VENTRICULAR FIBRILLATION,1
FR,VENTRICULAR SEPTAL DEFECT,1
FR,VERTEBRAL ARTERY DISSECTION,1
FR,VISION BLURRED,1
FR,VISUAL ACUITY REDUCED,1
FR,VISUAL BRIGHTNESS,1
FR,VOGT-KOYANAGI-HARADA SYNDROME,1
FR,VULVOVAGINAL BURNING SENSATION,1
FR,VULVOVAGINAL ERYTHEMA,1
FR,VULVOVAGINAL INJURY,1
FR,VULVOVAGINAL MYCOTIC INFECTION,1
FR,WALKING DISABILITY,1
GE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
GE,CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 1,1
DE,MULTIPLE SCLEROSIS RELAPSE,137
DE,MATERNAL EXPOSURE DURING PREGNANCY,88
DE,GAIT DISTURBANCE,60
DE,INFLUENZA LIKE ILLNESS,54
DE,BREAST CANCER,48
DE,FALL,47
DE,CHILLS,40
DE,EPILEPSY,39
DE,HEADACHE,38
DE,PAIN IN EXTREMITY,38
DE,FATIGUE,37
DE,HYPERTENSION,37
DE,HYPOAESTHESIA,37
DE,OPTIC NEURITIS,37
DE,PYREXIA,36
DE,DEATH,35
DE,DIZZINESS,34
DE,FOETAL EXPOSURE DURING PREGNANCY,31
DE,MYOCARDIAL INFARCTION,30
DE,CEREBROVASCULAR ACCIDENT,29
DE,PARAESTHESIA,29
DE,WEIGHT DECREASED,29
DE,VISUAL IMPAIRMENT,27
DE,INTERVERTEBRAL DISC PROTRUSION,24
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,23
DE,LOW BIRTH WEIGHT BABY,23
DE,PNEUMONIA,23
DE,MUSCULAR WEAKNESS,22
DE,ABORTION SPONTANEOUS,21
DE,CAESAREAN SECTION,21
DE,NASOPHARYNGITIS,21
DE,DEPRESSION,20
DE,MULTIPLE SCLEROSIS,20
DE,NAUSEA,20
DE,ALANINE AMINOTRANSFERASE INCREASED,18
DE,ANKLE FRACTURE,15
DE,BALANCE DISORDER,15
DE,DIABETES MELLITUS,15
DE,GENERAL PHYSICAL HEALTH DETERIORATION,15
DE,INJECTION SITE PAIN,15
DE,PAIN,15
DE,ASPARTATE AMINOTRANSFERASE INCREASED,14
DE,BACK PAIN,14
DE,DYSPNOEA,14
DE,INJECTION SITE ERYTHEMA,14
DE,PULMONARY EMBOLISM,14
DE,ABDOMINAL PAIN UPPER,13
DE,ARTHRALGIA,13
DE,FOETAL EXPOSURE TIMING UNSPECIFIED,13
DE,OSTEOARTHRITIS,13
DE,VOMITING,13
DE,ASTHENIA,12
DE,PREGNANCY,12
DE,PROLONGED LABOUR,12
DE,SENSORY DISTURBANCE,12
DE,THROMBOSIS,12
DE,CONTUSION,11
DE,CYSTITIS,11
DE,LOSS OF CONSCIOUSNESS,11
DE,MOBILITY DECREASED,11
DE,MYALGIA,11
DE,VISION BLURRED,11
DE,ARRHYTHMIA,10
DE,ATRIAL FIBRILLATION,10
DE,BRAIN NEOPLASM,10
DE,LIVER FUNCTION TEST ABNORMAL,10
DE,NEOPLASM MALIGNANT,10
DE,ROAD TRAFFIC ACCIDENT,10
DE,WEIGHT INCREASED,10
DE,CENTRAL NERVOUS SYSTEM LESION,9
DE,CHOLELITHIASIS,9
DE,CIRCULATORY COLLAPSE,9
DE,ERYSIPELAS,9
DE,MUSCULOSKELETAL STIFFNESS,9
DE,NEPHROLITHIASIS,9
DE,PALPITATIONS,9
DE,PRE-ECLAMPSIA,9
DE,SPEECH DISORDER,9
DE,TREMOR,9
DE,VISUAL ACUITY REDUCED,9
DE,ABSCESS,8
DE,DEPRESSED MOOD,8
DE,DIARRHOEA,8
DE,DIPLOPIA,8
DE,DRUG-INDUCED LIVER INJURY,8
DE,GASTRIC ULCER,8
DE,GASTRITIS,8
DE,INFECTION,8
DE,INFLUENZA,8
DE,INJECTION SITE ABSCESS,8
DE,LIVE BIRTH,8
DE,MALAISE,8
DE,MATERNAL EXPOSURE TIMING UNSPECIFIED,8
DE,OSTEONECROSIS,8
DE,PROCEDURAL PAIN,8
DE,URTICARIA,8
DE,UTERINE LEIOMYOMA,8
DE,VERTIGO,8
DE,ABDOMINAL PAIN,7
DE,ALOPECIA,7
DE,ANAPHYLACTIC SHOCK,7
DE,ANGINA PECTORIS,7
DE,APHASIA,7
DE,ARTHROPATHY,7
DE,BREECH PRESENTATION,7
DE,CEPHALO-PELVIC DISPROPORTION,7
DE,CEREBRAL HAEMORRHAGE,7
DE,CERVIX CARCINOMA,7
DE,COLON CANCER,7
DE,COUGH,7
DE,ERYTHEMA,7
DE,HEART RATE INCREASED,7
DE,HEMIPARESIS,7
DE,HEPATIC ENZYME INCREASED,7
DE,IMPAIRED HEALING,7
DE,INJECTION SITE INDURATION,7
DE,LEUKOPENIA,7
DE,MEMORY IMPAIRMENT,7
DE,MENTAL DISORDER,7
DE,MIGRAINE,7
DE,PREMATURE BABY,7
DE,PREMATURE RUPTURE OF MEMBRANES,7
DE,PYELONEPHRITIS,7
DE,RENAL FAILURE,7
DE,SEPSIS,7
DE,SKIN NECROSIS,7
DE,SLEEP DISORDER,7
DE,TENDON RUPTURE,7
DE,TRIGEMINAL NEURALGIA,7
DE,URINARY TRACT INFECTION,7
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,6
DE,BLOOD PRESSURE INCREASED,6
DE,COMA,6
DE,CONSTIPATION,6
DE,CORONARY ARTERY DISEASE,6
DE,DRUG INTOLERANCE,6
DE,FEELING ABNORMAL,6
DE,FOOT FRACTURE,6
DE,HAEMORRHAGE,6
DE,HYPERHIDROSIS,6
DE,HYPOTHYROIDISM,6
DE,INJECTION SITE HAEMORRHAGE,6
DE,LOWER LIMB FRACTURE,6
DE,MENISCUS INJURY,6
DE,MUSCLE SPASMS,6
DE,MUSCLE SPASTICITY,6
DE,NECROSIS,6
DE,OVARIAN CYST,6
DE,POST PROCEDURAL COMPLICATION,6
DE,PREMATURE DELIVERY,6
DE,PREMATURE LABOUR,6
DE,PROSTATE CANCER,6
DE,SKIN REACTION,6
DE,SYNCOPE,6
DE,TINNITUS,6
DE,UMBILICAL CORD AROUND NECK,6
DE,URINARY INCONTINENCE,6
DE,VIITH NERVE PARALYSIS,6
DE,APPENDICITIS,5
DE,AUTOIMMUNE THYROIDITIS,5
DE,BASAL CELL CARCINOMA,5
DE,BASEDOW^S DISEASE,5
DE,BILIARY COLIC,5
DE,BLINDNESS UNILATERAL,5
DE,BRONCHITIS,5
DE,CROHN^S DISEASE,5
DE,DISTURBANCE IN ATTENTION,5
DE,DRUG INEFFECTIVE,5
DE,DYSPHAGIA,5
DE,FACIAL PARESIS,5
DE,FEMORAL NECK FRACTURE,5
DE,FOETAL HEART RATE ABNORMAL,5
DE,GALLBLADDER DISORDER,5
DE,GESTATIONAL HYPERTENSION,5
DE,GLAUCOMA,5
DE,HAEMORRHAGE IN PREGNANCY,5
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,5
DE,MACULAR OEDEMA,5
DE,MALIGNANT MELANOMA,5
DE,MENORRHAGIA,5
DE,MONOPLEGIA,5
DE,PULMONARY VALVE STENOSIS,5
DE,RASH,5
DE,RETINAL HAEMORRHAGE,5
DE,SQUAMOUS CELL CARCINOMA OF SKIN,5
DE,SUDDEN HEARING LOSS,5
DE,SUICIDAL IDEATION,5
DE,THROMBOCYTOPENIA,5
DE,UNEVALUABLE EVENT,5
DE,ABORTION,4
DE,ABSCESS LIMB,4
DE,ACCIDENT,4
DE,BLADDER CANCER,4
DE,BLADDER DYSFUNCTION,4
DE,BLINDNESS,4
DE,BLOOD BILIRUBIN INCREASED,4
DE,BLOOD TEST ABNORMAL,4
DE,CARDIAC ARREST,4
DE,CARDIAC FAILURE,4
DE,CARDIOVASCULAR DISORDER,4
DE,CHONDROPATHY,4
DE,COGNITIVE DISORDER,4
DE,CONFUSIONAL STATE,4
DE,COORDINATION ABNORMAL,4
DE,DIPLEGIA,4
DE,DYSARTHRIA,4
DE,EPISTAXIS,4
DE,EYE PAIN,4
DE,FAT NECROSIS,4
DE,GASTRIC HAEMORRHAGE,4
DE,GASTROINTESTINAL DISORDER,4
DE,HEMIPLEGIA,4
DE,HERPES ZOSTER,4
DE,INFECTION SUSCEPTIBILITY INCREASED,4
DE,INGUINAL HERNIA,4
DE,INJECTION SITE HAEMATOMA,4
DE,INJECTION SITE INFLAMMATION,4
DE,INSOMNIA,4
DE,INTRACRANIAL ANEURYSM,4
DE,JOINT INJURY,4
DE,LIGAMENT RUPTURE,4
DE,LOSS OF CONTROL OF LEGS,4
DE,LUNG NEOPLASM MALIGNANT,4
DE,LYMPHADENOPATHY,4
DE,METASTASES TO LIVER,4
DE,MOTOR DYSFUNCTION,4
DE,MUSCULOSKELETAL DISORDER,4
DE,NEPHROTIC SYNDROME,4
DE,NORMAL NEWBORN,4
DE,OBSTRUCTED LABOUR,4
DE,OVARIAN CANCER,4
DE,PANCREATITIS,4
DE,PREMATURE SEPARATION OF PLACENTA,4
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,4
DE,PRURITUS,4
DE,PSORIASIS,4
DE,RENAL FAILURE ACUTE,4
DE,RESPIRATORY DISTRESS,4
DE,SCAR,4
DE,SEIZURE,4
DE,SENSATION OF HEAVINESS,4
DE,SINUSITIS,4
DE,SKIN INDURATION,4
DE,SUBCUTANEOUS ABSCESS,4
DE,SURGERY,4
DE,TACHYCARDIA,4
DE,THYROID MASS,4
DE,TIBIA FRACTURE,4
DE,TOOTH DISORDER,4
DE,TYPE 2 DIABETES MELLITUS,4
DE,UPPER LIMB FRACTURE,4
DE,VAGINAL HAEMORRHAGE,4
DE,WHITE BLOOD CELL COUNT INCREASED,4
DE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
DE,ABASIA,3
DE,ABDOMINAL DISCOMFORT,3
DE,ACNE,3
DE,ACUTE MYOCARDIAL INFARCTION,3
DE,ADVERSE EVENT,3
DE,AGEUSIA,3
DE,ANXIETY,3
DE,ASTHMA,3
DE,ATAXIA,3
DE,ATRIAL SEPTAL DEFECT,3
DE,BACTERIAL INFECTION,3
DE,BLADDER NEOPLASM,3
DE,BLISTER,3
DE,BLOOD CHOLESTEROL INCREASED,3
DE,BLOOD GLUCOSE DECREASED,3
DE,BLOOD GLUCOSE INCREASED,3
DE,BLOOD TRIGLYCERIDES INCREASED,3
DE,BREAST CANCER FEMALE,3
DE,BREAST CANCER METASTATIC,3
DE,BREAST CANCER RECURRENT,3
DE,C-REACTIVE PROTEIN INCREASED,3
DE,CARDIOMEGALY,3
DE,CARPAL TUNNEL SYNDROME,3
DE,CATARACT,3
DE,CEREBRAL INFARCTION,3
DE,CHEST PAIN,3
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
DE,DEAFNESS,3
DE,DRUG ABUSE,3
DE,DRUG HYPERSENSITIVITY,3
DE,DYSSTASIA,3
DE,ECTOPIC PREGNANCY,3
DE,FEELING COLD,3
DE,FEELING HOT,3
DE,FEELING OF BODY TEMPERATURE CHANGE,3
DE,FIBULA FRACTURE,3
DE,FOETAL MALPOSITION,3
DE,FOOT DEFORMITY,3
DE,GASTROINTESTINAL CARCINOMA,3
DE,GASTROINTESTINAL INFLAMMATION,3
DE,GESTATIONAL DIABETES,3
DE,GOITRE,3
DE,HAEMATOMA,3
DE,HAEMOGLOBIN DECREASED,3
DE,HELLP SYNDROME,3
DE,HEPATIC CYST,3
DE,HEPATIC FAILURE,3
DE,HEPATIC STEATOSIS,3
DE,HEPATITIS,3
DE,HOT FLUSH,3
DE,HUMERUS FRACTURE,3
DE,HYPERBILIRUBINAEMIA,3
DE,INDURATION,3
DE,INFLAMMATION,3
DE,INJECTION SITE INFECTION,3
DE,INJECTION SITE MASS,3
DE,INJECTION SITE NECROSIS,3
DE,INJECTION SITE SWELLING,3
DE,INTENTIONAL PRODUCT USE ISSUE,3
DE,JAUNDICE,3
DE,LABORATORY TEST ABNORMAL,3
DE,LIMB DISCOMFORT,3
DE,LIMB INJURY,3
DE,LIVER FUNCTION TEST INCREASED,3
DE,LIVER INJURY,3
DE,LUMBAR VERTEBRAL FRACTURE,3
DE,LYMPHOCYTE COUNT INCREASED,3
DE,METASTASES TO LUNG,3
DE,MONOPARESIS,3
DE,MUSCLE TIGHTNESS,3
DE,MUSCLE TWITCHING,3
DE,MYOSITIS,3
DE,NEPHRITIS,3
DE,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,3
DE,OCULAR ICTERUS,3
DE,OEDEMA PERIPHERAL,3
DE,OESOPHAGEAL CANDIDIASIS,3
DE,OROPHARYNGEAL PAIN,3
DE,OSTEOPOROSIS,3
DE,PANIC ATTACK,3
DE,PERIPHERAL SWELLING,3
DE,PLACENTAL TRANSFUSION SYNDROME,3
DE,PLATELET COUNT DECREASED,3
DE,PLATELET COUNT INCREASED,3
DE,PROCEDURAL COMPLICATION,3
DE,PROGRESSIVE MULTIPLE SCLEROSIS,3
DE,PULMONARY SARCOIDOSIS,3
DE,RESTLESSNESS,3
DE,RIB FRACTURE,3
DE,SINUS DISORDER,3
DE,SKIN CANCER,3
DE,STAPHYLOCOCCAL INFECTION,3
DE,SWELLING FACE,3
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,3
DE,THROMBOTIC MICROANGIOPATHY,3
DE,THYROID NEOPLASM,3
DE,TONSILLITIS,3
DE,URINARY RETENTION,3
DE,UROSEPSIS,3
DE,UTERINE CANCER,3
DE,VITAMIN D DEFICIENCY,3
DE,WHITE BLOOD CELL COUNT DECREASED,3
DE,WOUND,3
DE,WOUND DEHISCENCE,3
DE,ABDOMINAL ABSCESS,2
DE,ABDOMINAL ADHESIONS,2
DE,ABORTION MISSED,2
DE,ADJUSTMENT DISORDER,2
DE,AGGRESSION,2
DE,ALCOHOLISM,2
DE,AMNIOTIC FLUID VOLUME DECREASED,2
DE,ANIMAL BITE,2
DE,ANKYLOSING SPONDYLITIS,2
DE,ANORECTAL DISORDER,2
DE,ANTI-INTERFERON ANTIBODY POSITIVE,2
DE,ANTIBODY TEST POSITIVE,2
DE,ANXIETY DISORDER,2
DE,ARTERIOSCLEROSIS,2
DE,ARTHROPOD BITE,2
DE,ASCITES,2
DE,BLADDER DISORDER,2
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,2
DE,BLOOD PRESSURE FLUCTUATION,2
DE,BLOOD THYROID STIMULATING HORMONE DECREASED,2
DE,BODY TEMPERATURE FLUCTUATION,2
DE,BONE GIANT CELL TUMOUR,2
DE,BONE MARROW DISORDER,2
DE,BRAIN NEOPLASM BENIGN,2
DE,BRAIN STEM INFARCTION,2
DE,BRONCHIAL CARCINOMA,2
DE,BURSITIS,2
DE,CARDIAC DISORDER,2
DE,CARDIO-RESPIRATORY DISTRESS,2
DE,CARDITIS,2
DE,CAROTID ARTERY OCCLUSION,2
DE,CELLULITIS,2
DE,CENTRAL NERVOUS SYSTEM INFLAMMATION,2
DE,CEREBRAL HYPOPERFUSION,2
DE,CERVICAL DYSPLASIA,2
DE,CERVICAL INCOMPETENCE,2
DE,CERVICAL VERTEBRAL FRACTURE,2
DE,CERVICOBRACHIAL SYNDROME,2
DE,CHEST DISCOMFORT,2
DE,CHOLECYSTITIS,2
DE,CHROMATURIA,2
DE,COLITIS,2
DE,CORONARY ARTERY STENOSIS,2
DE,CYST,2
DE,DEAFNESS UNILATERAL,2
DE,DECREASED APPETITE,2
DE,DEEP VEIN THROMBOSIS,2
DE,DEHYDRATION,2
DE,DEPRESSION SUICIDAL,2
DE,DERMATITIS,2
DE,DEVELOPMENTAL HIP DYSPLASIA,2
DE,DISABILITY,2
DE,DISCOMFORT,2
DE,DRUG ERUPTION,2
DE,DYSPEPSIA,2
DE,EAGLE BARRETT SYNDROME,2
DE,ENCEPHALITIS,2
DE,EXERCISE TOLERANCE DECREASED,2
DE,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,2
DE,EYE DISORDER,2
DE,FACIAL PARALYSIS,2
DE,FAECAL INCONTINENCE,2
DE,FOETAL DEATH,2
DE,FOETAL GROWTH RESTRICTION,2
DE,FOETAL MALPRESENTATION,2
DE,FOETAL MONITORING ABNORMAL,2
DE,GASTRIC CANCER,2
DE,GASTROENTERITIS,2
DE,GASTROINTESTINAL INFECTION,2
DE,GENERAL SYMPTOM,2
DE,GLOSSODYNIA,2
DE,H1N1 INFLUENZA,2
DE,HAEMANGIOMA OF LIVER,2
DE,HAEMATOCHEZIA,2
DE,HALLUCINATION,2
DE,HAND FRACTURE,2
DE,HEART RATE DECREASED,2
DE,HEMIANAESTHESIA,2
DE,HEPATIC NEOPLASM,2
DE,HEPATITIS B,2
DE,HEPATITIS C,2
DE,HIP FRACTURE,2
DE,HYPEREMESIS GRAVIDARUM,2
DE,HYPERTENSIVE CRISIS,2
DE,HYPOAESTHESIA ORAL,2
DE,HYPOCHROMIC ANAEMIA,2
DE,HYPOTENSION,2
DE,HYPOTONIA,2
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
DE,IMMUNE SYSTEM DISORDER,2
DE,IMMUNODEFICIENCY,2
DE,INFECTED BITES,2
DE,INJECTION SITE ATROPHY,2
DE,INJECTION SITE BRUISING,2
DE,INJECTION SITE CALCIFICATION,2
DE,INJECTION SITE CELLULITIS,2
DE,INJECTION SITE WARMTH,2
DE,INSULINOMA,2
DE,INTESTINAL HAEMORRHAGE,2
DE,INTESTINAL OBSTRUCTION,2
DE,INVASIVE DUCTAL BREAST CARCINOMA,2
DE,IRON DEFICIENCY ANAEMIA,2
DE,ISCHAEMIC STROKE,2
DE,JAW CYST,2
DE,JAW FRACTURE,2
DE,JOINT LOCK,2
DE,JOINT SWELLING,2
DE,LACERATION,2
DE,LACK OF INJECTION SITE ROTATION,2
DE,LARGE FOR DATES BABY,2
DE,LARGE INTESTINE PERFORATION,2
DE,LEUKAEMIA,2
DE,LOCAL SWELLING,2
DE,LUNG ADENOCARCINOMA,2
DE,LUNG CANCER METASTATIC,2
DE,LUNG NEOPLASM,2
DE,LYMPHOCYTE COUNT DECREASED,2
DE,LYMPHOMA,2
DE,MENINGITIS,2
DE,MENTAL IMPAIRMENT,2
DE,METASTASES TO BONE,2
DE,METASTATIC MALIGNANT MELANOMA,2
DE,METRORRHAGIA,2
DE,MICTURITION DISORDER,2
DE,MICTURITION URGENCY,2
DE,MOOD SWINGS,2
DE,MOVEMENT DISORDER,2
DE,MUSCLE ATROPHY,2
DE,MUSCULOSKELETAL PAIN,2
DE,NECK PAIN,2
DE,NEOPLASM,2
DE,NEURODERMATITIS,2
DE,NEUROMYELITIS OPTICA,2
DE,NOCTURIA,2
DE,OBESITY,2
DE,OEDEMA,2
DE,OVARIAN DISORDER,2
DE,PANCREATITIS CHRONIC,2
DE,PANCYTOPENIA,2
DE,PANNICULITIS,2
DE,PARAPARESIS,2
DE,PATELLA FRACTURE,2
DE,PATENT DUCTUS ARTERIOSUS,2
DE,PELVIC CYST,2
DE,PERICARDIAL EFFUSION,2
DE,PERIPHERAL COLDNESS,2
DE,PERIPHERAL VENOUS DISEASE,2
DE,PERONEAL NERVE PALSY,2
DE,PERSONALITY CHANGE,2
DE,PHOBIA,2
DE,PHOTOPHOBIA,2
DE,PILONIDAL CYST,2
DE,PLACENTAL INSUFFICIENCY,2
DE,PLEURAL EFFUSION,2
DE,POLYDACTYLY,2
DE,POLYNEUROPATHY,2
DE,POLYP,2
DE,PORPHYRIA,2
DE,POST PROCEDURAL HAEMORRHAGE,2
DE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
DE,POSTOPERATIVE WOUND INFECTION,2
DE,PROTEINURIA,2
DE,PRURITUS GENERALISED,2
DE,PULMONARY OEDEMA,2
DE,PULPITIS DENTAL,2
DE,QUADRIPLEGIA,2
DE,RADIUS FRACTURE,2
DE,RECTAL CANCER,2
DE,RENAL CANCER,2
DE,RENAL COLIC,2
DE,RENAL FUNCTION TEST ABNORMAL,2
DE,RENAL NEOPLASM,2
DE,RESPIRATORY DISORDER,2
DE,RESPIRATORY TRACT OEDEMA,2
DE,RETINAL DETACHMENT,2
DE,RHABDOMYOLYSIS,2
DE,ROTATOR CUFF SYNDROME,2
DE,RUPTURED ECTOPIC PREGNANCY,2
DE,SCLERITIS,2
DE,SCLERODERMA,2
DE,SKIN ATROPHY,2
DE,SKIN ULCER,2
DE,SMALL FOR DATES BABY,2
DE,SOMNOLENCE,2
DE,SPINAL COLUMN STENOSIS,2
DE,SPINAL FRACTURE,2
DE,SPINAL PAIN,2
DE,STILLBIRTH,2
DE,STRABISMUS,2
DE,STRESS,2
DE,SUPRAVENTRICULAR EXTRASYSTOLES,2
DE,THYROID CANCER,2
DE,TONSIL CANCER,2
DE,TRISOMY 21,2
DE,TWIN PREGNANCY,2
DE,ULNAR NERVE PALSY,2
DE,UMBILICAL CORD ABNORMALITY,2
DE,UMBILICAL HERNIA,2
DE,URETERITIS,2
DE,UTERINE DISORDER,2
DE,UTERINE HAEMORRHAGE,2
DE,UTERINE PROLAPSE,2
DE,VARICOSE VEIN,2
DE,VENOUS THROMBOSIS,2
DE,VENTRICULAR EXTRASYSTOLES,2
DE,VERTIGO POSITIONAL,2
DE,VISUAL FIELD DEFECT,2
DE,VITREOUS DETACHMENT,2
DE,ABDOMINAL DISTENSION,1
DE,ABNORMAL LOSS OF WEIGHT,1
DE,ABORTION INDUCED,1
DE,ABSCESS ORAL,1
DE,ACCIDENT AT WORK,1
DE,ACCIDENTAL EXPOSURE TO PRODUCT,1
DE,ACOUSTIC NEURITIS,1
DE,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
DE,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
DE,ACUTE HEPATIC FAILURE,1
DE,ACUTE MYELOID LEUKAEMIA,1
DE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
DE,ACUTE SINUSITIS,1
DE,ACUTE STRESS DISORDER,1
DE,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,1
DE,ADRENAL GLAND CANCER,1
DE,ADVERSE DRUG REACTION,1
DE,AFFECT LABILITY,1
DE,AGITATION,1
DE,AGITATION NEONATAL,1
DE,AKINESIA,1
DE,ALANINE AMINOTRANSFERASE ABNORMAL,1
DE,ALCOHOL USE,1
DE,ALTERED STATE OF CONSCIOUSNESS,1
DE,AMAUROSIS,1
DE,AMNESIA,1
DE,AMNIORRHEXIS,1
DE,AMNIORRHOEA,1
DE,ANAEMIA,1
DE,ANAL ATRESIA,1
DE,ANAL FISSURE,1
DE,ANGIOPATHY,1
DE,ANHEDONIA,1
DE,AORTIC VALVE CALCIFICATION,1
DE,APATHY,1
DE,APNOEA,1
DE,APPENDICITIS PERFORATED,1
DE,APPLICATION SITE ACNE,1
DE,ARRESTED LABOUR,1
DE,ARTHRITIS,1
DE,ARTICULAR CALCIFICATION,1
DE,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
DE,ATELECTASIS,1
DE,ATONIC URINARY BLADDER,1
DE,ATRIAL THROMBOSIS,1
DE,ATRIOVENTRICULAR BLOCK,1
DE,ATRIOVENTRICULAR BLOCK COMPLETE,1
DE,ATYPICAL PNEUMONIA,1
DE,AUTISM SPECTRUM DISORDER,1
DE,AUTOIMMUNE HEPATITIS,1
DE,B-CELL LYMPHOMA,1
DE,BAND SENSATION,1
DE,BENIGN BREAST NEOPLASM,1
DE,BENIGN GASTRIC NEOPLASM,1
DE,BENIGN HEPATIC NEOPLASM,1
DE,BENIGN HYDATIDIFORM MOLE,1
DE,BENIGN NEOPLASM,1
DE,BENIGN NEOPLASM OF THYROID GLAND,1
DE,BENIGN PROSTATIC HYPERPLASIA,1
DE,BENIGN RENAL NEOPLASM,1
DE,BILIARY CIRRHOSIS PRIMARY,1
DE,BLADDER DISCOMFORT,1
DE,BLOOD CALCIUM INCREASED,1
DE,BLOOD CHROMOGRANIN A INCREASED,1
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
DE,BLOOD PRESSURE ABNORMAL,1
DE,BLOOD PRESSURE SYSTOLIC INCREASED,1
DE,BLOOD SODIUM DECREASED,1
DE,BLOOD TESTOSTERONE DECREASED,1
DE,BLOOD THYROID STIMULATING HORMONE INCREASED,1
DE,BLOOD URIC ACID INCREASED,1
DE,BLOOD URINE PRESENT,1
DE,BODY TEMPERATURE INCREASED,1
DE,BONE ATROPHY,1
DE,BONE CANCER,1
DE,BONE CONTUSION,1
DE,BONE LOSS,1
DE,BORRELIA TEST POSITIVE,1
DE,BRADYCARDIA,1
DE,BRAIN NEOPLASM MALIGNANT,1
DE,BRAIN OEDEMA,1
DE,BRAIN STEM SYNDROME,1
DE,BREAST ABSCESS,1
DE,BREAST CALCIFICATIONS,1
DE,BREAST CANCER STAGE II,1
DE,BREAST CANCER STAGE III,1
DE,BREAST DISORDER,1
DE,BREAST MASS,1
DE,BREAST NEOPLASM,1
DE,BREAST OEDEMA,1
DE,BRONCHIAL DISORDER,1
DE,BRONCHITIS CHRONIC,1
DE,BULIMIA NERVOSA,1
DE,BURNING SENSATION,1
DE,C-REACTIVE PROTEIN DECREASED,1
DE,CALCULUS URETERIC,1
DE,CARDIAC SEPTAL DEFECT,1
DE,CARDIOGENIC SHOCK,1
DE,CARDIOSPASM,1
DE,CARDIOVASCULAR INSUFFICIENCY,1
DE,CAROTID ARTERY ANEURYSM,1
DE,CAROTID ARTERY THROMBOSIS,1
DE,CARTILAGE INJURY,1
DE,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
DE,CEREBELLAR INFARCTION,1
DE,CEREBELLAR SYNDROME,1
DE,CEREBRAL ATROPHY,1
DE,CEREBRAL CYST,1
DE,CEREBRAL THROMBOSIS,1
DE,CEREBRAL VENOUS THROMBOSIS,1
DE,CERVIX CARCINOMA STAGE 0,1
DE,CERVIX CERCLAGE PROCEDURE,1
DE,CERVIX DISORDER,1
DE,CERVIX INFLAMMATION,1
DE,CHEILITIS,1
DE,CHLAMYDIAL INFECTION,1
DE,CHOLECYSTECTOMY,1
DE,CHOLECYSTITIS CHRONIC,1
DE,CHORIORETINOPATHY,1
DE,CHRONIC GASTRITIS,1
DE,CHRONIC PAROXYSMAL HEMICRANIA,1
DE,CHRONIC SINUSITIS,1
DE,CHRONIC TONSILLITIS,1
DE,CLINICALLY ISOLATED SYNDROME,1
DE,CLOSTRIDIUM DIFFICILE COLITIS,1
DE,CLUSTER HEADACHE,1
DE,COCCYDYNIA,1
DE,COLITIS ULCERATIVE,1
DE,COLLAGEN DISORDER,1
DE,COLON CANCER METASTATIC,1
DE,COLOUR BLINDNESS ACQUIRED,1
DE,COMMINUTED FRACTURE,1
DE,COMPLICATION OF PREGNANCY,1
DE,CONGENITAL ANOMALY,1
DE,CONGENITAL ANOMALY IN OFFSPRING,1
DE,CONGENITAL INGUINAL HERNIA,1
DE,CONGENITAL INTESTINAL MALFORMATION,1
DE,CONGENITAL MEGACOLON,1
DE,CONGENITAL PHARYNGEAL ANOMALY,1
DE,CONGENITAL RENAL DISORDER,1
DE,CONNECTIVE TISSUE DISORDER,1
DE,CONVULSION,1
DE,COR PULMONALE ACUTE,1
DE,CORNEAL GRAFT REJECTION,1
DE,CRANIOCEREBRAL INJURY,1
DE,CREUTZFELDT-JAKOB DISEASE,1
DE,CRYING,1
DE,CYSTITIS NONINFECTIVE,1
DE,CYTOGENETIC ABNORMALITY,1
DE,DEAFNESS PERMANENT,1
DE,DEATH NEONATAL,1
DE,DECUBITUS ULCER,1
DE,DEHYDROEPIANDROSTERONE INCREASED,1
DE,DEMENTIA,1
DE,DEMENTIA ALZHEIMER^S TYPE,1
DE,DENGUE FEVER,1
DE,DERMAL CYST,1
DE,DERMATITIS BULLOUS,1
DE,DERMATITIS PSORIASIFORM,1
DE,DERMOID CYST,1
DE,DEVICE EXPULSION,1
DE,DEVICE RELATED INFECTION,1
DE,DIAPHRAGMATIC HERNIA,1
DE,DIARRHOEA HAEMORRHAGIC,1
DE,DISEASE PROGRESSION,1
DE,DISLOCATION OF VERTEBRA,1
DE,DIVERTICULAR PERFORATION,1
DE,DIVERTICULITIS,1
DE,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
DE,DOUBLE URETER,1
DE,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
DE,DRUG DEPENDENCE,1
DE,DRUG EFFECT INCOMPLETE,1
DE,DRUG PRESCRIBING ERROR,1
DE,DRUG TOLERANCE DECREASED,1
DE,DRY EYE,1
DE,DRY SKIN,1
DE,DYSGRAPHIA,1
DE,DYSMENORRHOEA,1
DE,DYSMORPHISM,1
DE,DYSPHONIA,1
DE,EJECTION FRACTION ABNORMAL,1
DE,ELECTROCARDIOGRAM ABNORMAL,1
DE,ELECTROLYTE IMBALANCE,1
DE,EMBOLIA CUTIS MEDICAMENTOSA,1
DE,EMOTIONAL DISORDER,1
DE,EMOTIONAL DISTRESS,1
DE,ENDOCRINE NEOPLASM,1
DE,ENDOCRINE TEST ABNORMAL,1
DE,ENDOMETRIAL CANCER,1
DE,ENDOMETRIOSIS,1
DE,ENTEROCELE,1
DE,EOSINOPENIA,1
DE,EOSINOPHILIA,1
DE,ERECTILE DYSFUNCTION,1
DE,EROSIVE BALANITIS,1
DE,ERYTHEMA INFECTIOSUM,1
DE,ERYTHEMA MULTIFORME,1
DE,ERYTHEMA NODOSUM,1
DE,ESCHERICHIA INFECTION,1
DE,ESSENTIAL HYPERTENSION,1
DE,EXPOSURE DURING BREAST FEEDING,1
DE,EYE HAEMORRHAGE,1
DE,EYE IRRITATION,1
DE,EYE OEDEMA,1
DE,EYE SWELLING,1
DE,EYELID PTOSIS,1
DE,FACIAL BONES FRACTURE,1
DE,FACIAL PAIN,1
DE,FAILED TRIAL OF LABOUR,1
DE,FEAR OF DEATH,1
DE,FEBRILE CONVULSION,1
DE,FEEDING DISORDER,1
DE,FEEDING DISORDER NEONATAL,1
DE,FEEDING DISORDER OF INFANCY OR EARLY CHILDHOOD,1
DE,FEMORAL HERNIA,1
DE,FEMUR FRACTURE,1
DE,FIBROMYALGIA,1
DE,FISTULA,1
DE,FLATULENCE,1
DE,FLUID RETENTION,1
DE,FLUSHING,1
DE,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
DE,FOETAL HEART RATE DECELERATION ABNORMALITY,1
DE,FOETAL HEART RATE DECREASED,1
DE,FOETAL MALFORMATION,1
DE,FOREARM FRACTURE,1
DE,FRACTURE DELAYED UNION,1
DE,FRACTURED SACRUM,1
DE,FREEZING PHENOMENON,1
DE,FUNCTIONAL GASTROINTESTINAL DISORDER,1
DE,FUNGAL INFECTION,1
DE,FURUNCLE,1
DE,GAIT INABILITY,1
DE,GALLBLADDER OPERATION,1
DE,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
DE,GASTRIC DISORDER,1
DE,GASTRIC INFECTION,1
DE,GASTRIC MUCOSAL LESION,1
DE,GASTRIC PERFORATION,1
DE,GASTRIC STENOSIS,1
DE,GASTRITIS BACTERIAL,1
DE,GASTROINTESTINAL FUNGAL INFECTION,1
DE,GASTROINTESTINAL PAIN,1
DE,GENITAL ABSCESS,1
DE,GENITAL DISORDER FEMALE,1
DE,GENITAL TRACT INFLAMMATION,1
DE,GINGIVAL RECESSION,1
DE,GLIOBLASTOMA MULTIFORME,1
DE,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
DE,GLOMERULONEPHRITIS MEMBRANOUS,1
DE,GLOMERULONEPHRITIS MINIMAL LESION,1
DE,GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE,1
DE,GRAND MAL CONVULSION,1
DE,GRANULOCYTES ABNORMAL,1
DE,HAEMANGIOMA CONGENITAL,1
DE,HAEMATEMESIS,1
DE,HAEMATOLOGICAL MALIGNANCY,1
DE,HAEMATOMA INFECTION,1
DE,HAEMOLYTIC ANAEMIA,1
DE,HAEMOLYTIC URAEMIC SYNDROME,1
DE,HAEMORRHAGE INTRACRANIAL,1
DE,HAEMORRHAGIC OVARIAN CYST,1
DE,HAEMORRHOIDS,1
DE,HALLUCINATION_ AUDITORY,1
DE,HEAD INJURY,1
DE,HEARING IMPAIRED,1
DE,HEART SOUNDS ABNORMAL,1
DE,HEART VALVE INCOMPETENCE,1
DE,HELICOBACTER INFECTION,1
DE,HEMIANOPIA,1
DE,HEPATIC CANCER,1
DE,HEPATIC CIRRHOSIS,1
DE,HEPATIC ENCEPHALOPATHY,1
DE,HEPATIC FIBROSIS,1
DE,HEPATIC NECROSIS,1
DE,HEPATOCELLULAR INJURY,1
DE,HEPATOMEGALY,1
DE,HERPES OPHTHALMIC,1
DE,HERPES VIRUS INFECTION,1
DE,HIATUS HERNIA,1
DE,HIGH FOETAL HEAD,1
DE,HIP ARTHROPLASTY,1
DE,HIP DYSPLASIA,1
DE,HOSPITALISATION,1
DE,HYDROCELE,1
DE,HYPERACUSIS,1
DE,HYPERCHOLESTEROLAEMIA,1
DE,HYPERCOAGULATION,1
DE,HYPERGLYCAEMIA,1
DE,HYPERSENSITIVITY,1
DE,HYPERSENSITIVITY VASCULITIS,1
DE,HYPERSEXUALITY,1
DE,HYPERSOMNIA,1
DE,HYPERTHYROIDISM,1
DE,HYPERTONIC BLADDER,1
DE,HYPERTROPHIC CARDIOMYOPATHY,1
DE,HYPERVENTILATION,1
DE,HYPOKALAEMIA,1
DE,HYPOKINESIA,1
DE,HYPOVITAMINOSIS,1
DE,HYPOXIA,1
DE,IDIOPATHIC GENERALISED EPILEPSY,1
DE,ILEAL FISTULA,1
DE,ILEOSTOMY,1
DE,ILEUS,1
DE,IMMINENT ABORTION,1
DE,IMMUNOSUPPRESSION,1
DE,INCONTINENCE,1
DE,INCORRECT DOSE ADMINISTERED,1
DE,INDUCED LABOUR,1
DE,INFARCTION,1
DE,INFLAMMATION OF WOUND,1
DE,INFLAMMATORY MARKER INCREASED,1
DE,INFLAMMATORY PAIN,1
DE,INJECTION SITE DISCOMFORT,1
DE,INJECTION SITE HYPOAESTHESIA,1
DE,INJECTION SITE INJURY,1
DE,INJECTION SITE IRRITATION,1
DE,INJECTION SITE PAPULE,1
DE,INJECTION SITE PRURITUS,1
DE,INJECTION SITE REACTION,1
DE,INJECTION SITE SCAR,1
DE,INJECTION SITE THROMBOSIS,1
DE,INJECTION SITE ULCER,1
DE,INJECTION SITE VESICLES,1
DE,INJURY ASSOCIATED WITH DEVICE,1
DE,INNER EAR INFLAMMATION,1
DE,INTENTIONAL PRODUCT MISUSE,1
DE,INTERNAL HAEMORRHAGE,1
DE,INTRA-ABDOMINAL HAEMATOMA,1
DE,INTRACARDIAC THROMBUS,1
DE,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
DE,INTRANEURAL CYST,1
DE,INTRAOCULAR PRESSURE INCREASED,1
DE,INTRAPARTUM HAEMORRHAGE,1
DE,INTRASPINAL ABSCESS,1
DE,IRITIS,1
DE,IRON DEFICIENCY,1
DE,JAW DISORDER,1
DE,JC VIRUS INFECTION,1
DE,JOINT ABSCESS,1
DE,JOINT STIFFNESS,1
DE,KERATITIS,1
DE,KIDNEY SMALL,1
DE,KLINEFELTER^S SYNDROME,1
DE,KNEE DEFORMITY,1
DE,LACTIC ACIDOSIS,1
DE,LACTOSE INTOLERANCE,1
DE,LAGOPHTHALMOS,1
DE,LANGERHANS^ CELL HISTIOCYTOSIS,1
DE,LEFT VENTRICULAR FAILURE,1
DE,LEUKOCYTOSIS,1
DE,LHERMITTE^S SIGN,1
DE,LIMB OPERATION,1
DE,LIP BLISTER,1
DE,LIP DISORDER,1
DE,LIP INJURY,1
DE,LIP PAIN,1
DE,LIP SWELLING,1
DE,LIPOATROPHY,1
DE,LIPODYSTROPHY ACQUIRED,1
DE,LIPOSARCOMA,1
DE,LISTLESS,1
DE,LIVEDO RETICULARIS,1
DE,LIVER SARCOIDOSIS,1
DE,LOSS OF LIBIDO,1
DE,LOW DENSITY LIPOPROTEIN INCREASED,1
DE,LOWER RESPIRATORY TRACT INFECTION,1
DE,LUNG HYPERINFLATION,1
DE,LUNG INFECTION PSEUDOMONAL,1
DE,LUPUS-LIKE SYNDROME,1
DE,LYMPHOCYTE COUNT ABNORMAL,1
DE,LYMPHOEDEMA,1
DE,MACRODACTYLY,1
DE,MAJOR DEPRESSION,1
DE,MALARIA,1
DE,MALIGNANT HYPERTENSION,1
DE,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
DE,MALLORY-WEISS SYNDROME,1
DE,MASTITIS,1
DE,MATERNAL DISTRESS DURING LABOUR,1
DE,MEAN CELL HAEMOGLOBIN DECREASED,1
DE,MEAN CELL VOLUME DECREASED,1
DE,MEDICAL DEVICE SITE INFLAMMATION,1
DE,MEDICATION ERROR,1
DE,MEGAKARYOCYTES ABNORMAL,1
DE,MELAENA,1
DE,MELANOCYTIC NAEVUS,1
DE,MENINGIOMA,1
DE,MENINGIOMA BENIGN,1
DE,MENINGIOMA SURGERY,1
DE,MENSTRUAL DISORDER,1
DE,METASTASES TO ABDOMINAL CAVITY,1
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
DE,METASTASES TO LYMPH NODES,1
DE,METASTASES TO PANCREAS,1
DE,METASTATIC BRONCHIAL CARCINOMA,1
DE,MICROCYTIC ANAEMIA,1
DE,MIDDLE EAR INFLAMMATION,1
DE,MIGRAINE WITHOUT AURA,1
DE,MITRAL VALVE INCOMPETENCE,1
DE,MIXED INCONTINENCE,1
DE,MONOCYTE COUNT ABNORMAL,1
DE,MOOD ALTERED,1
DE,MOYAMOYA DISEASE,1
DE,MUCOSAL INFLAMMATION,1
DE,MULTIPLE ALLERGIES,1
DE,MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A,1
DE,MULTIPLE FRACTURES,1
DE,MYELITIS,1
DE,MYELOPROLIFERATIVE DISORDER,1
DE,MYOCLONIC EPILEPSY,1
DE,MYOSCLEROSIS,1
DE,NAIL BED INFLAMMATION,1
DE,NAIL DISORDER,1
DE,NASAL CONGESTION,1
DE,NASAL CYST,1
DE,NASAL POLYPS,1
DE,NEPHROCALCINOSIS,1
DE,NEPHROPATHY,1
DE,NEPHROSCLEROSIS,1
DE,NERVOUSNESS,1
DE,NEURALGIA,1
DE,NEUROENDOCRINE TUMOUR,1
DE,NEUROGENIC BLADDER,1
DE,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
DE,NEUTRALISING ANTIBODIES,1
DE,NEUTRALISING ANTIBODIES POSITIVE,1
DE,NEUTROPHIL COUNT INCREASED,1
DE,NIGHT SWEATS,1
GR,MULTIPLE SCLEROSIS RELAPSE,16
GR,ASPARTATE AMINOTRANSFERASE INCREASED,9
GR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
GR,PYREXIA,9
GR,ALANINE AMINOTRANSFERASE INCREASED,8
GR,DEATH,8
GR,DRUG INEFFECTIVE,8
GR,HAEMATOCRIT DECREASED,6
GR,HYPOAESTHESIA,6
GR,MATERNAL EXPOSURE DURING PREGNANCY,6
GR,MYOCARDIAL INFARCTION,6
GR,FATIGUE,5
GR,ASTHENIA,4
GR,FALL,4
GR,HEADACHE,4
GR,HYPERTENSION,4
GR,INFLUENZA LIKE ILLNESS,4
GR,LEUKOPENIA,4
GR,MUSCLE SPASTICITY,4
GR,THROMBOCYTOPENIA,4
GR,BASAL CELL CARCINOMA,3
GR,BREAST CANCER,3
GR,CENTRAL NERVOUS SYSTEM LESION,3
GR,CHILLS,3
GR,EPILEPSY,3
GR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,3
GR,PSORIASIS,3
GR,PYRAMIDAL TRACT SYNDROME,3
GR,RESPIRATORY TRACT INFECTION,3
GR,ABORTION SPONTANEOUS,2
GR,CAESAREAN SECTION,2
GR,CEREBROVASCULAR ACCIDENT,2
GR,CHRONIC SPONTANEOUS URTICARIA,2
GR,COMA,2
GR,CORONARY ARTERY DISEASE,2
GR,CORONARY ARTERY OCCLUSION,2
GR,DIPLOPIA,2
GR,DIZZINESS,2
GR,DUODENAL ULCER,2
GR,ERYTHEMA,2
GR,FEBRILE CONVULSION,2
GR,FOETAL EXPOSURE DURING PREGNANCY,2
GR,HEMIPARESIS,2
GR,LIPOMA,2
GR,LUNG NEOPLASM MALIGNANT,2
GR,NEURALGIA,2
GR,NEUTROPENIA,2
GR,OPTIC NEURITIS,2
GR,PLASMA CELL MYELOMA,2
GR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
GR,PULMONARY HYPERTENSION,2
GR,PYELONEPHRITIS,2
GR,RESPIRATORY DISTRESS,2
GR,SYNCOPE,2
GR,THYROID CANCER,2
GR,TRIGEMINAL NEURALGIA,2
GR,ABDOMINAL PAIN,1
GR,ABNORMAL BEHAVIOUR,1
GR,ABORTION INDUCED,1
GR,ABSCESS,1
GR,ACUTE KIDNEY INJURY,1
GR,ACUTE MYOCARDIAL INFARCTION,1
GR,ACUTE PULMONARY OEDEMA,1
GR,AGGRESSION,1
GR,ALBUMIN URINE PRESENT,1
GR,AMNESIA,1
GR,ANAEMIA,1
GR,ANAL FISTULA,1
GR,ANGINA PECTORIS,1
GR,ANGIOEDEMA,1
GR,ANGIOPATHY,1
GR,ANOREXIA NERVOSA,1
GR,ANOTIA,1
GR,APHASIA,1
GR,ARRHYTHMIA,1
GR,ARTHRITIS,1
GR,ATAXIA,1
GR,ATRIAL FIBRILLATION,1
GR,AUTOIMMUNE DISORDER,1
GR,BACK PAIN,1
GR,BALANCE DISORDER,1
GR,BEDRIDDEN,1
GR,BLINDNESS UNILATERAL,1
GR,BLOOD ALKALINE PHOSPHATASE INCREASED,1
GR,BLOOD CREATININE INCREASED,1
GR,BLOOD GLUCOSE INCREASED,1
GR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
GR,BLOOD UREA INCREASED,1
GR,BORDERLINE OVARIAN TUMOUR,1
GR,BRAIN MALFORMATION,1
GR,BREAST CANCER IN SITU,1
GR,BURNS FIRST DEGREE,1
GR,CARDIAC ARREST,1
GR,CARDIAC FAILURE,1
GR,CARDIOMEGALY,1
GR,CEREBRAL HAEMORRHAGE,1
GR,CERVICAL INCOMPETENCE,1
GR,CERVICAL POLYP,1
GR,CHEST PAIN,1
GR,CHOLECYSTITIS,1
GR,CHRONIC KIDNEY DISEASE,1
GR,COLITIS ISCHAEMIC,1
GR,CONTUSION,1
GR,CONVULSION,1
GR,CRANIOCEREBRAL INJURY,1
GR,CROHN^S DISEASE,1
GR,CUTANEOUS SARCOIDOSIS,1
GR,CYSTITIS,1
GR,DEAFNESS,1
GR,DEEP VEIN THROMBOSIS,1
GR,DEPRESSED MOOD,1
GR,DEPRESSION,1
GR,DEPRESSIVE SYMPTOM,1
GR,DIABETES MELLITUS,1
GR,DIASTOLIC DYSFUNCTION,1
GR,DISCOMFORT,1
GR,DISEASE PROGRESSION,1
GR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
GR,DRUG DOSE OMISSION,1
GR,DYSPHONIA,1
GR,ELECTROPHORESIS PROTEIN ABNORMAL,1
GR,ENCEPHALITIS,1
GR,EYE PAIN,1
GR,FACE OEDEMA,1
GR,FAECAL INCONTINENCE,1
GR,FALLOPIAN TUBE CYST,1
GR,FIBROADENOMA OF BREAST,1
GR,GAIT DISTURBANCE,1
GR,GASTRIC CANCER,1
GR,GASTRIC POLYPS,1
GR,GENERAL PHYSICAL HEALTH DETERIORATION,1
GR,GENERAL SYMPTOM,1
GR,GENERALISED ERYTHEMA,1
GR,GLIOBLASTOMA,1
GR,GLIOBLASTOMA MULTIFORME,1
GR,HAEMANGIOMA OF LIVER,1
GR,HAEMATOCRIT INCREASED,1
GR,HAEMATURIA,1
GR,HAEMOLYSIS,1
GR,HAEMOLYTIC URAEMIC SYNDROME,1
GR,HEPATIC ENZYME INCREASED,1
GR,HEPATIC LESION,1
GR,HERPES ZOSTER,1
GR,HYPERKALAEMIA,1
GR,HYPERLIPIDAEMIA,1
GR,HYPERTENSIVE CRISIS,1
GR,HYPERTRIGLYCERIDAEMIA,1
GR,HYPOTHERMIA,1
GR,HYSTERECTOMY,1
GR,ILIAC ARTERY OCCLUSION,1
GR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
GR,INCISION SITE INFECTION,1
GR,INCORRECT DOSE ADMINISTERED,1
GR,INJECTION SITE ABSCESS,1
GR,INJECTION SITE ERYTHEMA,1
GR,INJECTION SITE INDURATION,1
GR,INJECTION SITE INFLAMMATION,1
GR,INJECTION SITE INJURY,1
GR,INJECTION SITE NECROSIS,1
GR,INTERVERTEBRAL DISC PROTRUSION,1
GR,INVASIVE DUCTAL BREAST CARCINOMA,1
GR,IRON DEFICIENCY ANAEMIA,1
GR,ISCHAEMIC STROKE,1
GR,LACK OF INJECTION SITE ROTATION,1
GR,LARYNGEAL CANCER,1
GR,LIVE BIRTH,1
GR,LOCALISED OEDEMA,1
GR,LOWER LIMB FRACTURE,1
GR,LUPUS-LIKE SYNDROME,1
GR,LYMPHOCYTE PERCENTAGE INCREASED,1
GR,LYMPHOPENIA,1
GR,MACULOPATHY,1
GR,MALIGNANT HYPERTENSION,1
GR,MASS,1
GR,MEDICATION ERROR,1
GR,MENORRHAGIA,1
GR,MOBILITY DECREASED,1
GR,MONOCLONAL IMMUNOGLOBULIN PRESENT,1
GR,MONOCYTE PERCENTAGE INCREASED,1
GR,MONOPARESIS,1
GR,MOTOR DYSFUNCTION,1
GR,MULTIPLE SCLEROSIS,1
GR,MUSCULOSKELETAL PAIN,1
GR,MYASTHENIA GRAVIS,1
GR,MYELITIS TRANSVERSE,1
GR,MYOCARDITIS,1
GR,NAUSEA,1
GR,NEEDLE FATIGUE,1
GR,NEPHROLITHIASIS,1
GR,NERVE ROOT COMPRESSION,1
GR,NIEMANN-PICK DISEASE,1
GR,NORMAL NEWBORN,1
GR,NUCLEAR MAGNETIC RESONANCE IMAGING THORACIC ABNORMAL,1
GR,OEDEMA PERIPHERAL,1
GR,OESOPHAGEAL INFECTION,1
GR,OESOPHAGEAL ULCER,1
GR,OSTEONECROSIS,1
GR,OSTEOPOROSIS,1
GR,OVARIAN CANCER,1
GR,OVARIAN CYST,1
GR,PAIN IN EXTREMITY,1
GR,PANNICULITIS,1
GR,PAPILLOEDEMA,1
GR,PERSONALITY DISORDER,1
GR,PLACENTAL INSUFFICIENCY,1
GR,PLATELET COUNT DECREASED,1
GR,PNEUMONIA,1
GR,POLYARTHRITIS,1
GR,POLYP,1
GR,PREMATURE BABY,1
GR,PREMATURE RUPTURE OF MEMBRANES,1
GR,PRURITUS,1
GR,PSORIATIC ARTHROPATHY,1
GR,PSYCHOTIC DISORDER,1
GR,PULMONARY EMBOLISM,1
GR,PULMONARY SARCOIDOSIS,1
GR,PULPITIS DENTAL,1
GR,PURPURA,1
GR,PURULENT DISCHARGE,1
GR,QUADRIPLEGIA,1
GR,RASH,1
GR,RAYNAUD^S PHENOMENON,1
GR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
GR,RENAL COLIC,1
GR,RENAL NEOPLASM,1
GR,RESPIRATORY FAILURE,1
GR,RETINAL ARTERY OCCLUSION,1
GR,RHEUMATOID ARTHRITIS,1
GR,ROAD TRAFFIC ACCIDENT,1
GR,SALPINGITIS,1
GR,SARCOIDOSIS,1
GR,SERUM FERRITIN INCREASED,1
GR,SKIN REACTION,1
GR,SOFT TISSUE INFECTION,1
GR,SOMNOLENCE,1
GR,SPLENOMEGALY,1
GR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
GR,TACHYCARDIA,1
GR,TACHYPNOEA,1
GR,TENSION HEADACHE,1
GR,THROMBOCYTOSIS,1
GR,THROMBOPHLEBITIS,1
GR,THROMBOSIS,1
GR,THROMBOTIC MICROANGIOPATHY,1
GR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
GR,TIBIA FRACTURE,1
GR,TONGUE BITING,1
GR,TONSILLITIS,1
GR,TRANSAMINASES INCREASED,1
GR,TWIN PREGNANCY,1
GR,ULCER,1
GR,UMBILICAL HERNIA,1
GR,UPPER RESPIRATORY TRACT INFECTION,1
GR,URINARY INCONTINENCE,1
GR,UTERINE CANCER,1
GR,VENTRICULAR FIBRILLATION,1
GR,VIRAL INFECTION,1
GR,VISUAL ACUITY REDUCED,1
GR,VISUAL FIELD DEFECT,1
GR,WEIGHT DECREASED,1
GR,WHITE BLOOD CELL COUNT DECREASED,1
GR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
GT,ABDOMINAL DISTENSION,1
GT,DYSPNOEA,1
GT,FATIGUE,1
GT,FLUID RETENTION,1
GT,HYPOKINESIA,1
GT,MALAISE,1
GT,PERIPHERAL SWELLING,1
GT,RESPIRATORY ARREST,1
GN,INTENTIONAL PRODUCT USE ISSUE,2
GN,RESPIRATORY DISTRESS,2
GN,CARDIO-RESPIRATORY ARREST,1
GN,EBOLA DISEASE,1
GN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GN,OVERDOSE,1
HK,ECZEMA,3
HK,MULTIPLE SCLEROSIS RELAPSE,3
HK,INJECTION SITE PAIN,2
HK,LIPODYSTROPHY ACQUIRED,2
HK,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
HK,ABDOMINAL DISCOMFORT,1
HK,ABORTION MISSED,1
HK,ABORTION SPONTANEOUS,1
HK,ARRHYTHMIA,1
HK,DEATH,1
HK,FEAR,1
HK,HAEMOGLOBIN DECREASED,1
HK,HEADACHE,1
HK,HYPOAESTHESIA,1
HK,INFLUENZA LIKE ILLNESS,1
HK,INJECTION SITE ATROPHY,1
HK,INJECTION SITE BRUISING,1
HK,INJECTION SITE HAEMORRHAGE,1
HK,INJECTION SITE INFECTION,1
HK,INJECTION SITE REACTION,1
HK,LACK OF INJECTION SITE ROTATION,1
HK,MUSCULAR WEAKNESS,1
HK,NORMAL NEWBORN,1
HK,PALPITATIONS,1
HK,VERTIGO,1
HK,VISION BLURRED,1
HU,MULTIPLE SCLEROSIS RELAPSE,8
HU,DIZZINESS,2
HU,GAIT DISTURBANCE,2
HU,HYPOAESTHESIA,2
HU,MONOPARESIS,2
HU,PYREXIA,2
HU,ABDOMINAL PAIN UPPER,1
HU,ABORTION SPONTANEOUS,1
HU,ANAEMIA,1
HU,ANAPHYLACTIC SHOCK,1
HU,ARTHRALGIA,1
HU,ASPIRATION,1
HU,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
HU,BACK PAIN,1
HU,BACTERIAL TEST POSITIVE,1
HU,BLOOD PRESSURE DECREASED,1
HU,BONE PAIN,1
HU,BRADYCARDIA,1
HU,BRAIN NEOPLASM,1
HU,COUGH,1
HU,DECREASED APPETITE,1
HU,DEMYELINATION,1
HU,DIPLOPIA,1
HU,DISEASE PROGRESSION,1
HU,DISORIENTATION,1
HU,DRUG INEFFECTIVE,1
HU,EPILEPSY,1
HU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
HU,GENERAL SYMPTOM,1
HU,GENERALISED ANXIETY DISORDER,1
HU,HEPATIC ENZYME INCREASED,1
HU,HEPATITIS ACUTE,1
HU,INFLUENZA LIKE ILLNESS,1
HU,INJECTION SITE DERMATITIS,1
HU,INVASIVE DUCTAL BREAST CARCINOMA,1
HU,JOINT INJURY,1
HU,LEUKOPENIA,1
HU,LIMB INJURY,1
HU,LUNG NEOPLASM,1
HU,MATERNAL EXPOSURE DURING PREGNANCY,1
HU,MENORRHAGIA,1
HU,MUSCLE SPASMS,1
HU,MUSCULAR WEAKNESS,1
HU,MYALGIA,1
HU,NAUSEA,1
HU,NEUROMYOPATHY,1
HU,OPTIC NEURITIS,1
HU,PALLOR,1
HU,PERIPHERAL COLDNESS,1
HU,PULSE ABSENT,1
HU,RESTLESSNESS,1
HU,SQUAMOUS CELL CARCINOMA OF SKIN,1
HU,STRESS,1
HU,SYSTEMIC LUPUS ERYTHEMATOSUS,1
HU,TACHYCARDIA,1
HU,TRANSIENT PSYCHOSIS,1
HU,URINARY RETENTION,1
HU,VISION BLURRED,1
HU,WEIGHT BEARING DIFFICULTY,1
HU,WEIGHT DECREASED,1
IS,GESTATIONAL DIABETES,1
IS,PROLONGED LABOUR,1
IS,PROSTATE CANCER,1
IN,ABASIA,12
IN,MULTIPLE SCLEROSIS RELAPSE,11
IN,PYREXIA,11
IN,GAIT DISTURBANCE,6
IN,HYPOAESTHESIA,6
IN,DEATH,5
IN,LOSS OF CONSCIOUSNESS,5
IN,FALL,4
IN,MUSCULOSKELETAL DISORDER,4
IN,BLINDNESS,3
IN,CHILLS,3
IN,COMA,3
IN,DENGUE FEVER,3
IN,DIPLOPIA,3
IN,DRUG DOSE OMISSION,3
IN,FATIGUE,3
IN,HEMIPLEGIA,3
IN,MOBILITY DECREASED,3
IN,MUSCULAR WEAKNESS,3
IN,VISUAL IMPAIRMENT,3
IN,ABSCESS,2
IN,APHASIA,2
IN,ASTHENIA,2
IN,DRUG INEFFECTIVE,2
IN,DYSURIA,2
IN,HEADACHE,2
IN,HEPATOMEGALY,2
IN,INJURY,2
IN,INSOMNIA,2
IN,MATERNAL EXPOSURE DURING PREGNANCY,2
IN,MUSCULOSKELETAL STIFFNESS,2
IN,NEUROMYELITIS OPTICA,2
IN,PANCREATITIS,2
IN,SEIZURE,2
IN,SURGERY,2
IN,TYPHOID FEVER,2
IN,URINARY INCONTINENCE,2
IN,VISION BLURRED,2
IN,ABORTION SPONTANEOUS,1
IN,ACCIDENT,1
IN,ALANINE AMINOTRANSFERASE INCREASED,1
IN,AMNESIA,1
IN,ANAL INCONTINENCE,1
IN,ANXIETY,1
IN,ASPARTATE AMINOTRANSFERASE INCREASED,1
IN,ASPIRATION,1
IN,BACK PAIN,1
IN,BALANCE DISORDER,1
IN,BLINDNESS TRANSIENT,1
IN,BLINDNESS UNILATERAL,1
IN,BREAST CANCER,1
IN,BURNING SENSATION,1
IN,CARDIO-RESPIRATORY ARREST,1
IN,CATARACT,1
IN,CENTRAL NERVOUS SYSTEM LESION,1
IN,COGNITIVE DISORDER,1
IN,CONVULSION,1
IN,COORDINATION ABNORMAL,1
IN,COUGH,1
IN,DEAFNESS,1
IN,DIARRHOEA,1
IN,DIZZINESS,1
IN,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
IN,DRUG DEPENDENCE,1
IN,DYSARTHRIA,1
IN,DYSPHEMIA,1
IN,DYSPNOEA,1
IN,DYSSTASIA,1
IN,EAR PRURITUS,1
IN,EATING DISORDER,1
IN,EPILEPSY,1
IN,EYE HAEMORRHAGE,1
IN,EYE SWELLING,1
IN,FACIAL PARALYSIS,1
IN,FEELING COLD,1
IN,GAIT INABILITY,1
IN,GANGRENE,1
IN,GASTRIC CYST,1
IN,GENERAL PHYSICAL HEALTH DETERIORATION,1
IN,HEAD INJURY,1
IN,HEPATIC CIRRHOSIS,1
IN,HIP FRACTURE,1
IN,HIP SURGERY,1
IN,HYPERTENSION,1
IN,ILL-DEFINED DISORDER,1
IN,JAUNDICE,1
IN,LIVER DISORDER,1
IN,LOWER RESPIRATORY TRACT INFECTION,1
IN,MENTAL DISORDER,1
IN,MULTIPLE SCLEROSIS,1
IN,MUSCLE FATIGUE,1
IN,MUSCLE SPASMS,1
IN,MYOCARDIAL INFARCTION,1
IN,NO ADVERSE EVENT,1
IN,ORAL DISORDER,1
IN,ORAL PAIN,1
IN,PAIN IN EXTREMITY,1
IN,PARAESTHESIA,1
IN,PARESIS,1
IN,PERIPHERAL SWELLING,1
IN,POLLAKIURIA,1
IN,PREMATURE LABOUR,1
IN,PRURITUS,1
IN,RENAL DISORDER,1
IN,RESPIRATORY TRACT CONGESTION,1
IN,SKULL FRACTURE,1
IN,SLEEP DISORDER,1
IN,SPINAL CORD DISORDER,1
IN,STEROID THERAPY,1
IN,STRABISMUS,1
IN,STRESS,1
IN,STRONGYLOIDIASIS,1
IN,SUICIDAL IDEATION,1
IN,SYNCOPE,1
IN,THROMBOSIS,1
IN,URINARY RETENTION,1
IN,URINARY TRACT INFECTION,1
IN,VISUAL ACUITY REDUCED,1
IN,VOMITING,1
IN,WEIGHT DECREASED,1
IN,YELLOW SKIN,1
IR,AUTOIMMUNE UVEITIS,2
IR,MULTIPLE SCLEROSIS RELAPSE,2
IR,NEPHROLITHIASIS,2
IR,OPTIC ATROPHY,2
IR,OPTIC NEURITIS,2
IR,ACCIDENT,1
IR,ACOUSTIC NEUROMA,1
IR,AUTOIMMUNE DISORDER,1
IR,BLINDNESS,1
IR,CEREBRAL HAEMORRHAGE,1
IR,CONVULSION,1
IR,DEAFNESS UNILATERAL,1
IR,DISABILITY,1
IR,GENERALISED TONIC-CLONIC SEIZURE,1
IR,HEADACHE,1
IR,HEPATIC ENZYME INCREASED,1
IR,HYPOAESTHESIA,1
IR,INTENTIONAL PRODUCT USE ISSUE,1
IR,LIVER DISORDER,1
IR,MYALGIA,1
IR,MYOCARDIAL INFARCTION,1
IR,PSYCHOGENIC SEIZURE,1
IR,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
IR,SPLENIC INJURY,1
IR,TREATMENT NONCOMPLIANCE,1
IE,LOWER RESPIRATORY TRACT INFECTION,18
IE,HYPOAESTHESIA,11
IE,FATIGUE,8
IE,PAIN IN EXTREMITY,8
IE,INFLUENZA LIKE ILLNESS,7
IE,MALAISE,7
IE,MOBILITY DECREASED,7
IE,MULTIPLE SCLEROSIS RELAPSE,7
IE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
IE,INJECTION SITE ERYTHEMA,6
IE,MUSCULAR WEAKNESS,6
IE,ALANINE AMINOTRANSFERASE INCREASED,5
IE,BALANCE DISORDER,5
IE,DEATH,5
IE,HEADACHE,5
IE,INJECTION SITE PAIN,5
IE,MUSCLE SPASMS,5
IE,OPTIC NEURITIS,5
IE,PARAESTHESIA,5
IE,PNEUMONIA,5
IE,COUGH,4
IE,HEMIPARESIS,4
IE,INJECTION SITE BRUISING,4
IE,SEPSIS,4
IE,DRUG INEFFECTIVE,3
IE,FALL,3
IE,GAIT DISTURBANCE,3
IE,HYPONATRAEMIA,3
IE,MULTIPLE SCLEROSIS,3
IE,ABDOMINAL DISCOMFORT,2
IE,AMNESIA,2
IE,ARTHRALGIA,2
IE,ARTHRITIS,2
IE,ASPARTATE AMINOTRANSFERASE INCREASED,2
IE,ASTHENIA,2
IE,BACK PAIN,2
IE,BLINDNESS UNILATERAL,2
IE,BLOOD BILIRUBIN INCREASED,2
IE,CELLULITIS,2
IE,CENTRAL NERVOUS SYSTEM LESION,2
IE,CEREBROVASCULAR ACCIDENT,2
IE,CONSTIPATION,2
IE,CONTUSION,2
IE,COORDINATION ABNORMAL,2
IE,CYST,2
IE,DIPLOPIA,2
IE,DIZZINESS,2
IE,DRUG INTOLERANCE,2
IE,DYSARTHRIA,2
IE,EAR INFECTION,2
IE,EYE PAIN,2
IE,EYE SWELLING,2
IE,FEELING HOT,2
IE,GINGIVAL ABSCESS,2
IE,HYPERTENSION,2
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
IE,INJECTION SITE INDURATION,2
IE,INJECTION SITE REACTION,2
IE,INTERVERTEBRAL DISC PROTRUSION,2
IE,INTRADUCTAL PROLIFERATIVE BREAST LESION,2
IE,LOSS OF CONSCIOUSNESS,2
IE,MUSCULOSKELETAL STIFFNESS,2
IE,NASOPHARYNGITIS,2
IE,NEPHROLITHIASIS,2
IE,NEURALGIA,2
IE,OROPHARYNGEAL PAIN,2
IE,PAIN,2
IE,PAIN IN JAW,2
IE,PHARYNGITIS,2
IE,PNEUMONIA ASPIRATION,2
IE,PULMONARY EMBOLISM,2
IE,RENAL DISORDER,2
IE,RESPIRATORY TRACT INFECTION,2
IE,SENSATION OF HEAVINESS,2
IE,STAPHYLOCOCCAL INFECTION,2
IE,SYNCOPE,2
IE,TREATMENT NONCOMPLIANCE,2
IE,URINARY TRACT INFECTION,2
IE,VOMITING,2
IE,WHITE BLOOD CELL COUNT DECREASED,2
IE,ABDOMINAL PAIN,1
IE,ABORTION SPONTANEOUS,1
IE,ABSCESS,1
IE,ACCIDENT,1
IE,ADVERSE EVENT,1
IE,APPENDICITIS,1
IE,ARTHROPATHY,1
IE,ARTHROPOD BITE,1
IE,ASTHMA,1
IE,ASTROCYTOMA,1
IE,AVERSION,1
IE,BILIARY CIRRHOSIS PRIMARY,1
IE,BLADDER PAIN,1
IE,BLEPHAROSPASM,1
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IE,BLOOD URINE PRESENT,1
IE,BURNING SENSATION,1
IE,CANDIDA INFECTION,1
IE,CARDIAC FAILURE CONGESTIVE,1
IE,CARDIOMEGALY,1
IE,CAROTID ARTERY STENOSIS,1
IE,CHEST DISCOMFORT,1
IE,CHEST PAIN,1
IE,CHOLELITHIASIS,1
IE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IE,CIRCULATORY COLLAPSE,1
IE,COELIAC DISEASE,1
IE,COLITIS ULCERATIVE,1
IE,COMA,1
IE,CONGESTIVE CARDIOMYOPATHY,1
IE,CORONARY ARTERY DISEASE,1
IE,DECREASED APPETITE,1
IE,DEEP VEIN THROMBOSIS,1
IE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IE,DRUG DISPENSING ERROR,1
IE,DRUG DOSE OMISSION,1
IE,DRY EYE,1
IE,DYSPEPSIA,1
IE,DYSPHAGIA,1
IE,DYSPNOEA,1
IE,DYSSTASIA,1
IE,EAR OPERATION,1
IE,EPILEPSY,1
IE,ERYTHEMA MULTIFORME,1
IE,ESCHERICHIA URINARY TRACT INFECTION,1
IE,EXTRAGONADAL PRIMARY EMBRYONAL CARCINOMA,1
IE,EYE DISORDER,1
IE,EYE PRURITUS,1
IE,FACIAL PARESIS,1
IE,FAECAL INCONTINENCE,1
IE,FEELING OF BODY TEMPERATURE CHANGE,1
IE,FOOT FRACTURE,1
IE,GASTRITIS,1
IE,GLOMERULONEPHRITIS MINIMAL LESION,1
IE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IE,GOUT,1
IE,HAEMOGLOBIN DECREASED,1
IE,HAEMORRHAGIC ANAEMIA,1
IE,HIATUS HERNIA,1
IE,HIDRADENITIS,1
IE,HYPERSENSITIVITY,1
IE,HYPOPNOEA,1
IE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IE,INJECTION SITE HAEMORRHAGE,1
IE,INJECTION SITE INJURY,1
IE,INJECTION SITE LACERATION,1
IE,INJECTION SITE RASH,1
IE,INJECTION SITE SWELLING,1
IE,INJECTION SITE ULCER,1
IE,INSOMNIA,1
IE,INTRACRANIAL ANEURYSM,1
IE,JAUNDICE,1
IE,KIDNEY INFECTION,1
IE,LACK OF INJECTION SITE ROTATION,1
IE,LACRIMATION INCREASED,1
IE,LATENT TUBERCULOSIS,1
IE,LEFT VENTRICULAR DYSFUNCTION,1
IE,LEG AMPUTATION,1
IE,LUNG NEOPLASM MALIGNANT,1
IE,LYMPHOCYTE COUNT INCREASED,1
IE,MANIA,1
IE,MASTITIS,1
IE,MATERNAL EXPOSURE DURING PREGNANCY,1
IE,MEAN CELL HAEMOGLOBIN INCREASED,1
IE,MEAN CELL VOLUME INCREASED,1
IE,MEMORY IMPAIRMENT,1
IE,METASTATIC NEOPLASM,1
IE,MICTURITION DISORDER,1
IE,MIDDLE INSOMNIA,1
IE,MIGRAINE,1
IE,MIGRAINE WITH AURA,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MOOD ALTERED,1
IE,MYASTHENIA GRAVIS,1
IE,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
IE,NAUSEA,1
IE,NEPHROTIC SYNDROME,1
IE,NEUROENDOCRINE CARCINOMA METASTATIC,1
IE,NEUROTOXICITY,1
IE,NEUTROPHIL COUNT DECREASED,1
IE,NON-HODGKIN^S LYMPHOMA,1
IE,PALPITATIONS,1
IE,PARAPLEGIA,1
IE,PARKINSON^S DISEASE,1
IE,PERICARDIAL EFFUSION,1
IE,PERIPHERAL COLDNESS,1
IE,PLATELET COUNT DECREASED,1
IE,POOR PERIPHERAL CIRCULATION,1
IE,POST PROCEDURAL COMPLICATION,1
IE,PREGNANCY,1
IE,PRODUCT ADMINISTERED AT INAPPROPRIATE SITE,1
IE,PROGRESSIVE MULTIPLE SCLEROSIS,1
IE,PROSTATE CANCER,1
IE,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
IE,PSEUDOMONAS INFECTION,1
IE,PULMONARY ARTERIAL HYPERTENSION,1
IE,PULMONARY HYPERTENSION,1
IE,PULMONARY MASS,1
IE,PULMONARY OEDEMA,1
IE,RASH,1
IE,RENAL CANCER STAGE III,1
IE,RESTLESS LEGS SYNDROME,1
IE,RIGHT VENTRICULAR FAILURE,1
IE,ROAD TRAFFIC ACCIDENT,1
IE,SEIZURE,1
IE,SENSORY LOSS,1
IE,SERUM FERRITIN INCREASED,1
IE,SINUS TACHYCARDIA,1
IE,SINUSITIS,1
IE,SKIN DISCOLOURATION,1
IE,SLEEP DISORDER,1
IE,SMALL CELL LUNG CANCER METASTATIC,1
IE,STRESS,1
IE,TACHYCARDIA,1
IE,TOOTH DISORDER,1
IE,TOOTH INFECTION,1
IE,TOOTH REPAIR,1
IE,TRAUMATIC HAEMORRHAGE,1
IE,TYPE 2 DIABETES MELLITUS,1
IE,URINARY INCONTINENCE,1
IE,UTERINE CANCER,1
IE,UTERINE ENLARGEMENT,1
IE,UTERINE PROLAPSE,1
IE,VARICOSE VEIN,1
IE,VENTRICULAR TACHYCARDIA,1
IE,VERTIGO,1
IE,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
IE,VISION BLURRED,1
IE,VITAMIN D DECREASED,1
IE,WHITE BLOOD CELL COUNT INCREASED,1
IE,WOUND DEHISCENCE,1
IE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
IL,MATERNAL EXPOSURE DURING PREGNANCY,11
IL,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,7
IL,FALL,6
IL,MULTIPLE SCLEROSIS RELAPSE,6
IL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,6
IL,ASTHENIA,5
IL,ABORTION SPONTANEOUS,4
IL,INTERVERTEBRAL DISC PROTRUSION,4
IL,OPTIC NEURITIS,4
IL,PYREXIA,4
IL,SYNCOPE,4
IL,ABORTION INDUCED,3
IL,ALANINE AMINOTRANSFERASE INCREASED,3
IL,ASPARTATE AMINOTRANSFERASE INCREASED,3
IL,CAESAREAN SECTION,3
IL,DIZZINESS,3
IL,GAIT DISTURBANCE,3
IL,HEADACHE,3
IL,MULTIPLE SCLEROSIS,3
IL,PNEUMONIA,3
IL,VOMITING,3
IL,BACK PAIN,2
IL,CATHETERISATION CARDIAC,2
IL,CHILLS,2
IL,COGNITIVE DISORDER,2
IL,COMMUNICATION DISORDER,2
IL,CONDITION AGGRAVATED,2
IL,CONTUSION,2
IL,DEPRESSION,2
IL,FATIGUE,2
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IL,HEAD DISCOMFORT,2
IL,HEMIPARESIS,2
IL,HEPATIC ENZYME INCREASED,2
IL,HYPERTENSION,2
IL,INFLUENZA LIKE ILLNESS,2
IL,INSOMNIA,2
IL,INTRACRANIAL ANEURYSM,2
IL,LIPOSARCOMA,2
IL,LUNG ADENOCARCINOMA,2
IL,MALAISE,2
IL,MENINGOMYELOCELE,2
IL,MUSCULAR WEAKNESS,2
IL,SENSORY DISTURBANCE,2
IL,SEPSIS,2
IL,TRIGEMINAL NEURALGIA,2
IL,VIRAL INFECTION,2
IL,VISION BLURRED,2
IL,VISUAL IMPAIRMENT,2
IL,ABDOMINAL ABSCESS,1
IL,ABDOMINAL OPERATION,1
IL,ABDOMINAL PAIN,1
IL,ACUTE DISSEMINATED ENCEPHALOMYELITIS,1
IL,ACUTE MYOCARDIAL INFARCTION,1
IL,AMYLOIDOSIS,1
IL,APPENDICECTOMY,1
IL,ARRHYTHMIA,1
IL,ARTHRITIS INFECTIVE,1
IL,ATRIOVENTRICULAR BLOCK COMPLETE,1
IL,BALANCE DISORDER,1
IL,BENIGN LUNG NEOPLASM,1
IL,BLADDER PROLAPSE,1
IL,BLINDNESS UNILATERAL,1
IL,BLOOD ALBUMIN DECREASED,1
IL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IL,BLOOD PRESSURE DECREASED,1
IL,BLOOD SODIUM DECREASED,1
IL,BLOOD THYROID STIMULATING HORMONE DECREASED,1
IL,BONE PAIN,1
IL,BOWEN^S DISEASE,1
IL,BREAST CANCER,1
IL,BREAST CANCER METASTATIC,1
IL,CARDIAC ARREST,1
IL,CARDIAC DISORDER,1
IL,CARDIOVASCULAR EVALUATION,1
IL,CEREBROVASCULAR ACCIDENT,1
IL,CERVICAL INCOMPETENCE,1
IL,COLON CANCER,1
IL,COMA,1
IL,COMPLICATION OF DEVICE REMOVAL,1
IL,CONGENITAL CARDIOVASCULAR ANOMALY,1
IL,CONSTIPATION,1
IL,DEAFNESS,1
IL,DEATH,1
IL,DECUBITUS ULCER,1
IL,DEMENTIA,1
IL,DEVICE RELATED INFECTION,1
IL,DIABETES MELLITUS,1
IL,DIFFUSE LARGE B-CELL LYMPHOMA,1
IL,DIPLEGIA,1
IL,DIPLOPIA,1
IL,DRUG EFFECT INCOMPLETE,1
IL,DRUG INEFFECTIVE,1
IL,EMPHYSEMA,1
IL,ENDOMETRIAL ADENOCARCINOMA,1
IL,EPILEPSY,1
IL,ESSENTIAL HYPERTENSION,1
IL,EXPOSURE VIA FATHER,1
IL,FEELING ABNORMAL,1
IL,FEELING COLD,1
IL,FEELING HOT,1
IL,FEMUR FRACTURE,1
IL,FLUSHING,1
IL,FOETAL EXPOSURE DURING PREGNANCY,1
IL,FOETAL HEART RATE DECELERATION ABNORMALITY,1
IL,FOETAL MALFORMATION,1
IL,FRACTURED COCCYX,1
IL,FREQUENT BOWEL MOVEMENTS,1
IL,GASTROINTESTINAL NECROSIS,1
IL,GENERAL PHYSICAL CONDITION ABNORMAL,1
IL,GESTATIONAL HYPERTENSION,1
IL,GLOMERULONEPHRITIS MEMBRANOUS,1
IL,GLOMERULONEPHRITIS MINIMAL LESION,1
IL,GOITRE,1
IL,HAEMOLYTIC ANAEMIA,1
IL,HAEMORRHAGIC STROKE,1
IL,HEART RATE IRREGULAR,1
IL,HEART VALVE REPLACEMENT,1
IL,HEMIPLEGIA,1
IL,HEPATITIS C,1
IL,HIP ARTHROPLASTY,1
IL,HIV INFECTION,1
IL,HYDROMETRA,1
IL,HYPERHIDROSIS,1
IL,HYPOAESTHESIA,1
IL,HYPOKALAEMIA,1
IL,HYPOTHYROIDISM,1
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IL,INCORRECT DOSE ADMINISTERED,1
IL,INFECTIOUS THYROIDITIS,1
IL,INTENTIONAL PRODUCT MISUSE,1
IL,INTENTIONAL UNDERDOSE,1
IL,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
IL,INVESTIGATION,1
IL,KNEE OPERATION,1
IL,LEG AMPUTATION,1
IL,LIMB DISCOMFORT,1
IL,LIVER FUNCTION TEST ABNORMAL,1
IL,LOWER LIMB FRACTURE,1
IL,LUNG NEOPLASM,1
IL,LYMPHADENOPATHY,1
IL,LYMPHOCYTE COUNT ABNORMAL,1
IL,LYMPHOCYTE COUNT DECREASED,1
IL,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
IL,MECHANICAL VENTILATION,1
IL,MENINGIOMA,1
IL,METASTASES TO LIVER,1
IL,MONOPLEGIA,1
IL,MOTOR DYSFUNCTION,1
IL,MOVEMENT DISORDER,1
IL,MULTI-ORGAN FAILURE,1
IL,MUSCLE SPASMS,1
IL,MYALGIA,1
IL,MYELOPATHY,1
IL,MYOCARDIAL INFARCTION,1
IL,NAUSEA,1
IL,NEOPLASM MALIGNANT,1
IL,NORMAL NEWBORN,1
IL,OBESITY,1
IL,OPTIC ISCHAEMIC NEUROPATHY,1
IL,OSTEOPOROSIS,1
IL,OVARIAN CANCER,1
IL,PAIN,1
IL,PAIN IN EXTREMITY,1
IL,PAINFUL RESPIRATION,1
IL,PAPILLARY THYROID CANCER,1
IL,PARAESTHESIA,1
IL,PARALYSIS,1
IL,PLASMA CELL MYELOMA,1
IL,POSTOPERATIVE WOUND INFECTION,1
IL,PRE-ECLAMPSIA,1
IL,PRESCRIBED UNDERDOSE,1
IL,PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS,1
IL,PROGRESSIVE MULTIPLE SCLEROSIS,1
IL,PRURITUS,1
IL,QUADRIPLEGIA,1
IL,RASH,1
IL,RED BLOOD CELL COUNT ABNORMAL,1
IL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IL,ROAD TRAFFIC ACCIDENT,1
IL,SEIZURE,1
IL,SENSORY LOSS,1
IL,SJOGREN^S SYNDROME,1
IL,SKIN SENSITISATION,1
IL,SPEECH DISORDER,1
IL,SPINAL OPERATION,1
IL,STAPHYLOCOCCAL INFECTION,1
IL,STRESS,1
IL,SUICIDE ATTEMPT,1
IL,SUPRAVENTRICULAR TACHYCARDIA,1
IL,THERAPY NON-RESPONDER,1
IL,THROMBOSIS MESENTERIC VESSEL,1
IL,TRANSIENT ISCHAEMIC ATTACK,1
IL,TREMOR,1
IL,TRI-IODOTHYRONINE INCREASED,1
IL,TRISOMY 21,1
IL,UNDERDOSE,1
IL,URINARY INCONTINENCE,1
IL,URINARY TRACT INFECTION,1
IL,UTERINE DISORDER,1
IL,UTERINE LEIOMYOMA,1
IL,UTERINE NEOPLASM,1
IL,VITAMIN D DEFICIENCY,1
IL,WOUND,1
IT,PYREXIA,14
IT,HEADACHE,13
IT,MULTIPLE SCLEROSIS RELAPSE,12
IT,HYPERPYREXIA,10
IT,INFLUENZA,8
IT,INFLUENZA LIKE ILLNESS,8
IT,THROMBOCYTOPENIA,8
IT,DRUG INEFFECTIVE,6
IT,HYPERTRANSAMINASAEMIA,6
IT,ACUTE KIDNEY INJURY,5
IT,CHILLS,5
IT,ENDOMETRIAL ADENOCARCINOMA,5
IT,HAEMOLYTIC URAEMIC SYNDROME,5
IT,MATERNAL EXPOSURE DURING PREGNANCY,5
IT,MYALGIA,5
IT,NAUSEA,5
IT,NEUTROPENIA,5
IT,TRANSAMINASES INCREASED,5
IT,ARTHRALGIA,4
IT,INJECTION SITE PAIN,4
IT,LEUKOPENIA,4
IT,MALAISE,4
IT,MALIGNANT HYPERTENSION,4
IT,MIGRAINE,4
IT,MULTIPLE SCLEROSIS,4
IT,NEPHROTIC SYNDROME,4
IT,PULMONARY HYPERTENSION,4
IT,VERTIGO,4
IT,VOMITING,4
IT,ANAEMIA,3
IT,CONFUSIONAL STATE,3
IT,DIPLOPIA,3
IT,GLIOBLASTOMA,3
IT,HYPERTENSION,3
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
IT,INJECTION SITE REACTION,3
IT,INSOMNIA,3
IT,LIMB DISCOMFORT,3
IT,MALIGNANT MELANOMA IN SITU,3
IT,MYOCARDIAL INFARCTION,3
IT,NEPHROPATHY,3
IT,PAIN IN EXTREMITY,3
IT,PROTEINURIA,3
IT,RELAPSING FEVER,3
IT,TESTICULAR INFARCTION,3
IT,TESTICULAR SWELLING,3
IT,THROMBOTIC MICROANGIOPATHY,3
IT,TREMOR,3
IT,WEIGHT DECREASED,3
IT,ABORTION,2
IT,ABORTION SPONTANEOUS,2
IT,ANTI-THYROID ANTIBODY POSITIVE,2
IT,ASTHENIA,2
IT,BLOOD BILIRUBIN INCREASED,2
IT,BLOOD PRESSURE FLUCTUATION,2
IT,BRONCHOSPASM,2
IT,CARDIO-RESPIRATORY ARREST,2
IT,COMPLETED SUICIDE,2
IT,DEATH,2
IT,DEPRESSION,2
IT,DISABILITY,2
IT,DRUG-INDUCED LIVER INJURY,2
IT,EPISTAXIS,2
IT,EYE PAIN,2
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IT,HAEMOLYTIC ANAEMIA,2
IT,HEPATIC ENZYME INCREASED,2
IT,HERPES ZOSTER,2
IT,HISTIOCYTOSIS HAEMATOPHAGIC,2
IT,HYPOAESTHESIA,2
IT,INFARCTION,2
IT,INVASIVE DUCTAL BREAST CARCINOMA,2
IT,LIP OEDEMA,2
IT,LIPODYSTROPHY ACQUIRED,2
IT,LYMPHOCYTE COUNT DECREASED,2
IT,LYMPHOPENIA,2
IT,MOVEMENT DISORDER,2
IT,MUSCLE CONTRACTURE,2
IT,MUSCLE SPASTICITY,2
IT,OEDEMA,2
IT,PERICARDIAL EFFUSION,2
IT,PNEUMONIA,2
IT,PREGNANCY,2
IT,PULMONARY SARCOIDOSIS,2
IT,RASH,2
IT,RENAL FAILURE,2
IT,RESPIRATORY FAILURE,2
IT,RHINITIS ALLERGIC,2
IT,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,2
IT,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
IT,THYROIDITIS,2
IT,URINARY TRACT INFECTION,2
IT,VARICOSE VEIN,2
IT,ABDOMINAL DISCOMFORT,1
IT,ABORTION INCOMPLETE,1
IT,ACUTE CORONARY SYNDROME,1
IT,ACUTE MYELOID LEUKAEMIA,1
IT,ALANINE AMINOTRANSFERASE INCREASED,1
IT,AMYLASE INCREASED,1
IT,ANAPHYLACTIC REACTION,1
IT,ANGINA PECTORIS,1
IT,ANGIOPATHY,1
IT,ANTI-INTERFERON ANTIBODY,1
IT,ANTI-THYROID ANTIBODY,1
IT,ANXIETY,1
IT,APHTHOUS ULCER,1
IT,APPENDICITIS,1
IT,APPLICATION SITE NECROSIS,1
IT,ATRIAL FIBRILLATION,1
IT,BACTERIAL SEPSIS,1
IT,BASEDOW^S DISEASE,1
IT,BLADDER DYSFUNCTION,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLOOD GLUCOSE INCREASED,1
IT,BLOOD PRESSURE ABNORMAL,1
IT,BLOOD TRIGLYCERIDES INCREASED,1
IT,BLOOD UREA INCREASED,1
IT,BONE PAIN,1
IT,BRAIN STEM SYNDROME,1
IT,BREAST CANCER,1
IT,BREAST MASS,1
IT,BRONCHOPNEUMOPATHY,1
IT,CARDIAC ARREST,1
IT,CARDIAC DISORDER,1
IT,CARDIOVASCULAR DISORDER,1
IT,CENTRAL NERVOUS SYSTEM LESION,1
IT,CEREBELLAR HAEMORRHAGE,1
IT,CHEST DISCOMFORT,1
IT,CHEST PAIN,1
IT,CHOLELITHIASIS,1
IT,COLITIS ULCERATIVE,1
IT,COLON CANCER METASTATIC,1
IT,COMA,1
IT,CONDITION AGGRAVATED,1
IT,CONJUNCTIVAL HAEMORRHAGE,1
IT,CONVULSION,1
IT,CYSTITIS,1
IT,DERMATITIS,1
IT,DERMATITIS BULLOUS,1
IT,DIARRHOEA,1
IT,DIARRHOEA INFECTIOUS,1
IT,DISEASE PROGRESSION,1
IT,DISEASE RECURRENCE,1
IT,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
IT,DRUG INTOLERANCE,1
IT,DRY MOUTH,1
IT,DYSENTERY,1
IT,DYSPLASIA,1
IT,DYSPNOEA,1
IT,ENTEROCOLITIS HAEMORRHAGIC,1
IT,EXOPHTHALMOS,1
IT,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
IT,EYE DISORDER,1
IT,FALL,1
IT,FOETAL GROWTH RESTRICTION,1
IT,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III STAGE I,1
IT,FORMICATION,1
IT,FULL BLOOD COUNT ABNORMAL,1
IT,FUNCTIONAL GASTROINTESTINAL DISORDER,1
IT,FUNGAL INFECTION,1
IT,GLOMERULONEPHROPATHY,1
IT,HAEMATOCRIT DECREASED,1
IT,HAEMORRHOIDS,1
IT,HEMIPARESIS,1
IT,HODGKIN^S DISEASE NODULAR SCLEROSIS,1
IT,HYPERBILIRUBINAEMIA,1
IT,HYPERSENSITIVITY,1
IT,HYPERSENSITIVITY VASCULITIS,1
IT,HYPERTENSIVE CRISIS,1
IT,HYPERTHERMIA,1
IT,INDURATION,1
IT,INFLAMMATION,1
IT,INJECTION SITE ABSCESS,1
IT,INJECTION SITE BRUISING,1
IT,INJECTION SITE CELLULITIS,1
IT,INJECTION SITE HAEMATOMA,1
IT,INJECTION SITE INFECTION,1
IT,INJECTION SITE SCAB,1
IT,INTENTIONAL PRODUCT USE ISSUE,1
IT,LEUKODYSTROPHY,1
IT,LIPASE INCREASED,1
IT,LIVER DISORDER,1
IT,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
IT,LUNG ADENOCARCINOMA,1
IT,LUNG NEOPLASM MALIGNANT,1
IT,LUPUS-LIKE SYNDROME,1
IT,MALIGNANT MELANOMA,1
IT,MANTLE CELL LYMPHOMA,1
IT,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
IT,MENTAL DISORDER,1
IT,METAL POISONING,1
IT,METASTASES TO CENTRAL NERVOUS SYSTEM,1
IT,METASTASES TO LIVER,1
IT,METASTATIC MALIGNANT MELANOMA,1
IT,MICTURITION DISORDER,1
IT,MONOCYTOSIS,1
IT,MOUTH HAEMORRHAGE,1
IT,MUSCLE RIGIDITY,1
IT,MUSCULAR WEAKNESS,1
IT,MYELODYSPLASTIC SYNDROME,1
IT,NASAL OEDEMA,1
IT,NASOPHARYNGITIS,1
IT,NEPHROPATHY TOXIC,1
IT,NEURITIS CRANIAL,1
IT,NEUTROPHIL COUNT DECREASED,1
IT,NEUTROPHIL COUNT INCREASED,1
IT,NO ADVERSE EVENT,1
IT,NON-HODGKIN^S LYMPHOMA,1
IT,OLIGURIA,1
IT,OPTIC NEURITIS,1
IT,PAIN,1
IT,PALPITATIONS,1
IT,PANCREATITIS,1
IT,PANCREATITIS ACUTE,1
IT,PANCYTOPENIA,1
IT,PANIC DISORDER,1
IT,PAPILLARY THYROID CANCER,1
IT,PAPILLOMA,1
IT,PARAESTHESIA,1
IT,PERIPHERAL SWELLING,1
IT,PERIPHERAL VENOUS DISEASE,1
IT,PHAEOCHROMOCYTOMA,1
IT,PLATELET COUNT DECREASED,1
IT,PLEURAL EFFUSION,1
IT,POST PROCEDURAL COMPLICATION,1
IT,PROCEDURAL HAEMORRHAGE,1
IT,PRODUCT DOSAGE FORM ISSUE,1
IT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
IT,PSORIASIS,1
IT,PSORIATIC ARTHROPATHY,1
IT,PULMONARY ARTERIAL HYPERTENSION,1
IT,PULMONARY ARTERIAL PRESSURE ABNORMAL,1
IT,PULMONARY EMBOLISM,1
IT,PUSTULAR PSORIASIS,1
IT,PYODERMA,1
IT,RADIUS FRACTURE,1
IT,RASH ERYTHEMATOUS,1
IT,RECTAL HAEMORRHAGE,1
IT,RENAL ARTERY STENOSIS,1
IT,RENAL DISORDER,1
IT,RENAL FAILURE ACUTE,1
IT,RESPIRATORY ARREST,1
IT,RESPIRATORY DISTRESS,1
IT,RETINAL HAEMORRHAGE,1
IT,RETINOPATHY,1
IT,RHEUMATOID ARTHRITIS,1
IT,ROAD TRAFFIC ACCIDENT,1
IT,SENSORY DISTURBANCE,1
IT,SEPTIC PHLEBITIS,1
IT,SKIN NECROSIS,1
IT,SKIN REACTION,1
IT,SPINAL CORD INJURY,1
IT,STRABISMUS,1
IT,SUICIDAL BEHAVIOUR,1
IT,SWELLING,1
IT,SYNCOPE,1
IT,SYSTEMIC SCLERODERMA,1
IT,TESTIS CANCER,1
IT,THYROID FUNCTION TEST,1
IT,THYROID NEOPLASM,1
IT,THYROIDITIS SUBACUTE,1
IT,THYROXINE INCREASED,1
IT,TREATMENT NONCOMPLIANCE,1
IT,TREPONEMA TEST POSITIVE,1
IT,TRI-IODOTHYRONINE INCREASED,1
IT,TRICUSPID VALVE INCOMPETENCE,1
IT,UTERINE POLYPECTOMY,1
IT,UVEITIS,1
IT,VITREOUS DETACHMENT,1
IT,WHEEZING,1
IT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
JP,MULTIPLE SCLEROSIS RELAPSE,39
JP,HEPATIC FUNCTION ABNORMAL,21
JP,PYREXIA,17
JP,LYMPHOCYTE COUNT DECREASED,14
JP,WHITE BLOOD CELL COUNT DECREASED,11
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
JP,ALANINE AMINOTRANSFERASE INCREASED,9
JP,NO ADVERSE EVENT,9
JP,NAUSEA,7
JP,ASPARTATE AMINOTRANSFERASE INCREASED,6
JP,HYPOAESTHESIA,6
JP,DECREASED APPETITE,5
JP,DIZZINESS,5
JP,DRUG-INDUCED LIVER INJURY,5
JP,EPILEPSY,5
JP,RASH,5
JP,DEATH,4
JP,HEADACHE,4
JP,HERPES ZOSTER,4
JP,INFLUENZA LIKE ILLNESS,4
JP,INTENTIONAL PRODUCT USE ISSUE,4
JP,LYMPHOCYTE PERCENTAGE DECREASED,4
JP,VOMITING,4
JP,WHITE BLOOD CELL COUNT INCREASED,4
JP,ASTHENIA,3
JP,BLOOD BILIRUBIN INCREASED,3
JP,BREAST CANCER,3
JP,DEPRESSIVE SYMPTOM,3
JP,DYSURIA,3
JP,GAIT DISTURBANCE,3
JP,INTERSTITIAL LUNG DISEASE,3
JP,LIVER DISORDER,3
JP,LIVER FUNCTION TEST ABNORMAL,3
JP,MALAISE,3
JP,NASOPHARYNGITIS,3
JP,NEUROMYELITIS OPTICA,3
JP,OPTIC NEURITIS,3
JP,PNEUMONIA ASPIRATION,3
JP,SEPSIS,3
JP,VISUAL IMPAIRMENT,3
JP,ANTINUCLEAR ANTIBODY INCREASED,2
JP,BACTERAEMIA,2
JP,BLOOD PRESSURE INCREASED,2
JP,BLOOD TRIGLYCERIDES INCREASED,2
JP,C-REACTIVE PROTEIN INCREASED,2
JP,CAESAREAN SECTION,2
JP,CAMPYLOBACTER INFECTION,2
JP,CELLULITIS,2
JP,CENTRAL NERVOUS SYSTEM LESION,2
JP,CERVICAL RADICULOPATHY,2
JP,CHRONIC MYELOID LEUKAEMIA,2
JP,CONVULSION,2
JP,COORDINATION ABNORMAL,2
JP,DIABETES MELLITUS,2
JP,DIPLOPIA,2
JP,DRUG ERUPTION,2
JP,FACE OEDEMA,2
JP,FATIGUE,2
JP,FLUSHING,2
JP,HEART RATE DECREASED,2
JP,HEMIPARESIS,2
JP,HEPATIC ENZYME INCREASED,2
JP,HEPATITIS FULMINANT,2
JP,HYPERTENSION,2
JP,HYPERTRIGLYCERIDAEMIA,2
JP,INJECTION SITE HAEMORRHAGE,2
JP,INJECTION SITE PAIN,2
JP,INSOMNIA,2
JP,LEUKAEMIA,2
JP,METASTATIC MALIGNANT MELANOMA,2
JP,MULTIPLE SCLEROSIS,2
JP,MUSCLE SPASTICITY,2
JP,MUSCULAR WEAKNESS,2
JP,NEUTROPHIL PERCENTAGE INCREASED,2
JP,PALPITATIONS,2
JP,PLATELET COUNT DECREASED,2
JP,PRESCRIBED UNDERDOSE,2
JP,PYELONEPHRITIS,2
JP,RED BLOOD CELL COUNT INCREASED,2
JP,SENSORY DISTURBANCE,2
JP,TYPE 1 DIABETES MELLITUS,2
JP,VISUAL ACUITY REDUCED,2
JP,ABASIA,1
JP,ABDOMINAL DISCOMFORT,1
JP,ABDOMINAL DISTENSION,1
JP,ABDOMINAL PAIN,1
JP,ACNE,1
JP,ADVERSE EVENT,1
JP,ALOPECIA,1
JP,ALOPECIA AREATA,1
JP,ALTERED STATE OF CONSCIOUSNESS,1
JP,ANAEMIA,1
JP,APPENDICITIS,1
JP,ARTHRALGIA,1
JP,ASTHENOPIA,1
JP,ASTHMA,1
JP,ATRIAL FIBRILLATION,1
JP,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
JP,AUTOIMMUNE HYPOTHYROIDISM,1
JP,BACK PAIN,1
JP,BACTERIAL INFECTION,1
JP,BASOPHIL COUNT DECREASED,1
JP,BIPOLAR DISORDER,1
JP,BLEPHAROSPASM,1
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,1
JP,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
JP,BLOOD GLUCOSE INCREASED,1
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,1
JP,BLOOD PRESSURE DECREASED,1
JP,BLOOD PRESSURE SYSTOLIC INCREASED,1
JP,BLOOD UREA INCREASED,1
JP,BLOOD URINE PRESENT,1
JP,BONE MARROW FAILURE,1
JP,BRADYCARDIA,1
JP,BRAF V600E MUTATION POSITIVE,1
JP,BREAST CANCER RECURRENT,1
JP,BRONCHITIS,1
JP,CARDIAC ARREST,1
JP,CARDIAC FAILURE ACUTE,1
JP,CEREBRAL INFARCTION,1
JP,CHILLS,1
JP,CHOKING SENSATION,1
JP,CHOLECYSTITIS,1
JP,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
JP,COGNITIVE DISORDER,1
JP,COMPLEX REGIONAL PAIN SYNDROME,1
JP,CONCOMITANT DISEASE AGGRAVATED,1
JP,CONSTIPATION,1
JP,CONTRAST MEDIA ALLERGY,1
JP,COUGH,1
JP,CSF PROTEIN INCREASED,1
JP,CUTANEOUS CALCIFICATION,1
JP,CYANOSIS,1
JP,DEHYDRATION,1
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,1
JP,DIABETIC KETOACIDOSIS,1
JP,DIARRHOEA,1
JP,DISABILITY,1
JP,DISEASE RECURRENCE,1
JP,DISSEMINATED INTRAVASCULAR COAGULATION,1
JP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
JP,DRUG EFFECT INCOMPLETE,1
JP,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
JP,DRY SKIN,1
JP,DYSLALIA,1
JP,DYSPNOEA,1
JP,ECZEMA,1
JP,ELECTROCARDIOGRAM PR PROLONGATION,1
JP,ELECTROCARDIOGRAM QT PROLONGED,1
JP,EMERGENCY CARE,1
JP,EMOTIONAL DISTRESS,1
JP,ENDOCARDITIS,1
JP,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
JP,ENTEROCOLITIS HAEMORRHAGIC,1
JP,EOSINOPHILIC CELLULITIS,1
JP,EPIDIDYMITIS,1
JP,EUSTACHIAN TUBE PATULOUS,1
JP,FACIAL PARALYSIS,1
JP,FALL,1
JP,FEMUR FRACTURE,1
JP,FRACTURED COCCYX,1
JP,GANGRENE,1
JP,GASTRIC FISTULA,1
JP,GASTRITIS,1
JP,GASTROINTESTINAL DISORDER,1
JP,GASTROINTESTINAL HAEMORRHAGE,1
JP,GASTROINTESTINAL MUCOSAL DISORDER,1
JP,GENERALISED TONIC-CLONIC SEIZURE,1
JP,GINGIVAL PAIN,1
JP,GLAUCOMA,1
JP,GLIOBLASTOMA,1
JP,HAEMATOCHEZIA,1
JP,HAEMOLYTIC URAEMIC SYNDROME,1
JP,HEMIPLEGIA,1
JP,HEPATIC NECROSIS,1
JP,HEPATITIS ACUTE,1
JP,HUMERUS FRACTURE,1
JP,HYPERLIPIDAEMIA,1
JP,HYPOTENSION,1
JP,ILL-DEFINED DISORDER,1
JP,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
JP,INFECTED SKIN ULCER,1
JP,INFECTIVE ANEURYSM,1
JP,INJECTION SITE CALCIFICATION,1
JP,INJECTION SITE ERYTHEMA,1
JP,INJECTION SITE INDURATION,1
JP,INJECTION SITE INFECTION,1
JP,INJECTION SITE PRURITUS,1
JP,INJECTION SITE REACTION,1
JP,INJECTION SITE SWELLING,1
JP,INTENTIONAL PRODUCT MISUSE,1
JP,JAUNDICE,1
JP,LISTLESS,1
JP,LUNG NEOPLASM MALIGNANT,1
JP,LYMPHOCYTE COUNT INCREASED,1
JP,LYMPHOMA,1
JP,LYMPHOPENIA,1
JP,MANIA,1
JP,MASTECTOMY,1
JP,METASTASES TO BONE MARROW,1
JP,METASTASES TO LIVER,1
JP,METASTASES TO LUNG,1
JP,METASTASES TO LYMPH NODES,1
JP,METASTASES TO SKIN,1
JP,METASTATIC NEOPLASM,1
JP,MITOCHONDRIAL MYOPATHY,1
JP,MOBILITY DECREASED,1
JP,MONOCYTE COUNT DECREASED,1
JP,MONOPLEGIA,1
JP,MUSCLE SPASMS,1
JP,MUSCULOSKELETAL PAIN,1
JP,MYALGIA,1
JP,MYASTHENIA GRAVIS,1
JP,MYELODYSPLASTIC SYNDROME,1
JP,MYOCARDIAL INFARCTION,1
JP,NEEDLE ISSUE,1
JP,NEUROENDOCRINE CARCINOMA,1
JP,NEUROGENIC BLADDER,1
JP,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
JP,NEUTROPHIL COUNT ABNORMAL,1
JP,NEUTROPHIL COUNT INCREASED,1
JP,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
JP,NYSTAGMUS,1
JP,OLIGODENDROGLIOMA,1
JP,OROPHARYNGEAL PAIN,1
JP,OTITIS MEDIA CHRONIC,1
JP,OVERDOSE,1
JP,OXYGEN SATURATION DECREASED,1
JP,PAIN IN EXTREMITY,1
JP,PANNICULITIS LOBULAR,1
JP,PARALYSIS,1
JP,PATELLA FRACTURE,1
JP,PERIPHERAL CIRCULATORY FAILURE,1
JP,PERSONALITY DISORDER,1
JP,POST HERPETIC NEURALGIA,1
JP,PROCEDURAL PAIN,1
JP,PRODUCTIVE COUGH,1
JP,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
JP,PSORIASIS,1
JP,PSYCHOSOMATIC DISEASE,1
JP,PUBIS FRACTURE,1
JP,RENAL IMPAIRMENT,1
JP,RESPIRATORY SYMPTOM,1
JP,RETINAL HAEMORRHAGE,1
JP,RETINITIS,1
JP,RETINOPATHY,1
JP,RHINITIS ALLERGIC,1
JP,SCLEREMA,1
JP,SEASONAL ALLERGY,1
JP,SEIZURE,1
JP,SELF INJURIOUS BEHAVIOUR,1
JP,SEPTIC SHOCK,1
JP,SKIN ULCER,1
JP,SOMNOLENCE,1
JP,SPASTIC PARALYSIS,1
JP,STILLBIRTH,1
JP,STRESS,1
JP,SUICIDAL IDEATION,1
JP,SYNCOPE,1
JP,TENSION HEADACHE,1
JP,THYROID DISORDER,1
JP,THYROIDITIS SUBACUTE,1
JP,TONIC CONVULSION,1
JP,URINARY TRACT INFECTION,1
JP,URINE OUTPUT DECREASED,1
JP,VIITH NERVE PARALYSIS,1
JP,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
JP,VISION BLURRED,1
JP,VISUAL FIELD DEFECT,1
KR,MULTIPLE SCLEROSIS RELAPSE,3
KR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,3
KR,CENTRAL NERVOUS SYSTEM LESION,2
KR,COGNITIVE DISORDER,2
KR,DIZZINESS,2
KR,HYPERTHERMIA,2
KR,HYPOAESTHESIA,2
KR,ABORTION MISSED,1
KR,ASPIRATION,1
KR,BLOOD GLUCOSE INCREASED,1
KR,CELLULITIS,1
KR,CEREBRAL INFARCTION,1
KR,COMMUNICATION DISORDER,1
KR,COUGH,1
KR,DEAFNESS,1
KR,DEAFNESS UNILATERAL,1
KR,DEATH,1
KR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
KR,DEPRESSION,1
KR,FEELING HOT,1
KR,GAIT DISTURBANCE,1
KR,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
KR,GRAND MAL CONVULSION,1
KR,HEMIPARESIS,1
KR,HEPATIC ENZYME INCREASED,1
KR,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,1
KR,LUNG NEOPLASM MALIGNANT,1
KR,MATERNAL EXPOSURE DURING PREGNANCY,1
KR,MUSCULAR WEAKNESS,1
KR,MUSCULOSKELETAL STIFFNESS,1
KR,MYELITIS,1
KR,NASOPHARYNGITIS,1
KR,PARAESTHESIA,1
KR,PETIT MAL EPILEPSY,1
KR,PNEUMONIA,1
KR,PULMONARY EMBOLISM,1
KR,PULMONARY MASS,1
KR,PYREXIA,1
KR,SEIZURE,1
KR,THERAPEUTIC RESPONSE DECREASED,1
KR,THYROID CANCER,1
KR,TINNITUS,1
KR,TUBERCULOSIS,1
KR,VISION BLURRED,1
KW,COMA,1
KW,FATIGUE,1
KW,IMMOBILE,1
KW,MULTIPLE SCLEROSIS,1
LV,END STAGE RENAL DISEASE,1
LV,THROMBOTIC MICROANGIOPATHY,1
LB,ABORTION INDUCED,1
LB,ALOPECIA,1
LB,BLINDNESS UNILATERAL,1
LB,DRY SKIN,1
LB,GAIT DISTURBANCE,1
LB,MYOCARDIAL INFARCTION,1
LB,NEPHROTIC SYNDROME,1
LB,RENAL FAILURE,1
LB,SKIN LESION,1
LB,SUBDURAL HAEMATOMA,1
LT,ABSCESS LIMB,1
LT,SUBCUTANEOUS ABSCESS,1
LU,DIVERTICULITIS,2
LU,ASTHENIA,1
LU,EPILEPSY,1
LU,FATIGUE,1
LU,INSOMNIA,1
LU,INTERVERTEBRAL DISC PROTRUSION,1
LU,LARGE INTESTINE POLYP,1
LU,PRURITUS,1
LU,VIRAL INFECTION,1
MY,MULTIPLE SCLEROSIS RELAPSE,4
MY,CYSTITIS,3
MY,APHASIA,2
MY,BEDRIDDEN,2
MY,CARDIAC DISORDER,2
MY,PALLIATIVE CARE,2
MY,PARAPLEGIA,2
MY,PNEUMONIA,2
MY,PYREXIA,2
MY,FALL,1
MT,HIV INFECTION,1
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
MX,SEIZURE,3
MX,URINARY TRACT INFECTION,3
MX,EPILEPSY,2
MX,FEELING ABNORMAL,2
MX,HEADACHE,2
MX,MUSCULAR WEAKNESS,2
MX,PNEUMONIA,2
MX,TREMOR,2
MX,ACNE,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,ANXIETY,1
MX,ARM AMPUTATION,1
MX,ASPHYXIA,1
MX,ASTHENIA,1
MX,CHRONIC KIDNEY DISEASE,1
MX,DEATH,1
MX,DEPRESSION,1
MX,DISCOMFORT,1
MX,DIZZINESS,1
MX,DRUG HYPERSENSITIVITY,1
MX,DRUG INTOLERANCE,1
MX,DRUG PRESCRIBING ERROR,1
MX,DRUG-INDUCED LIVER INJURY,1
MX,DRY MOUTH,1
MX,GAIT DISTURBANCE,1
MX,HYPERCOAGULATION,1
MX,HYPERSENSITIVITY,1
MX,HYPOPHAGIA,1
MX,ILEUS PARALYTIC,1
MX,INFLUENZA LIKE ILLNESS,1
MX,INJURY,1
MX,LEUKOPENIA,1
MX,LIVER INJURY,1
MX,MULTIPLE SCLEROSIS RELAPSE,1
MX,NEUROGENIC BLADDER,1
MX,OVARIAN CANCER,1
MX,OVERDOSE,1
MX,PARAESTHESIA,1
MX,PULMONARY THROMBOSIS,1
MX,RENAL DISORDER,1
MX,ROAD TRAFFIC ACCIDENT,1
MX,TREATMENT NONCOMPLIANCE,1
ME,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
ME,ALANINE AMINOTRANSFERASE INCREASED,1
ME,ASPARTATE AMINOTRANSFERASE INCREASED,1
ME,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ME,BLOOD LACTATE DEHYDROGENASE INCREASED,1
ME,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ME,HEPATIC LESION,1
MA,ASCITES,1
MA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
MA,LYMPH NODE TUBERCULOSIS,1
MA,TUBERCULOSIS,1
MA,VITREOUS HAEMORRHAGE,1
NL,FATIGUE,38
NL,INFLUENZA LIKE ILLNESS,33
NL,MULTIPLE SCLEROSIS RELAPSE,31
NL,INJECTION SITE ERYTHEMA,27
NL,HEADACHE,20
NL,DEATH,17
NL,INJECTION SITE PAIN,16
NL,CHILLS,15
NL,GAIT DISTURBANCE,15
NL,PARAESTHESIA,13
NL,PNEUMONIA,13
NL,INJECTION SITE DISCOLOURATION,12
NL,MYALGIA,11
NL,BREAST CANCER,10
NL,FALL,10
NL,INJECTION SITE PRURITUS,10
NL,MALAISE,10
NL,MATERNAL EXPOSURE DURING PREGNANCY,10
NL,MUSCLE SPASMS,10
NL,MYOCARDIAL INFARCTION,10
NL,EPILEPSY,9
NL,INJECTION SITE REACTION,9
NL,ASTHENIA,8
NL,CEREBROVASCULAR ACCIDENT,8
NL,GENERAL PHYSICAL HEALTH DETERIORATION,8
NL,HYPERTENSION,8
NL,INJECTION SITE BRUISING,8
NL,NAUSEA,8
NL,URINARY TRACT INFECTION,8
NL,ABORTION SPONTANEOUS,7
NL,ARTHRALGIA,7
NL,DIZZINESS,7
NL,INJECTION SITE INDURATION,7
NL,PAIN IN EXTREMITY,7
NL,SKIN DISCOLOURATION,7
NL,TRANSIENT ISCHAEMIC ATTACK,7
NL,DRUG INEFFECTIVE,6
NL,ERYSIPELAS,6
NL,ERYTHEMA,6
NL,FEELING HOT,6
NL,HYPOAESTHESIA,6
NL,LIMB DISCOMFORT,6
NL,PALPITATIONS,6
NL,PYREXIA,6
NL,SOMNOLENCE,6
NL,STRESS,6
NL,CYSTITIS,5
NL,DEPRESSION,5
NL,EYE DISORDER,5
NL,INJECTION SITE SWELLING,5
NL,PULMONARY EMBOLISM,5
NL,SYNCOPE,5
NL,THROMBOSIS,5
NL,ANXIETY,4
NL,ARRHYTHMIA,4
NL,BURNING SENSATION,4
NL,CARDIAC ARREST,4
NL,CARDIAC DISORDER,4
NL,CONSTIPATION,4
NL,DECREASED APPETITE,4
NL,DIABETES MELLITUS,4
NL,INFLUENZA,4
NL,INJECTION SITE IRRITATION,4
NL,LIPODYSTROPHY ACQUIRED,4
NL,MULTIPLE SCLEROSIS,4
NL,MUSCULAR WEAKNESS,4
NL,MUSCULOSKELETAL DISORDER,4
NL,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,4
NL,PAIN,4
NL,VOMITING,4
NL,WEIGHT DECREASED,4
NL,WOUND,4
NL,ABDOMINAL PAIN UPPER,3
NL,ANKLE FRACTURE,3
NL,APHASIA,3
NL,ARTHROPATHY,3
NL,CENTRAL NERVOUS SYSTEM LESION,3
NL,CEREBROVASCULAR INSUFFICIENCY,3
NL,CHOLELITHIASIS,3
NL,DEPRESSED MOOD,3
NL,DRUG DOSE OMISSION,3
NL,FLUID RETENTION,3
NL,INJECTION SITE INFECTION,3
NL,INSOMNIA,3
NL,JOINT INJURY,3
NL,LACK OF INJECTION SITE ROTATION,3
NL,LYMPHOMA,3
NL,MALIGNANT MELANOMA,3
NL,MUSCULOSKELETAL DISCOMFORT,3
NL,PANCREATITIS,3
NL,PERIPHERAL COLDNESS,3
NL,POST PROCEDURAL COMPLICATION,3
NL,RESPIRATORY TRACT INFECTION,3
NL,ROAD TRAFFIC ACCIDENT,3
NL,SENSORY DISTURBANCE,3
NL,SENSORY LOSS,3
NL,SLEEP DISORDER,3
NL,SPEECH DISORDER,3
NL,TRIGEMINAL NEURALGIA,3
NL,UTERINE LEIOMYOMA,3
NL,WEIGHT INCREASED,3
NL,WHITE BLOOD CELL COUNT DECREASED,3
NL,ABDOMINAL DISCOMFORT,2
NL,ABDOMINAL PAIN,2
NL,ABSCESS,2
NL,ADVERSE DRUG REACTION,2
NL,BACK PAIN,2
NL,BLINDNESS UNILATERAL,2
NL,BLOOD CHOLESTEROL INCREASED,2
NL,BLOOD GLUCOSE FLUCTUATION,2
NL,BLOOD GLUCOSE INCREASED,2
NL,BODY TEMPERATURE DECREASED,2
NL,CARDIOMYOPATHY,2
NL,CAROTID ARTERY DISEASE,2
NL,CAROTID BODY TUMOUR,2
NL,CATARACT,2
NL,CEREBRAL INFARCTION,2
NL,CHEST PAIN,2
NL,COGNITIVE DISORDER,2
NL,COMPLICATION OF PREGNANCY,2
NL,CONFUSIONAL STATE,2
NL,DEEP VEIN THROMBOSIS,2
NL,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,2
NL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
NL,DRUG SPECIFIC ANTIBODY PRESENT,2
NL,DYSPNOEA,2
NL,FEELING ABNORMAL,2
NL,FINE MOTOR DELAY,2
NL,FOETAL EXPOSURE DURING PREGNANCY,2
NL,GASTRIC BYPASS,2
NL,GASTRIC HAEMORRHAGE,2
NL,GASTROINTESTINAL DISORDER,2
NL,HALLUCINATION,2
NL,HEPATIC INFECTION,2
NL,HERPES ZOSTER,2
NL,HODGKIN^S DISEASE,2
NL,HYPERHIDROSIS,2
NL,HYPOGLYCAEMIA,2
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
NL,INCORRECT DRUG ADMINISTRATION DURATION,2
NL,INGROWN HAIR,2
NL,INJECTION SITE EXTRAVASATION,2
NL,INJECTION SITE HYPOAESTHESIA,2
NL,INJECTION SITE INFLAMMATION,2
NL,INJECTION SITE MASS,2
NL,INTRADUCTAL PROLIFERATIVE BREAST LESION,2
NL,LOSS OF CONSCIOUSNESS,2
NL,LOSS OF CONTROL OF LEGS,2
NL,LUNG INFECTION,2
NL,LYME DISEASE,2
NL,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
NL,MENSTRUAL DISORDER,2
NL,MOTOR DYSFUNCTION,2
NL,MOVEMENT DISORDER,2
NL,MUSCULOSKELETAL STIFFNESS,2
NL,NECROSIS,2
NL,NEOPLASM,2
NL,NEPHROLITHIASIS,2
NL,NEURALGIA,2
NL,OESOPHAGEAL CARCINOMA,2
NL,OSTEOARTHRITIS,2
NL,OVARIAN CYST,2
NL,PANCREATITIS ACUTE,2
NL,PHOTOPHOBIA,2
NL,PREGNANCY,2
NL,PRODUCT USE ISSUE,2
NL,PRURITUS,2
NL,PYELONEPHRITIS,2
NL,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,2
NL,SLOW SPEECH,2
NL,SPINAL COMPRESSION FRACTURE,2
NL,SUICIDE ATTEMPT,2
NL,SYSTEMIC LUPUS ERYTHEMATOSUS,2
NL,THIRST,2
NL,THYROID DISORDER,2
NL,TREATMENT NONCOMPLIANCE,2
NL,URINARY TRACT DISORDER,2
NL,UTERINE CANCER,2
NL,UTERINE POLYP,2
NL,VISION BLURRED,2
NL,VISUAL ACUITY REDUCED,2
NL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
NL,ABASIA,1
NL,ABDOMINAL ABSCESS,1
NL,ABDOMINAL INFECTION,1
NL,ABDOMINAL WALL INFECTION,1
NL,ABDOMINAL WALL WOUND,1
NL,ABORTION INDUCED,1
NL,ACCIDENTAL DEATH,1
NL,ACUTE MYOCARDIAL INFARCTION,1
NL,ADENOCARCINOMA GASTRIC,1
NL,ADVERSE EVENT,1
NL,ALOPECIA,1
NL,ANAEMIA,1
NL,ANGELMAN^S SYNDROME,1
NL,ANGINA PECTORIS,1
NL,ANHEDONIA,1
NL,APNOEA,1
NL,APPENDICITIS,1
NL,APPENDIX DISORDER,1
NL,ARTERIAL DISORDER,1
NL,ARTERY DISSECTION,1
NL,ASCITES,1
NL,ASTHMA,1
NL,ATRIAL FIBRILLATION,1
NL,AUTOIMMUNE DISORDER,1
NL,BAND SENSATION,1
NL,BASAL CELL CARCINOMA,1
NL,BEHCET^S SYNDROME,1
NL,BENIGN INTRACRANIAL HYPERTENSION,1
NL,BILE DUCT CANCER,1
NL,BILE DUCT STONE,1
NL,BILIARY TRACT DISORDER,1
NL,BLADDER CANCER,1
NL,BLISTER,1
NL,BLISTER RUPTURE,1
NL,BODY TEMPERATURE INCREASED,1
NL,BONE CONTUSION,1
NL,BONE DEFORMITY,1
NL,BONE PAIN,1
NL,BRAIN NEOPLASM,1
NL,BREAST CALCIFICATIONS,1
NL,BREAST CANCER FEMALE,1
NL,BREAST CANCER IN SITU,1
NL,BREAST CANCER METASTATIC,1
NL,BREAST NEOPLASM,1
NL,BUNDLE BRANCH BLOCK RIGHT,1
NL,CARDIAC FAILURE,1
NL,CARDIAC VALVE DISEASE,1
NL,CARDIOVASCULAR DISORDER,1
NL,CAROTID ARTERY OCCLUSION,1
NL,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
NL,CEREBRAL AMYLOID ANGIOPATHY,1
NL,CEREBROVASCULAR DISORDER,1
NL,CHOLECYSTITIS ACUTE,1
NL,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NL,COLON ADENOMA,1
NL,COLOSTOMY,1
NL,COMA,1
NL,CONTUSION,1
NL,CONVULSION,1
NL,CRANIOTOMY,1
NL,DEAFNESS,1
NL,DECREASED IMMUNE RESPONSIVENESS,1
NL,DEFECT CONDUCTION INTRAVENTRICULAR,1
NL,DEPRESSION SUICIDAL,1
NL,DEVICE ISSUE,1
NL,DIARRHOEA,1
NL,DISABILITY,1
NL,DISTURBANCE IN ATTENTION,1
NL,DROOLING,1
NL,DRUG DEPENDENCE,1
NL,DRUG EFFECT DECREASED,1
NL,DRUG PRESCRIBING ERROR,1
NL,DYSAESTHESIA,1
NL,DYSPHAGIA,1
NL,DYSSTASIA,1
NL,EAR DISORDER,1
NL,ECTOPIC PREGNANCY,1
NL,EJECTION FRACTION DECREASED,1
NL,EMBOLIC STROKE,1
NL,EMOTIONAL DISORDER,1
NL,EPISTAXIS,1
NL,ERYTHEMA MULTIFORME,1
NL,EUTHANASIA,1
NL,EXTREMITY NECROSIS,1
NL,EYE HAEMORRHAGE,1
NL,EYE MOVEMENT DISORDER,1
NL,EYE SYMPTOM,1
NL,FAMILIAL AMYLOIDOSIS,1
NL,FAT NECROSIS,1
NL,FAT TISSUE INCREASED,1
NL,FEBRILE CONVULSION,1
NL,FEELING OF DESPAIR,1
NL,FEMUR FRACTURE,1
NL,FIBROMYALGIA,1
NL,FISTULA,1
NL,FOETAL DEATH,1
NL,FOETAL EXPOSURE TIMING UNSPECIFIED,1
NL,FOOD POISONING,1
NL,FUNCTIONAL GASTROINTESTINAL DISORDER,1
NL,GALLBLADDER DISORDER,1
NL,GASTRIC DISORDER,1
NL,GASTROENTERITIS,1
NL,GENERAL PHYSICAL CONDITION ABNORMAL,1
NL,GENERAL SYMPTOM,1
NL,GRANULOMATOSIS WITH POLYANGIITIS,1
NL,HAEMOGLOBIN DECREASED,1
NL,HAEMOPTYSIS,1
NL,HEAD DISCOMFORT,1
NL,HEART RATE IRREGULAR,1
NL,HEART VALVE INCOMPETENCE,1
NL,HEPATIC CANCER,1
NL,HEPATIC CIRRHOSIS,1
NL,HEPATIC FAILURE,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HEPATIC LESION,1
NL,HEPATITIS C,1
NL,HEPATITIS TOXIC,1
NL,HIP ARTHROPLASTY,1
NL,HIP FRACTURE,1
NL,HYPERGLYCAEMIA,1
NL,HYPERSOMNIA,1
NL,HYPERVENTILATION,1
NL,HYPOCALCAEMIA,1
NL,HYSTERECTOMY,1
NL,IMPAIRED WORK ABILITY,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INFECTION,1
NL,INFLAMMATION,1
NL,INJECTION SITE ABSCESS,1
NL,INJECTION SITE CELLULITIS,1
NL,INJECTION SITE NECROSIS,1
NL,INJECTION SITE WARMTH,1
NL,INTENTIONAL OVERDOSE,1
NL,INTERMITTENT CLAUDICATION,1
NL,INVASIVE DUCTAL BREAST CARCINOMA,1
NL,JC VIRUS INFECTION,1
NL,KNEE OPERATION,1
NL,LACERATION,1
NL,LEUKAEMIA,1
NL,LIP DISORDER,1
NL,LIPOATROPHY,1
NL,LIVE BIRTH,1
NL,LIVER FUNCTION TEST ABNORMAL,1
NL,LIVER INJURY,1
NL,LOCAL SWELLING,1
NL,LOCALISED INFECTION,1
NL,LOW BIRTH WEIGHT BABY,1
NL,LOWER RESPIRATORY TRACT INFECTION FUNGAL,1
NL,LUNG NEOPLASM MALIGNANT,1
NL,LYMPHADENOPATHY,1
NL,MENINGIOMA,1
NL,MENINGIOMA SURGERY,1
NL,MENINGITIS VIRAL,1
NL,MERALGIA PARAESTHETICA,1
NL,MESOTHELIOMA,1
NL,METASTASIS,1
NL,METASTATIC CARCINOMA OF THE BLADDER,1
NL,MICTURITION URGENCY,1
NL,MOBILITY DECREASED,1
NL,MULTIMORBIDITY,1
NL,MUSCLE RUPTURE,1
NL,MUSCLE TIGHTNESS,1
NL,MUSCULOSKELETAL PAIN,1
NL,NASAL DISORDER,1
NL,NASOPHARYNGITIS,1
NL,NECK PAIN,1
NL,NEUROBLASTOMA,1
NL,NO ADVERSE EVENT,1
NL,OEDEMA,1
NL,OSTEOMALACIA,1
NL,OVARIAN ADENOMA,1
NL,OVERDOSE,1
NL,PANCREATIC CARCINOMA,1
NL,PANCREATIC NEOPLASM,1
NL,PANOPHTHALMITIS,1
NL,PARALYSIS,1
NL,PERICARDITIS,1
NL,PERIPHERAL SWELLING,1
NL,PETIT MAL EPILEPSY,1
NL,PHARYNGEAL DISORDER,1
NL,PHLEBITIS INFECTIVE,1
NL,PITUITARY ENLARGEMENT,1
NL,PLACENTAL DISORDER,1
NL,PLASMA CELL MYELOMA,1
NL,PLATELET COUNT DECREASED,1
NL,PLEURAL EFFUSION,1
NL,PNEUMONIA BACTERIAL,1
NL,PNEUMOTHORAX,1
NL,POOR QUALITY SLEEP,1
NL,POST-TRAUMATIC STRESS DISORDER,1
NL,POSTOPERATIVE WOUND INFECTION,1
NL,PREMATURE BABY,1
NL,PRESYNCOPE,1
NL,PROCEDURAL HAEMORRHAGE,1
NL,PROCEDURAL PAIN,1
NL,PROSTATE CANCER,1
NL,PROSTATITIS,1
NL,PROTEIN DEFICIENCY,1
NL,PROTEINURIA,1
NL,PSYCHIATRIC SYMPTOM,1
NL,PSYCHOTIC DISORDER,1
NL,PULMONARY INFARCTION,1
NL,PULMONARY OEDEMA,1
NL,PULMONARY THROMBOSIS,1
NL,QUADRIPLEGIA,1
NL,RADICULAR SYNDROME,1
NL,RASH,1
NL,RASH ERYTHEMATOUS,1
NL,REMOVAL OF INTERNAL FIXATION,1
NL,RENAL IMPAIRMENT,1
NL,RESPIRATORY ARREST,1
NL,RESPIRATORY RATE INCREASED,1
NL,SCAR,1
NL,SINUS ARREST,1
NL,SINUS TACHYCARDIA,1
NL,SINUSITIS,1
NL,SKIN ATROPHY,1
NL,SKIN DISCOMFORT,1
NL,SKIN DISORDER,1
NL,SKIN EXFOLIATION,1
NL,SKIN FISSURES,1
NL,SKIN INFECTION,1
NL,SKIN WOUND,1
NL,SLEEP APNOEA SYNDROME,1
NL,SMALL SIZE PLACENTA,1
NL,SMEAR CERVIX ABNORMAL,1
NL,SOMNAMBULISM,1
NL,STEVENS-JOHNSON SYNDROME,1
NL,SUBACUTE SCLEROSING PANENCEPHALITIS,1
NL,SUBCUTANEOUS ABSCESS,1
NL,SUBDURAL HAEMATOMA,1
NL,TENDON RUPTURE,1
NL,TENSION,1
NL,TERATOMA,1
NL,TESTICULAR NEOPLASM,1
NL,THERAPEUTIC RESPONSE DECREASED,1
NL,THORACIC VERTEBRAL FRACTURE,1
NL,THYROID GLAND INJURY,1
NL,THYROIDECTOMY,1
NL,TINNITUS,1
NL,TREMOR,1
NL,TURNER^S SYNDROME,1
NL,TYPE 2 DIABETES MELLITUS,1
NL,UNDERDOSE,1
NL,UPPER LIMB FRACTURE,1
NL,URINARY CYSTECTOMY,1
NL,URINARY RETENTION,1
NL,URINARY TRACT INFECTION BACTERIAL,1
NL,UROSTOMY,1
NL,VEIN DISORDER,1
NL,VENOUS OCCLUSION,1
NL,VERTEBRAL ARTERY DISSECTION,1
NL,VERTIGO,1
NL,VIRAL PHARYNGITIS,1
NL,VITAMIN B12 DECREASED,1
NL,VOCAL CORD NODULE REMOVAL,1
NL,VULVAR DYSPLASIA,1
NL,WOUND COMPLICATION,1
NL,WOUND INFECTION,1
NZ,BIPOLAR DISORDER,1
NZ,ERYTHROMELALGIA,1
NZ,INFLUENZA LIKE ILLNESS,1
NZ,LARGE FOR DATES BABY,1
NZ,METASTASES TO CENTRAL NERVOUS SYSTEM,1
NZ,MUSCULOSKELETAL PAIN,1
NZ,PALLOR,1
NZ,PRURITUS,1
NZ,RASH ERYTHEMATOUS,1
NZ,RASH GENERALISED,1
NZ,SPEECH DISORDER,1
NZ,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
NZ,VOMITING,1
NZ,WEIGHT DECREASED,1
NI,CONVULSION,2
NI,ALOPECIA,1
NI,ASPIRATION BRONCHIAL,1
NI,BLOOD PRESSURE INCREASED,1
NI,BURNING SENSATION,1
NI,CARDIO-RESPIRATORY ARREST,1
NI,DISCOMFORT,1
NI,HYPOAESTHESIA,1
NI,INSOMNIA,1
NI,LIMB DISCOMFORT,1
NI,MULTIPLE SCLEROSIS RELAPSE,1
NI,MUSCLE SPASMS,1
NI,MUSCULOSKELETAL STIFFNESS,1
NI,PARAESTHESIA,1
NI,PNEUMONIA,1
NI,PRURITUS,1
NI,SEIZURE,1
NI,SENSORY LOSS,1
NI,STRESS AT WORK,1
NO,AORTIC DISSECTION,3
NO,MACULAR OEDEMA,3
NO,MULTIPLE SCLEROSIS RELAPSE,3
NO,THERAPY PARTIAL RESPONDER,3
NO,UNEVALUABLE EVENT,2
NO,ACUTE KIDNEY INJURY,1
NO,ANXIETY,1
NO,BLADDER CANCER,1
NO,CENTRAL NERVOUS SYSTEM LESION,1
NO,CEREBRAL DISORDER,1
NO,DEPRESSION,1
NO,DIPLOPIA,1
NO,DYSARTHRIA,1
NO,FACIAL PARALYSIS,1
NO,FATIGUE,1
NO,FEELING COLD,1
NO,FEELING HOT,1
NO,HAEMOLYTIC URAEMIC SYNDROME,1
NO,INJECTION SITE ABSCESS,1
NO,INTERNATIONAL NORMALISED RATIO FLUCTUATION,1
NO,MALAISE,1
NO,MUSCLE SPASTICITY,1
NO,MUSCULOSKELETAL DISORDER,1
NO,MUSCULOSKELETAL STIFFNESS,1
NO,NAUSEA,1
NO,OEDEMA,1
NO,OPTIC NEURITIS,1
NO,PANIC DISORDER,1
NO,PARALYSIS,1
NO,PERIPHERAL COLDNESS,1
NO,POST PROCEDURAL COMPLICATION,1
NO,PYREXIA,1
NO,RESTLESSNESS,1
NO,SERUM FERRITIN INCREASED,1
NO,SPEECH DISORDER,1
NO,VISION BLURRED,1
NO,VISUAL IMPAIRMENT,1
PA,BRAIN OEDEMA,2
PA,CHILLS,2
PA,PAIN IN EXTREMITY,2
PA,PYREXIA,2
PA,BRAIN NEOPLASM,1
PA,DENGUE FEVER,1
PA,DEPRESSION,1
PA,DIZZINESS,1
PA,DYSSTASIA,1
PA,EYE PAIN,1
PA,EYE SWELLING,1
PA,FEELING HOT,1
PA,GAIT DISTURBANCE,1
PA,GALLBLADDER DISORDER,1
PA,GRIP STRENGTH DECREASED,1
PA,HEADACHE,1
PA,HYPOAESTHESIA ORAL,1
PA,LOSS OF CONSCIOUSNESS,1
PA,MALAISE,1
PA,MENIERE^S DISEASE,1
PA,MULTIPLE SCLEROSIS RELAPSE,1
PA,OPTIC NEURITIS,1
PA,PAIN,1
PA,PARALYSIS,1
PA,POOR QUALITY SLEEP,1
PA,SENSATION OF HEAVINESS,1
PA,SPEECH DISORDER,1
PA,TRANSIENT ISCHAEMIC ATTACK,1
PA,VISION BLURRED,1
PE,CHILLS,2
PE,MALAISE,2
PE,ABORTION SPONTANEOUS,1
PE,GENERAL PHYSICAL HEALTH DETERIORATION,1
PE,GROIN INFECTION,1
PE,HEADACHE,1
PE,HERPES VIRUS INFECTION,1
PE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PE,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
PE,NECROSIS,1
PE,PAIN,1
PE,PNEUMONIA BACTERIAL,1
PE,PYREXIA,1
PE,ULCER,1
PE,UNEVALUABLE EVENT,1
PE,VOMITING,1
PE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PL,MULTIPLE SCLEROSIS RELAPSE,13
PL,DRUG INEFFECTIVE,5
PL,BIPOLAR I DISORDER,3
PL,HEADACHE,3
PL,MYOCARDIAL INFARCTION,3
PL,NECROSIS,3
PL,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,3
PL,ABORTION SPONTANEOUS,2
PL,ALANINE AMINOTRANSFERASE INCREASED,2
PL,ASPARTATE AMINOTRANSFERASE INCREASED,2
PL,BREAST CANCER,2
PL,CENTRAL NERVOUS SYSTEM LESION,2
PL,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,2
PL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
PL,MULTIPLE SCLEROSIS,2
PL,MYOCARDIAL ISCHAEMIA,2
PL,NEUROMYELITIS OPTICA,2
PL,OSTEOARTHRITIS,2
PL,PNEUMONIA,2
PL,PYREXIA,2
PL,SLEEP DISORDER,2
PL,WEIGHT DECREASED,2
PL,ACUTE HEPATIC FAILURE,1
PL,ADRENOMEGALY,1
PL,ANAPHYLACTIC SHOCK,1
PL,ANORECTAL DISORDER,1
PL,ARTHRALGIA,1
PL,ASTHMA,1
PL,BALANCE DISORDER,1
PL,BASEDOW^S DISEASE,1
PL,BRAIN DEATH,1
PL,BRAIN OEDEMA,1
PL,BREAST CANCER STAGE IV,1
PL,CAESAREAN SECTION,1
PL,CARDIAC ARREST,1
PL,CARDIOMYOPATHY,1
PL,CATARACT,1
PL,CEREBELLAR SYNDROME,1
PL,CEREBROVASCULAR ACCIDENT,1
PL,CHILLS,1
PL,COMA HEPATIC,1
PL,CONFUSIONAL STATE,1
PL,CONVULSION,1
PL,DELIRIUM,1
PL,DEPRESSED MOOD,1
PL,DIABETES MELLITUS INADEQUATE CONTROL,1
PL,DISEASE PROGRESSION,1
PL,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
PL,DRUG PRESCRIBING ERROR,1
PL,DYSPHAGIA,1
PL,ENDOMETRIAL ADENOCARCINOMA,1
PL,FALL,1
PL,FATIGUE,1
PL,FOOT FRACTURE,1
PL,GAIT DISTURBANCE,1
PL,GASTRITIS,1
PL,GENERAL PHYSICAL CONDITION ABNORMAL,1
PL,HAEMORRHAGIC FEVER,1
PL,HALLUCINATION,1
PL,HEMIANAESTHESIA,1
PL,HEPATIC ENCEPHALOPATHY,1
PL,HYPERTENSION,1
PL,HYPOAESTHESIA,1
PL,HYPOCHROMIC ANAEMIA,1
PL,HYPOTHYROIDISM,1
PL,HYPOTONIA,1
PL,INCORRECT DOSE ADMINISTERED,1
PL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
PL,INFLUENZA LIKE ILLNESS,1
PL,INVASIVE DUCTAL BREAST CARCINOMA,1
PL,LOSS OF CONSCIOUSNESS,1
PL,LUNG CANCER METASTATIC,1
PL,MALIGNANT MELANOMA IN SITU,1
PL,MATERNAL EXPOSURE DURING PREGNANCY,1
PL,MELANOCYTIC NAEVUS,1
PL,MENTAL DISORDER,1
PL,METRORRHAGIA,1
PL,MONOPARESIS,1
PL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
PL,MUSCULAR WEAKNESS,1
PL,NEPHROTIC SYNDROME,1
PL,NERVOUSNESS,1
PL,NEUROLOGICAL DECOMPENSATION,1
PL,OPTIC NEURITIS,1
PL,OVARIAN CANCER,1
PL,PAIN IN EXTREMITY,1
PL,PARAESTHESIA,1
PL,PARAPARESIS,1
PL,PELVIC FRACTURE,1
PL,PHARYNGITIS,1
PL,PROTEINURIA,1
PL,PYRAMIDAL TRACT SYNDROME,1
PL,RESPIRATORY ARREST,1
PL,RETCHING,1
PL,SENSORY DISTURBANCE,1
PL,SEPSIS,1
PL,SKIN DISCOLOURATION,1
PL,STAPHYLOCOCCAL SEPSIS,1
PL,SUBDURAL HAEMATOMA,1
PL,TEMPORAL ARTERITIS,1
PL,THROMBOSIS,1
PL,TONGUE BITING,1
PL,TRIGEMINAL NEURALGIA,1
PL,VERTIGO,1
PT,MULTIPLE SCLEROSIS RELAPSE,23
PT,DEPRESSION,10
PT,DIZZINESS,10
PT,MEMORY IMPAIRMENT,10
PT,BALANCE DISORDER,9
PT,HEADACHE,9
PT,MYALGIA,9
PT,ANXIETY,8
PT,ABDOMINAL PAIN UPPER,7
PT,GAIT DISTURBANCE,7
PT,GASTROINTESTINAL DISORDER,7
PT,MATERNAL EXPOSURE DURING PREGNANCY,7
PT,MUSCULAR WEAKNESS,7
PT,EOSINOPHILIA,6
PT,FLUSHING,6
PT,ISCHAEMIC STROKE,6
PT,SPEECH DISORDER,6
PT,CONDITION AGGRAVATED,5
PT,FALL,5
PT,PAIN,5
PT,BREAST CANCER,4
PT,CHILLS,4
PT,DRUG INEFFECTIVE,4
PT,FATIGUE,4
PT,INFLUENZA,4
PT,INFLUENZA LIKE ILLNESS,4
PT,PNEUMONIA,4
PT,ABORTION SPONTANEOUS,3
PT,ALANINE AMINOTRANSFERASE INCREASED,3
PT,ASPARTATE AMINOTRANSFERASE INCREASED,3
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
PT,HYPERTENSION,3
PT,HYPOAESTHESIA,3
PT,IMPAIRED SELF-CARE,3
PT,INJECTION SITE HAEMATOMA,3
PT,MALAISE,3
PT,MULTIPLE SCLEROSIS,3
PT,PAIN IN EXTREMITY,3
PT,TREMOR,3
PT,URINARY RETENTION,3
PT,ASTHENIA,2
PT,ATAXIA,2
PT,CELLULITIS,2
PT,CENTRAL NERVOUS SYSTEM LESION,2
PT,COLITIS ULCERATIVE,2
PT,CONSTIPATION,2
PT,DEPRESSED MOOD,2
PT,DRUG DOSE OMISSION,2
PT,DRUG-INDUCED LIVER INJURY,2
PT,DYSPNOEA,2
PT,FINE MOTOR SKILL DYSFUNCTION,2
PT,GALLBLADDER POLYP,2
PT,GLIOBLASTOMA,2
PT,HAEMORRHAGE,2
PT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
PT,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
PT,INSOMNIA,2
PT,INTENTIONAL PRODUCT MISUSE,2
PT,LIVE BIRTH,2
PT,MOBILITY DECREASED,2
PT,MUSCLE SPASMS,2
PT,MUSCULOSKELETAL DISORDER,2
PT,PERSONALITY DISORDER,2
PT,PREMATURE DELIVERY,2
PT,PYREXIA,2
PT,ROAD TRAFFIC ACCIDENT,2
PT,SOMATISATION DISORDER,2
PT,STRESS,2
PT,SUICIDAL IDEATION,2
PT,URINARY INCONTINENCE,2
PT,VOMITING,2
PT,ABASIA,1
PT,ABORTION INDUCED,1
PT,ACUTE MYOCARDIAL INFARCTION,1
PT,ADENOCARCINOMA,1
PT,AGGRESSION,1
PT,ANAL SPHINCTER ATONY,1
PT,ANAPHYLACTIC REACTION,1
PT,APPLICATION SITE INFLAMMATION,1
PT,ARRHYTHMIA,1
PT,ARTHRALGIA,1
PT,ATRIAL FIBRILLATION,1
PT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
PT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
PT,B-CELL LYMPHOMA,1
PT,BACK PAIN,1
PT,BENIGN HYDATIDIFORM MOLE,1
PT,BLINDNESS TRANSIENT,1
PT,BLINDNESS UNILATERAL,1
PT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PT,BLOOD CHOLESTEROL INCREASED,1
PT,BLOOD GLUCOSE ABNORMAL,1
PT,BLOOD TRIGLYCERIDES INCREASED,1
PT,BRADYCARDIA,1
PT,BURNOUT SYNDROME,1
PT,CAESAREAN SECTION,1
PT,CARDIO-RESPIRATORY ARREST,1
PT,CARDIOVASCULAR DISORDER,1
PT,CEPHALO-PELVIC DISPROPORTION,1
PT,CEREBRAL ATROPHY,1
PT,CEREBRAL ISCHAEMIA,1
PT,CEREBROVASCULAR ACCIDENT,1
PT,CHOLANGITIS ACUTE,1
PT,CHOLELITHIASIS,1
PT,CLONIC CONVULSION,1
PT,COLD SWEAT,1
PT,COMPLICATION OF PREGNANCY,1
PT,COORDINATION ABNORMAL,1
PT,CRANIOCEREBRAL INJURY,1
PT,CRYPTORCHISM,1
PT,DEMYELINATION,1
PT,DIABETES MELLITUS,1
PT,DISCOMFORT,1
PT,DISINHIBITION,1
PT,DRUG ABUSE,1
PT,DRY MOUTH,1
PT,DYSPHAGIA,1
PT,EAR PAIN,1
PT,ELECTROCARDIOGRAM ABNORMAL,1
PT,EPIGASTRIC DISCOMFORT,1
PT,ERYSIPELAS,1
PT,ERYTHEMA,1
PT,EXCESSIVE CERUMEN PRODUCTION,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EXTRASYSTOLES,1
PT,EYE OPERATION,1
PT,FACIAL PARALYSIS,1
PT,FEELING ABNORMAL,1
PT,FEELING HOT,1
PT,FIBROMA,1
PT,FLANK PAIN,1
PT,FLAVECTOMY,1
PT,FLUID RETENTION,1
PT,FOETAL EXPOSURE DURING PREGNANCY,1
PT,FOETAL GROWTH RESTRICTION,1
PT,FOETAL MALPOSITION,1
PT,GASTRITIS,1
PT,GENERAL PHYSICAL HEALTH DETERIORATION,1
PT,GENERALISED TONIC-CLONIC SEIZURE,1
PT,HAEMOPTYSIS,1
PT,HAEMORRHAGE IN PREGNANCY,1
PT,HEMIPARESIS,1
PT,HEPATIC STEATOSIS,1
PT,HIGH DENSITY LIPOPROTEIN INCREASED,1
PT,HOT FLUSH,1
PT,HYPOACUSIS,1
PT,HYPOKALAEMIA,1
PT,ILL-DEFINED DISORDER,1
PT,IMMUNOGLOBULINS ABNORMAL,1
PT,IMPAIRED HEALING,1
PT,IMPULSE-CONTROL DISORDER,1
PT,INCORRECT DOSE ADMINISTERED,1
PT,INFLAMMATORY BOWEL DISEASE,1
PT,INFLAMMATORY MARKER INCREASED,1
PT,INJECTION SITE ERYTHEMA,1
PT,INJECTION SITE HAEMORRHAGE,1
PT,INJECTION SITE NECROSIS,1
PT,INJECTION SITE PAIN,1
PT,INJECTION SITE REACTION,1
PT,INTENTIONAL OVERDOSE,1
PT,INTENTIONAL PRODUCT USE ISSUE,1
PT,INTERVERTEBRAL DISC OPERATION,1
PT,INTERVERTEBRAL DISC PROTRUSION,1
PT,JAUNDICE CHOLESTATIC,1
PT,LABORATORY TEST ABNORMAL,1
PT,LACRIMATION INCREASED,1
PT,LATENT TUBERCULOSIS,1
PT,LIMB DISCOMFORT,1
PT,LIP SWELLING,1
PT,LIPODYSTROPHY ACQUIRED,1
PT,LIVER FUNCTION TEST ABNORMAL,1
PT,LOSS OF CONTROL OF LEGS,1
PT,LOW BIRTH WEIGHT BABY,1
PT,LUNG ADENOCARCINOMA,1
PT,LUNG DISORDER,1
PT,LUNG NEOPLASM MALIGNANT,1
PT,LYMPHOPENIA,1
PT,MACULAR OEDEMA,1
PT,MALIGNANT MELANOMA,1
PT,MENINGIOMA,1
PT,MENTAL DISORDER,1
PT,MICTURITION URGENCY,1
PT,MUSCLE ATROPHY,1
PT,MUSCLE CONTRACTIONS INVOLUNTARY,1
PT,MUSCLE SPASTICITY,1
PT,MUSCLE TWITCHING,1
PT,MUSCULOSKELETAL PAIN,1
PT,NAUSEA,1
PT,NEUTROPHIL COUNT DECREASED,1
PT,NIGHTMARE,1
PT,NO ADVERSE EVENT,1
PT,OCULAR VASCULAR DISORDER,1
PT,OEDEMA PERIPHERAL,1
PT,ORAL HERPES,1
PT,ORGANIC BRAIN SYNDROME,1
PT,OROPHARYNGEAL DISCOMFORT,1
PT,OROPHARYNGEAL PAIN,1
PT,OSTEOARTHRITIS,1
PT,OSTEOPOROSIS,1
PT,OSTEOSCLEROSIS,1
PT,PALLOR,1
PT,PANCREATITIS,1
PT,PAPILLARY THYROID CANCER,1
PT,PARAESTHESIA,1
PT,PARAPARESIS,1
PT,PARKINSONISM,1
PT,PARTIAL SEIZURES,1
PT,PATELLA FRACTURE,1
PT,PLATELET COUNT DECREASED,1
PT,PLEURAL EFFUSION,1
PT,PNEUMONIA ASPIRATION,1
PT,POLYP,1
PT,POST PROCEDURAL CONSTIPATION,1
PT,PREGNANCY,1
PT,PROCEDURAL ANXIETY,1
PT,PRODUCT USE ISSUE,1
PT,PULMONARY HYPERTENSION,1
PT,PYELONEPHRITIS ACUTE,1
PT,RADICULOPATHY,1
PT,RECTAL HAEMORRHAGE,1
PT,RENAL COLIC,1
PT,RENAL SURGERY,1
PT,RESPIRATORY DISORDER,1
PT,RESPIRATORY TRACT INFECTION,1
PT,RETINAL VEIN THROMBOSIS,1
PT,RETINOPATHY HYPERTENSIVE,1
PT,SCIATICA,1
PT,SENSORY LOSS,1
PT,SKIN DISCOLOURATION,1
PT,SKIN NECROSIS,1
PT,SKIN REACTION,1
PT,SLEEP DISORDER,1
PT,SOMNOLENCE,1
PT,SPINAL COLUMN INJURY,1
PT,SPINAL LAMINECTOMY,1
PT,SPINAL OSTEOARTHRITIS,1
PT,SPLENIC INFARCTION,1
PT,STENT PLACEMENT,1
PT,SUICIDE ATTEMPT,1
PT,SWELLING FACE,1
PT,SYNCOPE,1
PT,TACHYARRHYTHMIA,1
PT,THROAT TIGHTNESS,1
PT,THROMBOCYTOPENIA,1
PT,TRANSITIONAL CELL CARCINOMA,1
PT,TRIGEMINAL NEURALGIA,1
PT,TUBERCULOSIS,1
PT,UMBILICAL CORD SHORT,1
PT,URINARY HESITATION,1
PT,URINARY TRACT DISORDER,1
PT,UTERINE CANCER,1
PT,UTERINE MASS,1
PT,UTERINE POLYP,1
PT,VAGUS NERVE DISORDER,1
PT,VASCULITIS,1
PT,VENOUS THROMBOSIS,1
PT,WEIGHT DECREASED,1
PT,WHITE BLOOD CELL COUNT DECREASED,1
PT,WOUND,1
PT,WRIST FRACTURE,1
PR,DEATH,8
PR,MULTIPLE SCLEROSIS RELAPSE,7
PR,ASTHENIA,5
PR,CHEST PAIN,4
PR,HEADACHE,3
PR,BALANCE DISORDER,2
PR,BLINDNESS,2
PR,DIABETES MELLITUS,2
PR,DRUG INEFFECTIVE,2
PR,DYSPNOEA,2
PR,GAIT DISTURBANCE,2
PR,HYPERTENSION,2
PR,MATERNAL EXPOSURE DURING PREGNANCY,2
PR,MOBILITY DECREASED,2
PR,MONOPLEGIA,2
PR,MULTIPLE SCLEROSIS,2
PR,PANIC ATTACK,2
PR,UNEVALUABLE EVENT,2
PR,ABASIA,1
PR,ABDOMINAL PAIN UPPER,1
PR,APPENDICITIS,1
PR,BLOOD GLUCOSE INCREASED,1
PR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
PR,CAESAREAN SECTION,1
PR,CARDIAC ARREST,1
PR,CEREBROVASCULAR ACCIDENT,1
PR,CHILLS,1
PR,CONDITION AGGRAVATED,1
PR,CONJUNCTIVITIS,1
PR,CONVULSION,1
PR,DEAFNESS,1
PR,DEAFNESS UNILATERAL,1
PR,DEPRESSION,1
PR,DIARRHOEA,1
PR,DRUG HYPERSENSITIVITY,1
PR,DRUG INTOLERANCE,1
PR,FALL,1
PR,FEAR,1
PR,GASTROINTESTINAL DISORDER,1
PR,GENERAL SYMPTOM,1
PR,HAEMOGLOBIN DECREASED,1
PR,HALLUCINATION,1
PR,HEMIPLEGIA,1
PR,HERPES ZOSTER,1
PR,HYPERCHOLESTEROLAEMIA,1
PR,HYPERSENSITIVITY,1
PR,HYPOACUSIS,1
PR,HYPOAESTHESIA,1
PR,ILL-DEFINED DISORDER,1
PR,INCONTINENCE,1
PR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
PR,INFLUENZA LIKE ILLNESS,1
PR,INJECTION SITE HAEMORRHAGE,1
PR,INJECTION SITE MASS,1
PR,INJECTION SITE RASH,1
PR,MUSCULAR WEAKNESS,1
PR,MUSCULOSKELETAL DISORDER,1
PR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
PR,PAIN,1
PR,PNEUMONIA,1
PR,POLLAKIURIA,1
PR,PRE-ECLAMPSIA,1
PR,PRODUCT QUALITY ISSUE,1
PR,RASH,1
PR,RECTAL HAEMORRHAGE,1
PR,SENILE OSTEOPOROSIS,1
PR,SKIN REACTION,1
PR,SPEECH DISORDER,1
PR,SUDDEN HEARING LOSS,1
PR,THYROIDITIS,1
PR,TONGUE DISCOLOURATION,1
PR,TREMOR,1
PR,URINARY TRACT INFECTION,1
PR,VENOUS INJURY,1
PR,VIRAL INFECTION,1
PR,VOMITING,1
PR,WEIGHT DECREASED,1
RO,DIZZINESS,2
RO,HEADACHE,2
RO,VERTIGO,2
RO,ACUTE MYOCARDIAL INFARCTION,1
RO,ALANINE AMINOTRANSFERASE INCREASED,1
RO,ALOPECIA,1
RO,ASPARTATE AMINOTRANSFERASE INCREASED,1
RO,BONE PAIN,1
RO,CHILLS,1
RO,DRUG DEPENDENCE,1
RO,DRUG DOSE OMISSION,1
RO,ECCHYMOSIS,1
RO,FATIGUE,1
RO,GAIT DISTURBANCE,1
RO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
RO,ILLNESS ANXIETY DISORDER,1
RO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
RO,INJECTION SITE INJURY,1
RO,LIBIDO DECREASED,1
RO,LYMPHOPENIA,1
RO,MUCOCUTANEOUS HAEMORRHAGE,1
RO,MULTIPLE SCLEROSIS RELAPSE,1
RO,MYALGIA,1
RO,ONYCHOCLASIS,1
RO,PAIN,1
RO,PARAESTHESIA,1
RO,PYREXIA,1
RO,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
RO,THROMBOCYTOPENIA,1
RO,UMBILICAL CORD AROUND NECK,1
RO,VOMITING,1
RO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
RU,DISEASE PROGRESSION,5
RU,LIVE BIRTH,5
RU,MATERNAL EXPOSURE DURING PREGNANCY,5
RU,INFLUENZA LIKE ILLNESS,3
RU,DRUG INTOLERANCE,2
RU,GESTATIONAL HYPERTENSION,2
RU,MULTIPLE SCLEROSIS RELAPSE,2
RU,RESPIRATORY DISORDER,2
RU,TACHYCARDIA,2
RU,ABDOMINAL PAIN,1
RU,AFFECT LABILITY,1
RU,ANAEMIA OF PREGNANCY,1
RU,ARTHRALGIA,1
RU,ASTHENIA,1
RU,BONE PAIN,1
RU,CARDIAC DISORDER,1
RU,CERVICAL POLYP,1
RU,CERVIX DISORDER,1
RU,CYTOPENIA,1
RU,DECREASED APPETITE,1
RU,DEPRESSION,1
RU,DIZZINESS,1
RU,ERYSIPELAS,1
RU,EXPANDED DISABILITY STATUS SCALE SCORE INCREASED,1
RU,FACE OEDEMA,1
RU,HEPATITIS ACUTE,1
RU,HYPERHIDROSIS,1
RU,IMMUNE THROMBOCYTOPENIC PURPURA,1
RU,IMMUNOSUPPRESSION,1
RU,INJECTION SITE INFLAMMATION,1
RU,INSOMNIA,1
RU,LOCALISED OEDEMA,1
RU,MOOD SWINGS,1
RU,MULTIPLE SCLEROSIS,1
RU,NAUSEA,1
RU,NERVOUSNESS,1
RU,NYSTAGMUS,1
RU,OPTIC ATROPHY,1
RU,PANCREATIC CARCINOMA,1
RU,PANCREATIC FISTULA,1
RU,PANCREATITIS,1
RU,PARAPARESIS,1
RU,PLEURISY,1
RU,PNEUMONIA,1
RU,QUALITY OF LIFE DECREASED,1
RU,RASH,1
RU,REFLEXES ABNORMAL,1
RU,RETINAL VASCULAR DISORDER,1
RU,ROMBERG TEST POSITIVE,1
RU,SEIZURE,1
RU,SUICIDAL IDEATION,1
RU,TEARFULNESS,1
RU,UPPER RESPIRATORY TRACT INFECTION,1
RU,URINARY INCONTINENCE,1
RU,UTERINE LEIOMYOMA,1
RU,VULVAL CANCER,1
RU,WEIGHT DECREASED,1
RU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
SA,MOYAMOYA DISEASE,2
SA,DENTOFACIAL ANOMALY,1
SA,FOETAL EXPOSURE DURING PREGNANCY,1
SA,INFERTILITY MALE,1
SA,PREMATURE BABY,1
RS,ACUTE MYOCARDIAL INFARCTION,1
RS,AORTIC RUPTURE,1
RS,BILE DUCT STONE,1
RS,CHOLECYSTITIS ACUTE,1
RS,CONCUSSION,1
RS,CYSTITIS,1
RS,HAEMOTHORAX,1
RS,RIB FRACTURE,1
RS,ROAD TRAFFIC ACCIDENT,1
RS,SKULL FRACTURE,1
RS,URINARY TRACT INFECTION,1
SG,INJECTION SITE ERYTHEMA,2
SG,INJECTION SITE HAEMORRHAGE,2
SG,VISION BLURRED,2
SG,INJECTION SITE BRUISING,1
SG,INJECTION SITE DISCHARGE,1
SG,INJECTION SITE INJURY,1
SG,INJECTION SITE PRURITUS,1
SG,MUSCULAR WEAKNESS,1
SG,PANNICULITIS,1
SG,PYREXIA,1
SK,MULTIPLE SCLEROSIS RELAPSE,7
SK,FOETAL EXPOSURE DURING PREGNANCY,5
SK,OPTIC NEURITIS,5
SK,PARAPARESIS,5
SK,MATERNAL EXPOSURE DURING PREGNANCY,4
SK,RADICULAR SYNDROME,4
SK,ATAXIA,2
SK,BACK PAIN,2
SK,CEREBROVASCULAR ACCIDENT,2
SK,DEATH,2
SK,INFECTIOUS MONONUCLEOSIS,2
SK,LIVE BIRTH,2
SK,PREMATURE DELIVERY,2
SK,ABASIA,1
SK,ANAEMIA,1
SK,ANGIOEDEMA,1
SK,APHASIA,1
SK,ARTHRALGIA,1
SK,BRAIN STEM SYNDROME,1
SK,BREAST CANCER STAGE III,1
SK,CELLULITIS,1
SK,CHEST WALL OPERATION,1
SK,CHOLELITHIASIS,1
SK,CHRONIC SINUSITIS,1
SK,DEAFNESS NEUROSENSORY,1
SK,DRUG INEFFECTIVE,1
SK,DRUG-INDUCED LIVER INJURY,1
SK,DYSLIPIDAEMIA,1
SK,ECTOPIC PREGNANCY,1
SK,FATIGUE,1
SK,FOOT DEFORMITY,1
SK,GASTROINTESTINAL INFLAMMATION,1
SK,GENERAL SYMPTOM,1
SK,HAEMORRHAGE IN PREGNANCY,1
SK,HYPERCHOLESTEROLAEMIA,1
SK,HYPERSPLENISM,1
SK,HYPERTENSION,1
SK,IMMUNE THROMBOCYTOPENIC PURPURA,1
SK,INTERNAL FIXATION OF SPINE,1
SK,INVASIVE DUCTAL BREAST CARCINOMA,1
SK,ISCHAEMIA,1
SK,KNEE OPERATION,1
SK,LARGE FOR DATES BABY,1
SK,LIPOMA,1
SK,LIVER DISORDER,1
SK,MAJOR DEPRESSION,1
SK,MICTURITION URGENCY,1
SK,MOTOR DYSFUNCTION,1
SK,MUSCLE RUPTURE,1
SK,NODULE,1
SK,PAIN,1
SK,PANCREATITIS CHRONIC,1
SK,PREMATURE BABY,1
SK,PREMATURE SEPARATION OF PLACENTA,1
SK,RETINAL VASCULITIS,1
SK,SENSORY DISTURBANCE,1
SK,SPLENECTOMY,1
SK,SUBCLAVIAN STEAL SYNDROME,1
SK,THROMBOCYTOPENIA,1
SK,TRISOMY 21,1
SK,UVEITIS,1
SK,VARICOCELE,1
SK,VISION BLURRED,1
SK,VISUAL ACUITY REDUCED,1
SI,FATIGUE,5
SI,INFLUENZA LIKE ILLNESS,5
SI,MULTIPLE SCLEROSIS RELAPSE,3
SI,CENTRAL NERVOUS SYSTEM LESION,2
SI,FEELING ABNORMAL,2
SI,HEADACHE,2
SI,NERVOUSNESS,2
SI,REPRODUCTIVE TRACT DISORDER,2
SI,RHABDOMYOLYSIS,2
SI,TREMOR,2
SI,AGITATION,1
SI,ARTHRALGIA,1
SI,ARTHROPATHY,1
SI,AUTOIMMUNE DISORDER,1
SI,BENIGN BREAST NEOPLASM,1
SI,BRADYCARDIA,1
SI,CARDIAC DISORDER,1
SI,CARDIAC FAILURE,1
SI,CHOLELITHIASIS,1
SI,DISEASE PROGRESSION,1
SI,DIZZINESS,1
SI,DYSARTHRIA,1
SI,FALL,1
SI,FOOD INTERACTION,1
SI,GAIT DISTURBANCE,1
SI,GENERAL PHYSICAL HEALTH DETERIORATION,1
SI,HYPERTENSION,1
SI,INFARCTION,1
SI,INJECTION SITE ATROPHY,1
SI,INJECTION SITE DISCOMFORT,1
SI,INJECTION SITE REACTION,1
SI,INVASIVE DUCTAL BREAST CARCINOMA,1
SI,ISCHAEMIC CARDIOMYOPATHY,1
SI,MALIGNANT GLIOMA,1
SI,MOOD ALTERED,1
SI,MULTIPLE SCLEROSIS,1
SI,NASOPHARYNGITIS,1
SI,NIGHT SWEATS,1
SI,PAIN IN EXTREMITY,1
SI,PITUITARY TUMOUR BENIGN,1
SI,POLYURIA,1
SI,RHEUMATIC DISORDER,1
SI,SJOGREN^S SYNDROME,1
SI,SKIN DISORDER,1
SI,VARICOSE VEIN,1
SI,VEIN DISORDER,1
ZA,FATIGUE,4
ZA,ALANINE AMINOTRANSFERASE INCREASED,3
ZA,BLOOD PRESSURE FLUCTUATION,3
ZA,DIZZINESS,3
ZA,GAIT DISTURBANCE,3
ZA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
ZA,HEART RATE DECREASED,3
ZA,INJECTION SITE ERYTHEMA,3
ZA,MALAISE,3
ZA,PAIN,3
ZA,ANXIETY,2
ZA,ASTHENIA,2
ZA,BACK PAIN,2
ZA,FEELING ABNORMAL,2
ZA,HEMIPARESIS,2
ZA,HYPOTENSION,2
ZA,INFLUENZA LIKE ILLNESS,2
ZA,INJECTION SITE PAIN,2
ZA,INTENTIONAL PRODUCT MISUSE,2
ZA,MULTIPLE SCLEROSIS RELAPSE,2
ZA,MYALGIA,2
ZA,NAUSEA,2
ZA,VISUAL IMPAIRMENT,2
ZA,WHITE BLOOD CELL COUNT DECREASED,2
ZA,ABDOMINAL DISCOMFORT,1
ZA,ABDOMINAL PAIN,1
ZA,ABDOMINAL PAIN UPPER,1
ZA,ADVERSE DRUG REACTION,1
ZA,APHAGIA,1
ZA,ARTHRALGIA,1
ZA,ARTHROPOD BITE,1
ZA,ASPARTATE AMINOTRANSFERASE INCREASED,1
ZA,BALANCE DISORDER,1
ZA,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ZA,BLOOD IRON DECREASED,1
ZA,BLOOD PRESSURE INCREASED,1
ZA,CAESAREAN SECTION,1
ZA,CHEST DISCOMFORT,1
ZA,CHEST PAIN,1
ZA,COMA,1
ZA,CRYING,1
ZA,DEATH,1
ZA,DEPRESSED MOOD,1
ZA,DEPRESSION,1
ZA,DIPLOPIA,1
ZA,DISCOMFORT,1
ZA,DISORIENTATION,1
ZA,DRUG HYPERSENSITIVITY,1
ZA,DRUG INEFFECTIVE,1
ZA,DRUG INTOLERANCE,1
ZA,FOAMING AT MOUTH,1
ZA,GAIT INABILITY,1
ZA,GASTRIC DISORDER,1
ZA,GASTRIC ULCER,1
ZA,HAEMOCHROMATOSIS,1
ZA,HEADACHE,1
ZA,HEART RATE INCREASED,1
ZA,HYPOAESTHESIA,1
ZA,IMMUNODEFICIENCY,1
ZA,IMPAIRED WORK ABILITY,1
ZA,INCORRECT DOSE ADMINISTERED,1
ZA,INJECTION SITE BRUISING,1
ZA,INJECTION SITE MASS,1
ZA,INSOMNIA,1
ZA,LOSS OF CONSCIOUSNESS,1
ZA,LUNG INFECTION,1
ZA,MATERNAL EXPOSURE DURING PREGNANCY,1
ZA,MIDDLE INSOMNIA,1
ZA,MIGRAINE,1
ZA,MUSCLE SPASMS,1
ZA,MUSCULAR WEAKNESS,1
ZA,NERVOUSNESS,1
ZA,NODULE,1
ZA,OCULAR DISCOMFORT,1
ZA,OPPORTUNISTIC INFECTION,1
ZA,PARAESTHESIA,1
ZA,PHOTOPHOBIA,1
ZA,RASH ERYTHEMATOUS,1
ZA,RASH GENERALISED,1
ZA,RASH PRURITIC,1
ZA,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
ZA,SEIZURE,1
ZA,SERUM FERRITIN INCREASED,1
ZA,SKIN MASS,1
ZA,SOMNOLENCE,1
ZA,SPEECH DISORDER,1
ZA,SUBCUTANEOUS ABSCESS,1
ZA,SYNCOPE,1
ZA,TEARFULNESS,1
ZA,TRANSFERRIN SATURATION DECREASED,1
ZA,TREMOR,1
ZA,ULCER HAEMORRHAGE,1
ZA,UNEVALUABLE EVENT,1
ZA,URINARY TRACT INFECTION,1
ZA,VERTIGO,1
ZA,VISION BLURRED,1
ZA,WEIGHT DECREASED,1
ZA,WOUND INFECTION STAPHYLOCOCCAL,1
ZA,WOUND NECROSIS,1
ZA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
ES,MULTIPLE SCLEROSIS RELAPSE,6
ES,DEATH,5
ES,BREAST CANCER,3
ES,DIZZINESS,3
ES,INFLUENZA LIKE ILLNESS,3
ES,MULTIPLE SCLEROSIS,3
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,3
ES,ACARODERMATITIS,2
ES,APPARENT DEATH,2
ES,AUTOIMMUNE HEPATITIS,2
ES,CELLULITIS,2
ES,CHEST DISCOMFORT,2
ES,CROHN^S DISEASE,2
ES,DEMYELINATING POLYNEUROPATHY,2
ES,DIABETIC RETINOPATHY,2
ES,DRUG-INDUCED LIVER INJURY,2
ES,FATIGUE,2
ES,HYPERTRANSAMINASAEMIA,2
ES,MACULAR OEDEMA,2
ES,MALAISE,2
ES,MUSCLE SPASMS,2
ES,NECROSIS,2
ES,NO ADVERSE EVENT,2
ES,PANCREATITIS,2
ES,PAPILLOMA VIRAL INFECTION,2
ES,THYROID ADENOMA,2
ES,TOXIC EPIDERMAL NECROLYSIS,2
ES,URINARY TRACT INFECTION,2
ES,URTICARIA,2
ES,ABDOMINAL PAIN,1
ES,ABORTION,1
ES,ACUTE KIDNEY INJURY,1
ES,ACUTE MYOCARDIAL INFARCTION,1
ES,ACUTE PULMONARY OEDEMA,1
ES,ALANINE AMINOTRANSFERASE ABNORMAL,1
ES,ALOPECIA,1
ES,ANGIOEDEMA,1
ES,ANXIETY,1
ES,ANXIETY DISORDER,1
ES,APHASIA,1
ES,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
ES,ASPHYXIA,1
ES,ATRIAL FIBRILLATION,1
ES,AUTOIMMUNE DISORDER,1
ES,BENIGN PROSTATIC HYPERPLASIA,1
ES,BLADDER CANCER,1
ES,BLISTER,1
ES,BLOOD TRIGLYCERIDES INCREASED,1
ES,BRUXISM,1
ES,CENTRAL NERVOUS SYSTEM LESION,1
ES,CEREBRAL ARTERY EMBOLISM,1
ES,CEREBRAL HAEMORRHAGE,1
ES,CEREBROVASCULAR ACCIDENT,1
ES,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
ES,CHRONIC MYELOID LEUKAEMIA,1
ES,COAGULOPATHY,1
ES,COGNITIVE DISORDER,1
ES,COMPLETED SUICIDE,1
ES,CONSTIPATION,1
ES,COUGH,1
ES,DEPRESSION,1
ES,DERMATITIS,1
ES,DIARRHOEA,1
ES,DISABILITY,1
ES,DISEASE PROGRESSION,1
ES,DISORIENTATION,1
ES,DOUBLE URETER,1
ES,DYSPHAGIA,1
ES,DYSPNOEA,1
ES,EPIDERMAL NECROSIS,1
ES,FALL,1
ES,FASCIITIS,1
ES,FEMUR FRACTURE,1
ES,FLUSHING,1
ES,FOETAL EXPOSURE DURING PREGNANCY,1
ES,GALLBLADDER DISORDER,1
ES,HAEMATOCHEZIA,1
ES,HAEMOLYTIC URAEMIC SYNDROME,1
ES,HEADACHE,1
ES,HEMIPLEGIA,1
ES,HEPATIC CANCER,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATITIS ACUTE,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERTENSION,1
ES,INJECTION SITE INDURATION,1
ES,INSOMNIA,1
ES,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
ES,LIP OEDEMA,1
ES,LUNG ADENOCARCINOMA,1
ES,LUNG NEOPLASM MALIGNANT,1
ES,MALIGNANT HYPERTENSION,1
ES,MALIGNANT MELANOMA STAGE II,1
ES,MALIGNANT MELANOMA STAGE III,1
ES,MUCOSAL INFLAMMATION,1
ES,MUSCLE RIGIDITY,1
ES,MUSCLE SPASTICITY,1
ES,MUSCULOSKELETAL PAIN,1
ES,MYOSITIS,1
ES,NEOPLASM RECURRENCE,1
ES,NEPHROANGIOSCLEROSIS,1
ES,NEPHROTIC SYNDROME,1
ES,NEUTRALISING ANTIBODIES POSITIVE,1
ES,NIKOLSKY^S SIGN,1
ES,OEDEMATOUS PANCREATITIS,1
ES,OPHTHALMIC HERPES ZOSTER,1
ES,OROPHARYNGEAL PAIN,1
ES,PANCREATITIS ACUTE,1
ES,PANNICULITIS,1
ES,PAPILLARY THYROID CANCER,1
ES,PARALYSIS,1
ES,PARONYCHIA,1
ES,PHLEBITIS,1
ES,PNEUMONIA,1
ES,PNEUMONIA ASPIRATION,1
ES,POLYMYOSITIS,1
ES,PROCEDURAL COMPLICATION,1
ES,PROTEINURIA,1
ES,PRURITUS GENERALISED,1
ES,PSYCHOTIC DISORDER,1
ES,PULMONARY EMBOLISM,1
ES,PULMONARY HYPERTENSION,1
ES,PULMONARY MASS,1
ES,PUNCTATE KERATITIS,1
ES,PYREXIA,1
ES,RASH MORBILLIFORM,1
ES,RAYNAUD^S PHENOMENON,1
ES,RENAL CANCER,1
ES,RENAL CANCER METASTATIC,1
ES,RENAL CYST,1
ES,RENAL MASS,1
ES,RENAL NECROSIS,1
ES,RENAL NEOPLASM,1
ES,RESPIRATORY FAILURE,1
ES,RETINAL INFARCTION,1
ES,RETINAL VASCULAR THROMBOSIS,1
ES,RETROPERITONEAL LYMPHADENOPATHY,1
ES,SENSORY DISTURBANCE,1
ES,SKIN BURNING SENSATION,1
ES,SKIN EXFOLIATION,1
ES,SKIN ULCER,1
ES,STOMATITIS,1
ES,THROMBOCYTOPENIC PURPURA,1
ES,THROMBOPHLEBITIS,1
ES,THROMBOSIS,1
ES,THROMBOTIC MICROANGIOPATHY,1
ES,THYROID NEOPLASM,1
ES,TRANSPOSITION OF THE GREAT VESSELS,1
ES,URINARY RETENTION,1
ES,UTERINE DISORDER,1
ES,UVEITIS,1
ES,VARICOSE VEIN,1
LK,CELLULITIS,1
LK,DIZZINESS,1
LK,SHOCK,1
LK,VIRAL INFECTION,1
LK,VISION BLURRED,1
SE,PYREXIA,4
SE,BACK DISORDER,2
SE,BLINDNESS,2
SE,DEEP VEIN THROMBOSIS,2
SE,FATIGUE,2
SE,LEUKOPENIA,2
SE,MATERNAL EXPOSURE DURING PREGNANCY,2
SE,ABDOMINAL DISCOMFORT,1
SE,ABORTION SPONTANEOUS,1
SE,ABSCESS,1
SE,ACCIDENTAL OVERDOSE,1
SE,ANAEMIA MACROCYTIC,1
SE,ASTHENIA,1
SE,BLOOD CREATININE INCREASED,1
SE,BREAST CANCER,1
SE,BUNDLE BRANCH BLOCK,1
SE,CARDIOMYOPATHY,1
SE,CENTRAL NERVOUS SYSTEM LESION,1
SE,CENTRAL NERVOUS SYSTEM LYMPHOMA,1
SE,COLON CANCER,1
SE,CONSTIPATION,1
SE,DEVICE ISSUE,1
SE,DIARRHOEA,1
SE,DIZZINESS,1
SE,DRUG INEFFECTIVE,1
SE,DYSSTASIA,1
SE,ENDOMETRIOSIS,1
SE,EPILEPSY,1
SE,ERYSIPELAS,1
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SE,GASTRIC DISORDER,1
SE,GESTATIONAL HYPERTENSION,1
SE,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
SE,HAEMOLYSIS,1
SE,HAEMORRHAGIC STROKE,1
SE,HEAD DISCOMFORT,1
SE,HYPERTENSION,1
SE,ILL-DEFINED DISORDER,1
SE,INFECTION,1
SE,INJECTION SITE INDURATION,1
SE,INJECTION SITE INFECTION,1
SE,INJECTION SITE NECROSIS,1
SE,LOSS OF CONSCIOUSNESS,1
SE,LYMPHOPENIA,1
SE,MACULAR DEGENERATION,1
SE,MALAISE,1
SE,MULTIPLE SCLEROSIS RELAPSE,1
SE,NAUSEA,1
SE,NEOPLASM,1
SE,NEOPLASM MALIGNANT,1
SE,NEPHROTIC SYNDROME,1
SE,NEUTROPENIA,1
SE,NO ADVERSE EVENT,1
SE,OPTIC NEURITIS,1
SE,PAIN,1
SE,PAIN IN EXTREMITY,1
SE,PHOTOPHOBIA,1
SE,PLATELET COUNT DECREASED,1
SE,POLYP,1
SE,PRE-ECLAMPSIA,1
SE,PRODUCT SUBSTITUTION ISSUE,1
SE,PROTEIN S DEFICIENCY,1
SE,PROTEINURIA,1
SE,PULMONARY EMBOLISM,1
SE,RAYNAUD^S PHENOMENON,1
SE,RETINAL EXUDATES,1
SE,STREPTOCOCCAL SEPSIS,1
SE,SUBCUTANEOUS ABSCESS,1
SE,THROMBOPHLEBITIS,1
SE,UHTHOFF^S PHENOMENON,1
SE,VENTRICULAR EXTRASYSTOLES,1
SE,VIRAL INFECTION,1
SE,VOLVULUS,1
SE,WEIGHT DECREASED,1
CH,INFLUENZA LIKE ILLNESS,18
CH,FALL,8
CH,INJECTION SITE ERYTHEMA,7
CH,MATERNAL EXPOSURE DURING PREGNANCY,6
CH,FATIGUE,5
CH,MYOCARDIAL INFARCTION,5
CH,PAIN,5
CH,PYREXIA,5
CH,ACUTE MYOCARDIAL INFARCTION,4
CH,ARTHRALGIA,4
CH,DEATH,4
CH,DIZZINESS,4
CH,GAIT DISTURBANCE,4
CH,INJECTION SITE INDURATION,4
CH,MULTIPLE SCLEROSIS,4
CH,MULTIPLE SCLEROSIS RELAPSE,4
CH,ABORTION SPONTANEOUS,3
CH,CEREBROVASCULAR ACCIDENT,3
CH,DEEP VEIN THROMBOSIS,3
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,3
CH,INJECTION SITE PAIN,3
CH,MOBILITY DECREASED,3
CH,PALPITATIONS,3
CH,PNEUMONIA,3
CH,SLEEP DISORDER,3
CH,ACUTE KIDNEY INJURY,2
CH,ANXIETY,2
CH,APPENDICITIS,2
CH,ASTHENIA,2
CH,BACK PAIN,2
CH,BONE GIANT CELL TUMOUR MALIGNANT,2
CH,BREAST CANCER,2
CH,CARDIAC ARREST,2
CH,CHEST PAIN,2
CH,CHORIORETINOPATHY,2
CH,COGNITIVE DISORDER,2
CH,CORONARY ARTERY THROMBOSIS,2
CH,DYSPNOEA,2
CH,FEMUR FRACTURE,2
CH,HEADACHE,2
CH,HEMIPLEGIA,2
CH,HYPERTENSION,2
CH,HYPOAESTHESIA,2
CH,INJECTION SITE ABSCESS,2
CH,INTERVERTEBRAL DISC PROTRUSION,2
CH,LIVE BIRTH,2
CH,MALAISE,2
CH,MIGRAINE,2
CH,NAUSEA,2
CH,NEOPLASM MALIGNANT,2
CH,OTITIS MEDIA,2
CH,PERICARDIAL EFFUSION,2
CH,PROCEDURAL PAIN,2
CH,PULMONARY EMBOLISM,2
CH,SEPSIS,2
CH,SYNOVIAL CYST,2
CH,TENDON RUPTURE,2
CH,THROMBOCYTOPENIA,2
CH,VIRAL INFECTION,2
CH,VISION BLURRED,2
CH,WOUND,2
CH,ABDOMINAL PAIN,1
CH,ABORTION INDUCED,1
CH,ABSCESS,1
CH,ABSCESS LIMB,1
CH,ACCIDENT,1
CH,ACUTE PSYCHOSIS,1
CH,ADENOCARCINOMA GASTRIC,1
CH,ADENOCARCINOMA PANCREAS,1
CH,ADJUSTMENT DISORDER,1
CH,ALTERED STATE OF CONSCIOUSNESS,1
CH,AMNESIA,1
CH,AMNIOTIC FLUID VOLUME DECREASED,1
CH,ANAEMIA,1
CH,ANGINA PECTORIS,1
CH,ANKLE FRACTURE,1
CH,ARRHYTHMIA,1
CH,ARTHRITIS,1
CH,ATRIOVENTRICULAR BLOCK,1
CH,AUTOIMMUNE HEPATITIS,1
CH,AVULSION FRACTURE,1
CH,BACTERIAL INFECTION,1
CH,BALANCE DISORDER,1
CH,BLADDER PERFORATION,1
CH,BRAIN TUMOUR OPERATION,1
CH,BREECH PRESENTATION,1
CH,BRONCHIAL CARCINOMA,1
CH,BURSITIS,1
CH,CAESAREAN SECTION,1
CH,CARDIAC FAILURE,1
CH,CARDIAC OPERATION,1
CH,CARDIOVASCULAR DISORDER,1
CH,CATHETER SITE HAEMATOMA,1
CH,CHILLS,1
CH,CLAVICLE FRACTURE,1
CH,COLITIS,1
CH,CONFUSIONAL STATE,1
CH,COOMBS NEGATIVE HAEMOLYTIC ANAEMIA,1
CH,CORNEAL TRANSPLANT,1
CH,CORONARY ARTERY DISEASE,1
CH,CORONARY ARTERY OCCLUSION,1
CH,CORONARY ARTERY STENOSIS,1
CH,COUGH,1
CH,CRANIOCEREBRAL INJURY,1
CH,CYSTITIS,1
CH,DERMO-HYPODERMITIS,1
CH,DEVICE ISSUE,1
CH,DIABETES MELLITUS,1
CH,DIARRHOEA,1
CH,DIPLEGIA,1
CH,DIPLOPIA,1
CH,DISEASE PROGRESSION,1
CH,DISORIENTATION,1
CH,DISTURBANCE IN ATTENTION,1
CH,DRUG DOSE OMISSION,1
CH,DRUG-INDUCED LIVER INJURY,1
CH,EAR PAIN,1
CH,ELECTROCARDIOGRAM P WAVE ABNORMAL,1
CH,ELECTROCARDIOGRAM QT PROLONGED,1
CH,EXPOSURE DURING PREGNANCY,1
CH,FAILED INDUCTION OF LABOUR,1
CH,FEAR,1
CH,FEEDING DISORDER NEONATAL,1
CH,FOETAL EXPOSURE DURING PREGNANCY,1
CH,FOETAL EXPOSURE TIMING UNSPECIFIED,1
CH,FOOT DEFORMITY,1
CH,FRACTURE PAIN,1
CH,FRUSTRATION,1
CH,FULL BLOOD COUNT DECREASED,1
CH,GASTRIC CANCER,1
CH,GENERAL SYMPTOM,1
CH,GLIOBLASTOMA,1
CH,GROIN ABSCESS,1
CH,HAEMORRHAGE,1
CH,HAND FRACTURE,1
CH,HEPATIC ADENOMA,1
CH,HEPATIC CIRRHOSIS,1
CH,HISTRIONIC PERSONALITY DISORDER,1
CH,HUMAN PAPILLOMA VIRUS TEST POSITIVE,1
CH,HUMERUS FRACTURE,1
CH,HYPERTENSIVE CRISIS,1
CH,HYPOTENSION,1
CH,ILEUS PARALYTIC,1
CH,IMMUNOGLOBULIN G4 RELATED SCLEROSING DISEASE,1
CH,IMMUNOLOGY TEST ABNORMAL,1
CH,IMPAIRED HEALING,1
CH,INFECTION,1
CH,INFLUENZA,1
CH,INGUINAL HERNIA,1
CH,INJECTION SITE DRYNESS,1
CH,INJECTION SITE HAEMATOMA,1
CH,INJECTION SITE REACTION,1
CH,INJECTION SITE SWELLING,1
CH,INJECTION SITE WARMTH,1
CH,INJURY ASSOCIATED WITH DEVICE,1
CH,INTENTIONAL OVERDOSE,1
CH,INTESTINAL HAEMORRHAGE,1
CH,INTESTINAL PERFORATION,1
CH,ISCHAEMIC STROKE,1
CH,JOINT DISLOCATION,1
CH,KERATOCONUS,1
CH,LABORATORY TEST INTERFERENCE,1
CH,LEUKAEMIA,1
CH,LEUKOPENIA,1
CH,LIGAMENT INJURY,1
CH,LIGAMENT SPRAIN,1
CH,LIVER DISORDER,1
CH,LIVER FUNCTION TEST ABNORMAL,1
CH,LOW BIRTH WEIGHT BABY,1
CH,LOWER LIMB FRACTURE,1
CH,LUNG NEOPLASM MALIGNANT,1
CH,MENISCUS CYST,1
CH,MENISCUS INJURY,1
CH,MENTAL DISORDER,1
CH,MERALGIA PARAESTHETICA,1
CH,METAMORPHOPSIA,1
CH,METASTASES TO LIVER,1
CH,METASTATIC BRONCHIAL CARCINOMA,1
CH,MIGRAINE WITHOUT AURA,1
CH,MITOCHONDRIAL MYOPATHY,1
CH,MOOD ALTERED,1
CH,MUSCLE CONTRACTIONS INVOLUNTARY,1
CH,MUSCULOSKELETAL STIFFNESS,1
CH,MYELODYSPLASTIC SYNDROME,1
CH,NEPHROPATHY,1
CH,OEDEMA,1
CH,OEDEMA PERIPHERAL,1
CH,OPHTHALMIC HERPES ZOSTER,1
CH,OPTIC NEURITIS,1
CH,OSTEOARTHRITIS,1
CH,PANCYTOPENIA,1
CH,PANIC ATTACK,1
CH,PAPILLARY THYROID CANCER,1
CH,PARAESTHESIA,1
CH,PARALYSIS,1
CH,PHYSICAL DISABILITY,1
CH,PIGMENTATION DISORDER,1
CH,PITUITARY TUMOUR BENIGN,1
CH,POLYARTHRITIS,1
CH,PORPHYRIA NON-ACUTE,1
CH,POST PROCEDURAL INFECTION,1
CH,POSTOPERATIVE ADHESION,1
CH,POSTURE ABNORMAL,1
CH,PREGNANCY,1
CH,PREMATURE DELIVERY,1
CH,PREMATURE LABOUR,1
CH,PROCEDURAL HAEMORRHAGE,1
CH,PRODUCT FORMULATION ISSUE,1
CH,PRODUCT USE ISSUE,1
CH,PSORIASIS,1
CH,PSORIATIC ARTHROPATHY,1
CH,PULMONARY OEDEMA,1
CH,PYELONEPHRITIS,1
CH,RADIUS FRACTURE,1
CH,RECTAL PROLAPSE,1
CH,RENAL CANCER,1
CH,RETROPERITONEAL FIBROSIS,1
CH,RHEUMATOID ARTHRITIS,1
CH,RIB FRACTURE,1
CH,SENSORY DISTURBANCE,1
CH,SINUSITIS,1
CH,SOMNOLENCE,1
CH,SPINAL OSTEOARTHRITIS,1
CH,STRESS,1
CH,SUDDEN HEARING LOSS,1
CH,SUICIDE ATTEMPT,1
CH,SUSAC^S SYNDROME,1
CH,TACHYCARDIA,1
CH,TENDON PAIN,1
CH,TERATOGENICITY,1
CH,TESTIS CANCER,1
CH,THROMBOTIC MICROANGIOPATHY,1
CH,THYROID FUNCTION TEST ABNORMAL,1
CH,THYROID HORMONES INCREASED,1
CH,TIBIA FRACTURE,1
CH,TOBACCO ABUSE,1
CH,TRANSAMINASES INCREASED,1
CH,TRANSIENT ISCHAEMIC ATTACK,1
CH,TRIGEMINAL NEURALGIA,1
CH,TRISOMY 21,1
CH,TUMOUR RUPTURE,1
CH,UPPER LIMB FRACTURE,1
CH,UROSEPSIS,1
CH,UTERINE CANCER,1
CH,VACCINATION SITE PAIN,1
CH,VACCINATION SITE SWELLING,1
CH,VENOUS THROMBOSIS,1
CH,VENTRICULAR HYPOKINESIA,1
CH,VENTRICULAR TACHYCARDIA,1
CH,VERTIGO,1
CH,VIITH NERVE PARALYSIS,1
CH,VISUAL IMPAIRMENT,1
CH,VOMITING,1
CH,WEIGHT INCREASED,1
CH,WHITE BLOOD CELL COUNT DECREASED,1
CH,WRIST FRACTURE,1
TW,ASTHENIA,6
TW,DISCOMFORT,6
TW,DEPRESSION,5
TW,FALL,3
TW,FEELING ABNORMAL,3
TW,HAEMORRHAGE,3
TW,HEADACHE,3
TW,PNEUMONIA,3
TW,ACTIVITIES OF DAILY LIVING IMPAIRED,2
TW,CELLULITIS,2
TW,COUGH,2
TW,DEATH,2
TW,DIZZINESS,2
TW,DYSPHAGIA,2
TW,EMOTIONAL DISORDER,2
TW,GAIT DISTURBANCE,2
TW,HYPOAESTHESIA,2
TW,HYPOKINESIA,2
TW,INJECTION SITE PAIN,2
TW,INSOMNIA,2
TW,MEMORY IMPAIRMENT,2
TW,MOOD ALTERED,2
TW,MULTIPLE SCLEROSIS RELAPSE,2
TW,MUSCULAR WEAKNESS,2
TW,PAIN IN EXTREMITY,2
TW,POOR QUALITY SLEEP,2
TW,PYREXIA,2
TW,SUICIDE ATTEMPT,2
TW,TREMOR,2
TW,VISION BLURRED,2
TW,VISUAL IMPAIRMENT,2
TW,ABASIA,1
TW,ABORTION,1
TW,ALANINE AMINOTRANSFERASE INCREASED,1
TW,AMYLASE INCREASED,1
TW,ANAEMIA,1
TW,ASPARTATE AMINOTRANSFERASE INCREASED,1
TW,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
TW,BACILLUS BACTERAEMIA,1
TW,BLINDNESS,1
TW,BLOOD CHOLESTEROL INCREASED,1
TW,BLOOD GLUCOSE INCREASED,1
TW,BLOOD TRIGLYCERIDES INCREASED,1
TW,BONE MARROW FAILURE,1
TW,BRAIN NEOPLASM,1
TW,BRONCHITIS,1
TW,CEREBROVASCULAR ACCIDENT,1
TW,CHILLS,1
TW,CHOKING,1
TW,COMA,1
TW,CRANIAL NERVE INFECTION,1
TW,DIABETES MELLITUS,1
TW,DRUG EFFECT DECREASED,1
TW,DRUG-INDUCED LIVER INJURY,1
TW,DRY SKIN,1
TW,DYSARTHRIA,1
TW,EXOSTOSIS,1
TW,EXPOSURE VIA FATHER,1
TW,FATIGUE,1
TW,GASTRIC HAEMORRHAGE,1
TW,GENERAL PHYSICAL CONDITION ABNORMAL,1
TW,GENERAL PHYSICAL HEALTH DETERIORATION,1
TW,HEPATIC STEATOSIS,1
TW,HYPOCHROMASIA,1
TW,IMMUNE SYSTEM DISORDER,1
TW,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TW,INITIAL INSOMNIA,1
TW,INJECTION SITE SWELLING,1
TW,INJECTION SITE ULCER,1
TW,LIVER FUNCTION TEST ABNORMAL,1
TW,LYMPHOMA,1
TW,MALAISE,1
TW,MOUTH BREATHING,1
TW,MUSCULOSKELETAL STIFFNESS,1
TW,MYASTHENIA GRAVIS,1
TW,MYELOPATHY,1
TW,NASOPHARYNGITIS,1
TW,NEPHROLITHIASIS,1
TW,NOCTURIA,1
TW,NUCLEAR MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL,1
TW,OESOPHAGEAL VARICES HAEMORRHAGE,1
TW,PARKINSON^S DISEASE,1
TW,PRURITUS,1
TW,PULMONARY OEDEMA,1
TW,SHOCK,1
TW,SKIN ODOUR ABNORMAL,1
TW,SMOOTH MUSCLE ANTIBODY,1
TW,SWELLING,1
TW,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TW,THERMAL BURN,1
TW,THYROID FUNCTION TEST ABNORMAL,1
TW,TREATMENT NONCOMPLIANCE,1
TW,TRIGEMINAL NEURALGIA,1
TW,TURNER^S SYNDROME,1
TW,UNEVALUABLE EVENT,1
TW,URINARY TRACT DISORDER,1
TW,URINARY TRACT INFECTION,1
TW,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
TH,NEUROMYELITIS OPTICA,15
TH,FATIGUE,8
TH,PYREXIA,3
TH,DECREASED APPETITE,2
TH,RENAL FAILURE,2
TH,ABASIA,1
TH,ARTHROPOD BITE,1
TH,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
TH,ASTHENIA,1
TH,BLOOD BILIRUBIN ABNORMAL,1
TH,CYSTITIS,1
TH,DEATH,1
TH,DENGUE FEVER,1
TH,DEPRESSED MOOD,1
TH,DEPRESSION,1
TH,DISEASE PROGRESSION,1
TH,HEADACHE,1
TH,HEPATIC ENZYME INCREASED,1
TH,HYPOAESTHESIA,1
TH,HYPOKINESIA,1
TH,IMMOBILE,1
TH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
TH,INJECTION SITE SCAR,1
TH,LIMB DISCOMFORT,1
TH,MUSCLE SPASMS,1
TH,MUSCULOSKELETAL STIFFNESS,1
TH,NECK PAIN,1
TH,PAIN,1
TH,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
TH,SENSORY LOSS,1
TH,SKIN IRRITATION,1
TH,STRESS,1
TH,UNEVALUABLE EVENT,1
TH,URINARY TRACT INFECTION,1
TH,VISION BLURRED,1
TH,WALKING DISABILITY,1
TH,WHITE BLOOD CELL COUNT DECREASED,1
TN,MULTIPLE SCLEROSIS RELAPSE,8
TN,GAIT DISTURBANCE,6
TN,DRUG DOSE OMISSION,5
TN,PARAESTHESIA,5
TN,INFLUENZA LIKE ILLNESS,4
TN,INJECTION SITE ERYTHEMA,4
TN,INJECTION SITE PAIN,4
TN,PYREXIA,4
TN,ABASIA,3
TN,ABORTION SPONTANEOUS,3
TN,DIZZINESS,3
TN,HYPOTHYROIDISM,3
TN,INJECTION SITE BRUISING,3
TN,JOINT SWELLING,3
TN,MATERNAL EXPOSURE DURING PREGNANCY,3
TN,VOMITING,3
TN,BACK PAIN,2
TN,BALANCE DISORDER,2
TN,CHEST DISCOMFORT,2
TN,DIABETES MELLITUS,2
TN,ENURESIS,2
TN,ERYTHEMA,2
TN,FATIGUE,2
TN,FOETAL EXPOSURE DURING PREGNANCY,2
TN,HEADACHE,2
TN,HEPATOCELLULAR INJURY,2
TN,HYPERGLYCAEMIA,2
TN,INSOMNIA,2
TN,LHERMITTE^S SIGN,2
TN,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
TN,NORMAL NEWBORN,2
TN,PAIN,2
TN,PARALYSIS,2
TN,PRURITUS,2
TN,SYSTEMIC LUPUS ERYTHEMATOSUS,2
TN,TOXIC SKIN ERUPTION,2
TN,TREATMENT NONCOMPLIANCE,2
TN,ALANINE AMINOTRANSFERASE INCREASED,1
TN,ALOPECIA,1
TN,ANAEMIA,1
TN,ANGINA PECTORIS,1
TN,ANTINUCLEAR ANTIBODY POSITIVE,1
TN,ARTHRALGIA,1
TN,ASPARTATE AMINOTRANSFERASE INCREASED,1
TN,ASTHENIA,1
TN,BLOOD PRESSURE INCREASED,1
TN,CAESAREAN SECTION,1
TN,CENTRAL NERVOUS SYSTEM LESION,1
TN,COELIAC DISEASE,1
TN,COMPLICATION OF PREGNANCY,1
TN,CONDITION AGGRAVATED,1
TN,CONSTIPATION,1
TN,CONTUSION,1
TN,DECREASED APPETITE,1
TN,DELIRIUM,1
TN,DEPRESSION SUICIDAL,1
TN,DRUG DOSE TITRATION NOT PERFORMED,1
TN,DYSPNOEA,1
TN,EPISTAXIS,1
TN,ERYTHEMA MULTIFORME,1
TN,FEAR OF INJECTION,1
TN,FOETAL DISTRESS SYNDROME,1
TN,FOETAL MALFORMATION,1
TN,FUNGAL INFECTION,1
TN,GASTRIC HAEMORRHAGE,1
TN,GASTRIC ULCER PERFORATION,1
TN,HAEMOGLOBIN DECREASED,1
TN,HAEMORRHAGE,1
TN,HEPATIC CIRRHOSIS,1
TN,HEPATITIS C,1
TN,HYPOKINESIA,1
TN,INJECTION SITE ABSCESS,1
TN,INJECTION SITE INFECTION,1
TN,INJECTION SITE PAPULE,1
TN,INJECTION SITE RASH,1
TN,INJECTION SITE SCAR,1
TN,LABOUR COMPLICATION,1
TN,LIPODYSTROPHY ACQUIRED,1
TN,LIPOSUCTION,1
TN,LIVE BIRTH,1
TN,LOCAL SWELLING,1
TN,MOTOR DYSFUNCTION,1
TN,MOVEMENT DISORDER,1
TN,MULTIPLE SCLEROSIS,1
TN,MUSCULOSKELETAL STIFFNESS,1
TN,NAUSEA,1
TN,OVARIAN CYST,1
TN,PAIN IN EXTREMITY,1
TN,PANCREATITIS ACUTE,1
TN,PHOTOSENSITIVITY REACTION,1
TN,PLEURAL EFFUSION,1
TN,POST PROCEDURAL HAEMORRHAGE,1
TN,PRODUCT AVAILABILITY ISSUE,1
TN,RAYNAUD^S PHENOMENON,1
TN,RENAL FAILURE ACUTE,1
TN,SCAR,1
TN,SENSATION OF HEAVINESS,1
TN,SKIN DEPIGMENTATION,1
TN,SKIN DISCOLOURATION,1
TN,SKIN EXFOLIATION,1
TN,SKIN HYPOPIGMENTATION,1
TN,SKIN LESION,1
TN,SUTURE RUPTURE,1
TN,TEMPERATURE INTOLERANCE,1
TN,URINARY TRACT INFECTION,1
TN,UTERINE CYST,1
TN,UTERINE HAEMORRHAGE,1
TN,UTERINE LEIOMYOMA,1
TN,WEIGHT DECREASED,1
TN,WHITE MATTER LESION,1
TR,MULTIPLE SCLEROSIS RELAPSE,23
TR,ASTHENIA,20
TR,MATERNAL EXPOSURE DURING PREGNANCY,20
TR,ALANINE AMINOTRANSFERASE INCREASED,16
TR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,16
TR,ASPARTATE AMINOTRANSFERASE INCREASED,15
TR,INJECTION SITE ERYTHEMA,15
TR,ABORTION SPONTANEOUS,14
TR,DIABETES MELLITUS,14
TR,GAIT DISTURBANCE,14
TR,INJECTION SITE BRUISING,14
TR,FATIGUE,13
TR,DEATH,12
TR,INJECTION SITE PAIN,11
TR,MYOCARDIAL INFARCTION,11
TR,PYREXIA,11
TR,HEADACHE,10
TR,NAUSEA,10
TR,VOMITING,10
TR,HEPATIC ENZYME INCREASED,9
TR,HYPERTENSION,9
TR,HYPOAESTHESIA,9
TR,CHOLELITHIASIS,8
TR,INJECTION SITE MASS,8
TR,OSTEOPOROSIS,8
TR,DIZZINESS,7
TR,WEIGHT DECREASED,7
TR,BLOOD ALKALINE PHOSPHATASE INCREASED,6
TR,EPILEPSY,6
TR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
TR,MUSCLE CONTRACTIONS INVOLUNTARY,6
TR,ABORTION INDUCED,5
TR,BALANCE DISORDER,5
TR,CHILLS,5
TR,LOSS OF CONSCIOUSNESS,5
TR,NEPHROLITHIASIS,5
TR,PNEUMONIA,5
TR,URINARY TRACT INFECTION,5
TR,UTERINE LEIOMYOMA,5
TR,ABASIA,4
TR,ANGINA PECTORIS,4
TR,ARTHRALGIA,4
TR,AUTOIMMUNE THYROIDITIS,4
TR,BACK PAIN,4
TR,BLOOD TEST ABNORMAL,4
TR,DECREASED APPETITE,4
TR,DYSPNOEA,4
TR,FOETAL HEART RATE ABNORMAL,4
TR,GALLBLADDER DISORDER,4
TR,INFLUENZA,4
TR,LUNG NEOPLASM MALIGNANT,4
TR,MATERNAL EXPOSURE TIMING UNSPECIFIED,4
TR,MEMORY IMPAIRMENT,4
TR,MUSCULAR WEAKNESS,4
TR,TREMOR,4
TR,VISUAL IMPAIRMENT,4
TR,ANAEMIA,3
TR,APPENDICITIS,3
TR,BLINDNESS,3
TR,BLOOD CHOLESTEROL INCREASED,3
TR,BLOOD COUNT ABNORMAL,3
TR,BLOOD GLUCOSE INCREASED,3
TR,CEREBROVASCULAR ACCIDENT,3
TR,DRUG DOSE OMISSION,3
TR,DYSPHAGIA,3
TR,EXPOSURE VIA FATHER,3
TR,FOETAL EXPOSURE DURING PREGNANCY,3
TR,GLAUCOMA,3
TR,HAEMOGLOBIN DECREASED,3
TR,INSOMNIA,3
TR,LYMPHOMA,3
TR,MENSTRUATION IRREGULAR,3
TR,MUSCLE CONTRACTURE,3
TR,MYALGIA,3
TR,OVARIAN CYST,3
TR,PAIN IN EXTREMITY,3
TR,PALPITATIONS,3
TR,SYNCOPE,3
TR,TRIGEMINAL NEURALGIA,3
TR,TUBERCULOSIS,3
TR,URINARY INCONTINENCE,3
TR,UTERINE CANCER,3
TR,YELLOW SKIN,3
TR,ABSCESS LIMB,2
TR,ANTI-THYROID ANTIBODY POSITIVE,2
TR,ANXIETY,2
TR,APHTHOUS STOMATITIS,2
TR,ARRHYTHMIA,2
TR,ASPIRATION,2
TR,BLINDNESS TRANSIENT,2
TR,BLOOD TRIGLYCERIDES INCREASED,2
TR,BONE DISORDER,2
TR,BREAST CANCER,2
TR,BURNING SENSATION,2
TR,CATARACT,2
TR,CENTRAL NERVOUS SYSTEM LESION,2
TR,CEREBRAL HAEMORRHAGE,2
TR,CHEST PAIN,2
TR,CLEFT PALATE,2
TR,CONSTIPATION,2
TR,DRUG HYPERSENSITIVITY,2
TR,EYE INFECTION,2
TR,FALL,2
TR,FOETAL DEATH,2
TR,HAEMATOCRIT DECREASED,2
TR,HALLUCINATION,2
TR,HEMIPARESIS,2
TR,HYPERHIDROSIS,2
TR,HYPOTENSION,2
TR,HYPOTHYROIDISM,2
TR,INFECTION,2
TR,INJECTION SITE PRURITUS,2
TR,INJECTION SITE REACTION,2
TR,INTERVERTEBRAL DISC PROTRUSION,2
TR,INTRACARDIAC THROMBUS,2
TR,LACK OF INJECTION SITE ROTATION,2
TR,MALNUTRITION,2
TR,MEAN CELL HAEMOGLOBIN DECREASED,2
TR,MEAN CELL VOLUME DECREASED,2
TR,MENTAL DISABILITY,2
TR,MULTIPLE SCLEROSIS,2
TR,NERVOUSNESS,2
TR,PAIN,2
TR,PANCREATITIS ACUTE,2
TR,PERINEAL CYST,2
TR,PULMONARY EMBOLISM,2
TR,PULMONARY HYPERTENSION,2
TR,PULMONARY MASS,2
TR,RASH PUSTULAR,2
TR,RED CELL DISTRIBUTION WIDTH INCREASED,2
TR,RENAL FAILURE,2
TR,RENAL IMPAIRMENT,2
TR,SCOLIOSIS,2
TR,SEPSIS,2
TR,SLEEP APNOEA SYNDROME,2
TR,SUICIDAL IDEATION,2
TR,UHTHOFF^S PHENOMENON,2
TR,UVEITIS,2
TR,VITAMIN B12 DEFICIENCY,2
TR,WOUND,2
TR,ABDOMINAL PAIN UPPER,1
TR,ABORTION MISSED,1
TR,ACUTE PROMYELOCYTIC LEUKAEMIA,1
TR,AFFECTIVE DISORDER,1
TR,AGITATION,1
TR,ALANINE AMINOTRANSFERASE DECREASED,1
TR,ALOPECIA,1
TR,AMNESTIC DISORDER,1
TR,ANKLE FRACTURE,1
TR,APATHY,1
TR,ARNOLD-CHIARI MALFORMATION,1
TR,ARTHROPATHY,1
TR,ASPHYXIA,1
TR,ASTHMA,1
TR,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,1
TR,AUTOIMMUNE HEPATITIS,1
TR,AUTOIMMUNE UVEITIS,1
TR,BACK DISORDER,1
TR,BENIGN VAGINAL NEOPLASM,1
TR,BILIRUBIN CONJUGATED INCREASED,1
TR,BLADDER CANCER,1
TR,BLIGHTED OVUM,1
TR,BLOOD BILIRUBIN INCREASED,1
TR,BLOOD DISORDER,1
TR,BLOOD GLUCOSE DECREASED,1
TR,BLOOD GLUCOSE FLUCTUATION,1
TR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
TR,BLOOD PRESSURE DECREASED,1
TR,BLOOD THYROID STIMULATING HORMONE INCREASED,1
TR,BRADYCARDIA,1
TR,BREAST ABSCESS,1
TR,BREAST CANCER STAGE II,1
TR,BRONCHITIS,1
TR,BRONCHOPULMONARY ASPERGILLOSIS,1
TR,CARDIAC ARREST,1
TR,CARDIAC DISORDER,1
TR,CARDIAC VALVE DISEASE,1
TR,CARDIOVASCULAR DISORDER,1
TR,CARTILAGE HYPERTROPHY,1
TR,CEREBRAL CYST,1
TR,CEREBRAL INFARCTION,1
TR,CERVICAL DYSPLASIA,1
TR,CHEST DISCOMFORT,1
TR,CHOLESTASIS,1
TR,CHRONIC HEPATITIS,1
TR,COELIAC DISEASE,1
TR,COGNITIVE DISORDER,1
TR,COLITIS,1
TR,COLITIS ULCERATIVE,1
TR,CYST,1
TR,DEAFNESS,1
TR,DEMENTIA ALZHEIMER^S TYPE,1
TR,DEPRESSION,1
TR,DIABETIC COMA,1
TR,DIABETIC NEUROPATHY,1
TR,DIARRHOEA INFECTIOUS,1
TR,DIPLOPIA,1
TR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
TR,DYSSTASIA,1
TR,EAR HAEMORRHAGE,1
TR,ECTOPIC PREGNANCY,1
TR,ECZEMA,1
TR,ENCEPHALOPATHY,1
TR,ENDOMETRIAL HYPERPLASIA,1
TR,EPISTAXIS,1
TR,ERYSIPELAS,1
TR,ERYTHEMA,1
TR,EYE DISORDER,1
TR,EYE HAEMORRHAGE,1
TR,EYE PAIN,1
TR,FACIAL PARESIS,1
TR,FEEDING DISORDER,1
TR,FEELING ABNORMAL,1
TR,FEMUR FRACTURE,1
TR,FIBROMYALGIA,1
TR,FOETAL CARDIAC DISORDER,1
TR,FOETAL EXPOSURE TIMING UNSPECIFIED,1
TR,FOLLICULITIS,1
TR,GAIT INABILITY,1
TR,GAMMA-GLUTAMYLTRANSFERASE,1
TR,GASTRIC HAEMORRHAGE,1
TR,GASTRIC ULCER,1
TR,GENERAL PHYSICAL HEALTH DETERIORATION,1
TR,GENITAL ABSCESS,1
TR,GOITRE,1
TR,GRANULOCYTE COUNT DECREASED,1
TR,GROIN INFECTION,1
TR,HAEMATEMESIS,1
TR,HEARING IMPAIRED,1
TR,HEPATIC MASS,1
TR,HEPATIC NECROSIS,1
TR,HEPATIC STEATOSIS,1
TR,HEPATITIS B SURFACE ANTIBODY POSITIVE,1
TR,HEPATOMEGALY,1
TR,HERPES SIMPLEX,1
TR,HYPERGLYCAEMIA,1
TR,HYPERSENSITIVITY,1
TR,HYPERTRICHOSIS,1
TR,HYPOAESTHESIA ORAL,1
TR,HYPOGLYCAEMIA,1
TR,HYPOKINESIA,1
TR,IMMUNE THROMBOCYTOPENIC PURPURA,1
TR,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
TR,INFLUENZA LIKE ILLNESS,1
TR,INGROWN HAIR,1
TR,INJECTION SITE HAEMORRHAGE,1
TR,INJECTION SITE SCAR,1
TR,INJECTION SITE SWELLING,1
TR,INJECTION SITE WARMTH,1
TR,INTESTINAL OBSTRUCTION,1
TR,INTRAOCULAR PRESSURE INCREASED,1
TR,IRON DEFICIENCY,1
TR,IRRITABLE BOWEL SYNDROME,1
TR,JOINT DEPOSIT,1
TR,JUVENILE IDIOPATHIC ARTHRITIS,1
TR,LARGE INTESTINE POLYP,1
TR,LEUKOPENIA,1
TR,LIGAMENT SPRAIN,1
TR,LIMB IMMOBILISATION,1
TR,LOCAL SWELLING,1
TR,LOWER LIMB FRACTURE,1
TR,LOWER RESPIRATORY TRACT INFECTION,1
TR,LUNG DISORDER,1
TR,LYMPHOCYTE PERCENTAGE INCREASED,1
TR,MACULAR DEGENERATION,1
TR,MAJOR DEPRESSION,1
TR,MALFORMATION VENOUS,1
TR,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
TR,MENINGIOMA,1
TR,MENINGITIS,1
TR,MENTAL DISORDER,1
TR,MIGRAINE,1
TR,MOUTH HAEMORRHAGE,1
TR,MOVEMENT DISORDER,1
TR,MUSCLE SWELLING,1
TR,MUSCULOSKELETAL DISCOMFORT,1
TR,NASAL CYST,1
TR,NEPHROTIC SYNDROME,1
TR,NERVOUS SYSTEM DISORDER,1
TR,NEUROMYELITIS OPTICA,1
TR,OCULAR HYPERAEMIA,1
TR,OCULAR ICTERUS,1
TR,OEDEMA,1
TR,ORAL DISCOMFORT,1
TR,OSTEOMALACIA,1
TR,OSTEONECROSIS,1
TR,PARAESTHESIA,1
TR,PARATHYROID TUMOUR MALIGNANT,1
TR,PARESIS,1
TR,PELVIC FRACTURE,1
TR,PEMPHIGUS,1
TR,PERIPHERAL SWELLING,1
TR,PLATELET COUNT INCREASED,1
TR,PLATELET DISTRIBUTION WIDTH DECREASED,1
TR,PLEURISY,1
TR,PROCALCITONIN INCREASED,1
TR,PRURITUS GENERALISED,1
TR,PULMONARY OEDEMA,1
TR,PULMONARY TUBERCULOSIS,1
TR,PYELONEPHRITIS,1
TR,RASH,1
TR,RECTAL HAEMORRHAGE,1
TR,REFLUX GASTRITIS,1
TR,RENAL ATROPHY,1
TR,RESPIRATORY FAILURE,1
TR,RESTLESS LEGS SYNDROME,1
TR,RETINAL VASCULITIS,1
TR,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
TR,SEPTAL PANNICULITIS,1
TR,SERUM FERRITIN INCREASED,1
TR,SJOGREN^S SYNDROME,1
TR,SKIN INFECTION,1
TR,SMALLPOX,1
TR,SOMNOLENCE,1
TR,SPEECH DISORDER,1
TR,SPINAL COLUMN STENOSIS,1
TR,SPINAL CORD INJURY,1
TR,STRESS,1
TR,SUDDEN INFANT DEATH SYNDROME,1
TR,SUICIDE ATTEMPT,1
TR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TR,TESTICULAR NEOPLASM,1
TR,TESTIS CANCER,1
TR,THROMBOPHLEBITIS,1
TR,THYROID CANCER,1
TR,THYROID NEOPLASM,1
TR,TINNITUS,1
TR,TONSILLITIS,1
TR,TOOTHACHE,1
TR,TOXIC GOITRE,1
TR,TOXIC NODULAR GOITRE,1
TR,TOXICITY TO VARIOUS AGENTS,1
TR,TRI-IODOTHYRONINE FREE DECREASED,1
TR,TRISOMY 18,1
TR,TYPE 1 DIABETES MELLITUS,1
TR,UNEVALUABLE EVENT,1
TR,UNRESPONSIVE TO STIMULI,1
TR,URTICARIA,1
TR,UTERINE CYST,1
TR,UTERINE POLYP,1
TR,VASCULAR GRAFT,1
TR,VASCULITIS,1
TR,VISION BLURRED,1
TR,VITAMIN B12 DECREASED,1
TR,VITAMIN B12 INCREASED,1
TR,VITAMIN D INCREASED,1
TR,WEIGHT INCREASED,1
TR,WOLFF-PARKINSON-WHITE SYNDROME,1
TR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
UA,PULMONARY TUBERCULOSIS,1
AE,LEUKOPENIA,1
AE,LOWER RESPIRATORY TRACT INFECTION,1
GB,INFLUENZA LIKE ILLNESS,49
GB,MALAISE,46
GB,MULTIPLE SCLEROSIS RELAPSE,45
GB,DEATH,41
GB,DRUG DOSE OMISSION,33
GB,LOWER RESPIRATORY TRACT INFECTION,33
GB,HEADACHE,31
GB,FALL,26
GB,BREAST CANCER,24
GB,FATIGUE,23
GB,INJECTION SITE ERYTHEMA,21
GB,INJECTION SITE PAIN,21
GB,PNEUMONIA,21
GB,URINARY TRACT INFECTION,21
GB,MYOCARDIAL INFARCTION,17
GB,DEPRESSION,14
GB,THROMBOTIC MICROANGIOPATHY,14
GB,SEPSIS,13
GB,CHEST PAIN,12
GB,DYSPNOEA,12
GB,GAIT DISTURBANCE,12
GB,MOBILITY DECREASED,12
GB,THROMBOCYTOPENIA,12
GB,ABORTION SPONTANEOUS,11
GB,ALANINE AMINOTRANSFERASE INCREASED,11
GB,CEREBROVASCULAR ACCIDENT,11
GB,HYPERTENSION,11
GB,INJECTION SITE BRUISING,11
GB,INJECTION SITE REACTION,11
GB,MATERNAL EXPOSURE DURING PREGNANCY,11
GB,DIZZINESS,10
GB,FEELING ABNORMAL,10
GB,INJECTION SITE INFECTION,10
GB,MULTIPLE SCLEROSIS,10
GB,PAIN,10
GB,VOMITING,10
GB,DEPRESSED MOOD,9
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
GB,ANKLE FRACTURE,8
GB,ARTHRALGIA,8
GB,CELLULITIS,8
GB,CONTUSION,8
GB,FOETAL CARDIAC DISORDER,8
GB,INJECTION SITE HAEMORRHAGE,8
GB,MUSCULAR WEAKNESS,8
GB,PLATELET COUNT DECREASED,8
GB,VENTRICULAR SEPTAL DEFECT,8
GB,WEIGHT DECREASED,8
GB,ABORTION INDUCED,7
GB,ACUTE MYOCARDIAL INFARCTION,7
GB,ASPARTATE AMINOTRANSFERASE INCREASED,7
GB,BLINDNESS,7
GB,DIABETES MELLITUS,7
GB,INFECTION,7
GB,LIVER FUNCTION TEST ABNORMAL,7
GB,NAUSEA,7
GB,PAIN IN EXTREMITY,7
GB,PYREXIA,7
GB,ANXIETY,6
GB,BALANCE DISORDER,6
GB,CHILLS,6
GB,CONFUSIONAL STATE,6
GB,DIARRHOEA,6
GB,INSOMNIA,6
GB,MUSCLE SPASMS,6
GB,NASOPHARYNGITIS,6
GB,NEOPLASM MALIGNANT,6
GB,OPTIC NEURITIS,6
GB,PANCREATITIS ACUTE,6
GB,SURGERY,6
GB,CHOLELITHIASIS,5
GB,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,5
GB,DRUG INEFFECTIVE,5
GB,GENERAL SYMPTOM,5
GB,HAEMOLYTIC URAEMIC SYNDROME,5
GB,HYPOAESTHESIA,5
GB,INJECTION SITE MASS,5
GB,INJECTION SITE SWELLING,5
GB,MALIGNANT HYPERTENSION,5
GB,MALIGNANT MELANOMA,5
GB,MEMORY IMPAIRMENT,5
GB,SLEEP DISORDER,5
GB,STRESS,5
GB,SYNCOPE,5
GB,TREMOR,5
GB,VIRAL INFECTION,5
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,5
GB,ALOPECIA,4
GB,ARTHROPATHY,4
GB,BREAST CANCER FEMALE,4
GB,CIRCULATORY COLLAPSE,4
GB,DECREASED APPETITE,4
GB,EMOTIONAL DISTRESS,4
GB,ENCEPHALOMYELITIS,4
GB,FEELING HOT,4
GB,HAEMOGLOBIN DECREASED,4
GB,HAEMORRHAGE,4
GB,HYPERHIDROSIS,4
GB,INCONTINENCE,4
GB,INFLUENZA,4
GB,INJECTION SITE PRURITUS,4
GB,INTENTIONAL PRODUCT USE ISSUE,4
GB,LIMB INJURY,4
GB,MENTAL DISORDER,4
GB,MIGRAINE,4
GB,MUSCULOSKELETAL STIFFNESS,4
GB,NEPHROLITHIASIS,4
GB,OROPHARYNGEAL PAIN,4
GB,OVARIAN CANCER,4
GB,PALPITATIONS,4
GB,PANCREATITIS CHRONIC,4
GB,RECTAL HAEMORRHAGE,4
GB,RENAL FAILURE ACUTE,4
GB,RENAL IMPAIRMENT,4
GB,SPEECH DISORDER,4
GB,THROMBOTIC THROMBOCYTOPENIC PURPURA,4
GB,UNEVALUABLE EVENT,4
GB,WHITE BLOOD CELL COUNT DECREASED,4
GB,ABDOMINAL PAIN UPPER,3
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,3
GB,ADVERSE DRUG REACTION,3
GB,ADVERSE EVENT,3
GB,ANGINA PECTORIS,3
GB,ARTHRITIS,3
GB,ASTHENIA,3
GB,BACK DISORDER,3
GB,BIPOLAR DISORDER,3
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,3
GB,BLOOD GLUCOSE INCREASED,3
GB,BLOOD TEST ABNORMAL,3
GB,BRAIN NEOPLASM,3
GB,CARDIAC FAILURE,3
GB,COUGH,3
GB,CRYING,3
GB,DISABILITY,3
GB,EPILEPSY,3
GB,EXPOSURE VIA FATHER,3
GB,FEMUR FRACTURE,3
GB,FOETAL EXPOSURE DURING PREGNANCY,3
GB,GASTROINTESTINAL DISORDER,3
GB,HIP ARTHROPLASTY,3
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
GB,INJECTION SITE ABSCESS,3
GB,INJECTION SITE CELLULITIS,3
GB,INTERVERTEBRAL DISC DISORDER,3
GB,INVASIVE DUCTAL BREAST CARCINOMA,3
GB,ISCHAEMIA,3
GB,LACK OF INJECTION SITE ROTATION,3
GB,LETHARGY,3
GB,LIMB DISCOMFORT,3
GB,LOCAL SWELLING,3
GB,LOSS OF CONSCIOUSNESS,3
GB,LOWER LIMB FRACTURE,3
GB,LUNG INFECTION,3
GB,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,3
GB,OSTEONECROSIS,3
GB,PARAESTHESIA,3
GB,PSORIASIS,3
GB,RENAL DISORDER,3
GB,ROAD TRAFFIC ACCIDENT,3
GB,SCIATICA,3
GB,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,3
GB,SELF INJURIOUS BEHAVIOUR,3
GB,SPINAL OPERATION,3
GB,SUICIDAL IDEATION,3
GB,THROMBOSIS,3
GB,TRIGEMINAL NEURALGIA,3
GB,UHTHOFF^S PHENOMENON,3
GB,ABSCESS,2
GB,ADRENAL NEOPLASM,2
GB,ADVERSE REACTION,2
GB,AMNESIA,2
GB,ATRIAL FIBRILLATION,2
GB,BACK PAIN,2
GB,BLOOD UREA DECREASED,2
GB,BODY TEMPERATURE INCREASED,2
GB,CARDIAC DISORDER,2
GB,CEREBRAL THROMBOSIS,2
GB,CHEST DISCOMFORT,2
GB,CHOLECYSTITIS INFECTIVE,2
GB,COLITIS MICROSCOPIC,2
GB,COMPLICATION OF PREGNANCY,2
GB,CONJUNCTIVITIS,2
GB,CRANIOPHARYNGIOMA,2
GB,CYST,2
GB,CYSTITIS,2
GB,DEEP VEIN THROMBOSIS,2
GB,DEMYELINATION,2
GB,DEVICE ISSUE,2
GB,DEVICE RELATED INFECTION,2
GB,DISEASE PROGRESSION,2
GB,DISORIENTATION,2
GB,DIVERTICULITIS,2
GB,DRUG INTOLERANCE,2
GB,DYSGEUSIA,2
GB,DYSPHAGIA,2
GB,DYSPNOEA AT REST,2
GB,DYSSTASIA,2
GB,ECZEMA,2
GB,EMOTIONAL DISORDER,2
GB,EXPOSURE DURING PREGNANCY,2
GB,EYE INFECTION,2
GB,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,2
GB,GALLBLADDER DISORDER,2
GB,GASTROINTESTINAL INFECTION,2
GB,GENERAL PHYSICAL HEALTH DETERIORATION,2
GB,HAEMATOCRIT DECREASED,2
GB,HAEMORRHOIDS,2
GB,HEPATIC FUNCTION ABNORMAL,2
GB,HIP FRACTURE,2
GB,HYSTERECTOMY,2
GB,ILL-DEFINED DISORDER,2
GB,IMPAIRED HEALING,2
GB,INCORRECT DOSE ADMINISTERED,2
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
GB,INJECTION SITE FIBROSIS,2
GB,INJECTION SITE MACULE,2
GB,INJECTION SITE WARMTH,2
GB,JAUNDICE,2
GB,KIDNEY INFECTION,2
GB,KNEE ARTHROPLASTY,2
GB,LACERATION,2
GB,LIGAMENT RUPTURE,2
GB,LIP SWELLING,2
GB,LOCALISED INFECTION,2
GB,LUNG DISORDER,2
GB,LYMPHOCYTE COUNT DECREASED,2
GB,LYMPHOEDEMA,2
GB,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
GB,MENINGITIS,2
GB,MENORRHAGIA,2
GB,MOOD ALTERED,2
GB,MOTOR DYSFUNCTION,2
GB,MUSCLE DISORDER,2
GB,MUSCULOSKELETAL DISORDER,2
GB,MUSCULOSKELETAL PAIN,2
GB,MYALGIA,2
GB,MYOCARDIAL ISCHAEMIA,2
GB,NERVOUS SYSTEM DISORDER,2
GB,NIGHT SWEATS,2
GB,OSTEOARTHRITIS,2
GB,OVERDOSE,2
GB,PANCREATITIS,2
GB,PAPILLARY THYROID CANCER,2
GB,PARALYSIS,2
GB,PARKINSON^S DISEASE,2
GB,PELVIC HAEMORRHAGE,2
GB,PLATELET COUNT ABNORMAL,2
GB,PROCEDURAL PAIN,2
GB,PROTEINURIA,2
GB,PULMONARY ARTERIAL HYPERTENSION,2
GB,PULMONARY EMBOLISM,2
GB,PULMONARY OEDEMA,2
GB,RASH GENERALISED,2
GB,RENAL FUNCTION TEST ABNORMAL,2
GB,RETINAL EXUDATES,2
GB,RIB FRACTURE,2
GB,SEIZURE,2
GB,SENSATION OF HEAVINESS,2
GB,SINUS BRADYCARDIA,2
GB,SKIN LESION,2
GB,SPINAL FRACTURE,2
GB,STILLBIRTH,2
GB,THERAPY CESSATION,2
GB,THROAT TIGHTNESS,2
GB,TRISOMY 21,2
GB,URINARY INCONTINENCE,2
GB,URINARY RETENTION,2
GB,URTICARIA,2
GB,UTERINE DISORDER,2
GB,VAGINAL HAEMORRHAGE,2
GB,VARICOSE VEIN,2
GB,VERTIGO,2
GB,VISUAL IMPAIRMENT,2
GB,WISDOM TEETH REMOVAL,2
GB,WOUND INFECTION,2
GB,ABASIA,1
GB,ABDOMINAL ABSCESS,1
GB,ABDOMINAL DISTENSION,1
GB,ABDOMINAL PAIN,1
GB,ABDOMINAL WALL WOUND,1
GB,ABSCESS LIMB,1
GB,ACCIDENT,1
GB,ACINIC CELL CARCINOMA OF SALIVARY GLAND,1
GB,ACNE,1
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
GB,ACUTE KIDNEY INJURY,1
GB,ACUTE PSYCHOSIS,1
GB,AGEUSIA,1
GB,ALPHA-1 ANTI-TRYPSIN INCREASED,1
GB,ANAL INCONTINENCE,1
GB,ANAPHYLACTIC SHOCK,1
GB,ANGIOEDEMA,1
GB,ANOSMIA,1
GB,ANTIPHOSPHOLIPID SYNDROME,1
GB,AORTIC VALVE INCOMPETENCE,1
GB,APATHY,1
GB,APHAGIA,1
GB,APHASIA,1
GB,APHONIA,1
GB,APPENDIX DISORDER,1
GB,ARRHYTHMIA,1
GB,ARTERIAL HAEMORRHAGE,1
GB,ARTHROSCOPY,1
GB,ASCITES,1
GB,ATAXIA,1
GB,ATYPICAL PNEUMONIA,1
GB,AUTOIMMUNE HEPATITIS,1
GB,AVIAN INFLUENZA,1
GB,B-LYMPHOCYTE COUNT DECREASED,1
GB,BACTERAEMIA,1
GB,BAND SENSATION,1
GB,BILE DUCT OBSTRUCTION,1
GB,BLINDNESS TRANSIENT,1
GB,BLISTER,1
GB,BLOOD ALBUMIN DECREASED,1
GB,BLOOD COPPER DECREASED,1
GB,BLOOD COUNT ABNORMAL,1
GB,BLOOD CREATININE DECREASED,1
GB,BLOOD CREATININE INCREASED,1
GB,BLOOD LACTATE DEHYDROGENASE INCREASED,1
GB,BLOOD PRESSURE DECREASED,1
GB,BLOOD PRESSURE FLUCTUATION,1
GB,BLOOD PRESSURE INCREASED,1
GB,BODY TEMPERATURE FLUCTUATION,1
GB,BONE MARROW TRANSPLANT,1
GB,BRACHIAL PLEXUS INJURY,1
GB,BRADYCARDIA,1
GB,BRAIN STEM STROKE,1
GB,BREAST CANCER METASTATIC,1
GB,BREAST CANCER RECURRENT,1
GB,BREAST MASS,1
GB,BRONCHIAL WALL THICKENING,1
GB,BRONCHOSPASM,1
GB,BURNING SENSATION,1
GB,C-REACTIVE PROTEIN INCREASED,1
GB,CALCULUS BLADDER,1
GB,CAMPYLOBACTER INFECTION,1
GB,CANDIDA INFECTION,1
GB,CANDIDIASIS,1
GB,CARCINOID TUMOUR OF THE SMALL BOWEL,1
GB,CARDIAC PACEMAKER INSERTION,1
GB,CARDIOGENIC SHOCK,1
GB,CATARACT,1
GB,CEREBRAL ATROPHY,1
GB,CEREBRAL HAEMANGIOMA,1
GB,CEREBRAL HAEMORRHAGE,1
GB,CEREBRAL INFARCTION,1
GB,CERVIX CARCINOMA,1
GB,CERVIX DISORDER,1
GB,CHEMOTHERAPY,1
GB,CHOLECYSTECTOMY,1
GB,CHOLELITHIASIS OBSTRUCTIVE,1
GB,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
GB,CHRONIC MYELOID LEUKAEMIA,1
GB,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
GB,CLAVICLE FRACTURE,1
GB,CLUMSINESS,1
GB,COGNITIVE DISORDER,1
GB,COLD SWEAT,1
GB,COMA,1
GB,CONDITION AGGRAVATED,1
GB,CONGENITAL CARDIOVASCULAR ANOMALY,1
GB,CONSTIPATION,1
GB,CORONARY ARTERY BYPASS,1
GB,CROHN^S DISEASE,1
GB,CYANOSIS,1
GB,CYTOMEGALOVIRUS INFECTION,1
GB,DELIRIUM,1
GB,DEMENTIA,1
GB,DEPRESSION SUICIDAL,1
GB,DERMATITIS,1
GB,DERMATITIS ACNEIFORM,1
GB,DEVICE BREAKAGE,1
GB,DIABETES INSIPIDUS,1
GB,DILATATION VENTRICULAR,1
GB,DIPLEGIA,1
GB,DISCOMFORT,1
GB,DIZZINESS POSTURAL,1
GB,DRUG ABUSE,1
GB,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
GB,DRUG DEPENDENCE,1
GB,DRUG DISPENSING ERROR,1
GB,DRUG-INDUCED LIVER INJURY,1
GB,DYSARTHRIA,1
GB,DYSPHONIA,1
GB,DYSPNOEA EXERTIONAL,1
GB,DYSPRAXIA,1
GB,EATING DISORDER,1
GB,ECZEMA INFECTED,1
GB,EJECTION FRACTION DECREASED,1
GB,ELECTROCARDIOGRAM T WAVE INVERSION,1
GB,ENCEPHALITIS,1
GB,END STAGE RENAL DISEASE,1
GB,ENDOCARDITIS BACTERIAL,1
GB,ENDOMETRIAL CANCER,1
GB,ENDOPHTHALMITIS,1
GB,EPISTAXIS,1
GB,ERYTHEMA,1
GB,ESCHERICHIA SEPSIS,1
GB,ESCHERICHIA URINARY TRACT INFECTION,1
GB,EYE HAEMORRHAGE,1
GB,EYE PAIN,1
GB,EYELID OEDEMA,1
GB,FACE OEDEMA,1
GB,FACIAL PARALYSIS,1
GB,FEAR,1
GB,FEAR OF INJECTION,1
GB,FEELING COLD,1
GB,FEELING OF BODY TEMPERATURE CHANGE,1
GB,FEMORAL NECK FRACTURE,1
GB,FIBRIN D DIMER INCREASED,1
GB,FIBROADENOMA OF BREAST,1
GB,FISTULA,1
GB,FOCAL NODULAR HYPERPLASIA,1
GB,FOETAL DEATH,1
GB,FOREIGN BODY,1
GB,FRACTURE,1
GB,FULL BLOOD COUNT ABNORMAL,1
GB,FULL BLOOD COUNT DECREASED,1
GB,FUNCTIONAL GASTROINTESTINAL DISORDER,1
GB,GAIT INABILITY,1
GB,GALLBLADDER OPERATION,1
GB,GASTRIC DISORDER,1
GB,GASTRITIS,1
GB,GASTRITIS EROSIVE,1
GB,GASTROENTERITIS,1
GB,GASTROENTERITIS VIRAL,1
GB,GASTROINTESTINAL NEOPLASM,1
GB,GASTROINTESTINAL STROMAL TUMOUR,1
GB,GASTROOESOPHAGEAL REFLUX DISEASE,1
GB,GENERALISED TONIC-CLONIC SEIZURE,1
GB,GESTATIONAL DIABETES,1
GB,GINGIVITIS,1
GB,GLAUCOMA,1
GB,GLOBULINS INCREASED,1
GB,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
GB,HAEMATOCHEZIA,1
GB,HAEMATURIA,1
GB,HAEMOLYTIC ANAEMIA,1
GB,HALLUCINATION_ VISUAL,1
GB,HAND FRACTURE,1
GB,HANGOVER,1
GB,HEARING IMPAIRED,1
GB,HEART RATE INCREASED,1
GB,HEART RATE IRREGULAR,1
GB,HEAT STROKE,1
GB,HEPATIC ADENOMA,1
GB,HEPATIC CYST,1
GB,HEPATOMEGALY,1
GB,HERPES ZOSTER,1
GB,HIATUS HERNIA,1
GB,HIP SURGERY,1
GB,HOMICIDAL IDEATION,1
GB,HUMAN PAPILLOMA VIRUS TEST POSITIVE,1
GB,HYPERGLYCAEMIA,1
GB,HYPERSENSITIVITY,1
GB,HYPERTENSIVE NEPHROPATHY,1
GB,HYPERTONIA,1
GB,HYPERTROPHIC CARDIOMYOPATHY,1
GB,HYPOGLYCAEMIA,1
GB,HYPOKINESIA,1
GB,HYPOPITUITARISM,1
GB,HYPOPNOEA,1
GB,HYPOTENSION,1
GB,HYPOTHYROIDISM,1
GB,HYPOVENTILATION NEONATAL,1
GB,IMPATIENCE,1
GB,INCORRECT PRODUCT STORAGE,1
GB,INFECTIOUS COLITIS,1
GB,INFUSION RELATED REACTION,1
GB,INJECTION RELATED REACTION,1
GB,INJECTION SITE DISCOMFORT,1
GB,INJECTION SITE DRYNESS,1
GB,INJECTION SITE EXTRAVASATION,1
GB,INJECTION SITE HAEMATOMA,1
GB,INJECTION SITE INDURATION,1
GB,INJECTION SITE INJURY,1
GB,INJECTION SITE IRRITATION,1
GB,INJECTION SITE LACERATION,1
GB,INJECTION SITE NECROSIS,1
GB,INJECTION SITE RASH,1
GB,INJECTION SITE SCAB,1
GB,INJECTION SITE VESICLES,1
GB,INTENTIONAL UNDERDOSE,1
GB,INTERNATIONAL NORMALISED RATIO INCREASED,1
GB,INTESTINAL PERFORATION,1
GB,INTRA-ABDOMINAL HAEMATOMA,1
GB,IRREGULAR BREATHING,1
GB,IRRITABILITY,1
GB,IRRITABLE BOWEL SYNDROME,1
GB,JOINT DISLOCATION,1
GB,JOINT INJURY,1
GB,JOINT SWELLING,1
GB,KAPOSI^S SARCOMA,1
GB,LABYRINTHITIS,1
GB,LACRIMATION INCREASED,1
GB,LEUKAEMIA,1
GB,LEUKOCYTOSIS,1
GB,LEUKOPENIA,1
GB,LIP AND/OR ORAL CAVITY CANCER,1
GB,LIP DISCOLOURATION,1
GB,LIPOMA,1
GB,LIVE BIRTH,1
GB,LOSS OF CONTROL OF LEGS,1
GB,LUNG CANCER METASTATIC,1
GB,LUNG NEOPLASM MALIGNANT,1
GB,LYMPHANGITIS,1
GB,MALE GENITAL EXAMINATION ABNORMAL,1
GB,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
GB,MEAN CELL HAEMOGLOBIN DECREASED,1
GB,MEAN PLATELET VOLUME DECREASED,1
GB,MENINGIOMA,1
GB,MENINGITIS BACTERIAL,1
GB,MENINGITIS VIRAL,1
GB,MENSTRUAL DISORDER,1
GB,METASTASES TO BONE,1
GB,METASTASES TO LIVER,1
GB,METASTASES TO LUNG,1
GB,METASTASES TO LYMPH NODES,1
GB,METASTASES TO PERITONEUM,1
GB,MONARTHRITIS,1
GB,MONOCYTE COUNT DECREASED,1
GB,MOOD SWINGS,1
GB,MUMPS,1
GB,MUSCLE ATROPHY,1
GB,MUSCLE TWITCHING,1
GB,MUSCULOSKELETAL CHEST PAIN,1
GB,MYCOSIS FUNGOIDES,1
GB,NEEDLE FATIGUE,1
GB,NEEDLE ISSUE,1
GB,NEOPLASM,1
GB,NEOVASCULARISATION,1
GB,NEPHROTIC SYNDROME,1
GB,NERVE INJURY,1
GB,NEUTROPENIA,1
GB,NEUTROPHIL COUNT DECREASED,1
GB,NEUTROPHIL COUNT INCREASED,1
GB,NIGHT BLINDNESS,1
GB,NON-HODGKIN^S LYMPHOMA,1
GB,NORMAL NEWBORN,1
GB,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,1
GB,OCULAR ICTERUS,1
GB,OEDEMA,1
GB,OEDEMA PERIPHERAL,1
GB,ORCHITIS,1
GB,ORGAN FAILURE,1
GB,OROPHARYNGEAL SPASM,1
GB,OSTEOMYELITIS,1
GB,OVARIAN CANCER METASTATIC,1
GB,OVARIAN CANCER STAGE III,1
GB,OVERWEIGHT,1
GB,PALLOR,1
GB,PANIC REACTION,1
GB,PAPILLOEDEMA,1
GB,PARAPLEGIA,1
GB,PELVIC FRACTURE,1
GB,PERINEAL ULCERATION,1
GB,PERIPHERAL NERVE INFECTION,1
GB,PERIPHERAL NERVE PALSY,1
GB,PERIPROSTHETIC FRACTURE,1
GB,PERITONITIS,1
GB,PERSONALITY CHANGE,1
GB,PERTUSSIS,1
GB,PHOBIA,1
GB,PHYSIOTHERAPY,1
GB,PITUITARY TUMOUR BENIGN,1
GB,PNEUMOCYSTIS JIROVECII INFECTION,1
GB,PNEUMONIA ASPIRATION,1
GB,PNEUMONIA BACTERIAL,1
GB,PNEUMOTHORAX,1
GB,POLYHYDRAMNIOS,1
GB,POLYURIA,1
GB,POOR QUALITY SLEEP,1
GB,POST HERPETIC NEURALGIA,1
GB,POST PROCEDURAL COMPLICATION,1
GB,POST PROCEDURAL HAEMORRHAGE,1
GB,POST PROCEDURAL INFECTION,1
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
GB,POSTOPERATIVE WOUND INFECTION,1
GB,POSTURE ABNORMAL,1
GB,PRECANCEROUS CELLS PRESENT,1
GB,PREGNANCY,1
GB,PREMATURE BABY,1
GB,PREMATURE LABOUR,1
GB,PROCEDURAL ANXIETY,1
GB,PROCEDURAL COMPLICATION,1
GB,PRODUCT QUALITY ISSUE,1
GB,PROSTATE CANCER STAGE III,1
GB,PRURITUS,1
GB,PRURITUS GENERALISED,1
GB,PSYCHOTIC DISORDER,1
GB,PULMONARY SARCOIDOSIS,1
GB,PULMONARY SEPSIS,1
GB,PYELONEPHRITIS,1
GB,PYELONEPHRITIS ACUTE,1
GB,RASH,1
GB,RASH MACULAR,1
GB,RASH PRURITIC,1
GB,RED BLOOD CELL COUNT DECREASED,1
GB,RED CELL FRAGMENTATION SYNDROME,1
GB,REFLUX GASTRITIS,1
GB,RELAPSING-REMITTING MULTIPLE SCLEROSIS,1
GB,RENAL CYST,1
GB,RENAL FAILURE,1
GB,RESPIRATORY DISORDER,1
GB,RESPIRATORY DISTRESS,1
GB,RETINAL ANEURYSM,1
GB,RETINAL VEIN OCCLUSION,1
GB,RHABDOMYOLYSIS,1
GB,RHEUMATOID ARTHRITIS,1
GB,RHINORRHOEA,1
GB,ROTATOR CUFF SYNDROME,1
GB,SCAN ABNORMAL,1
GB,SENSORY DISTURBANCE,1
GB,SEPTIC SHOCK,1
GB,SERUM FERRITIN INCREASED,1
GB,SHOULDER OPERATION,1
GB,SKIN BACTERIAL INFECTION,1
GB,SKIN DISCOLOURATION,1
GB,SKIN SENSITISATION,1
GB,SKIN ULCER,1
GB,SOCIAL AVOIDANT BEHAVIOUR,1
GB,SOFT TISSUE NECROSIS,1
GB,SPERM CONCENTRATION DECREASED,1
GB,SPONDYLITIS,1
GB,SPONDYLOLISTHESIS,1
GB,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
GB,STAPHYLOCOCCAL INFECTION,1
GB,STATUS MIGRAINOSUS,1
GB,STEM CELL TRANSPLANT,1
GB,STRESS AT WORK,1
GB,SUFFOCATION FEELING,1
GB,SUICIDE ATTEMPT,1
GB,SUPERFICIAL VEIN PROMINENCE,1
GB,SWELLING FACE,1
GB,SYSTOLIC HYPERTENSION,1
GB,T-LYMPHOCYTE COUNT DECREASED,1
GB,TENDON DISORDER,1
GB,TENDON RUPTURE,1
GB,TENOSYNOVITIS STENOSANS,1
GB,TERMINAL STATE,1
GB,TESTIS CANCER,1
GB,THERAPEUTIC RESPONSE SHORTENED,1
GB,THROAT CANCER,1
GB,THROMBOCYTOPENIC PURPURA,1
GB,THROMBOPHLEBITIS SUPERFICIAL,1
GB,THYROID ADENOMA,1
GB,THYROID MASS,1
GB,THYROIDECTOMY,1
GB,TOE AMPUTATION,1
GB,TONSILLITIS,1
GB,TOOTH ABSCESS,1
GB,TOOTHACHE,1
GB,TRACHEO-OESOPHAGEAL FISTULA,1
GB,TRANSFUSION,1
GB,TRANSIENT ISCHAEMIC ATTACK,1
GB,TRANSPOSITION OF THE GREAT VESSELS,1
GB,TYPE 2 DIABETES MELLITUS,1
GB,UPPER RESPIRATORY TRACT INFECTION,1
GB,URINE ODOUR ABNORMAL,1
GB,UTERINE CANCER,1
GB,VAGINAL DISCHARGE,1
GB,VAGINAL PROLAPSE,1
GB,VASCULAR GRAFT,1
GB,VASCULITIS GASTROINTESTINAL,1
GB,VENTRICULAR TACHYCARDIA,1
GB,VISION BLURRED,1
GB,VISUAL ACUITY REDUCED,1
GB,VITREOUS HAEMORRHAGE,1
GB,VOMITING PROJECTILE,1
GB,VULVOVAGINAL PAIN,1
GB,WEIGHT INCREASED,1
GB,WHITE BLOOD CELL COUNT ABNORMAL,1
GB,WHITE BLOOD CELL DISORDER,1
GB,WHITE BLOOD CELLS URINE POSITIVE,1
GB,WOUND,1
GB,WOUND SECRETION,1
GB,WRIST FRACTURE,1
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
GB,YELLOW SKIN,1
US,INFLUENZA LIKE ILLNESS,5940
US,MULTIPLE SCLEROSIS RELAPSE,5472
US,FATIGUE,5166
US,MEMORY IMPAIRMENT,4620
US,GAIT DISTURBANCE,4348
US,FALL,3907
US,PAIN,3447
US,HEADACHE,3431
US,MULTIPLE SCLEROSIS,2985
US,INJECTION SITE PAIN,2949
US,MALAISE,2769
US,ASTHENIA,2498
US,ANXIETY,2427
US,DRUG INEFFECTIVE,2394
US,HYPOAESTHESIA,2346
US,DRUG DOSE OMISSION,2247
US,BALANCE DISORDER,2175
US,PAIN IN EXTREMITY,2172
US,DEPRESSION,2061
US,MOBILITY DECREASED,1998
US,NAUSEA,1932
US,INJECTION SITE BRUISING,1895
US,FEELING ABNORMAL,1887
US,DEATH,1841
US,MUSCULAR WEAKNESS,1787
US,PYREXIA,1756
US,STRESS,1623
US,DIZZINESS,1616
US,TREMOR,1611
US,GENERAL SYMPTOM,1564
US,URINARY TRACT INFECTION,1563
US,CHILLS,1506
US,INJECTION SITE HAEMORRHAGE,1504
US,COGNITIVE DISORDER,1460
US,INJECTION SITE ERYTHEMA,1447
US,NASOPHARYNGITIS,1384
US,VISUAL IMPAIRMENT,1378
US,MUSCLE SPASMS,1375
US,INFLUENZA,1341
US,DIARRHOEA,1282
US,PARAESTHESIA,1257
US,VOMITING,1243
US,CONFUSIONAL STATE,1233
US,INSOMNIA,1214
US,BACK PAIN,1193
US,CONTUSION,1188
US,CENTRAL NERVOUS SYSTEM LESION,1170
US,ABASIA,1095
US,PNEUMONIA,1087
US,ADVERSE DRUG REACTION,1075
US,ARTHRALGIA,1016
US,MUSCULOSKELETAL DISORDER,939
US,WEIGHT DECREASED,934
US,HYPERTENSION,932
US,FLUSHING,788
US,INJECTION SITE REACTION,780
US,PRURITUS,778
US,DYSPNOEA,771
US,MIGRAINE,765
US,AMNESIA,758
US,MYALGIA,750
US,DRUG INTOLERANCE,741
US,UNDERDOSE,733
US,ADVERSE EVENT,722
US,CEREBROVASCULAR ACCIDENT,696
US,MUSCULOSKELETAL STIFFNESS,686
US,COORDINATION ABNORMAL,681
US,VISION BLURRED,665
US,MYOCARDIAL INFARCTION,657
US,ABDOMINAL PAIN UPPER,651
US,NERVOUSNESS,641
US,SPEECH DISORDER,632
US,HYPERSENSITIVITY,630
US,RASH,623
US,ALOPECIA,580
US,COUGH,569
US,INJURY ASSOCIATED WITH DEVICE,560
US,INJECTION SITE MASS,558
US,ABDOMINAL DISCOMFORT,547
US,ADVERSE REACTION,547
US,OPTIC NEURITIS,547
US,BURNING SENSATION,541
US,DEPRESSED MOOD,539
US,WEIGHT INCREASED,538
US,DIABETES MELLITUS,535
US,ARTHRITIS,530
US,BREAST CANCER,528
US,LOSS OF CONSCIOUSNESS,524
US,CONVULSION,520
US,FEAR,511
US,FEELING HOT,504
US,DEHYDRATION,502
US,HYPERHIDROSIS,495
US,VISUAL ACUITY REDUCED,494
US,SEIZURE,491
US,HAEMORRHAGE,490
US,SOMNOLENCE,486
US,CONSTIPATION,475
US,LOSS OF CONTROL OF LEGS,474
US,URTICARIA,472
US,CHEST PAIN,458
US,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,455
US,GENERAL PHYSICAL HEALTH DETERIORATION,453
US,FRUSTRATION,450
US,MENTAL IMPAIRMENT,446
US,SINUSITIS,445
US,ERYTHEMA,441
US,DYSSTASIA,438
US,DECREASED APPETITE,426
US,FEELING COLD,424
US,APHASIA,410
US,HEPATIC ENZYME INCREASED,410
US,ROAD TRAFFIC ACCIDENT,399
US,VERTIGO,399
US,URINARY INCONTINENCE,398
US,BLINDNESS,393
US,CYSTITIS,382
US,GASTRIC DISORDER,382
US,SUICIDAL IDEATION,379
US,BRONCHITIS,373
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,372
US,INTERVERTEBRAL DISC PROTRUSION,364
US,MUSCLE SPASTICITY,363
US,INFECTION,354
US,PERIPHERAL SWELLING,351
US,WHITE BLOOD CELL COUNT DECREASED,351
US,HERPES ZOSTER,347
US,HOT FLUSH,347
US,PERONEAL NERVE PALSY,345
US,HEMIPARESIS,341
US,TEMPERATURE INTOLERANCE,336
US,INJECTION SITE SWELLING,335
US,BLOOD PRESSURE INCREASED,332
US,NEPHROLITHIASIS,331
US,THROMBOSIS,328
US,ARTHROPATHY,323
US,LOCAL SWELLING,321
US,HEAD INJURY,320
US,GASTROINTESTINAL DISORDER,314
US,CELLULITIS,313
US,DYSPHAGIA,307
US,OROPHARYNGEAL PAIN,305
US,NECK PAIN,301
US,DYSARTHRIA,294
US,DIPLOPIA,293
US,IRRITABILITY,293
US,SEPSIS,292
US,PALPITATIONS,288
US,SURGERY,287
US,THERAPY CESSATION,287
US,DRUG HYPERSENSITIVITY,282
US,FEAR OF INJECTION,279
US,CARDIAC DISORDER,274
US,STAPHYLOCOCCAL INFECTION,274
US,ABDOMINAL PAIN,273
US,MUSCLE TIGHTNESS,273
US,CRYING,270
US,ANAEMIA,268
US,HEART RATE INCREASED,262
US,HYPOTENSION,261
US,BLADDER DISORDER,260
US,INJECTION SITE PRURITUS,260
US,INJECTION SITE INDURATION,255
US,PROCEDURAL ANXIETY,252
US,SENSORY DISTURBANCE,252
US,DRUG EFFECT DECREASED,251
US,ANKLE FRACTURE,250
US,KNEE ARTHROPLASTY,249
US,DYSGRAPHIA,246
US,HEARING IMPAIRED,246
US,HYPERSOMNIA,242
US,BLINDNESS UNILATERAL,240
US,CATARACT,239
US,CONDITION AGGRAVATED,236
US,JOINT SWELLING,236
US,BLOOD GLUCOSE INCREASED,234
US,HIP FRACTURE,234
US,NEOPLASM MALIGNANT,232
US,EMOTIONAL DISTRESS,231
US,GASTROOESOPHAGEAL REFLUX DISEASE,228
US,ANGER,225
US,DYSPEPSIA,224
US,MATERNAL EXPOSURE DURING PREGNANCY,224
US,MUSCULOSKELETAL PAIN,222
US,SCAR,222
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,220
US,CHEST DISCOMFORT,219
US,HYPOACUSIS,219
US,NEURALGIA,217
US,POOR VENOUS ACCESS,217
US,SYNCOPE,217
US,DISTURBANCE IN ATTENTION,214
US,ILL-DEFINED DISORDER,211
US,NEUROPATHY PERIPHERAL,211
US,OSTEOARTHRITIS,210
US,POLLAKIURIA,209
US,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,205
US,LIVER FUNCTION TEST ABNORMAL,204
US,LIVER DISORDER,202
US,RENAL FAILURE,201
US,HALLUCINATION,200
US,UPPER LIMB FRACTURE,198
US,THYROID DISORDER,197
US,INJECTION SITE SCAR,195
US,BLOOD CHOLESTEROL INCREASED,194
US,ABDOMINAL DISTENSION,193
US,ASTHMA,192
US,LOWER LIMB FRACTURE,192
US,RHINORRHOEA,191
US,BACK DISORDER,190
US,EYE DISORDER,190
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,187
US,KIDNEY INFECTION,187
US,DYSKINESIA,186
US,LACERATION,185
US,ABORTION SPONTANEOUS,184
US,MENTAL DISORDER,184
US,PANIC ATTACK,184
US,DECUBITUS ULCER,183
US,MOTOR DYSFUNCTION,183
US,HYSTERECTOMY,182
US,SENSATION OF HEAVINESS,182
US,SWELLING,181
US,INJECTION SITE RASH,180
US,MOOD SWINGS,180
US,UNEVALUABLE EVENT,179
US,DYSPHONIA,176
US,JOINT INJURY,176
US,LETHARGY,176
US,LIMB DISCOMFORT,175
US,MUSCLE ATROPHY,173
US,DRY MOUTH,171
US,DEAFNESS,170
US,LIMB INJURY,170
US,PULMONARY EMBOLISM,170
US,PARALYSIS,166
US,FIBROMYALGIA,165
US,FOOT FRACTURE,165
US,INCONTINENCE,162
US,INJECTION SITE ATROPHY,162
US,ATRIAL FIBRILLATION,161
US,CARDIAC FAILURE CONGESTIVE,161
US,VIRAL INFECTION,161
US,EMOTIONAL DISORDER,160
US,MULTIPLE ALLERGIES,159
US,SLEEP DISORDER,158
US,SKIN DISCOLOURATION,155
US,CHOLELITHIASIS,153
US,MATERNAL EXPOSURE TIMING UNSPECIFIED,153
US,OSTEOPOROSIS,153
US,URINARY RETENTION,153
US,NO ADVERSE EVENT,152
US,HIP ARTHROPLASTY,150
US,TRIGEMINAL NEURALGIA,150
US,DISEASE PROGRESSION,149
US,MUSCLE TWITCHING,149
US,DISCOMFORT,147
US,EYE PAIN,146
US,OEDEMA PERIPHERAL,146
US,DYSURIA,144
US,INJECTION SITE DISCOLOURATION,144
US,BONE PAIN,142
US,RHEUMATOID ARTHRITIS,142
US,CARPAL TUNNEL SYNDROME,141
US,EXPOSURE VIA DIRECT CONTACT,141
US,TYPE 2 DIABETES MELLITUS,141
US,WHITE BLOOD CELL COUNT INCREASED,141
US,CORONARY ARTERY OCCLUSION,140
US,BLOOD POTASSIUM DECREASED,139
US,CAESAREAN SECTION,139
US,OVERDOSE,139
US,POST PROCEDURAL COMPLICATION,138
US,RIB FRACTURE,138
US,UPPER RESPIRATORY TRACT INFECTION,138
US,IMPAIRED HEALING,137
US,DEMENTIA,134
US,DISORIENTATION,132
US,PROCEDURAL PAIN,131
US,CONCUSSION,130
US,LUNG NEOPLASM MALIGNANT,129
US,SPINAL COLUMN STENOSIS,129
US,NERVE INJURY,127
US,INJECTION SITE INFECTION,126
US,TRANSIENT ISCHAEMIC ATTACK,126
US,GASTROENTERITIS VIRAL,124
US,INTERVERTEBRAL DISC DEGENERATION,124
US,LIGAMENT SPRAIN,124
US,VITAMIN D DECREASED,124
US,BLISTER,122
US,DECREASED IMMUNE RESPONSIVENESS,122
US,DEEP VEIN THROMBOSIS,122
US,DIVERTICULITIS,122
US,ROTATOR CUFF SYNDROME,122
US,HYPERAESTHESIA,120
US,NIGHT SWEATS,120
US,SINUS DISORDER,120
US,DEVICE MALFUNCTION,119
US,NASAL CONGESTION,119
US,WOUND,118
US,PROGRESSIVE MULTIPLE SCLEROSIS,117
US,PANCREATITIS,116
US,COMA,115
US,GALLBLADDER DISORDER,115
US,CLOSTRIDIUM DIFFICILE INFECTION,114
US,INJURY,114
US,SLUGGISHNESS,114
US,WRIST FRACTURE,114
US,AGRAPHIA,113
US,BLOOD PRESSURE DECREASED,113
US,FRUSTRATION TOLERANCE DECREASED,113
US,SWELLING FACE,113
US,TREATMENT FAILURE,113
US,HYPOTHYROIDISM,112
US,INCORRECT DOSE ADMINISTERED,112
US,PLATELET COUNT DECREASED,112
US,PRESCRIBED UNDERDOSE,112
US,UTERINE LEIOMYOMA,110
US,FAECAL INCONTINENCE,109
US,POOR QUALITY SLEEP,109
US,RENAL DISORDER,109
US,RESTLESS LEGS SYNDROME,109
US,SYSTEMIC LUPUS ERYTHEMATOSUS,108
US,TINNITUS,108
US,HYPOTONIA,107
US,INJECTION SITE WARMTH,107
US,VEIN DISORDER,107
US,DYSGEUSIA,106
US,FEELING OF BODY TEMPERATURE CHANGE,106
US,PHOBIA,106
US,BACK INJURY,105
US,FLATULENCE,103
US,INJECTION SITE URTICARIA,103
US,LOCALISED INFECTION,103
US,FEMUR FRACTURE,102
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,102
US,HERNIA,100
US,PANIC REACTION,99
US,PERIPHERAL COLDNESS,99
US,SCIATICA,99
US,GAIT INABILITY,98
US,MICTURITION URGENCY,98
US,SKIN CANCER,98
US,THERAPEUTIC RESPONSE UNEXPECTED,98
US,HEART RATE DECREASED,97
US,SPINAL FRACTURE,97
US,BAND SENSATION,96
US,BIPOLAR DISORDER,96
US,HAEMOGLOBIN DECREASED,96
US,APHAGIA,95
US,CHOLECYSTECTOMY,95
US,INCREASED TENDENCY TO BRUISE,95
US,NERVOUS SYSTEM DISORDER,95
US,SKIN LESION,95
US,BODY TEMPERATURE INCREASED,94
US,AGITATION,93
US,DRY SKIN,93
US,FUNGAL INFECTION,93
US,PULMONARY THROMBOSIS,93
US,SUICIDE ATTEMPT,93
US,EPILEPSY,91
US,JOINT STIFFNESS,90
US,SKIN DISORDER,90
US,CARDIAC ARREST,89
US,INJECTION SITE NODULE,89
US,LYMPHADENOPATHY,89
US,DRUG SPECIFIC ANTIBODY PRESENT,88
US,INTENTIONAL PRODUCT MISUSE,88
US,CORONARY ARTERY DISEASE,87
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,87
US,SLEEP APNOEA SYNDROME,87
US,SPINAL PAIN,87
US,DRUG EFFECT INCOMPLETE,86
US,NEEDLE ISSUE,86
US,PSORIASIS,86
US,RASH PRURITIC,86
US,RENAL IMPAIRMENT,86
US,DECREASED INTEREST,85
US,HYPOKINESIA,85
US,IMMUNE SYSTEM DISORDER,85
US,MALIGNANT MELANOMA,85
US,NERVE COMPRESSION,85
US,PRURITUS GENERALISED,85
US,SPINAL OPERATION,85
US,EPISTAXIS,83
US,MOOD ALTERED,83
US,RASH PAPULAR,83
US,RESPIRATORY DISORDER,83
US,SPINAL DISORDER,83
US,EAR INFECTION,82
US,HYPOPHAGIA,82
US,MENISCUS INJURY,82
US,BLOOD COUNT ABNORMAL,81
US,APATHY,80
US,BLOOD PRESSURE ABNORMAL,80
US,FOETAL EXPOSURE DURING PREGNANCY,80
US,LOWER EXTREMITY MASS,80
US,INJECTION SITE CELLULITIS,79
US,IRRITABLE BOWEL SYNDROME,79
US,SNEEZING,79
US,DYSPHEMIA,78
US,MASS,78
US,PROSTATE CANCER,78
US,SKIN ULCER,78
US,INJECTION SITE EXTRAVASATION,77
US,KNEE OPERATION,77
US,LABORATORY TEST ABNORMAL,77
US,SKIN REACTION,77
US,BLOOD URINE PRESENT,76
US,JOINT DISLOCATION,76
US,CROHN^S DISEASE,75
US,GENERALISED TONIC-CLONIC SEIZURE,75
US,GLAUCOMA,75
US,MUSCLE DISORDER,75
US,PNEUMONIA ASPIRATION,75
US,WALKING AID USER,75
US,HANGOVER,74
US,OVARIAN CYST,74
US,TOOTH DISORDER,74
US,ATAXIA,73
US,INFLAMMATION,73
US,SKIN BURNING SENSATION,73
US,COLD SWEAT,72
US,COLITIS,72
US,HAEMATOMA,72
US,BLOOD GLUCOSE DECREASED,70
US,EYE SWELLING,70
US,INTERVERTEBRAL DISC DISORDER,70
US,NEEDLE FATIGUE,70
US,OSTEONECROSIS,70
US,RASH MACULAR,70
US,THINKING ABNORMAL,70
US,THROAT IRRITATION,70
US,VITAMIN D DEFICIENCY,70
US,ABNORMAL BEHAVIOUR,69
US,INTESTINAL OBSTRUCTION,69
US,BLOOD TEST ABNORMAL,68
US,INTRACRANIAL ANEURYSM,68
US,THYROID CANCER,68
US,TOOTHACHE,68
US,APHONIA,67
US,COLON CANCER,67
US,CYST,67
US,EAR PAIN,67
US,INJECTION SITE DISCOMFORT,67
US,MENORRHAGIA,67
US,MIDDLE INSOMNIA,67
US,PHARYNGITIS STREPTOCOCCAL,67
US,ARTHROPOD BITE,66
US,EXOSTOSIS,66
US,VIITH NERVE PARALYSIS,66
US,ACCIDENT,65
US,ACTIVITIES OF DAILY LIVING IMPAIRED,65
US,ALANINE AMINOTRANSFERASE INCREASED,65
US,BLINDNESS TRANSIENT,65
US,BLOOD IRON DECREASED,65
US,GRAND MAL CONVULSION,65
US,LARYNGITIS,65
US,PAIN OF SKIN,65
US,RED BLOOD CELL COUNT DECREASED,65
US,SCOLIOSIS,65
US,UROSEPSIS,65
US,ACNE,64
US,BEDRIDDEN,64
US,BRAIN NEOPLASM,64
US,EYE MOVEMENT DISORDER,64
US,HEMIPLEGIA,64
US,JC VIRUS TEST POSITIVE,64
US,OSTEOMYELITIS,64
US,RESTLESSNESS,64
US,DEVICE RELATED INFECTION,63
US,SEASONAL ALLERGY,63
US,TOOTH INFECTION,63
US,HEPATIC STEATOSIS,62
US,LUNG DISORDER,62
US,POST PROCEDURAL INFECTION,62
US,VARICOSE VEIN,62
US,ASPARTATE AMINOTRANSFERASE INCREASED,61
US,CARDIAC FAILURE,61
US,FLUID RETENTION,61
US,HEART RATE IRREGULAR,61
US,HEPATIC FAILURE,61
US,INJECTION SITE IRRITATION,61
US,NEUROGENIC BLADDER,61
US,RASH GENERALISED,61
US,SPINAL FUSION SURGERY,61
US,BONE DISORDER,60
US,IMPAIRED SELF-CARE,60
US,MUSCLE STRAIN,60
US,RESPIRATORY ARREST,60
US,RESPIRATORY FAILURE,60
US,SKIN EXFOLIATION,60
US,CHOKING,59
US,FACIAL PAIN,59
US,GASTRIC ULCER,59
US,LIGAMENT RUPTURE,59
US,RASH ERYTHEMATOUS,59
US,VENOUS INJURY,59
US,AGGRESSION,58
US,GASTRIC BYPASS,58
US,HYPERTHYROIDISM,58
US,PARANOIA,58
US,RESPIRATORY TRACT INFECTION,58
US,STOMATITIS,58
US,ULCER,58
US,LOWER RESPIRATORY TRACT INFECTION,57
US,MOVEMENT DISORDER,57
US,NIGHTMARE,57
US,NORMAL NEWBORN,57
US,THERMAL BURN,57
US,TOOTH FRACTURE,57
US,WHEELCHAIR USER,57
US,APPENDICITIS,56
US,FEELING JITTERY,56
US,HEPATIC ENZYME ABNORMAL,56
US,ANGINA PECTORIS,55
US,CENTRAL VENOUS CATHETERISATION,55
US,CEREBRAL HAEMORRHAGE,55
US,CHROMATURIA,55
US,DISABILITY,55
US,THYROID FUNCTION TEST ABNORMAL,55
US,MUSCULOSKELETAL DISCOMFORT,54
US,SENSORY LOSS,54
US,BASAL CELL CARCINOMA,53
US,BLADDER CANCER,53
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,53
US,DRY EYE,53
US,GALLBLADDER OPERATION,53
US,LUNG INFECTION,53
US,ARRHYTHMIA,52
US,EATING DISORDER,52
US,LYMPHOEDEMA,52
US,MENTAL STATUS CHANGES,52
US,OVERWEIGHT,52
US,PROCEDURAL COMPLICATION,52
US,RENAL FAILURE ACUTE,52
US,RETINAL DETACHMENT,52
US,ENDOMETRIOSIS,51
US,FACIAL BONES FRACTURE,51
US,LIP SWELLING,51
US,PHOTOSENSITIVITY REACTION,51
US,TACHYCARDIA,51
US,THROAT TIGHTNESS,51
US,ACUTE KIDNEY INJURY,50
US,ANAPHYLACTIC SHOCK,50
US,CLUMSINESS,50
US,HEAD DISCOMFORT,50
US,INCOHERENT,50
US,INJECTION SITE ABSCESS,50
US,PRODUCTIVE COUGH,50
US,ANTI-INTERFERON ANTIBODY POSITIVE,49
US,ARTERIAL OCCLUSIVE DISEASE,49
US,FACE INJURY,49
US,FEEDING DISORDER,49
US,HIATUS HERNIA,49
US,INJECTION SITE INJURY,49
US,PALLOR,49
US,SKIN MASS,49
US,TENSION,49
US,TOOTH ABSCESS,49
US,CARDIAC OPERATION,48
US,HAND FRACTURE,48
US,HYPOAESTHESIA ORAL,48
US,INFUSION RELATED REACTION,48
US,ABNORMAL DREAMS,47
US,DENTAL CARIES,47
US,DEVICE DIFFICULT TO USE,47
US,INVASIVE DUCTAL BREAST CARCINOMA,47
US,LYMPHOCYTE COUNT DECREASED,47
US,OBESITY,47
US,PHARYNGEAL OEDEMA,47
US,PULMONARY OEDEMA,47
US,READING DISORDER,47
US,UHTHOFF^S PHENOMENON,47
US,UNRESPONSIVE TO STIMULI,47
US,WHEEZING,47
US,ANAPHYLACTIC REACTION,46
US,BACTERIAL INFECTION,46
US,BLOOD TRIGLYCERIDES INCREASED,46
US,IMPAIRED DRIVING ABILITY,46
US,LOW BIRTH WEIGHT BABY,46
US,LUMBAR SPINAL STENOSIS,46
US,OVARIAN CANCER,46
US,POST PROCEDURAL HAEMORRHAGE,46
US,TENDONITIS,46
US,APPENDICECTOMY,45
US,BLOOD SODIUM DECREASED,45
US,DEAFNESS UNILATERAL,45
US,DERMATITIS CONTACT,45
US,FEELING OF DESPAIR,45
US,HAEMATOCHEZIA,45
US,RETCHING,45
US,THIRST,45
US,URINARY TRACT DISORDER,45
US,ASPIRATION,44
US,LIVER FUNCTION TEST INCREASED,44
US,MUSCULOSKELETAL CHEST PAIN,44
US,PHOTOPHOBIA,44
US,PSYCHOMOTOR HYPERACTIVITY,44
US,TOOTH EXTRACTION,44
US,BREAST CANCER STAGE I,43
US,COLITIS ULCERATIVE,43
US,GASTRITIS,43
US,INTRADUCTAL PROLIFERATIVE BREAST LESION,43
US,LARGE INTESTINE POLYP,43
US,MUSCLE FATIGUE,43
US,PNEUMOTHORAX,43
US,PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS,43
US,PULMONARY MASS,43
US,SPONDYLITIS,43
US,UNDERWEIGHT,43
US,GASTROINTESTINAL HAEMORRHAGE,42
US,HEMIANAESTHESIA,42
US,INJECTION SITE NECROSIS,42
US,LIVER INJURY,42
US,LYMPHOMA,42
US,PELVIC FRACTURE,42
US,SEPTIC SHOCK,42
US,SKIN INFECTION,42
US,SPINAL OSTEOARTHRITIS,42
US,UTERINE CANCER,42
US,VISUAL FIELD DEFECT,42
US,WOUND INFECTION,42
US,ARTHRITIS INFECTIVE,41
US,CARDIOMEGALY,41
US,INJECTION SITE ULCER,41
US,MENSTRUATION IRREGULAR,41
US,ORAL HERPES,41
US,PRESYNCOPE,41
US,SKIN IRRITATION,41
US,ATROPHY,40
US,BURSITIS,40
US,CARDIOMYOPATHY,40
US,EXPOSURE VIA SKIN CONTACT,40
US,HAEMATOCRIT DECREASED,40
US,HAEMORRHOIDS,40
US,INJECTION SITE SCAB,40
US,SKIN ATROPHY,40
US,SWOLLEN TONGUE,40
US,TIBIA FRACTURE,40
US,TREATMENT NONCOMPLIANCE,40
US,VAGINAL HAEMORRHAGE,40
US,DRUG WITHDRAWAL SYNDROME,39
US,INTENTIONAL PRODUCT USE ISSUE,39
US,LYME DISEASE,39
US,MENOPAUSE,39
US,MONOPLEGIA,39
US,OCULAR HYPERAEMIA,39
US,PAIN IN JAW,39
US,POST-TRAUMATIC STRESS DISORDER,39
US,PUNCTURE SITE HAEMORRHAGE,39
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,39
US,BRADYPHRENIA,38
US,CANDIDA INFECTION,38
US,CORONARY ARTERIAL STENT INSERTION,38
US,ECZEMA,38
US,FINE MOTOR SKILL DYSFUNCTION,38
US,IMPAIRED WORK ABILITY,38
US,INJECTION SITE VESICLES,38
US,THYROID NEOPLASM,38
US,ACCIDENTAL OVERDOSE,37
US,ACUTE MYOCARDIAL INFARCTION,37
US,BLOOD PRESSURE FLUCTUATION,37
US,CARDIAC FLUTTER,37
US,CARDIAC VALVE DISEASE,37
US,CEREBRAL ATROPHY,37
US,DELIRIUM,37
US,INITIAL INSOMNIA,37
US,VITREOUS FLOATERS,37
US,AFFECT LABILITY,36
US,BLADDER DYSFUNCTION,36
US,CORONARY ARTERY BYPASS,36
US,DRUG DELIVERY DEVICE IMPLANTATION,36
US,FUNCTIONAL GASTROINTESTINAL DISORDER,36
US,INTENTIONAL UNDERDOSE,36
US,OEDEMA,36
US,OSTEOPENIA,36
US,REACTION TO PRESERVATIVES,36
US,RECTAL HAEMORRHAGE,36
US,WHITE BLOOD CELL COUNT ABNORMAL,36
US,AORTIC ANEURYSM,35
US,CARDIAC PACEMAKER INSERTION,35
US,DEPRESSED LEVEL OF CONSCIOUSNESS,35
US,HEPATITIS C,35
US,IMPAIRED GASTRIC EMPTYING,35
US,MAJOR DEPRESSION,35
US,PRODUCT USE ISSUE,35
US,PSYCHOTIC DISORDER,35
US,RUBBER SENSITIVITY,35
US,SCRATCH,35
US,SINUS CONGESTION,35
US,SKIN INDURATION,35
US,AGEUSIA,34
US,BRAIN INJURY,34
US,CERVIX CARCINOMA,34
US,EYE IRRITATION,34
US,HYPERTONIC BLADDER,34
US,INDURATION,34
US,INJECTION SITE HYPOAESTHESIA,34
US,INJECTION SITE INFLAMMATION,34
US,MENSTRUAL DISORDER,34
US,NERVE ROOT COMPRESSION,34
US,OXYGEN SATURATION DECREASED,34
US,TOOTH LOSS,34
US,URINE ODOUR ABNORMAL,34
US,ABDOMINAL HERNIA,33
US,AUTOIMMUNE THYROIDITIS,33
US,CARTILAGE INJURY,33
US,CLAVICLE FRACTURE,33
US,DERMATITIS ALLERGIC,33
US,FEELING DRUNK,33
US,FOOT DEFORMITY,33
US,HEPATIC FUNCTION ABNORMAL,33
US,HIP SURGERY,33
US,MENINGIOMA,33
US,NEOPLASM,33
US,PREMATURE BABY,33
US,ABSCESS,32
US,APPENDICITIS PERFORATED,32
US,BREAST CANCER FEMALE,32
US,CERVICAL SPINAL STENOSIS,32
US,DECREASED ACTIVITY,32
US,EAR DISCOMFORT,32
US,FAECES DISCOLOURED,32
US,GOITRE,32
US,INTESTINAL PERFORATION,32
US,LACK OF INJECTION SITE ROTATION,32
US,MACULAR DEGENERATION,32
US,NECK SURGERY,32
US,OPTIC NERVE DISORDER,32
US,PULMONARY HYPERTENSION,32
US,RAYNAUD^S PHENOMENON,32
US,RENAL CANCER,32
US,SARCOIDOSIS,32
US,UTERINE DISORDER,32
US,APPARENT DEATH,31
US,BRADYCARDIA,31
US,BRAIN OEDEMA,31
US,DRUG DISPENSING ERROR,31
US,ESCHERICHIA INFECTION,31
US,FIBULA FRACTURE,31
US,FORMICATION,31
US,GOUT,31
US,HAEMATEMESIS,31
US,HYPERLIPIDAEMIA,31
US,JOINT LOCK,31
US,LEUKAEMIA,31
US,LIMB OPERATION,31
US,PRE-ECLAMPSIA,31
US,RESPIRATORY TRACT CONGESTION,31
US,SHOULDER OPERATION,31
US,SKIN WARM,31
US,TYPE 1 DIABETES MELLITUS,31
US,VITAMIN B12 DECREASED,31
US,ABNORMAL LOSS OF WEIGHT,30
US,ANEURYSM,30
US,ANTIBODY TEST POSITIVE,30
US,BLEPHAROSPASM,30
US,CEREBRAL DISORDER,30
US,CHONDROPATHY,30
US,COELIAC DISEASE,30
US,DRUG-INDUCED LIVER INJURY,30
US,EXTRA DOSE ADMINISTERED,30
US,FURUNCLE,30
US,GLUCOSE TOLERANCE IMPAIRED,30
US,HEART VALVE INCOMPETENCE,30
US,PANCREATIC CARCINOMA,30
US,PARAPLEGIA,30
US,PHOTOPSIA,30
US,PLASMA CELL MYELOMA,30
US,POSTOPERATIVE WOUND INFECTION,30
US,ANIMAL BITE,29
US,ATYPICAL PNEUMONIA,29
US,BASEDOW^S DISEASE,29
US,BREAST CANCER STAGE II,29
US,CATARACT OPERATION,29
US,DEPRESSION SUICIDAL,29
US,ECTOPIC PREGNANCY,29
US,HICCUPS,29
US,IMMUNODEFICIENCY,29
US,JAUNDICE,29
US,ORAL PAIN,29
US,PULMONARY FIBROSIS,29
US,SPINAL COMPRESSION FRACTURE,29
US,WEIGHT BEARING DIFFICULTY,29
US,ASTHENOPIA,28
US,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,28
US,DELUSION,28
US,ESCHERICHIA URINARY TRACT INFECTION,28
US,FEAR OF NEEDLES,28
US,FOOT OPERATION,28
US,GLOSSODYNIA,28
US,HEPATIC CIRRHOSIS,28
US,HEPATOMEGALY,28
US,MUSCLE RUPTURE,28
US,NECK INJURY,28
US,NEUTRALISING ANTIBODIES POSITIVE,28
US,POOR PERIPHERAL CIRCULATION,28
US,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,28
US,RENAL PAIN,28
US,ULCER HAEMORRHAGE,28
US,AMENORRHOEA,27
US,ANAL INCONTINENCE,27
US,COMMUNICATION DISORDER,27
US,CONJUNCTIVITIS,27
US,DEMENTIA ALZHEIMER^S TYPE,27
US,DEVICE FAILURE,27
US,DEVICE ISSUE,27
US,ENCEPHALOPATHY,27
US,EXCORIATION,27
US,EYE HAEMORRHAGE,27
US,INCISION SITE INFECTION,27
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,27
US,PARKINSON^S DISEASE,27
US,PERICARDIAL EFFUSION,27
US,POSTURE ABNORMAL,27
US,PRESCRIBED OVERDOSE,27
US,STRABISMUS,27
US,TENDON RUPTURE,27
US,VASCULAR INJURY,27
US,WOUND INFECTION STAPHYLOCOCCAL,27
US,ABDOMINAL PAIN LOWER,26
US,BLOOD CREATININE INCREASED,26
US,BREAST CANCER RECURRENT,26
US,BREAST MASS,26
US,CALCULUS BLADDER,26
US,CATHETER PLACEMENT,26
US,CERVICAL VERTEBRAL FRACTURE,26
US,EXPOSURE VIA FATHER,26
US,FOOD ALLERGY,26
US,FOOD POISONING,26
US,FRACTURE,26
US,HYPOGLYCAEMIA,26
US,INCORRECT PRODUCT STORAGE,26
US,INFECTED SKIN ULCER,26
US,INTENTIONAL OVERDOSE,26
US,LACRIMATION INCREASED,26
US,MUSCLE CONTRACTIONS INVOLUNTARY,26
US,MUSCLE RIGIDITY,26
US,PERIORBITAL CONTUSION,26
US,PROLONGED LABOUR,26
US,QUALITY OF LIFE DECREASED,26
US,RELAPSING-REMITTING MULTIPLE SCLEROSIS,26
US,RETINAL TEAR,26
US,SKIN ABRASION,26
US,BLOOD GLUCOSE ABNORMAL,25
US,BREECH PRESENTATION,25
US,CHOLECYSTITIS,25
US,CHRONIC KIDNEY DISEASE,25
US,EMPHYSEMA,25
US,EYE PRURITUS,25
US,GANGRENE,25
US,GROIN PAIN,25
US,HYPOKALAEMIA,25
US,JOINT RANGE OF MOTION DECREASED,25
US,MYELITIS TRANSVERSE,25
US,OESOPHAGEAL DISORDER,25
US,PATIENT DISSATISFACTION WITH TREATMENT,25
US,SLOW SPEECH,25
US,SUICIDAL BEHAVIOUR,25
US,SYNOVIAL CYST,25
US,THYROID MASS,25
US,ACCIDENTAL UNDERDOSE,24
US,AUTOIMMUNE DISORDER,24
US,CARDIOVASCULAR DISORDER,24
US,CLOSTRIDIUM DIFFICILE COLITIS,24
US,COLONOSCOPY,24
US,COMPLETED SUICIDE,24
US,DEMYELINATION,24
US,DIZZINESS POSTURAL,24
US,ELECTROCARDIOGRAM ABNORMAL,24
US,ENERGY INCREASED,24
US,ERECTILE DYSFUNCTION,24
US,GASTRIC ULCER HAEMORRHAGE,24
US,GESTATIONAL DIABETES,24
US,HAEMORRHAGIC STROKE,24
US,HALLUCINATION_ AUDITORY,24
US,HALLUCINATION_ VISUAL,24
US,INFUSION SITE PAIN,24
US,LIMB MASS,24
US,PHARYNGITIS,24
US,ROTATOR CUFF REPAIR,24
US,SINUS HEADACHE,24
US,SJOGREN^S SYNDROME,24
US,SUPRAVENTRICULAR TACHYCARDIA,24
US,TENDERNESS,24
US,TOXICITY TO VARIOUS AGENTS,24
US,UPPER EXTREMITY MASS,24
US,VOLVULUS,24
US,ACCIDENTAL EXPOSURE TO PRODUCT,23
US,BLOOD DISORDER,23
US,CAROTID ARTERY OCCLUSION,23
US,COAGULOPATHY,23
US,DEVICE BREAKAGE,23
US,FLANK PAIN,23
US,HOMICIDAL IDEATION,23
US,INFUSION SITE BRUISING,23
US,INJECTION SITE LACERATION,23
US,MEDICAL DEVICE COMPLICATION,23
US,PARAESTHESIA ORAL,23
US,POLYMENORRHOEA,23
US,PREGNANCY,23
US,RENAL FUNCTION TEST ABNORMAL,23
US,SMALL INTESTINAL OBSTRUCTION,23
US,THYROIDECTOMY,23
US,VAGINAL INFECTION,23
US,WOUND DEHISCENCE,23
US,ABSCESS LIMB,22
US,ANAESTHETIC COMPLICATION,22
US,DIPLEGIA,22
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,22
US,EXTRASYSTOLES,22
US,EYE INFECTION,22
US,EYELID PTOSIS,22
US,HAIR TEXTURE ABNORMAL,22
US,HYPERKERATOSIS,22
US,INJECTION RELATED REACTION,22
US,INJECTION SITE DRYNESS,22
US,MANIA,22
US,MEDICATION ERROR,22
US,MUSCLE INJURY,22
US,NEUROLOGICAL SYMPTOM,22
US,NOCTURIA,22
US,PERSONALITY CHANGE,22
US,PLEURAL EFFUSION,22
US,RENAL FAILURE CHRONIC,22
US,UPPER-AIRWAY COUGH SYNDROME,22
US,WEIGHT FLUCTUATION,22
US,BODY TEMPERATURE DECREASED,21
US,BRADYKINESIA,21
US,BRAIN NEOPLASM BENIGN,21
US,BREAST PAIN,21
US,CHRONIC LYMPHOCYTIC LEUKAEMIA,21
US,DEVICE DISLOCATION,21
US,ERUCTATION,21
US,FLUID INTAKE REDUCED,21
US,HEART RATE ABNORMAL,21
US,HUNGER,21
US,LAZINESS,21
US,LEUKOPENIA,21
US,MITRAL VALVE PROLAPSE,21
US,NEUROMYELITIS OPTICA,21
US,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,21
US,PARANASAL SINUS HYPERSECRETION,21
US,PERIPHERAL VASCULAR DISORDER,21
US,PERSONALITY DISORDER,21
US,POLYARTHRITIS,21
US,SCAB,21
US,SPINAL CORD COMPRESSION,21
US,STENT PLACEMENT,21
US,TUBERCULOSIS,21
US,UVEITIS,21
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,21
US,ANHEDONIA,20
US,BLADDER PROLAPSE,20
US,BLOOD POTASSIUM INCREASED,20
US,BRAIN NEOPLASM MALIGNANT,20
US,BREAST CANCER STAGE III,20
US,BURNOUT SYNDROME,20
US,CEREBRAL THROMBOSIS,20
US,CHOLECYSTITIS INFECTIVE,20
US,COMPLEX PARTIAL SEIZURES,20
US,ENDOMETRIAL CANCER,20
US,GASTROINTESTINAL PAIN,20
US,GRIP STRENGTH DECREASED,20
US,HERPES VIRUS INFECTION,20
US,HYPERACUSIS,20
US,HYPERGLYCAEMIA,20
US,INJECTION SITE HYPERTROPHY,20
US,INTERVERTEBRAL DISC OPERATION,20
US,MACULAR OEDEMA,20
US,MALNUTRITION,20
US,NODULE,20
US,ORAL MUCOSAL BLISTERING,20
US,PANCREATIC DISORDER,20
US,RENAL CYST,20
US,SPIDER VEIN,20
US,SPONDYLOLISTHESIS,20
US,TEARFULNESS,20
US,TRANSFUSION,20
US,ABNORMAL SENSATION IN EYE,19
US,BENIGN NEOPLASM,19
US,BLADDER SPASM,19
US,BONE CONTUSION,19
US,CARDIO-RESPIRATORY ARREST,19
US,CEREBRAL INFARCTION,19
US,COLOSTOMY,19
US,CRANIOCEREBRAL INJURY,19
US,GASTROINTESTINAL INFECTION,19
US,HEPATITIS,19
US,IMPATIENCE,19
US,INJECTION SITE HAEMATOMA,19
US,INTERVERTEBRAL DISC COMPRESSION,19
US,MENSTRUATION DELAYED,19
US,NARCOLEPSY,19
US,NYSTAGMUS,19
US,OESOPHAGEAL STENOSIS,19
US,ORTHOSTATIC HYPOTENSION,19
US,PSYCHIATRIC SYMPTOM,19
UY,MEMORY IMPAIRMENT,2
UY,GAIT DISTURBANCE,1
VE,CAESAREAN SECTION,2
VE,MATERNAL EXPOSURE DURING PREGNANCY,2
VE,MUSCULAR WEAKNESS,2
VE,ESCHAR,1
VE,FALL,1
VE,FATIGUE,1
VE,INFLUENZA LIKE ILLNESS,1
VE,MEMORY IMPAIRMENT,1
VE,MUSCULOSKELETAL STIFFNESS,1
VE,OPTIC NEURITIS,1
VE,PARAESTHESIA,1
VE,PATELLA FRACTURE,1
VE,PROCEDURAL HAEMORRHAGE,1
VE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
VE,SEPSIS,1
VE,THERAPY CESSATION,1
VE,UNDERDOSE,1
VE,UTERINE LEIOMYOMA,1
VE,WOUND INFECTION,1
VI,ABORTION SPONTANEOUS,1
VI,MATERNAL EXPOSURE DURING PREGNANCY,1
YE,ARTHRITIS,1
